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<Abstract> 24 
Cell signaling pathways, such as Wnt, Hedgehog (Hh), Notch, and Hippo, are essential for 25 
embryogenesis, organogenesis, and tissue homeostasis.  In this study, we analyzed 415 genes 26 
involved in these pathways in the allotetraploid frog, Xenopus laevis.  Most genes are 27 
retained in two subgenomes called L and S (193 homeologous gene pairs and 29 singletons). 28 
This conservation rate of homeologs is much higher than that of all genes in the X. laevis 29 
genome (86.9% vs 60.2%).  Among singletons, 24 genes are retained in the L subgenome, a 30 
rate similar to the average for all genes (82.8% vs 74.6%).  In addition, as general 31 
components of signal transduction, we also analyzed 32 heparan sulfate proteoglycan 32 
(HSPG)-related genes and eight TLE/Groucho transcriptional corepressors-related genes. In 33 
these gene sets, all homeologous pairs have been retained.  Transcriptome analysis using 34 
RNA-seq data from developmental stages and adult tissues demonstrated that most 35 
homeologous pairs of signaling components have variable expression patterns, in contrast to 36 
the conservative expression profiles of homeologs for transcription factors.  Our results 37 
indicate that homeologous gene pairs for cell signaling regulation have tended to become 38 
subfunctionalized after allotetraploidization. Diversification of signaling pathways by 39 
subfunctionalization of homeologs may enhance environmental adaptability.  These results 40 
provide insights into the evolution of signaling pathways after polyploidization. 41 
42 
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Whole genome duplication (WGD) caused by polyploidization is considered to have been a 49 
major driver of organismal evolution by providing new functions and networks of genes 50 
(Holland et al., 1994; Ohno, 1970; Van de Peer et al., 2009). WGD, however, could also cause 51 
gene-dosage defects. Furthermore, in the case of allopolyploidization, it could also lead to 52 
protein-protein incompatibilities. How gene expression levels and patterns are modulated 53 
since genome duplication remains to be elucidated. 54 
 The African clawed frog, Xenopus laevis, is widely used as a model organism for 55 
embryology and cellular physiology. Xenopus laevis is an allotetraploid frog that arose from 56 
interspecific hybridization of diploid progenitors only 17-18 million years ago (Session et al., 57 
2016). By comparing its genome with that of a closely related diploid frog, X. tropicalis, X. 58 
laevis can be a good model system for evolutionary studies regarding genome duplication. In 59 
X. laevis, two subgenomes, L (long) and S (short), were identified as sets of homeologous 60 
chromosomes with different lengths and distributions of inactivated transposon sequences 61 
(“fossil” transposons) (Matsuda et al., 2015; Session et al., 2016). Orthologous genomic 62 
positions between subgenomes are termed “homeologous” and homeologous genes are known 63 
as “homeologs.”  64 
Previous whole genome analyses suggested that the L subgenome has higher gene 65 
retention rates and gene expression levels (Session et al., 2016). In addition, it was shown that 66 
genes involved in DNA repair, RNA polymerase pathways, and other metabolic pathways 67 
have tended to lose the one homeolog, whereas homeolog pairs for DNA-binding proteins and 68 
major developmental signaling pathways are retained at higher rates (Session et al., 2016). 69 
Similarly, a large scale transcriptomic data analysis suggested that genes for DNA-binding 70 
proteins manifest conservative expression profiles between homeologs, whereas some 71 
metabolic pathway genes exhibit variable expression profiles (Session et al., 2016). However, 72 
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it was unclear whether some genes of developmental signaling pathways have specific 73 
expression profiles. Because automated annotation analyses are superficial, more detailed 74 
analyses need to be performed. Particularly, subcellular localization varies among components 75 
of cell signaling pathways and may influence expression profile variation. 76 
 In this study, we examined Wnt, Hedgehog (Hh), Notch, and Hippo signaling 77 
components. These signaling pathways have essential roles in development and disease. 78 
Although some components of Wnt, Hh, and Hippo signaling pathways in the X. laevis 79 
genome have been analyzed (Session et al., 2016), we analyzed many additional gene pairs 80 
involved in those pathways (Wnt, 108 vs 48; Hh, 18 vs 13 Hippo, 48 vs 15). In addition, we 81 
also analyzed Notch signaling components and some factors involved in signal transduction 82 
in general, heparan sulfate proteoglycans (HSPG), and TLE/Groucho transcriptional 83 
corepressors. HSPG and TLE are also important for modulating cell signaling levels in the 84 
extracellular space and in nuclei. Other major signaling pathways (TGFβ and FGF) have been 85 
analyzed by other groups (Suzuki et al. in press-1; Suzuki et al., in press-2). Utilizing the 86 
genomic sequences and transcriptomes of X. laevis, we examined retention rates and 87 
expression profiles of genes involved in cell signaling pathways between homeologs. Our 88 
results describe notable cases of subfunctionalization of genes related to cell signaling 89 
pathways just after genome duplication. 90 
 91 
<Materials and Methods> 92 
Gene identification and syntenic analysis 93 
All analyzed genes were identified with X. laevis genome assembly v9.1 and gene models 94 
v1.8. For unannotated genes, we performed BLAST or BLAT searches, using sequences in the 95 
NCBI X. laevis cDNA/EST database and gene models from X. tropicalis genome assembly 96 
v9. We manually corrected gene models with gaps (Ns) and incorrect splicing, based on 97 
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RefSeq and sequence homology. The FASTA file of primary transcript sequences used in this 98 
study is available in the Supplementary Data of Watanabe et al. (in press). Syntenic analysis 99 
was also performed with genome assemblies of X. laevis (v9.1) and X. tropicalis (v9), 100 
Nanorana parkeri, v2 (Tibetan frog), Homo sapiens, hg38 (human), Gallus gallus, Galgal4 101 
(chicken), Lepisosteus oculatus, LepOcu1 (spotted gar), Danio rerio, GRCz10 (zebrafish), 102 
and Oryzias latipes, HdrR (medaka). The Xenopus database, Xenbase (Karpinka et al., 2015), 103 
was used for gene identification and expression analyses.  104 
 105 
RNA-seq data analysis 106 
RNA-seq data of oocyte stages, embryonic stages, and adult tissues of Xenopus laevis J-strain 107 
(Session et al., 2016) were used for transcriptomic analyses (accession numbers in NCBI Gene 108 
Expression Omnibus: GSE73430 for oocytes and embryos, GSE73419 for adult organs). 109 
Expression levels were quantified as TPM (transcripts per million) as described in Session et 110 
al. (2016). Briefly, RNA-seq reads were mapped to primary transcript sequences using bwa-111 
mem, and transcripts per million (TPM) were calculated using RSEM.  To reveal differences 112 
in the expression of homeologous genes, before running RSEM we removed read hits with 113 
either (1) additional targets, or (2) partial alignments to genome segments containing 114 
insertions or deletions. RNA-seq data contained two biologically independent replicates 115 
(named “Taira201203” and “Ueno201210”) for embryos and adult tissues, but only 116 
“Ueno201210” for oocytes.  For stage 35, we used “Ueno201302” because “Ueno201210” 117 
has a much smaller number of reads (data of “Ueno201210” and “Ueno201302” are from 118 
siblings). These clutches will be called Clutch T for Taira’s data and Clutch U for Ueno’s data, 119 
respectively. To make comparisons with expression profiles in X. tropicalis, we used public 120 
transcriptome data from embryonic stages (Tan et al., 2013). RNA-seq reads of X. tropicalis 121 
embryonic samples were mapped to the v9 genome assembly and expression levels were 122 
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calculated as described above. TPM values of each gene in each clutch are presented in 123 
Suppl.Data 1 for X. laevis and Suppl. Data 2 for X. tropicalis. 124 
 125 
Transcriptome correlation analysis 126 
The work flow of transcriptome correlation analysis is shown in Figure 1A. Prior to analysis, 127 
all TPM values ≤0.5 were reduced to 0 because they are supposed to be irreproducible (Session 128 
et al., 2016). For correlation analysis of homeologous genes, transcriptomic datasets from 11 129 
developmental stages (egg to st40) and from 14 adult tissues were analyzed separately to 130 
examine reproducibility. Correlations between homeologs were examined using Pearson’s 131 
correlation coefficient and Student’s paired t-test on log2-transformed data [log2(TPM+1)] as 132 
described in the rainbow trout paper (Berthelot et al., 2014) with a python package. Homeolog 133 
pairs were categorized into four groups based on (1) correlation (HC: high correlation, P≤0.05; 134 
NC: no-significant correlation, P>0.05, Pearson’s correlation test) and (2) expression levels 135 
(SE: similar/slightly different expression levels, P>0.05; DE: different expression levels, 136 
P≤0.05, Student’s paired t-test). Finally, we collected homeolog pairs that were categorized 137 
into the same group in both Clutches T and U. If the category was inconsistent between 138 
clutches (a typical case is in Fig. 1F), those genes were categorized as “inconsistent (inc. in 139 
Suppl. Data 3)” and were excluded from subsequent comparative analyses (see Results). 140 
 141 
Epigenetic analysis and comparative genomics 142 
Chromatin-immunoprecipitation sequencing (ChIP-seq) data of trimethylated histone H3 143 
lysine 4 (H3K4me3) and p300 and methylated DNA sequencing (Methyl-seq) data at st10.5 144 
of X. laevis embryos (Session et al., 2016, and G. J. C. Veenstra, personal communication) 145 
were visualized using a track hub of the UCSC genome browser 146 
(http://veenstra.ncmls.nl/trackhub.htm). A Vista plot was generated with Vista tool 147 
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(http://genome.lbl.gov/vista/index.shtml) to show the sequence conservation between X. 148 
tropicalis genome and X. laevis subgenomes. 149 
 150 
<Results and Discussions> 151 
Overview of gene annotation and transcriptome correlation analysis 152 
Here we identified 204 Wnt signaling pathway genes, 33 Hh signaling pathway genes, 88 153 
Notch signaling pathway genes, 91 Hippo pathway genes, 32 HSPG related genes, and 8 154 
TLE/Groucho corepressors in X. laevis genome (Suppl. Data 3). They include 213 homeolog 155 
pairs and 29 singletons. Among them, all orthologs of X. tropicalis genes were found, and no 156 
Xenopus lineage-specific gene expansions were found, except for two wnt11b genes in X. 157 
tropicalis (see below). This contrasts with Xenopus lineage-specific tandem duplications of 158 
some TGFβ signaling ligands (vg1, nodal3, and nodal5; Session et al., 2016, Suzuki et al., in 159 
press-1) and some transcription factors (bix1, sox17b, and ventx; Session et al., 2016, 160 
Watanabe et al., in press).  24 singleton genes (82.8%) originated from the L subgenome. 161 
This tendency is consistent with the whole genome analysis of X. laevis (Session et al., 2016). 162 
In addition to genes identified by automated annotation in v1.8 gene models, we identified 31 163 
genes (see Suppl. Data 3 for details). Consequently, two singletons (ppp2ca.S and neurl4.S) 164 
was newly identified and a misidentified singleton (dll4.L) was found (see below for details).  165 
 For all genes analyzed in this study, expression data and results of transcriptome 166 
correlation analysis at developmental stages and in adult tissues are provided in Suppl. Data 167 
1 and Suppl. Data 3. Unfortunately, we could not analyze transcriptome correlation of 168 
homeolog pairs for dvl2 and dll4 due to the loss of gene models (see below). On the basis of 169 
transcriptome correlation analysis (see Materials and Methods and Fig. 1A), we divided 170 
homeolog pairs into four groups: HCSE (high correlation with similar/slightly different 171 
expression levels, a typical case is in Fig. 1B), HCDE (high correlation with different 172 
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expression levels, a typical case is in Fig. 1C), NCSE (no-significant correlation with 173 
similar/slightly different expression levels, a typical case is in Fig. 1D), and NCDE (no-174 
significant correlation with different expression levels, a typical case is in Fig. 1E). HCSE 175 
indicates conservative expression profiles. The NC groups potentially include 176 
subfunctionalized or neofunctionalized genes, and DE groups potentially include 177 
nonfunctionalized genes. 119 homeologs (56%) exhibited consistent results between clutches 178 
during developmental stages and 140 in adult tissues (66%) also did (see Suppl. Data 3 for 179 
details). These levels are comparable to those of all 8,789 homeolog pairs identified in Session 180 
et al. (2016) (48% and 64%, respectively). 181 
During developmental stages, signaling pathway components are categorized into the 182 
four groups at similar rates for all homeologous gene pairs in v1.8 gene models (p = 0.18, 4x2 183 
Fisher’s exact test, two-sided). On the other hand, in adult tissues, significant differences in 184 
distributions of genes in 4 groups were observed between signaling genes and all genes (p= 185 
0.0098, 4x2 Fisher’s exact test, two-sided), in which signaling genes showed a higher rate in 186 
HCDE (Table 1). These results indicate that homeologous pairs of cell signaling components 187 
exhibit more variable expression profiles in adult tissues than in embryos, suggesting that 188 
genes involved in signaling pathways are prone to become subfunctionalized spatially, rather 189 
than temporally. In addition, signaling components include far fewer “HCSE” genes than 190 
transcription factors (thoroughly analyzed in Watanabe et al., in press) in both developmental 191 
stages and adult tissues (Table 1; P=0.00024 and 2.8e-11 for developmental stages and adult 192 
tissues, respectively, 2x2 Fisher’s exact test, two-sided). These data suggest that expression 193 
profiles of cell signaling components are much more variable than transcription factors, 194 
although both play important roles in embryogenesis and organogenesis. Detailed analyses of 195 
singletons and variable expression profiles are described below.  196 
197 
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Wnt signaling  198 
The Wnt signaling pathway is widely conserved in metazoans and participates in embryonic 199 
patterning (Adamska et al., 2010; Niehrs, 2010). Wnt signaling also serves various functions 200 
in tissue differentiation and cellular morphogenesis in development and disease (Clevers, 201 
2006; Clevers and Nusse, 2012; Hoppler and Kavanagh, 2007; MacDonald et al., 2009). Many 202 
studies have shown that numerous factors participate in the Wnt pathway (Fig. 2A). In this 203 
study, we analyzed 108 gene pairs (listed on Suppl. Table 1) that were chosen from the Wnt 204 
homepage (http://web.stanford.edu/group/nusselab/cgi-bin/wnt/) and recent reports (Cruciat 205 
and Niehrs, 2013; Kakugawa et al., 2015; Zhang et al., 2015).  206 
 207 
(I) Syntenic analysis 208 
At first, we performed syntenic analysis to examine whether each gene possesses a 209 
homeologous pair in X. laevis (Fig. 2B-E and 3A-B; Suppl. Fig. 1; Session et al., 2016). 210 
Among Wnt signaling-related genes, 13 genes (wnt2b, wnt11b, lrp5, porcn, rspo3, dkkx, sfrp4, 211 
shisa4, tiki1, notum2, csnk1g2, ppp2ca, and tcf7) lost a homeolog in X. laevis; wnt2b, wnt11b, 212 
lrp5, and tcf7 were described in Session et al. (2016). All of these except shisa4 and tcf7 213 
retained their homeologs on the L chromosomes.   214 
 In X. tropicalis, two wnt11b genes, which were annotated as wnt11b and wnt11-like.1, 215 
are located adjacently, but in opposite directions. Now they were renamed as wnt11b.1 and 216 
wnt11b.2 in Xenbase, respectively (Fig. 3A), although they had been named as wnt11b.e1 and 217 
wnt11b.e2 (Session et al., 2016). On the other hand, X. laevis has only one wnt11b gene, 218 
wnt11b.L, due to the loss of wnt11b.S (Fig. 3A). A phylogenetic tree of wnt11 genes suggested 219 
that two wnt11b genes in X. tropicalis emerged by gene duplication (Suppl. Fig. 2A). 220 
Originally, the wnt11b gene was annotated as “wnt11” in Xenopus and zebrafish (Heisenberg 221 
et al., 2000; Ku and Melton, 1993; Makita et al., 1998), whereas another wnt11 gene was 222 
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annotated as “wnt11r” in Xenopus and zebrafish (Garriock et al., 2005; Matsui et al., 2005) 223 
(Fig. 3A). However, in mammals, the ortholog of “wnt11r” has been identified as wnt11 224 
because wnt11b was lost in the lineage (Fig. 3A). After the discovery of wnt11b in chickens, 225 
these two groups of wnt11 genes were finally identified by a phylogenetic analysis (Hardy et 226 
al., 2008), which was confirmed by our more comprehensive phylogenetic and syntenic 227 
analyses (Fig. 3A and Suppl. Fig. 2A). To avoid confusion between old names and new ones, 228 
here we renamed orthologs of “wnt11r” as wnt11a in Xenopus (Fig. 3B). Interestingly, wnt11b 229 
was also lost in a teleost lineage, including medaka (Fig. 3A). Frequent losses of wnt11b genes 230 
in several vertebrate lineages may be related to the loss of wnt11b.S in X. laevis, implying that 231 
wnt11b has dispensable roles which can be compensated by other wnt genes. Conversely, 232 
orthologs of wnt11a are conserved in all vertebrates and in both subgenomes of X. laevis, 233 
indicating that wnt11a has indispensable roles in vertebrate systems. This difference between 234 
wnt11a and wnt11b seems to be related to their expression profiles, as described below. 235 
 236 
(II) Differences of expression profiles between homeologs 237 
We next examined expression profiles of Wnt signaling factors obtained from comprehensive 238 
transcriptome data (Session et al., 2016), especially focusing on differences between 239 
homeologs. According to subcellular localization, we classified these genes into six groups 240 
(1) Wnt ligands, (2) Frizzled (Fzd) receptors, (3) other extracellular/membrane factors for 241 
positive regulation (EC/M-pos), (4) extracellular /membrane factors for negative regulation 242 
(EC/M-neg), (5) cytoplasmic factors (CP), and (6) nuclear factors (Nuc) (Fig. 2A).  243 
 Transcriptome correlation analysis showed that Wnt signaling components exhibit 244 
similar expression properties to those of all analyzed genes in Session et al. (2016) during 245 
developmental stages and in adult tissues (p=0.57 and 0.32, 4x2 Fisher’s exact test, two-sided). 246 
However, when we carefully examined signaling components in different subcellular 247 
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locations, we found that Fzd receptors are prone to show higher correlation coefficient scores 248 
of homeolog expression patterns during development in both clutches (Suppl. Fig. 3A,B). 249 
Second, extracellular components (ligands, receptors and other extracellular/membrane 250 
factors) and intracellular components (cytoplasmic and nuclear factors) are associated with 251 
different transcriptome correlation groups in adult tissues (Table 1, p=0.026, 4x2 Fisher’s 252 
exact test, two-sided). Extracellular components include more NC genes and intracellular 253 
genes include more HCDE genes (Table 1). Third, extracellular components showed lower 254 
correlation coefficient scores of homeolog expression patterns than intracellular components 255 
in adult tissues of both clutches (Suppl. Fig. 3C,D). From these results, it seems that 256 
extracellular components of Wnt signaling are relatively more subfunctionalized than 257 
intracellular components in X. laevis, particularly in adult tissues. Detailed features of 258 
homeologous gene expression are described below.  259 
 260 
(1) Wnt ligands 261 
In Xenopus, 21 Wnt paralogs have been identified. These paralogs, except for wnt2b and 262 
wnt11b, retain their homeologous pairs in X. laevis (Figs. 2B and 3A). Among Wnt ligands, 263 
only wnt5a.S and wnt11b.L are expressed at significant levels (TPM>1) in eggs (wnt5a.S, 264 
TPM=2.93~3.29; wnt11b.L, TPM=152.97~240.85; Suppl. Data 1, Figs. 3C and 4B), 265 
consistent with their maternal expression; they function together for body axis formation in X. 266 
laevis (Cha et al., 2008; Tao et al., 2005). In contrast to wnt5a.S, wnt5a.L is not expressed in 267 
eggs (TPM=0~0.06) (Suppl. Data 1 and Figs. 3C and 4B). These facts suggest that wnt11b.L, 268 
which is also highly expressed during oogenesis and in ovary (Fig. 3C), is enriched in eggs 269 
for body axis determination via Wnt signaling and that only single copies of wnt11b and wnt5a 270 
are used as maternal Wnt ligands in X. laevis, possibly due to dosage-sensitive regulation after 271 
allotetraploidization.  272 
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In X. tropicalis, transcriptomic data from embryos (Tan et al., 2013) showed that 273 
wnt11b.1 and wnt5a were maternally expressed at higher levels (TPM= 23.91 and 18.55 at the 274 
two-cell stage). On the other hand, wnt11b.2 and wnt11a are not so highly expressed during 275 
cleavage stages (TPM=3.05 and 3.84 at the two-cell stage). It is likely that X. tropicalis also 276 
uses wnt5a and wnt11b for axis determination, because other Wnt ligands, except for wnt1 277 
(TPM=1.47 at the two-cell stage) are not significantly expressed during cleavage stages 278 
(TPM<1). However, although we cannot compare TPM values for different conditions, 279 
organisms, and filtering methods, the comparison between X. laevis and X. tropicalis suggests 280 
that the amount of wnt11 mRNA stored in eggs changed dramatically after divergence of the 281 
two species. Our transcriptomic analysis of X. laevis and X. tropicalis suggests that wnt11b 282 
mainly functions for maternal axis determination and early development, but that wnt11a 283 
functions during later development and adulthood (Garriock et al., 2005; Garriock and Krieg, 284 
2007; Glinka et al., 1996; Ku and Melton, 1993; Tao et al., 2005). In zebrafish and chicken, 285 
wnt11b also functions as a maternal factor and its expression is restricted to early 286 
embryogenesis (Hardy et al., 2008; Heisenberg et al., 2000; Makita et al., 1998). This limited 287 
function of wnt11b may be related to loss of wnt11b genes in several vertebrate lineages (Fig. 288 
3A). 289 
Transcriptomic data also revealed embryo-specific and adult-specific Wnt ligands. 290 
For example, Wnt8a is an embryo-specific Wnt ligand, because wnt8a.L and wnt8a.S are 291 
abundantly expressed from st 9 to 25, but not in adult tissues (TPM<1) except wnt8a.L in testis 292 
of clutch T (TPM=1.24) (Suppl. Fig. 4F, Suppl. Data 1). This suggests that Wnt8a is a highly 293 
specific Wnt ligand for AP-patterning of the early embryo. On the other hand, Wnt2 and 294 
Wnt7c are adult-specific Wnt ligands, although their expression levels are not so high (Suppl. 295 
Fig. 4A,E, Suppl. Data 1).  296 
With regard to differential expression of Wnt ligands, wnt11 homeologs showed 297 
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HCDE expression profiles with higher expression levels of the L gene in both developmental 298 
stages and adult tissues (Fig. 3C). This result indicates that wnt11a.L dominates wnt11a.S. 299 
Similarly, wnt4 and wnt8a exhibited HCDE expression profiles with stronger expression of 300 
the L gene (Suppl. Fig. 4B, F). Conversely, wnt1 showed DE expression profiles in both 301 
developmental stages and adult tissues with stronger expression of the S gene (Fig. 4A). In 302 
cases of NCSE expression profiles such as wnt6 and wnt10a (Suppl. Fig. 4C, H), a homeolog 303 
showed stronger expression in specific tissues. Together with other examples (Suppl. Fig. 4), 304 
variable expression profiles of Wnt ligand genes appear to reflect subfunctionalization of 305 
homeologs in X. laevis.  306 
 307 
(2) Fzd receptors  308 
Frizzled (Fzd) is a receptor that interacts with Wnt ligands in the extracellular space. In 309 
Xenopus, ten paralogs have been identified. Unlike Wnt ligands, no singletons were found. 310 
Transcriptome correlation analysis revealed seven genes during embryogenesis and four genes 311 
in adult tissues that showed variable expression profiles between the L and S subgenomes 312 
(Table 1). As mentioned above, Fzd genes showed higher correlation coefficient scores during 313 
developmental stages (Suppl. Fig. 3A, B). However, no genes were consistently categorized 314 
as HCSE between the two clutches and five genes were categorized as HCDE (Table 1), 315 
suggesting that expression levels of Fzd homeologs were highly variable even though their 316 
temporal expression patterns are highly correlated. 317 
Among Fzd genes, the expression level of fzd7 is highest during embryonic stages, 318 
while fzd7.L is dominant to fzd7.S during embryogenesis (NCDE) and in some adult tissues 319 
(kidney, ovary, and spleen; HCDE) (Fig. 4D). Similar to fzd7, fzd5 homeologs also showed 320 
NC expression profiles during development (NCSE, Fig. 4C). In adult tissues, fzd9 showed 321 
NCSE patterns, although fzd9 homeologs are similarly expressed during development (Suppl. 322 
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Fig. 5D). On the other hand, fzd2, fzd4, and fzd8 homeologs showed DE expression profiles 323 
in which S genes are more highly expressed than L genes (Suppl. Fig. 5A-C). These data 324 
indicate that homeologs of Fzd receptors are also highly subfunctionalized in X. laevis, 325 
possibly due to dosage-sensitive regulation of membrane factors in the limited space of the 326 
plasma membrane. 327 
 328 
(3) Extracellular/membrane factors for positive regulation (EC/M-pos) 329 
Together with Wnt ligands and Fzd receptors, other extracellular/membrane factors activate 330 
Wnt signaling as agonists (rspondin (rspo), norrin (ndp)), (co)receptors (lrp, lgr, ror, and ryk), 331 
or secretion promoters (porcupine (porcn), wntless (wls)) of Wnt ligands. In the EC/M-pos 332 
group, lrp5, porcn, and rspo3 were singletons on L chromosomes (Fig. 2C, Suppl. Fig. 1A; 333 
Session et al., 2016). Transcriptomic data showed that ror1.L was primarily expressed in 334 
embryos (st12-25) and also in adult tissues such as heart, kidney, and testis, expression profiles 335 
of which were categorized as DE (Fig. 4E). On the other hand, in cases of lgr4 and ryk, the S 336 
gene is more strongly expressed in some embryonic stages and adult tissues, categorized as 337 
HCDE, except lgr4 in adult tissues of clutch T (Suppl. Fig. 6A, F). Interestingly, rspo2 338 
homeologs showed an NCSE expression profile at developmental stages with an expression 339 
shift from S to L at embryonic st10-12, possibly corresponding to higher expression of rspo2.L 340 
in brain, eye, and lung, and of rspo2.S in ovary, although it was categorized as HCSE in adult 341 
tissues (Fig. 4F). lrp6 also showed an NCSE pattern with a shift of expression dominance 342 
from L to S at st10-12 during developmental stages, and an HCDE pattern in adult tissues with 343 
higher expression levels of the S gene (Suppl. Fig. 6C). Together with other examples of 344 
variable expression patterns (Suppl. Fig. 6B, D, E), homeologous genes in the EC/M-pos 345 
group are suggested to be also well subfunctionalized in X. laevis. 346 
 347 
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(4) Extracellular/membrane factors for negative regulation (EC/M- neg) 348 
EC/M-neg factors have crucial roles in modulation of Wnt signaling levels by inhibiting 349 
Wnt/receptor interactions (such as cerberus, dkk, and sfrp), processing Wnt proteins (notum 350 
and tiki), ubiquitinating Fzd receptors (rnf43 and znrf3), and inhibiting receptor maturation 351 
(shisa) (Cruciat and Niehrs, 2013; Kakugawa et al., 2015; Zhang et al., 2015).  352 
In the EC/M-neg group, dkkx.L, notum2.L, sfrp4.L, shisa4.S, and trabd2a.L (tiki1.L) 353 
are singletons. As for other components, transcriptomic data indicated that many homeologous 354 
gene pairs are differentially expressed during embryogenesis or in adult tissues (Table 1). For 355 
example, in sfrp1, the L gene predominates during embryogenesis and in some adult tissues, 356 
categorized as DE (Fig. 4G), whereas, in cer1, the S gene is dominant, although it was 357 
categorized as HCSE in clutch U, possibly due to few stages expressing cer1 genes (Fig. 4H). 358 
In other cases, apcdd1, dkk3, frzb2, kremem1, shisa1, shisa2, and znrf3 show L-dominant DE 359 
profiles, whereas notum1, rnf43, sfrpx, and tpbg show S-dominant DE profiles, in 360 
developmental stages, adult tissues, or both (Fig. 4I, Suppl. Fig. 7A,B,D-F,H-J,M,O). Notably, 361 
sfrp5 and sostdc1 exhibit NCSE profiles during developmental stages with changing dominant 362 
homeologs (Suppl. Fig. 7G, K). These results suggest that many homeologous genes in the 363 
EC/M-neg category have been highly subfunctionalized in X. laevis. 364 
To examine how these variable expression patterns of homeologs are regulated, we 365 
also investigated epigenetic states on genomic loci around those homeologs (Fig. 5). At stage 366 
10.5 (early gastrula), ChIP-seq data of H3K4me3 and p300 demonstrated that homeologs with 367 
stronger expression (cer1.S and sfrp1.L) exhibit stronger enrichment of H3K4me3 around 368 
promoters and of p300 at enhancers (Fig. 5B, C). It has been shown that an enhancer of cer1 369 
(named U1 enhancer) activates cer1 in dorsal endomesoderm (Sudou et al., 2012; Yamamoto 370 
et al., 2003). A comparison of core sequences of the U1 enhancer in Xenopus showed that the 371 
enhancer sequence of cer1.S is the most derived among Xenopus genes and it exhibits stronger 372 
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enhancer activity in the dorsal region of the embryo than an ancestral sequence (Sudou et al., 373 
2012). In the case of sfrp1, a binding peak of p300 in the first intron disappears in the locus 374 
of sfrp1.S (Fig. 5C). A comparison of genomic sequences of sfrp1 loci between the X. laevis 375 
L subgenome, S subgenome, and the X. tropicalis genome demonstrated that the sequence 376 
corresponding to the sfrp1.L-specific p300 peak is conserved in X. tropicalis, but deleted from 377 
the X. laevis S subgenome. These observations indicate that enhancer sequence alterations 378 
lead to preferential enrichment of enhancer/promoter epigenetic markers of a homeolog, 379 
resulting in biased expression levels between homeologs. 380 
381 
(5) Cytoplasmic factors (CP)382 
CP factors transduce Wnt signaling to modulate gene expression and cellular morphology. 383 
Among them, Dishevelled (Dvl) is a key factor to transduce Wnt signaling pathways from Fzd 384 
receptors. As mentioned above, two singleton genes were identified, casein kinase1γ2 385 
(csnk1g2) and protein phosphatase 2 catalytic subunit alpha (ppp2ca) in CP genes (Fig. 2E 386 
and Suppl. Fig. 1B). Although dvl2.S was not identified in gene models v1.8, it was previously 387 
identified in gene models v1.6 of genome assembly v7.1. dvl2.S sequences also exist in the 388 
corresponding region of scaffold_20 of genome assembly v9.1.  RNA-seq analysis using 389 
v1.6 gene models demonstrated that dvl2.S had similar expression levels to dvl2.L in embryos 390 
and adult tissues (data not shown).  Therefore, we concluded that dvl2 homeologs are 391 
conserved in X. laevis.   392 
It should be noted that expression levels of dvl2 and β-catenin (ctnnb1) are very high 393 
in eggs (dvl2.L, TPM=191.87~700.12; ctnnb1.L, TPM=268.1~492.53; ctnnb1.S, 394 
TPM=459.02~502.81). This result is consistent with the fact that for induction of a secondary 395 
axis by microinjection, higher doses of cytoplasmic factor mRNA, such as disheveled (dvl) or 396 
β-catenin, are necessary than for extracellular factors such as xWnt8 (Sokol et al., 1992; Smith 397 
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and Harland 1991; Sokol et al., 1995; Funayama et al., 1995). 398 
Expression profiles of CP genes exhibited a greater tendency to DE categories in 399 
adult tissues than all other Wnt signaling components (Table 1; P=0.0096, Fisher’s exact test, 400 
two-sided). For example, β-catenin homeologs are similarly expressed in embryos (HCSE), 401 
but their expression levels are variable in adult tissues (HCDE) (Fig. 1B, Suppl. Fig. 8G). 402 
Moreover, axin2 showed HCDE expression profiles in both embryos and adult tissues with 403 
stronger expression of the L gene, whereas the S gene is dominantly expressed in gsk3b (Fig. 404 
4J,K). ChIP-seq data around axin2 homeologs suggested that H3K4me3 enrichment on the 405 
promoter and p300 enrichment on an enhancer are correlated with their biased expression 406 
levels (Fig. 5A). Other examples also indicate variable expression levels of CP genes; axin1, 407 
ccdc88c, csnk1a1, csnk1d, cxxc4, dvl1, dvl3, and gsk3a are L gene dominant, csnk2a1, csnk2b 408 
and ctnnb1l are S-dominant (Suppl. Fig. 7). Because many CP genes are involved in 409 
destabilization of β-catenin, our results imply that single copies of genes related to enzymatic 410 
processing of β-catenin are sufficient, allowing homeologs to diversify expression levels. 411 
412 
(6) Nuclear factors (Nuc)413 
The HMG box transcription factor, Tcf/Lef, is one of the important transcription factors for 414 
canonical Wnt signaling transduction (Clevers and Nusse, 2012; MacDonald et al., 2009) (see 415 
Fig. 6A). Tcf genes are highly conserved among metazoans (Adamska et al., 2010) and there 416 
are four subfamilies in vertebrates, Tcf7 (Tcf1), Tcf7l1 (Tcf3), Tcf7l2 (Tcf4), and Lef1 (Arce 417 
et al., 2006; Hoppler and Kavanagh, 2007). Each subfamily has various splicing isoforms and 418 
molecular functions of these subfamilies are diversified in development and disease (Arce et 419 
al., 2006; Hoppler and Kavanagh, 2007). In Xenopus, it has been shown that Tcf7 and Lef1 420 
mainly activate Wnt target genes, whereas Tcf7l1 and Tcf7l2 function as both activators and 421 
repressors for Wnt target genes.  422 
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According to transcriptomic data, Tcf/Lef genes, tcf7.S, tcf7l1.L, and tcf7l1.S are 423 
maternally expressed, and tcf7l1.S expression is especially persistent during embryogenesis 424 
(Fig. 6B,C). During later developmental stages and in adult tissues, there are slight differences 425 
with stronger expression of tcf7l1.S (HCDE categories) (Fig. 6C). Expression levels of both 426 
tcf7l2.L and tcf7l2.S are low (less than 5 tpm) during embryogenesis, but they showed NCSE 427 
profiles in both clutches, suggesting temporal subfunctionalization. In adult tissues, tcf7l2 428 
homeologs showed HCSE expression profiles with strong expression (more than 5 tpm) in 429 
brain, intestine, and spleen (Fig. 6D). lef1.L starts to be expressed at an early gastrula stage 430 
(st10), earlier than lef1.S (late gastrula stage, st12), and expression levels of lef1.L are higher 431 
than those of lef1.S during development (HCDE) (Fig. 6E). However, there are no strong 432 
differences between lef1.L and lef1.S in adult tissues, categorized as HCSE (Fig. 6E). These 433 
data suggest that Tcf/Lef homeologous pairs in X. laevis are subfunctionalized to some extent, 434 
but not so dramatically as other Wnt signaling components. 435 
436 
Hedgehog signaling 437 
Hedgehog (Hh) is an important morphogen that is evolutionarily conserved from Drosophila 438 
to humans (McMahon et al., 2003). The Hh ligand binds to its receptor Patched, which results 439 
in de-inhibition of Smoothened (Smo, a downstream membrane-bound signaling mediator), 440 
and activation of signal transduction (Fig. 7A). In Xenopus, however, the Hh signaling 441 
pathway has not been studied in sufficient detail to understand the diversity of pathway 442 
components. In this study, we analyzed 18 gene pairs in the Hh pathway (including genes 443 
analyzed in Session et al., 2016).  A whole gene list examined here and in Session et al. 444 
(2016) is summarized in Suppl. Table 2.  445 
(I) Syntenic analysis446 
Syntenic analyses revealed that, in addition to hhat (Session et al., 2016), two more genes lost 447 
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their homeologs on S chromosomes (stk36 [a homolog of Drosophila fused (fu)], kif7 [a 448 
homolog of Drosophila costal2 (cos2)]). In genomic regions corresponding to stk36.S and 449 
kif7.S, neighboring genes are also missing (Fig. 7B,C), while loss of hhat.S appears to be a 450 
single gene deletion (Session et al., 2016). 451 
452 
(II) Expression profiles453 
We also examined expression profiles of Hh signaling components using RNA-seq data 454 
(Session et al., 2016) during development and in adult tissues, focusing on differences in their 455 
homeologs. We classified these genes into three groups: (1) ligands and extracellular factors, 456 
(2) receptor and membrane-bound factors, and (3) cytoplasmic, ciliary, and nuclear factors,457 
according to their subcellular localizations (Fig. 7A). Most L genes are expressed at higher 458 
levels during developmental stages and in adult tissues than S genes, consistent with overall 459 
gene expression profiles (Session et al., 2016). Expression patterns are detailed below. 460 
461 
(1) Hh ligands462 
In mammals, three ligands, i.e., Sonic Hedgehog (Shh), Indian Hedgehog (Ihh), and Desert 463 
Hedgehog (Dhh) have been identified (Ingham and Placzek, 2006). Similarly, X. laevis has 464 
three ligands (Ekker et al., 1995; Takabatake et al., 1997). According to RNA-seq results, shh 465 
and dhh are highly expressed during embryogenesis (Fig. 8A). Expression profiles of shh 466 
homeologs were highly correlated, but the expression level of shh.L is higher than that of shh.S 467 
(HCDE in clutch T, but HCSE in clutch U), while dhh homeologs were categorized as HCSE 468 
during embryogenesis. ihh homeologs were also categorized as HCSE, but homeologs showed 469 
lower expression during early embryogenesis (although they are expressed at certain levels 470 
from the tailbud stage). In adult tissues, all pairs of ligands are categorized as HCDE and L 471 
genes of all ligands are dominant (Fig.8A).  472 
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473 
(2) Hh receptor/membrane factors 474 
L genes of ptch1 and ptch2 were predominantly expressed during embryogenesis (both 475 
HCDE). However, in adult tissues, homeologous pairs of ptch1 and ptch2 showed similar 476 
expression levels, except for ptch2 in spleen (Fig. 8B). smo homeologs showed HCDE profiles 477 
in both embryos and adult tissues, in which smo.L was more heavily expressed (Suppl. Fig. 478 
9A). ptch1, ptch2, and smo show higher expression around the neurulation stage, possibly 479 
reflecting the importance of Hh signaling in neural tube patterning. A hedgehog-binding 480 
inhibitor gene, hhip, showed dominant expression in the L gene during embryogenesis and in 481 
adult tissues, particularly in lung (Suppl. Fig. 9B). 482 
We also examined epigenetic states of smo homeologs in embryos (Suppl. Fig. 10A). 483 
ChIP-seq data at st10.5 showed stronger enrichment of H3K4me3 and p300 at the promoter 484 
and enhancer of smo.L than of smo.S. Interestingly, enhancer sequences showing biased 485 
enrichment of p300 at st10.5 are globally conserved between smo.L, smo.S, and X. tropicalis 486 
smo (Suppl. Fig. 10B), suggesting that either very slight modifications of transcription factor 487 
binding sequences in enhancers caused the difference, or that other controlling regions far 488 
away from genes contribute to them. 489 
490 
(3) Cytoplasmic, ciliary and nuclear factors491 
One of the striking features of Hh signaling is that the primary cilium is essential in vertebrates 492 
(Wilson and Chuang, 2010). Several key components of the Hh pathway, including Ptch1, 493 
Smo, and Gli transcription factors, are known to be enriched in cilia (Goetz and Anderson, 494 
2010). Here, we analyzed transcriptional data of a transducer of Hh signaling located in 495 
cytoplasm and nucleus and in cilium length mediators. 496 
Three Gli transcription factors are identified in X. laevis, as in mammals. All gli genes 497 
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are expressed from late gastrula stage, and almost all of their homeologs showed correlated 498 
expression at developmental stages and in adult tissues (Suppl. Fig. 9C-E). gli1.S was more 499 
heavily expressed especially in Clutch T (Suppl. Fig. 9C). gli2.L was dominant during 500 
embryogenesis and in adult tissues, resulting in HCDE (Suppl. Fig. 9D). Except for Clutch T 501 
at developmental stages, the homeologous pair of gli3 showed similar expression levels in 502 
embryos and adults (Suppl. Fig. 9E). Other transducers of Hh signaling (sufu and prkaca) 503 
showed correlated expression between homeologs, except for singleton genes (stk36 and kif7) 504 
during embryogenesis and in adult tissues (Suppl. Fig. 9F-I). It should be noted that the 505 
requirement of stk36 for Hh signaling in Xenopus remains to be tested, because the 506 
requirement diverged in vertebrates (Chen et al., 2005; Murone et al., 2000; Wilson et al., 507 
2009; Yamamoto et al., 2015), in contrast to the critical role of fu in Drosophila Hh signaling. 508 
Arl13b and Foxj1 are known to regulate Hh signaling so as to positively control 509 
ciliary length (Caspary et al., 2007; Cruz et al., 2010; Lu et al., 2015). The expression level of 510 
arl13b was significantly different between homeologs (Suppl. Fig. 9J). Although foxj1 was 511 
categorized as HCSE, somewhat different expression was observed just around neurulation 512 
(st12-15) (Suppl. Fig. 9K). These results imply that ciliary length became regulated by 513 
subfunctionalization of ciliary genes just after genome duplication in X. laevis, due to the 514 
importance of ciliary length for Hh ligand gradient formation or reception during neural 515 
patterning.  516 
 517 
Proteoglycans 518 
Heparan sulfate (HS) proteoglycans (HSPGs) are cell surface molecules that are important for 519 
morphogen gradient formation and reception of signaling factors including Wnt, Hh, FGF, 520 
and BMP signaling pathways (Sarrazin et al., 2011; Yan and Lin, 2009). HSPGs consist of a 521 
core protein and covalently attached HS chains (Fig. 9A). They can serve as co-receptors, and 522 
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also facilitate ligand-receptor interactions. 523 
(I) core proteins 524 
HSPG core proteins are conserved through the animal kingdom and are expressed in 525 
a stage- and tissue-specific manner. They are divided into three groups according to their 526 
localization: transmembrane HSPGs including syndecans, glycosylphosphatidylinositol-527 
anchored HSPGs (glypicans), and secreted HSPGs. Here, we focus on the two membrane-528 
bound types of HSPGs.  529 
In vertebrates, six glypicans are identified and divided into two groups orthologous 530 
to Drosophila dally and dally-like protein (dlp). gpc3/5 is the dally family and the others 531 
belong to the dlp family. The transmembrane protein Syndecan has four genes in vertebrates, 532 
but only one in Drosophila. The amount of HSPG protein on the cell surface is critical for 533 
growth factor distribution or signaling activity, but it remains an open question whether 534 
expression changes after genome duplication. Therefore, we analyzed HSPG expression 535 
profiles (all genes analyzed are listed in Suppl. Table 3) during embryogenesis and in adult 536 
tissues in X. laevis. 537 
 There are no singletons among syndecans or glypicans. During embryogenesis, 538 
almost all homeologous pairs of each proteoglycan showed correlated expression patterns 539 
through developmental stages. For instance, expression levels of sdc2 homeologs are lower in 540 
oocytes, but higher during developmental stages (Fig. 9C). However, sdc4 homeologs were 541 
categorized as NCSE (Fig. 1D). sdc4.S is higher, especially during egg and blastula stages (st8 542 
and 9), whereas sdc4.L is higher from gastrula to early neurula stages (st12 and 15). High 543 
expression of sdc4 in gastrula stages is consistent with the function of Syndecan in planar cell 544 
polarity (Escobedo et al., 2013); however, roles of maternal Syndecans are still unknown. On 545 
the other hand, in X. tropicalis, sdc4 is not highly expressed during cleavage stages (Tan et al., 546 
2013, Suppl. Data2). Taken together, these results suggest that sdc4.S acquired a new function 547 
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at about the egg stage in X. laevis. 548 
Expression levels of glypican genes during embryogenesis are similar between 549 
homeologs (Fig. 9B; Suppl. Fig. 11A-D), except for gpc4 during neurulation stages, at which 550 
the L gene predominated (Suppl. Fig. 11C). In adult tissues, glypicans are highly expressed in 551 
brain, including gpc3 and gpc6, which are not highly expressed during embryogenesis (Fig. 552 
9B, Suppl. Fig. 11A-E). Comparing each homeologous gene pair, L gene expression levels of 553 
gpc1, gpc2, and gpc4 are higher in many tissues, categorized as HCDE, except gpc4 in clutch 554 
U.  555 
 556 
(II) Modification enzymes 557 
Sugar chains are attached to their core proteins and processed by a series of modifications. 558 
Sugar chain modifications are initiated by N-deacetylase/N-sulfotransferase (NDST), which 559 
removes an N-acetyl group from GlcNAc of a nascent sugar chain (N-acetyl heparosan) and 560 
substitutes the free amino group with sulfate, forming N-sulfo HS (Fig. 9A). This process is 561 
essential for generation of sulfated, ligand binding sites in HS (Lindahl et al., 1998) and both 562 
Syndecans and Glypicans could be substrates of Ndst. Subsequently HS is modulated by O-563 
sulfotransferases (Sulf). Recently, it was shown that 6-O-sulfatation by sulf1 influences the 564 
Shh gradient in the neural tube in X. tropicalis (Ramsbottom et al., 2014). Here we analyzed 565 
ndst and sulf genes. 566 
Homeologs of ndst1 showed NC expression patterns during development. ndst1.L 567 
expression increased from the egg stage to st12 and decreased from st25~30 to st40, whereas 568 
ndst1.S expression decreased from st8 to st12 and increased from st15 to st25~30. Although 569 
it was categorized as NCSE in clutch U, expression levels of the L gene are stronger than those 570 
of the S genes in many stages. ndst1.L is also more strongly expressed in oocytes and adult 571 
ovary (Fig. 9D). In addition, the L gene of ndst2 is dominant during embryonic stages and 572 
© 2017 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
24 
 
adult tissues (Suppl. Fig. 11G). In embryos, ndst3 and ndst4 homeologs show only faint 573 
expression (TPM <1; see Suppl. Data 1). Therefore, S genes of ndst are not highly expressed 574 
in eggs, where sdc4.S is highly expressed (Fig. 1D), suggesting no substrate specificity in Ndst 575 
with regard to subgenome. In adult tissues, all ndst genes are highly expressed in brain, similar 576 
to the expression of glypicans, and homeologs other than ndst2 showed conservative 577 
expression profiles (HCSE). 578 
Two sulfatases were identified in Xenopus, sulf1 and sulf2. During embryonic stages, 579 
the L gene of sulf1 was more highly expressed (Suppl. Fig. 11H, I), while homeologous genes 580 
of sulf2 showed NC expression patterns with different temporal expression changes. 581 
Consistent with the sulf1 requirement in neural tube patterning, sulf1 was highly expressed 582 
during the early neurula stage. In adult tissues, sulf1.S is strongly expressed in lung, in contrast 583 
to its very low expression in embryos. Over all, homeologous genes of sulf1 and sulf2 are 584 
similarly expressed in adult tissues.  585 
 586 
Notch signaling 587 
Notch signaling is evolutionarily conserved in metazoans (Gazave et al., 2009), and controls 588 
differentiation, proliferation, and apoptosis during development and in multiple tissues 589 
(Guruharsha et al., 2012). Notch signaling is activated by the ligand (Delta/Jagged), and the 590 
receptor, Notch, is processed by series of proteolyses. After the receptor release from its 591 
transmembrane tether by proteolysis, the Notch intracellular domain (NICD) is transferred to 592 
the nucleus and activates target genes (Kopan and Ilagan, 2009) (Fig. 10A).  593 
Here we analyzed 48 gene pairs that were chosen from the map of the Notch pathway on the 594 
KEGG website (Kyoto Encyclopedia of Genes and Genomes) (http://www.genome.jp/kegg/) 595 
and some reviews (Gazave et al., 2009; Guruharsha et al., 2012; Kopan and Ilagan, 2009) 596 
(listed on Suppl. Table 4).  597 




(1) Syntenic analysis 599 
Syntenic analysis revealed that seven genes lost their S homeologs (dtx3-like1, dtx3l-600 
like, dtx4, hey2, neurl2, pofut1, and rfng), while neurl4 lost the L homeolog (Figs. 2C and 601 
10B-H, Suppl. Table 4). Among eight singleton genes, pofut1.S and rfng.S are pseudogenes 602 
(Fig. 10B,C). Seven of eight Notch signaling-related singletons were caused by gene losses 603 
on S chromosomes, similar to all analyzed genes (Session et al., 2016). 604 
We found that dll4.L was misidentified as a singleton by genomic analysis (Session 605 
et al., 2016). Although the full sequence of the dll4 gene was only found on the L chromosome, 606 
partial sequences of putative S genes were found on some scaffolds. In particular, some 607 
putative dll4.S sequences are located on the edge of scaffold_34, in which synteny of 608 
surrounding genes is conserved in the L subgenome and the X. tropicalis genome. Because we 609 
could not find any pseudogene-like sequences, such as frameshift mutations or stop codon 610 
insertions in putative dll4.S sequences, we concluded that dll4 retains the homeolog pair. 611 
 612 
(2) Expression profiles 613 
According to their subcellular localization, we classified genes into four groups (1) 614 
ligands/receptors, (2) other extracellular/membrane factors, (3) cytoplasmic factors, and (4) 615 
nuclear factors (Fig. 10A). Hes transcription factors are also involved in Notch signaling, but 616 
were analyzed separately in another paper in this special issue (Watanabe et al., in press). 617 
We examined expression profiles of Notch signaling genes and compared expression 618 
levels between L and S genes. Transcriptome correlation analysis showed that extracellular 619 
components of Notch signaling exhibited more HCDE profiles than intracellular components 620 
in adult tissues (Table 1; P=0.030, 2x2 Fisher’s exact test, two-sided). This result suggests that 621 
expression levels of extracellular components are more variable for the Notch signaling 622 
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pathway in adult tissues. 623 
Expression patterns of dlc (one of the Delta ligands, also called dll2) homeologs are 624 
categorized as HCDE, and expression of dlc.L is clearly dominant around gastrula stages (Fig. 625 
11C). Epigenetic data showed that H3K4me3 and p300 on the promoter and enhancers at 626 
gastrula stage are strongly enriched on dlc.L, but less so on dlc.S (Fig. 11A) However, 627 
sequence comparisons of p300 binding regions between L and S subgenomes showed that all 628 
enhancer sequences are conserved between dlc.L and dlc.S (Fig. 11B). Interestingly, levels of 629 
DNA methylation of the dlc.L promoter are very low, but those of the dlc.S promoter are high 630 
(Fig. 11A). These data suggest that differential expression of dlc homeologs is controlled by 631 
DNA demethylation of their promoter regions. 632 
A homeologous pair of jag1 showed interesting temporal expression patterns, 633 
categorized as NCSE. jag1.S is highly expressed during early developmental stages, while 634 
jag1.L is high during late developmental stages (Fig. 11D), suggesting subfunctionalization 635 
after allotetraploidization. In other factors in the extracellular/membrane category, the 636 
metalloprotease gene, adam17.L, is more strongly expressed throughout embryogenesis and 637 
in many adult tissues, being categorized as NCDE and HCDE (Fig. 11E). Among γ-secretase 638 
subunits, aph1a.S showed stronger expression in embryos and adult tissues (Fig. 11F). In the 639 
cytoplasmic factor category, dtx2.L and nedd4l.S, both of which encode the E3 ubiquitin ligase 640 
for Notch receptor endocytosis, are more strongly expressed in embryos (Fig. 11G,H). Among 641 
nuclear factors, the NICD interacting transcriptional activator, maml1, showed HCDE profiles 642 
with stronger expression of the S gene in embryos (Fig. 1C). Together with other examples of 643 
variable expression profiles (Suppl. Fig. 12), homeologous genes encoding Notch signaling 644 
components are also well subfunctionalized in X. laevis. 645 
 646 
Hippo signaling 647 
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The Hippo signaling pathway is evolutionarily conserved and controls organ size by 648 
regulating cell proliferation, apoptosis, movement, and fate (Varelas, 2014; Yu et al., 2015). 649 
Unlike other signaling pathways, the Hippo pathway does not have a simple ligand/receptor 650 
mechanism for signaling input. To recognize cell density, activity of the Hippo pathway is 651 
regulated by cell-cell contact, planar cell polarity, mechanical cues, and also by intracellular 652 
stresses (Varelas, 2014; Yu et al., 2015). Such stimuli are finally transduced to inactivate 653 
YAP/TAZ protein, which activates cell proliferation together with the TEAD transcription 654 
factor (Fig. 12A).   655 
 656 
(1) Syntenic analysis 657 
Here we analyzed 48 gene pairs chosen from the Hippo pathway map on the KEGG 658 
website (Kyoto Encyclopedia of Genes and Genomes) (http://www.genome.jp/kegg/) and 659 
some reviews (Varelas, 2014; Yu et al., 2015) (listed on Suppl. Table 5).  660 
Syntenic analysis revealed that four homeolog pairs lost the S gene (crb1, limd1, 661 
rassf4, and taz) and lats1 lost the L gene (Session et al., 2016) (Fig. 12B-E, Suppl. Table 5). 662 
Interestingly, gene loss in X. laevis genome was also observed in one of the homeologous 663 
genes of cyclin H and its partner gene cdk7, which are target genes of Hippo pathway (Session 664 
et al., 2016). Simultaneous gene loss of taz and cyclin H/cdk7 may imply that dosage-sensitive 665 
regulation occurs in cell cycle regulation after allotetraploidization. 666 
 667 
(2) Expression profiles 668 
We examined expression profiles of genes in Hippo signaling and compared 669 
expression levels between homeologous gene pairs (Table 5). The ratio of the number of genes 670 
categorized into 4 groups are similar to that in all analyzed genes (Session et al., 2016), but 671 
slightly different in the adult, especially high rate in HCDE (p = 0.12, 4x2 Fisher’s exact test, 672 
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two-sided; p=0.02, 2x2 (HCDE and others) Fisher’s exact test, two-sided). Details of 673 
individual gene expression patterns are described below. 674 
According to their subcellular localization, we classified genes into three groups, (1) 675 
transmembrane factors, (2) cytoplasmic factors, and (3) nuclear factors (Fig. 12A). Expression 676 
patterns of each homeologous pair of stk3 and stk4 (also called mst2 and mst1, respectively) 677 
and Drosophila hippo orthologs are highly correlated, but expression levels are significantly 678 
different during embryogenesis and in adult tissues (except for stk3 in adult tissues of Clutch 679 
T) (Fig. 12F, G, Suppl. Fig. 13Q, R). stk3.S is more strongly expressed in oocytes and gastrula 680 
stage embryos, whereas stk4.L is more strongly expressed in later stage embryos, and many 681 
tissues. 682 
The LATS/MOB complex causes cytoplasmic destruction or retention of YAP/TAZ 683 
molecules, which results in inhibition of the nuclear localization of YAP/TAZ (Varelas, 2014; 684 
Yu et al., 2015). Two orthologs of lats (homeologs of lat1 and lat2) are identified in X. laevis. 685 
lats1.S is a singleton, as described above. lats2 homeologs are categorized as HCSE during 686 
embryogenesis, but they show different expression levels in adult tissues (NCDE in Clutch T 687 
and HCDE in Clutch U). lats2.S is more strongly expressed in almost all tissues (Fig. 12H). 688 
On the other hand, mob1a homeologs show HCDE profiles with stronger expression of the L 689 
gene in adult tissues (Fig. 12I). 690 
Yorkie is a key factor for the Drosophila Hippo pathway, in which it regulates gene 691 
expression together with Scalloped. Two Yorkie paralogs, yap1 and taz, are identified in 692 
vertebrates. The two paralogs are considered to have similar functions. However, it is known 693 
that yap1 has essential roles in many tissues, but taz only functions in mesenchymal stem cell 694 
differentiation (Hong et al., 2005) and in Wnt signaling (Azzolin et al., 2012), according to 695 
assays in cell culture and zebrafish. As mentioned above, taz.L became a singleton, whereas 696 
homeologous genes of yap1 are conserved, implying that taz.S was lost due to its limited utility.  697 
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However, expression profiles indicate that taz.L is strongly expressed throughout oogenesis 698 
to early embryogenesis and in ovary (Suppl. Fig. 13X). In X. tropicalis, taz expression is 699 
dramatically decreased after gastrulation (Suppl. Fig. 14). Thus, maternal expression of taz is 700 
conserved in Xenopus, but strong expression of taz in later stage embryos is specific to X. 701 
laevis. The expression pattern of yap1 is categorized as HCDE in both embryos and adults. 702 
yap1.L is more strongly expressed during embryonic stages and in many tissues such as eye, 703 
lung, and skin (Fig. 12J). The relationship between the divergence of yap1/taz expression 704 
patterns and allotetraploidization needs to be addressed in the future. 705 
Together with other examples (Suppl. Fig. 13), many Hippo pathway genes possess 706 
highly variable expression profiles between homeologs, especially in adult tissues. Because 707 
the Hippo pathway controls organ sizes, our results may explain how X. laevis acquired its 708 
larger body size after allotetraploidization. 709 
 710 
TLE/Groucho transcriptional corepressors 711 
TLE/Groucho family genes have crucial roles in gene repression, forming complexes 712 
with various transcription factors and recruiting histone deacetylase (HDAC) (Buscarlet and 713 
Stifani, 2007; Cinnamon and Paroush, 2008). By interacting with many kinds of transcription 714 
factors, such as Fox, Nkx, Pax, Gsc, Hesx and Otx, TLE occupies cis-regulatory modules for 715 
tissue-specific genes during development (Yasuoka et al., 2014). The Tcf/TLE complex 716 
represses transcription of target genes of canonical Wnt signaling when signaling is off (Fig. 717 
6A).  Similarly, the Rbpj/TLE complex represses Notch signaling.  Therefore, TLE has a 718 
role to keep signaling turned off.   719 
In vertebrates, there are four TLE paralogs, TLE1, TLE2, TLE3 and TLE4 and a 720 
truncated TLE paralog AES; however, TLE3 was lost in Xenopus (Roth et al., 2010). In 721 
Xenopus, all TLE related genes reside on XLA1, in which tle2 and aes are tandemly located 722 
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in opposite directions and tle1 and tle4 are also (Fig. 13A).  X. laevis retains all TLE-related 723 
gene homeologs, and interestingly, dominantly expressed homeologs are opposite between 724 
neighboring genes during development. That is, L genes are dominant in tle1 and tle2, but S 725 
genes are dominant in tle4 and aes (Fig. 13B-E).  Except for tle4 in clutch T, they showed 726 
HCDE expression profiles. In adult tissues, tle1, tle2, and aes showed HCDE profiles with the 727 
same tendencies of expression dominance as in embryos (Fig. 13B-C, E). But tle4 showed 728 
stronger expression levels of the L gene in clutch T (Fig. 13D).  729 
Notably, expression profiles of TLE-related genes in the L subgenome, but not those 730 
in the S subgenome, resemble those in X. tropicalis during development (Suppl. Fig. 14).  731 
These results suggest that the L subgenome retains an ancestral state conserved in X. tropicalis, 732 
but that the S subgenome lost some evolutionary constraints and was more readily altered. 733 
 734 
Conclusion 735 
In this study, we analyzed 416 genes involved in Wnt, Hh, Notch, and Hippo pathways in X. 736 
laevis. Also, 32 HSPG-related genes and 8 TLE/Groucho-related genes were analyzed.  737 
Among them, we found 29 singletons, 24 of which are located on L chromosomes, a rate 738 
similar to all analyzed genes (82.8% vs 74.6%). Through transcriptome correlation analysis, 739 
signaling genes are often HCDE (highly correlated but different expression levels) in adult 740 
tissues, compared with the genome average. This contrasts with genes encoding transcription 741 
factors, which are more similarly expressed between homeologs (high rate of HCSE) 742 
(Watanabe et al., in press). These results suggest that expression patterns and levels of 743 
signaling factors are variable after genome duplication. 744 
Considering the induction mechanism of differential expression, it is probably due to 745 
changes of transcriptional regulatory machineries, such as cis-regulatory sequences and 746 
epigenetic modifications. Indeed, preliminary epigenetic analysis showed that DNA 747 
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methylation levels and H3K4me3 enrichment on promoter regions, and p300 enrichment on 748 
enhancer regions are associated with differential expression levels of homeologs (Session et 749 
al., 2016). Our analyses illustrated three patterns of regulation and expression: 1. acquisition 750 
of a cis-regulatory sequence leads to increased expression of a homeolog (cer1, Figs. 4H and 751 
5B, see Sudou et al., 2012 for detail analysis on the sequence); 2. loss of a cis-regulatory 752 
sequence leads to decreased expression of a homeolog (sfrp1, Figs. 4G and 5C); 3. DNA 753 
methylation of the promoter leads to silencing of a homeolog (dlc, Figs 11A,C). Future 754 
functional analyses of these cis-regulatory modules (e.g. transgenic reporter assays) should 755 
reveal their roles in differential expression, leading to a better understanding of 756 
subfunctionalization after genome duplication.  757 
What biological meanings underlie the variable expression profiles of homeologs? 758 
One may be protein-protein incompatibilities, meaning L gene to L gene or S gene to S gene-759 
specific protein interactions. Actually, we observed more L gene-dominant expression profiles 760 
among signaling genes than S gene-dominant, consistent with whole genome analysis 761 
(Session et al., 2016). However, we did not find a strong tendency for genes from a given 762 
subgenome to predominate throughout a protein complex, such as ligand/receptor, 763 
enzyme/substrate, and transcription factor/cofactor complexes. Thus, there is no obvious 764 
protein-protein incompatibility regarding the genes from different subgenomes. More simply, 765 
it is likely that single copies of genes are sufficient for signal transduction, particularly 766 
enzymatic reactions. For instance, cytoplasmic components of Wnt and Hippo pathways and 767 
extracellular/membrane components of Notch pathway include many enzymes and exhibit 768 
many HCDE profiles (Table1, Figs. 4, 11, and 12, Suppl. Figs. 8, 12, and 13). The other 769 
possible meaning of variable expression is dosage compensation, due to the limited space for 770 
the distribution of extracellular, membrane, and cytoplasmic factors for signaling-pathway 771 
related genes after genome duplication. This contrasts with genes encoding transcription 772 
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factors, in which homeologs are more similarly expressed (Watanabe et al., in press) possibly 773 
because their working space, cis-regulatory modules, was also duplicated. 774 
Here we observed many cases of temporally and spatially subfunctionalized 775 
homeologous genes (mainly NCSE profiles). The underlying mechanism must be changes of 776 
stage/tissue-specific cis-regulatory regions. Epigenetic studies on each stage and tissue should 777 
provide more useful information about different uses of various enhancers for homeologs. 778 
How variable expression patterns, achieved by changes in transcriptional regulation, led to 779 
functional diversification will be addressed in the future. 780 
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<Figure legends> 982 
Fig. 1. Criteria and examples of transcriptome correlation analysis 983 
(A) Criteria for categorization of homeologous gene expression.  See Materials and Methods 984 
for details.  All results are presented in Suppl. Data3.  (B-E) Examples of four groups.  985 
Group names are presented in each graph.  In case of inconsistencies, group names in 986 
different clutches are presented separately.  (B) ctnnb1.L (β-catenin.L) and ctnnb1.S (β-987 
catenin.S) showed quite similar expression patterns (HCSE).  (C) maml1.L showed highly 988 
correlated, but stronger expression than maml1.S throughout developmental stages (st8-12) 989 
(HCDE).  (D) sdc4.L and sdc4.S showed different expression patterns during development 990 
(NCSE).  (E) numbl.L showed stronger expression than numbl.S and the two expression 991 
patterns are quite different throughout developmental stages.  (F) An example of inconsistent 992 
categories between clutches.  frat1.S was expressed at higher levels than frat1.L during 993 
development in Clutch T (HCDE), but both showed similar expression levels in Clutch U 994 
(HCSE).  Line graphs show expression levels of genes during oogenesis and embryogenesis.  995 
Magenta, L genes; Blue, S genes; circles, Clutch T; triangles, Clutch U. 996 
 997 
Fig. 2. Syntenic analyses of Wnt signaling-related singletons in X. laevis and X. tropicalis. 998 
(A) Schematic view of the Wnt signaling pathway. Categories based on subcellular 999 
localization are indicated at the right.  (B) Synteny around wnt2b. XLA2L retains conserved 1000 
synteny around wnt2b with X. tropicalis chromosome 2 (XTR2), but several rearrangements 1001 
may have occurred in XLA2S. (C) Synteny around rspo3. Complicated rearrangements were 1002 
observed on both L and S chromosomes. (D) Comparison of sfrp4 loci.  sfrp4.S was lost in 1003 
a large deletion (~23 Mb) between velo1 and sept7 on XLA6S. (E) Comparison of genomic 1004 
loci surrounding ppp2ca and tcf7. XLA3S retains conserved synteny with XTR3, even though 1005 
LOC100489679 was deleted. On the other hand, XLA3L lost tcf7 and there was a large 1006 
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inversion close to vdac1.L. In addition, a pseudogene of ppp2ca.L, shown with a dashed box, 1007 
was found between vdac1.L and LOC100488619.L. Magenta boxes show singletons involved 1008 
in Wnt signaling, except hey2 in (C), which is related to Notch signaling. Double diagonal 1009 
lines indicate a large gap between genes. Diagonal lines on the genome signify deletion of 1010 
genes. Dashed lines represent putative inversion events. In each panel, only representative 1011 
gene models are shown for comparison.  1012 
 1013 
Fig. 3. Frequent loss of wnt11b genes in vertebrate lineages and variable expression 1014 
patterns of wnt11a homeologs. 1015 
(A) Synteny around the wnt11b gene in vertebrates. wnt11b.S was deleted from X. laevis 1016 
chromosome 8S (XLA8S) together with neighboring genes. Orthologs of wnt11b were also 1017 
deleted in humans (HSAX) and medaka (OLA10). After the divergence of Xenopus and 1018 
Nanorana, a large inversion seems to have occured between igbp1 and stard10-like, as 1019 
indicated by dashed lines. (B) Synteny around the wnt11a gene in vertebrates. Although a 1020 
genomic rearrangement was found in XLA2L, wnt11a orthologs and synteny are highly 1021 
conserved among vertebrates. HSA, Homo sapiens; GGA, Gallus gallus (chicken); NPA, 1022 
Nanorana parkeri (Tibetan frog), XTR, Xenopus tropicalis; XLA, Xenopus laevis; LOC, 1023 
Lepisosteus oculatus (spotted gar); DRE, Danio rerio (zebrafish); OLA, Oryzias latipes 1024 
(medaka). (C) Expression profiles of wnt11a.L, wnt11a.S and wnt11b.L. Data are shown in 1025 
graphs similar to those in Fig. 1. See text for detailed explanations of variable expression 1026 
profiles. 1027 
 1028 
Fig. 4. Variable expression profiles of Wnt signaling-components (Wnt ligands, Frizzled 1029 
receptors, other extracellular/membrane factors, and cytoplasmic factors). 1030 
(A-K) Variable expression profiles of Wnt signaling components. Data are shown in graphs 1031 
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similar to those in Fig. 1. See text for detailed explanations of variable expression profiles. 1032 
 1033 
Fig. 5. Correlations of epigenetic states and variable expression profiles 1034 
(A-C) Genome browser representations of ChIP-seq and DNA methylation data using X. 1035 
laevis gastrula embryos (st10.5) demonstrated biased enrichment of H3K4me3 and p300 1036 
between homeologous genomic regions near axin2, cer1, and sfrp1. ChIP-seq results from 1037 
biological replicates are shown separately. Green, H3K4me3; yellow, p300; gray, DNA 1038 
methylation; bracket, strong enrichment of H3K4me3 on the promoter of the more strongly 1039 
expressed homeolog; arrowhead, strong enrichment of p300 on enhancers of the more strongly 1040 
expressed homeolog. (D) A vista plot represents sequence conservation in the genomic region 1041 
around sfrp1 in X. laevis and X. tropicalis. The sequence of sfrp1.L was used as a reference. 1042 
Light blue, UTR; dark blue, coding sequences; orange, conserved non-coding sequences. 1043 
Dashed lines and magenta boxes in (C) and (D) correspond to each other. 1044 
 1045 
Fig. 6. Variable expression patterns of Tcf/Lef genes. 1046 
(A) Schematic drawing of transcriptional regulation for Wnt target genes by Tcf/Lef. The Tcf 1047 
family has a β-catenin-binding domain and a TLE/Groucho-binding domain in addition to the 1048 
HMG box DNA-binding domain. When canonical Wnt signaling is off, Tcf protein represses 1049 
target genes by forming a complex with TLE transcriptional corepressors. When canonical 1050 
Wnt signaling is activated, β-catenin accumulates in the nucleus, Tcf forms a complex with β-1051 
catenin, and recruits other coactivators for transcription of target genes. (B-E) Expression 1052 
profiles of tcf/lef genes. Data are shown in graphs similar to those in Fig. 1. See text for 1053 
detailed explanations of variable expression profiles. 1054 
 1055 
Fig. 7. Schematic view of Hh signaling and syntenic analyses of its singletons 1056 
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(A) Overview of the Hedgehog (Hh) signaling pathway. Categories based on subcellular 1057 
localization are indicated at the right. (B-C) A schematic comparison of syntenies around kif7 1058 
(B) and stk36 (C) in X. tropicalis and X. laevis. Only representative gene models are listed for 1059 
comparison. Regions where corresponding gene models are missing on S chromosomes are 1060 
outlined in grey.  1061 
 1062 
Fig. 8. Variable expression profiles of Hh ligands and Ptch receptors. 1063 
(A) Expression profiles of Hh ligands. (B) Expression profiles of Ptch receptors. 1064 
Transcriptomic data are shown in graphs similar to those in Fig. 1. See text for detailed 1065 
explanations of differential expression. 1066 
 1067 
Fig. 9. Genes involved in heparan sulfate proteoglycans also showed variable expression 1068 
profiles 1069 
(A) Schematic diagram of Glypican (Gpc) and Syndecan (Sdc). Solid lines and branches show 1070 
core protein and glycosaminoglycan chains, respectively. N-deacetylase/N-sulfotransferase 1071 
(NDST) removes N-acetyl groups from GlcNAc of nascent sugar chains (N-acetyl heparosan) 1072 
and substitutes the free amino group with sulfate (N-sulfo HS). (B-D) Expression profiles of 1073 
gpc1, gpc2, sdc4, and ndst1. Transcriptomic data are shown in graphs similar to those in Fig. 1074 
1. See text for detailed explanations of variable expression. 1075 
 1076 
Fig. 10. Syntenic analyses of Notch signaling-related singletons 1077 
(A) Schematic view of the Notch signaling pathway. Categories based on subcellular 1078 
localization are indicated at the right. (B-H) Syntenies around singletons, shown in magenta 1079 
boxes, involved in Notch signaling. Pseudogenes are shown with dashed boxes (pofut1.S and 1080 
rfng.S). (C) A pseudogene of rfng.S and syntenic genes of rfng are located in scaffold_27 in 1081 
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the X. laevis genome. (D) In the X. tropicalis genome, dtx3l-like is located at the end of 1082 
scaffold_734, together with syntenic genes. Syntenic genes of dtx3l-like are located in 1083 
scaffold_27 in the X. laevis genome, but dtx3l-like is deleted. Taken together with rfng.S (C), 1084 
scaffold_27 seems to belong to XLA9_10S. (E) dtx3-like1.S was removed from XLA8S by a 1085 
large deletion. (F) dtx4.S was deleted together with neighboring genes from XLA7S. (G) 1086 
Together with the loss of neurl2.S in XLA9_10S, many syntenic genes became singletons via 1087 
pseudogenization. (H) In the X. tropicalis genome, neurl4 is located at the end of scaffold_393 1088 
together with syntenic genes. In XLA3L, neurl4.L and acap1.L are deleted, but their 1089 
homeologs are located with syntenic genes in scaffold_20. Together with the observation of 1090 
dvl2.S (see text), scaffold_20 seems to belong to XLA3S.  1091 
 1092 
Fig. 11. Variable expression of Notch signaling factors and its epigenetic basis 1093 
(A) Genome browser representations of ChIP-seq and DNA methylation data using X. laevis 1094 
gastrula embryos (st10.5) demonstrated biased enrichment of H3K4me3 and p300 between 1095 
homeologous genomic regions of dlc. A blue box shows highly demethylated region of the 1096 
dlc.L promoter. (B) A Vista plot shows conservation of p300 binding cis-regulatory regions 1097 
around dlc genes in Xenopus. See Fig. 5 for explanations of genome browser representations 1098 
and Vista plots. (C-H) Expression profiles of Notch signaling-related genes. Data are shown 1099 
in graphs similar to those in Fig. 1. See text for detailed explanations of variable expression 1100 
profiles. 1101 
 1102 
Fig. 12. Syntenic and transcriptomic analyses of Hippo signaling-related genes 1103 
(A) Schematic view of the Hippo signaling pathway. Categories based on subcellular 1104 
localization are indicated at the right. (B-E) Syntenies around singleton genes, which are 1105 
shown in magenta boxes, involved in Hippo signaling. A pseudogene, rassf4.S, is shown in a 1106 
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dashed box. (F-J) Expression profiles of Hippo pathway factors. Data are shown in graphs 1107 
similar to those in Fig. 1. See text for detailed explanations of variable expression profiles. 1108 
 1109 
Fig.13. Syntenic and transcriptomic analysis of TLE/Groucho genes 1110 
(A) Genomic organization of TLE/Groucho-related genes on XTR1, XLA1L, and XLA1S. 1111 
The homeolog with dominant expression is indicated at the bottom (L or S gene). (B-E) 1112 
Expression profiles of TLE-related genes. Data are shown in graphs similar to those in Fig. 1. 1113 
See text for detailed explanations of variable expression profiles. 1114 
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Table 1. Results of transcriptome correlation analysis 
 
 
       Developmental stages  Adult tissues        
  HCSE HCDE NCSE NCDE HCSE HCDE NCSE NCDE 
Signaling pathway components 
  Wnt signaling 
   Wnt ligands 1 4 2 1 7 2 2 0 
 Fzd receptors 0 5 1 1 4 3 0 1 
 Extracellular-Membrane Positive 2 2 2 0 1 3 1 0 
 Extracellular-Membrane Negative 6 8 2 2 7 4 2 0 
 Cytoplasmic 3 8 1 3 4 13 0 0 
 Nuclear 0 2 1 0 2 1 0 0 
    total 12 29 9 7 25 26 5 1      
  Hh signaling 
 Ligands 2 0 0 0 0 3 0 0 
 Receptor-Membrane 0 3 0 0 2 2 0 0 
 Cytoplasmic-Cilia-Nuclear 2 1 0 0 2 3 0 0 
    total 4 4 0 0 4 8 0 0      
  HSPG 
 Core protein 0 3 2 0 5 3 0 0 
 Enzyme 0 1 0 0 4 1 0 0 
    total 0 4 2 0 9 4 0 0      
  Notch signaling 
 Ligands-Receptors 1 1 1 0 1 2 0 0 
 Extracellular-Membrane 2 4 0 2 2 8 0 0 
 Cytoplasmic 1 4 2 1 7 4 0 0 
 Nuclear 0 1 1 0 3 1 0 0 
    total 4 10 4 3 13 15 0 0      
  Hippo signaling 
 Membrane 1 1 0 0 1 4 0 0 
 Cytoplasmic 7 9 3 2 5 13 1 0 
 Nuclear 0 2 0 0 1 2 0 0 
    total 8 12 3 2 7 19 1 0      
  TLE 0 3 0 0 0 3 0 0      
  total 28 62 18 12 58 75 6 1 
  total (%) 23.3 51.7 15.0 10.0 41.4 53.6 4.3 0.7    
Transcription factors  
     (Watanabe et al., submitted)  
  total 56 48 10 7 100 12 8 3 
  total (%) 45.5 39.0 8.1 5.7 81.3 9.8 6.5 2.4    
All annotated homeologous pairs 
     (Session et al., submitted) 
  total 1,061 1,960 480 674 2,263 2,655 307 369 
  total (%) 25.4 46.9 11.5 16.1 40.5 47.5 5.5 6.6    
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Highlights 
1. Genes of several signaling pathways are thoroughly characterized in Xenopus laevis.  
2. Conservation rate of homeologs is much higher than that of all genes in the X. laevis genome. 
3. Most homeologs show variable expression patterns, in contrast to transcription factors.  
4. Homeologs with variable expression profiles are probably subfunctionalized, enhancing 
environmental adaptability. 
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<Notes of Supplementary Data> 
Supplementary Data 1 
Suppl. Data 1 represents all transcriptome data of X. laevis analyzed in this study.  Tpm values of each 
gene in developmental stages and adult tissues of two clutches (T and U) are listed. 
 
Supplementary Data 2 
Suppl. Data 2 represents all transcriptome data of X. tropicalis analyzed in this study.  The average tpm 
values of RNA-seq data from biological replicates, which were sequenced in Tan et al., 2013, are listed. 
Gene names and IDs are based on X. tropicalis genome assembly v9. 
 
Supplementary Data 3 
Suppl. Data 3 represents all gene names, IDs, and results of the transcriptome correlation analysis.  In 
columns D and G, newly annotated genes and manually corrected gene models in this study are shown 
in yellow.  Some gene names used in this study are different from names in v1.8.3 annotation, which 
are shown in orange.  In columns from I to N, results of the transcriptome correlation analysis are 
indicated.  n/a means that a homeolog is not expressed in TPM>0.5 throughout all stages/tissues.  inc. 
means that categorized groups in Clutch T and U are inconsistent. 
 
<Supplemental figure legends> 
Suppl. Fig. 1. Syntenic analyses of singleton genes involved in Wnt signaling 
(A) Comparison of genomic loci around porcn.  In X. tropicalis, porcn is located in scaffold_5369 
where there is no other gene model.  In X. laevis, porcn.S is eliminated from XLA8S by a single gene 
deletion.  Syntenic genes of porcn (ebp and tbc1d25) are also located in scaffolds but not in 
chromosome assemblies in X. tropicalis.  Especially, ebp was found in genome assembly v4.1 but not 
found in v9.  (B) Syntenic analysis of csnk1g2.  csnk1g2.S is deleted by a large deleteion (~100 kb) 
together with surrounding genes.  (C) Pseudogenes.  BLAT search revealed pseudogenes for dkkx.S, 
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notum2.S, shisa4.L, and trabd2a.S (tiki1.S).  Dashed line boxes indicate pseudogenes.  Magenta boxes 
are genes involved in the Wnt signaling. 
 
Suppl. Fig. 2. Analyses on wnt11 genes 
(A) A phylogenic tree of wnt11 genes using amino acid sequences.  Alignments of sequences were 
performed with MAFFT (v7.221) (Katoh et al., 2002) using the auto strategy.  Unaligned regions were 
trimmed with TrimAl (v1.2rev59) (Capella-Gutiérrez et al., 2009) using the gappyout option.  The 
maximum likelihood method with PROTGAMMAAUTO was used to construct phylogenetic trees with 
RAxML (v8.2.0) (Stamatakis, 2014).  Bootstrap support values for nodes are indicated (n=100).  
Wnt11 of amphioxus (Bfl_wnt11) was used as an outgroup.  Vertebrate Wnt11 genes were separated 
into two clades, Wnt11a and Wnt11b.  A scale bar of branch length indicates substitutions per site.  
Hsa, Homo sapiens; Gga, Gallus gallus (chicken); Npa, Nanorana parkeri (Tibetan frog), Xtr, Xenopus 
tropicalis; Xla, Xenopus laevis; Loc, Lepisosteus oculatus (spotted gar); Dre, Danio rerio (zebrafish); 
Bfl, Branchiostoma floridae (amphioxus). (B) Expression profiles of wnt11 genes (wnt11a, wnt11b.1, 
and wnt11b.2) in X. tropicalis are represented in line graphs.  See text for detailed explanations. 
References: 
Capella-Gutierrez, S., Silla-Martinez, J.M., Gabaldon, T., 2009. trimAl: a tool for automated alignment 
trimming in large-scale phylogenetic analyses. Bioinformatics (Oxford, England) 25, 1972-1973. 
Katoh, K., Misawa, K., Kuma, K., Miyata, T., 2002. MAFFT: a novel method for rapid multiple 
sequence alignment based on fast Fourier transform. Nucleic acids research 30, 3059-3066. 
Stamatakis, A., 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large 
phylogenies. Bioinformatics (Oxford, England) 30, 1312-1313. 
 
Suppl. Fig. 3. Variability of gene expression patterns in Wnt signaling genes. 
(A-D) The distribution of Pearson’s correlation coefficient scores was shown by box-whisker plots 
separately for stages and tissues of each clutch. Genes are categorized into their subcellular localizations 
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according to Fig. 2A. The statistical significance of the difference between categories was examined by 
2x2 Fisher’s exact test. 
 
Suppl. Fig. 4. Transcriptomic analyses of Wnt ligands 
Expression profiles of homeologs of wnt2 (A), wnt4 (B), wnt6 (C), wnt7a (D), wnt7c (E), wnt8a (F), 
wnt9b (G), wnt10a (H). (A) wnt2.L shows slightly strong expression around st.25.  (B) Expression 
patterns of wnt4 homeologs are categorized as HCDE and L gene is dominant in both embryos and adult 
tissues.  (C) Expression patterns of wnt6 homeologs are categorized as NCSE in both embryos and 
adult tissues.  (D) wnt7a is categorized as NCDE at developmental stages but HCSE in the adult.  (E) 
Expression levels of wnt7c homeologs are very low at developmental stages, while they are high in 
brain, eye and skin of the adult.  (F) wnt8a shows HCDE pattern in embryos but low expression in 
adults.  wnt8a.L is more strongly expressed during gastrulation.  (G) wnt9b is categorized as HCDE in 
embryos and as NCSE and HCSE in adult tissues of Clutch T and U.  wnt9b.S is highly expressed 
during tailbud stage and in kidney.  (H) L gene of wnt10a shows slightly higher expression especially 
after neurulation stage and in lung.   
 
Suppl. Fig. 5. Transcriptomic analyses of Fzd receptors 
(A) Expression profiles of fzd2 homeologs are categorized as HCDE in both embryos and adult tissues.  
As well as in embryonic stages, fzd2.S is more strongly expressed in adult tissues.  (B) Expression 
profiles of fzd4 homeologs are also categorized as HCDE.  fzd4.S is dominantly expressed in embryos 
and in some adult tissues such as lung, ovary, stomach, and testis.  (C) fzd8.S has around 2-fold 
expression levels to fzd8.L in embryonic stages from st10 to 30, categorized as HCDE.  In adult tissues, 
fzd8.S showed slightly higher expression in heart, intestine, spleen, and stomach and categorized as DE 
in both clutches.  (D) fzd9.L showed stronger expression in adult tissues and its expression levels are 
not correlated with fzd9.S (NCDE).  fzd9.L is also more heavily expressed throughout developmental 
stages in Clutch T but not in Clutch U. (E) fzd10.L tends to be expressed at higher levels, although 
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categories were inconsistent between clutches. 
 
Suppl. Fig. 6. Transcriptomic analyses of Wnt signaling related genes categorized in EC/M-pos 
(A) lgr4.S shows higher expression through developmental stages, categorized as HCDE, and it also 
shows slightly higher expression in heart and intestine of the adult.  (B) Expression profiles of lgr5 
homeologs show NC patterns in embryos and in adult tissues of Clutch U.  lgr5.L is more strongly 
expressed in testis. (C) lrp6.L is more strongly expressed in egg to blastula (st8, 9), but lrp6.S is more 
strongly expressed in adult tissues (about 2-fold in many cases), resulting in NCSE (stages) and HCDE 
(tissues).  (D) ndp homeologs show high expression after gastrulation stage, but their expression levels 
are not highly correlated especially in Clutch U.  ndp.L is dominantly expressed in brain, eye, intestine, 
and lung, whereas ndp.S predominates in ovary, resulting in NCSE.  (E) Expression levels of rspo1 
homeologs are very low during embryogenesis (TPM <1) but rspo1.L appears to be dominant.  
Similarly, rspo1.L is more strongly expressed in adult tissues such as brain, intestine, and spleen, 
showing DE patterns.  (F) Expression profiles of ryk homeologs are categorized as HCDE in both 
embryos and adult tissues, in which the S gene is dominant. 
 
Suppl. Fig. 7. Transcriptomic analyses of Wnt signaling-related genes categorized in EC/M-neg 
(A) Expression profiles of apcdd1 show dominant expression of apcdd1.L during early embryogenesis 
(eggs to st10) and in ovary.  (B) Expression profiles of dkk3 homeologs show DE patterns in both 
embryos and adult tissues.  dkk3.L is dominantly expressed in embryos and many tissues.  However, 
it should be noted that dkk3.S is more strongly expressed in heart.  (C) Expression profiles of frzb 
homeologs show HCSE patterns in both embryos (Clutch U) and adult tissues (two clutches).  
However, frzb.L shows higher expression in brain and heart, and frzb.S shows higher expression in 
spleen.  (D) Expression profiles of kremen1 homeologs in adult tissues are categorized as HCDE, in 
which kremen1.L is more strongly expressed in many adult tissues such as brain and testis.  (E) 
notum1.S is more strongly expressed during development, resulting in HCDE.  However, notum1.L is 
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more strongly expressed in brain, eye, and testis.  Interestingly, expression levels of notum1 homeologs 
in lung show a high inter-clutch variation.  (F) Expression profiles of rnf43 homeologs in embryos and 
adult tissues show HCDE and NCSE profiles.  rnf43.S is more strongly expressed in embryos and in 
intestine, ovary, and skin.  However, rnf43.L is more strongly expressed in heart.  (G) Expression 
profiles of sfrp5 homeologs show NCSE patterns with changing the dominant homeolog from S to L 
around st30 during development, but HCSE patterns in adult tissues.  (H) Expression profiles of sfrpx 
homeologs are categorized as DE in both embryos and adult tissues.  sfrpxS is more strongly expressed, 
especially in oocytes, blastula to gastrula stages (st8-10), and ovary.  (I) Expression profiles of shisa1 
homeologs show that shisa1.L has stronger expression from oogenesis stage (oo12) to blastula stage 
(st9) and in ovary (HCDE in embryos).  (J) Expression profiles of shisa2 homeologs show L-dominant 
HCDE patterns in both embryos and adult tissues.  (K) Expression profiles of sostdc1 homeologs in 
embryos are categorized as NCSE at developmental stages.  sostdc1.S is dominantly expressed in 
gastrula stages (st10, 12), while sostdc1.L expression increases from st15 and, at the same time, 
sostdc1.S expression starts to decrease.  In adult tissues, sostdc1 homeologs show HCDE (Clutch T) 
and HCSE (Clutch U) profilles.  (L) Expression levels of trabd2b (tiki2) homeologs are very low 
especially in Clutch U, although they show a HCDE profile with stronger expression of the L gene in 
Clutch T.  In adult tissues. trabd2b homeologs show NCSE profiles.  (M) Expression profiles of tpbg 
homeologs in embryos are HCDE, in which tpbg.S show higher expression from eggs to st10.  tpbg.S 
is also more strongly expressed in ovary and testis (Clutch T), although tpbg is categorized as HCSE in 
adult tissues.  (N) Expression profiles of wif1 homeologs are HCDE in adult tissues.  wif1.L show 
dominant expression in some adult tissues, intestine, kidney, ovary, and spleen.  (O) Expression 
profiles of znrf3 homeologs are categorized as NCDE at developmental stages but HCSE (Clutch T) or 
HCDE (Clutch U) in adult tissues.  znfr3.L has stronger expression from egg to blastula (st9).   
 
Suppl. Fig. 8. Transcriptomic analyses of Wnt signaling-related genes categorized in CP 
(A) Expression profiles of axin1 show L gene-dominant HCDE patterns in adult tissues, whereas they 
© 2017 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
show a S gene-dominant HCDE pattern in embryos of Clutch U.  (B) ccdc88c.L is dominantly 
expressed in embryos and adult tissues, resulting in DE profiles.  (C) csnk1a1 homeologs also show L 
gene dominant expression profiles in embryos and adult tissues.  (D) Expression profiles of csnk1d 
homeologs are also HCDE in embryos with stronger expression of the L gene.  In adult tissues, they 
are similarly expressed (especially in Clutch U).  (E) Conversely, csnk2a1 homeologs show S 
gene-dominant DE profiles in embryos and adult tissues.  (F) Expression profiles of csnk2b homeologs 
also show S gene-dominant patterns in embryos and adult tissues, categorized as DE.  (G) ctnnb1 
(β-catenin) homeologs are similarly expressed in embryos (also shown in Fig. 1B; HCSE), but 
differently expressed in adult tissues (HCDE).  (H) ctnnbl1 (β-catenin-like 1) homeologs are also 
expressed during development and in adult tissues, but their expression levels are much weaker than 
those of ctnnb1.  Similar to ctnnb1, ctnnbl1.S has slightly stronger expression.  (I) Expression profiles 
of cxxc4 homeologs show L gene-dominant HCDE patterns in adult tissues and embryos of Clutch U.  
In embryos of Clutch T, cxxc4 homeologs show quite similar expression profiles (HCSE).  (J) dvl1.L is 
dominantly expressed during development (NCDE) and in adult tissues (HCDE).  However, dvl1.S has 
strong expression in some tissues such as brain, intestine, and lung.  (K) dvl3.L is also dominantly 
expressed during development and in adult tissues (HCDE).  Expression of dvl3 homeologs is mainly 
in ovary and in eggs to st10 (maternal expression).  (L) gsk3.L is more strongly expressed in embryos 
and all tissues, resulting in HCDE. 
 
Suppl. Fig. 9. Transcriptomic analyses of genes involved in the Hh signaling 
Expression profiles of smo (A), hhip (B), gli1 (C), gli2 (D), gli3 (E), prkaca (F), kif7 (G), stk36 (H), 
sufu (I), arl13b (J) and foxj1 (K).  (A)in smo is categorized as HCDE in both embryos and adult tissues.  
The expression level of smo.L increases from blastula (st8) to tailbud stage (st25), consistent with the 
essential role of Hh signaling for neural patterning.  L gene of smo is also dominant in many tissues, 
such as eye, heart, kidney, lung ovary and testis. Epigenetic analysis of smo is in Suppl. Fig. 10A.  (B) 
hhip.L is dominantly expressed in both embryos and adult tissues. (C-E) Expression patterns of gli 
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genes are highly correlated but in many developmental stages and adult tissues.  During embryogenesis, 
all gli genes shows higher expression from gastrula stage, consistent with the importance of Hh 
signaling in neural patterning.  The difference in their expression level of homeologs is detected in gli2 
(in both clutches).  The S gene shows higher expression.  In adult tissues, their expression levels are 
categorized as DE in gli1 and gli2, but SE in gli3.  (F) Expression patterns of prkaca homeologs are 
highly correlated (HC) in both embryos and adult tissues but expression levels are inconsistent between 
clutches.  (G-H) kif7.L and stk36.L are singletons. These two genes are highly expressed during 
oogenesis and/or early embryonic stages. In adult, kif7.L is high in testis, stk36.L is high in ovary and 
testis. sufu homeologs are similarly expressed in both embryos and adult tissues, especially they are 
highly expressed in blastula stages (st8-9), ovary and testis. (I) sufu homeologs show correlated 
expression, categorized as HCSE.  (J-K) Expression profiles of genes involved in ciliogenesis. 
arl13b.L is dominantly expressed during embryogenesis, especially around gastrula stages (st9-12) (J), 
while foxj1.S shows slightly higher expression during neurula stages (st12-15) (K).  
 
Suppl. Fig. 10. Epigenetic analyses of smoothened gene 
(A) ChIP-seq data at st10.5 showed stronger enrichment of H3K4me3 and p300 at the promoter and 
enhancer of smo.L than of smo.S. (B) Enhancer sequences are globally conserved between smo.L, smo.S, 
and X. tropicalis smo.  
 
Suppl. Fig. 11. Transcriptomic analyses of HSPG-related genes 
(A-E) Expression profiles of glypicans.  Expression levels of glypican genes during embryogenesis are 
similar between homeologs (A-D and Fig. 9B), except for gpc4 during neurulation stages, at which the 
L gene predominated (Suppl. Fig. 11C). In adult tissues, glypicans are highly expressed in brain, 
including gpc3 and gpc6, which are not highly expressed during embryogenesis (B,E). Comparing each 
homeologous gene pair, L gene expression levels of gpc1, gpc2, and gpc4 are higher in many tissues, 
categorized as HCDE, except gpc4 in clutch U.  
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(F-I) Expression profiles of ndst and sulf genes. (F) ndst1 shows HCSE pattern in adult tissues(G) L 
gene of ndst2 is dominantly expressed in embryonic stages and adult tissues, categorized as HCDE. (H) 
During embryonic stages, sulf1.L is more highly expressed. Especially, sulf1.L was highly expressed at 
around the early neurula stage (st12). (I) Homeologous genes of sulf2 show not highly correlated 
patterns (HC) but slightly similar expression patterns during embryogenesis.  The expression levels are 
slightly different at tailbud stage.  In the adult tissues, the gene shows HCSE pattern.  
 
Suppl. Fig. 12. Transcriptomic analyses of Notch signaling genes 
Expression profiles of dlc (A), notch1 (B), notch2 (C), notch3 (D), psen2 (E), psenen (F), furin (G), 
pofut2 (H), dtx5 (I), skp1 (J), nedd4 (K), mib1 (L), numb (M), hey1 (N), maml2 (O) and maml3 (P). (A) 
Expression levels of dlc homeologs are categorized as SE in both clutches.  (B-D) Expressions of notch1, 
notch2, notch3 genes show highly correlated patterns in the adult tissues and the expression level was 
categorized as DE, except for notch2.  During embryogenesis, notch3 homeologs show no-significant 
correlated expression patterns (NC).  Expression of the S gene is a little bit high at st8 and st15-30, 
while that of the L gene is high at st10-15.  (E-G) psen2, psenen and furin are categorized as HCDE in 
both embryos and adult tissues.  Particularly, L gene of psen2 is dominant from oogenesis stage to st9 
(E).  (H) pofut2 shows NCDE pattern during embryogenesis (L gene is dominant from egg stage to st12), 
but HCDE pattern in the adult tissues.  (I-M) Expressions of cytoplasmic genes are categorized as 
HCDE (dtx5 (I), mib1 (L), numb (M)) or NCDE (skp1 (J)), except for a gene categorized different group 
between clutches (nedd4 (K)).  In both clutches, nedd4 shows different expression levels (DE).  These 
results suggest that cytoplasmic factors also have been changed their expression pattern between each 
homeolog after genome duplication.  (N-P) hey1 shows NCSE pattern in developmental stages (N), and 
maml3 shows HCDE pattern in adult tissues (P).  maml2 (O) shows inconsistent pattern between 
clutches but in both clutches the gene shows different expression levels between homeologs (DE). 
 
Suppl. Fig. 13. Transcriptomic analyses of Hippo signaling-related genes 
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(A-C) Expression profiles of transmembrane factors. (A) crb2 is categorized as HCSE during 
embryogenesis but HCDE in adult tissues. crb2.L is highly expressed in adult eye and heart. (B-C) fat1 
and fat2 show different expression levels between each homeolog in both embryos and adult tissues.  
In particular, expression level of fat1.S is higher than fat1.L in intestine (B) and expression level of 
fat2.S is higher than fat2.L during early neurula to late tailbad stage (st15-40) (C). (D-W) Expression 
profiles of cytoplasmic factors. (D) Although statistical results were not consistent between clutches, 
amot1.L is high during oogenesis and early embryogenesis stages and amot1.S is high after gastrulation 
(from st12) in developmental stages. In adult tissues, amot1.S is highly expressed in ovary and testis, 
categorized as NCSE. (E) ctnna1 homeologs show HCDE pattern in both embryos and adult tissues. 
Expression level of ctnna1.S is higher than ctnna1.L during gastrula to early neurula (st10-15). The S 
gene is also dominant in many tissues, including heart, intestine, kidney, lung and skin. (F) frmd6 
homeologs show no-significant correlated expression pattern (NC). frmd6.L is highly expressed during 
blastula (st8-9). (G-H) Expression level of llgl1 (G) and llgl2 (H) is particularly high during blastula 
(st8-9). llgl2 is also highly expressed in ovary. Particularly, llgl1 is categorized as NCSE. (I) Both L and 
S gene of mob1a is maternally expressed. They show highly correlated expression patterns (HC). (J) 
mob1b shows NCSE pattern. (K-O) Homeologs of nf2 (K), prkci (L), ptpn14 (M), rassf2 (N) shows 
different expression levels (DE), and homeologs of sav1 (O) show NCSE pattern at least in one clutch. 
nf2 (K), prkci (L), ptpn14 (M), rassf2 (N) and sav1 (O) are highly expressed during blastula (st8-9) and 
early gastrula (st10). (P) scrib shows HCDE pattern in embryos and adult tissues. Especially, scrib.L is 
highly expressed in ovary. (Q-R) stk3 (Q) and stk4 (R) shows HCDE pattern at least in one clutch. (S) 
Homeologs of tjp2 show different expression levels (DE). tjp2.L is highly expressed during neurula 
(st12-20). (T) Expression levels of tjp3homeologs are different (DE). (U) wwc1.S is highly expressed 
during blastula (st8-9), categorized as NCDE. (V-W) Genes of wwc2 and wwc3 are categorized as 
HCDE. Expression level of wwc2.S is higher than wwc2.L during blastula and neurula (st8-15) and 
many adult tissues such as lung, heart and kidney (V). Expression level of wwc3.L is higher than 
wwc3.S in heart and lung (W). 
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(X-Z) Expression profiles of nuclear factors. (X) taz.L, a singleton,  is strongly expressed throughout 
oogenesis to early embryogenesis (oo12-st40) and in ovary. (Y-Z) tead1 and vgll4 show different 
expression level at least in one clutch. tead1.S (Y) and vgll4.L (Z) are highly expressed compared to 
each homeolog during blastula to early gastrula (st8-10). 
 
Suppl. Fig. 14. Expression profiles of yap1 and taz in X. tropicalis 
In contrast to X. laevis (Suppl. Fig. 13X), expression of X. tropicalis taz is highly specific in early 
embryonic stages and greatly decreases at the early neurula stage (st13).  On the other hand, yap1 is 
continuously expressed during X. tropicalis development similarly to that in X. laevis (Fig. 12J). 
 
Suppl. Fig. 15. Comparison of expression profiles of TLE/Groucho genes between Xenopus 
tropicalis genome and Xenopus laevis L and S subgenomes 
Expression profiles of TLE genes during embryonic development are compared between X. tropicalis 
genes (A), X. laevis L genes (B), and X. laevis S genes (C).  For comparison, all examined stages are 
aligned and the same abscissa is used for each species.  For X. laevis genes, averages of tpm values in 
Clutch T and U are shown in graphs. 
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*Singletons (12/108). **RNAseq data was not found in a homeologue due to the loss of 
gene model. 
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Supplementary Table 2. Hh signaling pathway related genes analyzed in this study. 
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Supplementary Table 3. HSPG related genes analyzed in this study. 
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*Singletons (8/48). ** RNAseq data was not found in a homeologue due to the loss of gene 
model. 
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Supplementary Table 5. Genes in the Hippo signaling pathway analyzed in this study 
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gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
Wnt signaling_Wnt ligands wnt1.L 0 0 0.03 0.04 0.04 3.85 3.87 4.56 1.28 0.34 0.21 wnt1.S 0.63 2.25 3.1 5.32 6.72 14.48 13.51 13.58 5.43 3.54 3.18 wnt1.L 0 0 0.02 0 0.04 0 0 0 3.9 1.46 1.4 0.2 0.12 0 wnt1.S 0.78 1.8 1.13 0.2 0.97 1.84 3.81 3.97 7.14 2.31 2.72 1.74 1.61 0.67
Wnt signaling_Wnt ligands wnt2.L 0.3 0 0 0 0 0 0.1 1.74 0.76 0.06 0.18 wnt2.S 0 0 0 0 0 0 0 0.09 0.07 0.15 0.12 wnt2.L 0.02 0.06 0.05 0 0.13 0 0 0 0 0 0.74 0.45 0.02 0.11 wnt2.S 0.06 0.07 0.19 0 0 0 0 0.17 0.14 0 0 0 0.04 0
Wnt signaling_Wnt ligands wnt2b.L 0 0 0 0 0.15 11.38 12.69 7.47 3.26 2.1 2.91 wnt2b.L 0 0 0 0 0 0 0 0 1.5 2.5 2.4 0.88 1.05 0
Wnt signaling_Wnt ligands wnt3.L 0 0 0 0 0 0.78 1.11 1.29 1.26 0.99 0.48 wnt3.S 0 0.36 0 0 0 0 0.18 0 0.1 0 0.09 wnt3.L 0.09 0 0.12 0 0 0 0 0 0 1.88 1.34 1.4 0.94 0 wnt3.S 0.04 0.11 0.18 0 0 0 0 0 0 0 0 0 0.06 0
Wnt signaling_Wnt ligands wnt3a.L 0 0 0.02 0 0.71 5.59 4.28 3.5 0.97 0.52 0.63 wnt3a.S 0 0 0 0 0.11 0.59 1.3 1.09 0.06 0.25 0 wnt3a.L 0 0 0 0 0 0 0.02 0.22 3.84 0.31 0.43 0.27 0.35 0 wnt3a.S 0 0 0 0 0 0 0 0.27 0.56 0.09 0.38 0.05 0.06 0
Wnt signaling_Wnt ligands wnt4.L 0 0.27 0.09 0.64 1.7 26.35 18.64 12.35 3.33 2.15 2 wnt4.S 0 0 0.13 0 0 2.13 1.62 1.57 1.12 0.93 0.25 wnt4.L 0.02 0.05 0.14 0 0 0.26 0.11 0.86 12.85 10.12 6.04 3.47 1.47 0 wnt4.S 0 0 0.07 0 0 0 0 0 0.15 0.92 1.4 0.82 0.32 0
Wnt signaling_Wnt ligands wnt5a.L 0.06 4.88 5.28 4.83 1.7 6.37 5.58 8.32 2.8 0.88 0.95 wnt5a.S 2.93 17 15.53 8.88 6.53 9.13 6.65 5.78 3.81 2.48 2.24 wnt5a.L 0.02 0 0.13 0 2.81 2.9 0.89 0.68 3.3 2.85 4.02 2.45 1.53 0.05 wnt5a.S 0.47 0.92 0.76 3.29 10.5 9 2.56 3.6 5.39 2.95 3.2 1.42 1.54 0.71
Wnt signaling_Wnt ligands wnt5b.L 0.18 0.19 0.47 15.87 53.11 57.13 40.24 29.05 18.58 14.81 15.49 wnt5b.S 0.1 0.73 1.58 15.34 33.49 28.32 23.54 15.35 7.35 3.25 2.68 wnt5b.L 2.42 1.28 3.95 0 0.66 0.72 32.89 57.73 60.54 67.88 43.61 20.26 14.61 0 wnt5b.S 1.06 0.63 1.2 0.42 0.32 0.53 36.44 59.64 40.57 52.01 31.34 8.08 3.54 0.14
Wnt signaling_Wnt ligands wnt6.L 0 0 0.05 0 0.06 0.93 0.73 2.18 2.88 3.24 0.74 wnt6.S 0 0.71 0.14 0 0 0 0.14 2.1 0.47 1.08 0.13 wnt6.L 0 0 0.03 0.04 0 0.05 0 0.14 0 0.44 2.37 2.09 0.97 0 wnt6.S 0.06 0.08 0.51 0 0.37 0.27 0.51 0.19 0 0.36 1.48 0.29 0.16 0
Wnt signaling_Wnt ligands wnt7a.L 0 0 0.31 0.19 0.18 0.32 0.64 1.11 1.77 3.92 2.49 wnt7a.S 0.08 1.02 1.44 1.46 1.6 1.11 1.73 1.75 2.49 1.9 1.13 wnt7a.L 0 0 0 0 0 0 1.14 0.43 0.18 0.54 1.05 3.31 3.34 0 wnt7a.S 0.57 0.85 1.01 0.22 1.23 1.79 1.31 1.34 1.35 1.5 1.66 2.57 1.71 0.18
Wnt signaling_Wnt ligands wnt7b.L 0 0 0 0 0 0 0 0.45 0.82 0.41 0.62 wnt7b.S 0 0 0 0 0 0.95 1.75 1.24 0.18 0.5 0.45 wnt7b.L 0 0 0 0 0 0.08 0 0 0 0 0 0.54 0.47 0 wnt7b.S 0 0 0 0 0 0 0 0 0.18 0.54 0.3 0.4 0.33 0
Wnt signaling_Wnt ligands wnt7c.L 0 0 0 0.04 0.12 0 0.04 0.09 0 0.02 0.09 wnt7c.S 0 0 0 0 0 0 0 0 0.09 0.2 0 wnt7c.L 0.01 0 0 0 0 0 0 0.05 0.29 0.03 0.1 0.04 0.06 0 wnt7c.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wnt signaling_Wnt ligands wnt8a.L 0 0.87 15.77 178.81 150.33 32.97 35.93 23.72 5.92 0.39 0 wnt8a.S 0 0 4.02 47.36 64.67 16 17.03 10.09 1.39 0.06 0.04 wnt8a.L 0 0.15 0 0 0 12.22 240.91 233.12 75.91 11.96 16.32 2.96 0.1 0 wnt8a.S 0 0 0 0 0 4.03 62.69 80.32 23.41 7.76 8 0.61 0.03 0
Wnt signaling_Wnt ligands wnt8b.L 0 0.07 0.07 0.21 0.48 4.97 3.31 2.23 0.65 0.18 0.2 wnt8b.S 0 0 0.05 0.26 10.74 8.38 6.29 5.68 2.06 0.52 0.55 wnt8b.L 0 0.07 0 0 0.18 0.03 0.21 0.15 1.74 0.18 0.2 0.09 0.11 0 wnt8b.S 0.01 0.03 0 0 0 0.05 0.53 9.01 7.63 0.8 0.63 0.25 0.31 0
Wnt signaling_Wnt ligands wnt9a.L 0.03 0 0.02 0.12 0.05 0.84 0.77 2.07 1.59 1.05 1.31 wnt9a.S 0 0 0 0 0.46 2.55 3.8 4.19 2.08 1.23 1 wnt9a.L 0.02 0 0.04 0.02 0 0 0.02 0.06 0.73 0.16 0.42 0.25 0.37 0 wnt9a.S 0 0.01 0 0 0 0 0 0.25 0.86 0.37 0.87 0.46 0.43 0
Wnt signaling_Wnt ligands wnt9b.L 0 0 0.14 0.17 0 0.28 0.85 1.43 1.73 1.61 0.87 wnt9b.S 0.23 0.14 0.33 0.4 0.32 0.48 1.46 3.87 4.49 4.84 2.47 wnt9b.L 0 0 0.07 0 0 0.41 0.17 0 0.32 0.72 0.94 2.08 1.25 0 wnt9b.S 0.02 0.03 0.02 0.29 0.31 0.51 0.58 0.13 0.27 1.45 3.58 4.46 2.98 0.33
Wnt signaling_Wnt ligands wnt10a.L 0 0 0 0 0 9.3 7.93 7.65 5.85 4.42 1.16 wnt10a.S 0 0 0.02 0 0 0.63 1.28 2.86 2.48 1.24 0.5 wnt10a.L 0.02 0.02 0 0 0 0 0 0.05 4.73 2.28 3.01 1.91 1.42 0.04 wnt10a.S 0 0 0 0 0 0.07 0.03 0 0.13 0.64 1.03 1 0.79 0
Wnt signaling_Wnt ligands wnt10b.L 0 0 0 0 0.2 0.99 1.19 3.19 1.99 1.89 1.47 wnt10b.S 0.43 1.23 1.47 0.62 0.28 0.55 0.97 1.62 1.89 1.37 1.12 wnt10b.L 0 0 0 0 0 0 0.05 0 0.21 0.19 0.65 1.21 1.21 0 wnt10b.S 0.39 1.11 0.98 0.05 0.48 0.48 0.15 0.09 0.14 0.16 0.27 0.38 0.43 0
Wnt signaling_Wnt ligands wnt11a.L 0 0 0 2.6 11.75 8.5 12.71 15.24 16.91 13.78 10.82 wnt11a.S 0 0 0 0.19 6.85 2.82 6.33 9.09 5.88 2.79 1.8 wnt11a.L 0.01 0.04 0 0 0 0 1.48 12.6 6.45 5.38 8.56 12.39 10.08 0 wnt11a.S 0 0 0 0 0 0 0.19 7.76 2.84 5.66 7.32 5.85 2.62 0
Wnt signaling_Wnt ligands wnt11b.L 152.97 77.81 99.15 156.36 194.16 89.38 71.29 58.11 48.99 27.13 14.19 wnt11b.L 146.73 68.92 120.62 240.85 120.38 96.06 176.85 301.2 158.66 58.27 52.76 40.66 22.23 240.35
Wnt signaling_Wnt ligands wnt16.L 0 0 0 0.17 0 0 0 0.79 0.4 0.18 0.14 wnt16.S 0 0.58 0.43 0.17 0 0 0 0.23 0.32 0.09 0.21 wnt16.L 0 0 0 0 0 0 0 0 0 0 0.28 0.15 0.12 0 wnt16.S 0 0.26 0 0.12 0.56 0.42 0 0 0 0.12 0 0 0 0
Wnt signaling_Fzd receptors fzd1.L 51.33 76.53 54.53 9.79 1.23 4.9 6.49 7.15 8.99 8.36 10.8 fzd1.S 6.51 17.04 22.12 6.48 0 1.11 2.15 2.53 2.47 3.46 3.62 fzd1.L 8.58 11.38 7.55 85.57 76.85 60.48 4.16 0.7 1.67 4.73 5.38 5.77 5.27 82.79 fzd1.S 1.96 1.68 4.97 30.62 56.12 39.63 2.12 0.25 0.52 2.39 3.18 2.08 2.02 27.3
Wnt signaling_Fzd receptors fzd2.L 0.15 0 0 1.22 3.55 6.69 4.04 4.59 4.72 4.13 3.33 fzd2.S 0.69 0.74 0.93 8.12 19.18 36.88 27.82 29.37 35.3 31.26 34.05 fzd2.L 0 0 0 0.71 0 0.18 2.25 3.58 5.07 14.48 16.25 12.29 9.2 0.97 fzd2.S 0.54 1.68 0.44 3.23 0.45 0.48 8.35 17.61 40.72 45.61 39.35 37.16 31.99 2.99
Wnt signaling_Fzd receptors fzd3.L 0.8 7.38 8.78 10.29 11.77 32.76 24.97 25.25 25.1 17.49 13.31 fzd3.S 0.45 1.67 2.06 5.12 9.04 17.59 13.84 12.74 15.26 10.51 7.96 fzd3.L 0.45 0.68 2.63 0.57 5.24 6.5 7.2 11.3 22.69 9.63 10.94 8.38 6.37 0.41 fzd3.S 0.92 0.77 2.45 0.34 0.89 1.84 7.05 11.05 15.72 10.15 10.18 8.56 5.67 0.18
Wnt signaling_Fzd receptors fzd4.L 0 0 0.8 0.96 1.95 1.85 1.52 1.9 0.78 1.18 0.28 fzd4.S 7.48 5.8 10.28 19.3 43.38 30.3 20.58 16.28 16.34 11.13 7.92 fzd4.L 0.03 0 0.42 0.1 0 0.34 0.56 3.34 0.52 1.59 1.44 0.95 0.42 0.13 fzd4.S 3.68 4.96 6.81 7.46 5.27 8.52 12.74 38.69 26.24 23.13 16.53 12.34 9.04 5.39
Wnt signaling_Fzd receptors fzd5.L 0.3 7.34 9 7.1 1.84 4.26 6.17 13.7 5.97 3.24 2.36 fzd5.S 0.73 1.84 1.7 0.84 2.08 1.92 3.56 9.52 9.25 5.62 3.45 fzd5.L 0.21 0.39 0.35 0.52 10.04 9.57 2.98 0.73 0.76 1.34 2.15 1.55 0.92 0.39 fzd5.S 0.24 0.55 0.52 0.47 1.42 1.34 0.26 0.96 0.61 1.04 2.08 1.88 1.85 0.31
Wnt signaling_Fzd receptors fzd6.L 0.81 4.23 4.07 5.08 12.2 13.1 11.23 11.73 10.92 8.86 6.38 fzd6.S 0.22 3.09 2.72 4 6.48 6.88 7.18 11.06 8.18 6.69 4.02 fzd6.L 2.99 3.54 5.48 0.21 4.01 4.48 6.75 7.5 12.24 9.31 8.81 7.59 5.45 0.1 fzd6.S 1.22 0.85 4.91 0.36 2.83 3.07 2.04 3.77 5.59 6.96 7.92 6.38 3.64 0.33
Wnt signaling_Fzd receptors fzd7.L 171.76 209.19 226.38 449.32 406.05 195.96 144.44 101.02 86.29 48.98 31.1 fzd7.S 2.22 4.35 30.82 203.74 106.24 101.35 80.13 60.13 46.84 17.72 11.51 fzd7.L 13.52 31.41 26.96 363.05 230.3 202.76 373.46 402.32 193.06 86.06 69.49 45.19 26.9 278.9 fzd7.S 0.95 1.97 1.31 5.33 1.5 26.9 174.65 101.77 92.1 46 37.93 23.26 11.61 2.69
Wnt signaling_Fzd receptors fzd8.L 0.08 0.7 3.89 14.09 17.75 14.77 13.47 8.72 8.74 8.03 6.56 fzd8.S 0.4 1.04 6.23 26.18 46.46 38.75 34.21 23.28 20.73 13.12 9.82 fzd8.L 0.03 0.1 0.06 0.46 0.21 3.49 15.3 19.76 14.96 19.42 14.03 13.97 13.82 0.19 fzd8.S 0.24 1.08 0.53 0.4 0.61 4.19 31.14 52.46 46.36 33.82 26.63 22.88 14.11 0.42
Wnt signaling_Fzd receptors fzd9.L 0.23 0.65 0.6 0.47 0.08 0.35 0.71 2.71 2.41 3.35 2.22 fzd9.S 0 0.17 0.11 0.07 0.06 0 0.23 1.93 2.24 2.41 0.93 fzd9.L 0 0.03 0.03 0.13 0.72 0.41 0.09 0 0.09 1.1 2.45 2.01 1.5 0.06 fzd9.S 0 0 0 0.19 0.15 0.05 0 0 0 1.16 4.17 3.68 2.07 0.13
Wnt signaling_Fzd receptors fzd10.L 0.47 1.28 5.72 18.61 114.36 69.32 44.69 34.4 28.56 18.58 17.57 fzd10.S 0.53 1.26 2.37 9.03 76.69 49.71 33.98 27.09 17.82 13 9.41 fzd10.L 0.2 0.39 0.38 0.51 0.28 5.93 42.95 161.36 136.48 55.25 45.58 32.07 19.12 0.3 fzd10.S 0.53 0.47 0.43 1.49 0.95 1.51 16.14 98.48 107.89 27.25 26.25 14.43 8.71 1.19
Wnt signaling_Extracellular-Membrane Positive lrp5.L 4.9 27.28 35.58 13.74 5.49 7.08 9.77 14.32 7.72 4.4 2.25 lrp5.L 0.95 2.16 10.92 1.57 17.29 24.59 4.35 4.65 4.66 4.39 4.99 3.28 1.64 0.84
Wnt signaling_Extracellular-Membrane Positive lrp6.L 18.42 44.14 50.1 38.76 4.94 7.08 9.02 8.51 5.45 4.3 2.41 lrp6.S 2 19.03 23.63 21.55 8.82 11.71 12.26 13.49 10.77 8.77 3.93 lrp6.L 0.95 0.96 2.49 56.86 102.23 92.28 44.5 6.53 4.38 16.47 14.27 7.98 4.36 30.71 lrp6.S 1.33 1.09 4.01 8.32 39.33 37.08 35.48 10.17 5.76 22.33 18.16 10.55 5.83 3.02
Wnt signaling_Extracellular-Membrane Positive ror1.L 0.65 2.89 2.71 1.62 7.52 12.97 12.62 9.15 3.16 2.11 2 ror1.S 0.06 1.48 1.44 1.08 1.73 1.49 1.38 1.65 0.46 0.34 0.43 ror1.L 0.27 1.02 0.34 0.02 1.38 0.48 0.56 4.37 5.74 2.15 1.54 0.49 0.58 0 ror1.S 0.02 0 0.04 0 0.43 0.81 0.6 0.74 0.47 0.36 0.63 0.19 0.23 0
Wnt signaling_Extracellular-Membrane Positive ror2.L 0.15 0.19 0.13 18.6 116.3 46.5 30.38 24.35 19.17 12.51 8.69 ror2.S 4.11 3.14 3.26 7.72 52.71 38.65 27.06 25.2 12.74 5.55 4.02 ror2.L 0.04 0.04 0.05 0.08 0.08 0.06 20.91 103.79 55.02 11.71 12.23 5.54 4.21 0 ror2.S 0.49 2.09 2.01 2.43 1.91 1.7 7.41 41.75 34.57 7.43 6.44 3.16 2.19 2.57
Wnt signaling_Extracellular-Membrane Positive ryk.L 16.47 99.26 101.21 95.91 35.27 23.95 19.35 20.58 15.12 10.04 6.97 ryk.S 36.73 152.83 153.97 119.98 38.02 23.06 17.75 18 21.76 20.33 14.97 ryk.L 1.74 2.8 17.3 27.29 161.44 149.4 107.74 40.84 22.7 21.36 16.74 9.41 7.45 12.12 ryk.S 20.42 9.37 59.31 47.95 231.7 216.52 99.95 32.93 17.1 27.52 21.67 20.87 17.81 31.02
Wnt signaling_Extracellular-Membrane Positive porcn.L 9.66 22.34 30.6 19.39 11.88 4.65 11.75 18.4 33.19 46.4 50.78 porcn.L 229.48 74.96 150.93 9.38 34.19 33.72 42.55 23.04 10.68 24.31 35.07 74.55 88.62 6.72
Wnt signaling_Extracellular-Membrane Positive wls.L 26.38 28.42 24.66 24.05 23.41 27.14 20.31 18.54 13.87 10.63 8.07 wls.S 23.76 20.06 18.76 19.53 16.74 15.79 13.52 16.4 16.42 13.93 13.52 wls.L 5.02 20.69 21.76 24.66 30.92 28.83 24.47 15.31 18.86 11.57 13.03 7.7 5.63 21.3 wls.S 6.93 14.89 13.27 27.51 26.55 22.37 22.44 15.95 9.71 9.51 11.74 9.52 7.65 26.25
Wnt signaling_Extracellular-Membrane Positive rspo1.L 0 0 0 0.07 0.49 0.38 0.51 0.88 0.56 0.28 0.42 rspo1.S 0 0 0 0 0 0 0 0 0 0 0 rspo1.L 0 0 0 0 0 0 0.3 0.09 0 0 0.36 0.13 0.08 0 rspo1.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wnt signaling_Extracellular-Membrane Positive rspo2.L 0.29 0.69 0.81 1.48 15.14 3.75 4.3 5.29 5.29 6.19 4.98 rspo2.S 3.71 9.33 7.55 4.27 4.32 0.98 2.65 2.69 1.78 1.61 1.87 rspo2.L 0.1 0.15 0.68 0.48 0.81 0.79 1.66 24.8 8.04 4.9 6.51 6.99 5.13 0.22 rspo2.S 3.09 1.64 6.3 3.68 9.04 9.7 5.92 4.95 1.21 2.11 3.28 1.26 0.99 3.32
Wnt signaling_Extracellular-Membrane Positive rspo3.L 0 0 0 0.08 4.11 11.22 9.24 10.44 3.28 2.06 1.74 rspo3.L 0 0 0 0 0 0 0 1.96 3.69 2.39 2.33 1.11 1.18 0
Wnt signaling_Extracellular-Membrane Positive lgr4.L 6.6 24.25 24.61 12.34 2.03 1.72 3.41 4.77 4.28 4.01 3.42 lgr4.S 13.63 25.06 19.32 11.36 6.62 13.59 16.25 15.62 13.47 11.04 9.12 lgr4.L 1.61 2.18 5.53 6.77 27.02 23.19 4.77 0.7 0.55 1.96 2.98 2.65 2.27 3.63 lgr4.S 4.22 5.55 5.18 29.18 30.42 26.02 10.49 8.03 9.24 10.44 10.47 8.47 6.96 14.79
Wnt signaling_Extracellular-Membrane Positive lgr5.L 2.22 2.44 3.22 1.68 0.68 2.2 1.84 2.26 1.62 0.74 0.63 lgr5.S 1.06 0.98 1.11 1.05 0.91 2.66 2.14 1.75 1.36 0.8 0.49 lgr5.L 0 0.02 0.07 0.48 0.42 0.9 0.26 0.15 0.28 0.18 0.34 0.18 0.14 0.25 lgr5.S 0.01 0.28 0.01 0.74 0.47 0.55 0.38 0.29 1.23 0.27 0.28 0.14 0.22 0.52
Wnt signaling_Extracellular-Membrane Positive ndp.L 0 0 0 0 0.89 3.17 4.4 4.04 1 1.39 2.28 ndp.S 0.65 0.31 0 0 0.12 1.66 4.73 4.4 3.6 1.72 1.54 ndp.L 0 0 0 0 0 0 0 0 1.34 2.22 0.38 0.61 0.6 0 ndp.S 1.39 1.89 2.1 0.18 0.27 0 0 0 0 0.9 2.68 1.23 0.65 0.24
Wnt signaling_Extracellular-Membrane Negative frzb.L 1.11 0.31 0.91 66.57 139.96 18.48 11.29 8.04 3.52 4.39 7.23 frzb.S 0 0.08 1.28 134.67 104.41 5.3 2.84 2.83 1.03 1.78 3.37 frzb.L 0.47 0.62 0.21 0.35 0 0.2 51.89 86.82 19.03 2.19 2.04 0.83 0.86 0.24 frzb.S 0 0.05 0 0.14 0.1 0.08 92.9 59.15 10.13 0.97 1.76 0.25 0.53 0.09
Wnt signaling_Extracellular-Membrane Negative frzb2.L 0 0.36 0.36 27.45 70.85 21.19 21.25 16.65 2.29 0.03 0.02 frzb2.S 0 0 0.18 0.44 29.96 7.65 7.89 4.71 0.71 0 0 frzb2.L 0 0.41 0.13 0 0.54 0.51 27.95 49.78 21.18 4.7 6.11 0.96 0 0.06 frzb2.S 0 0 0 0 0 0 4.18 27.51 13.58 4.85 5.03 0.19 0 0
Wnt signaling_Extracellular-Membrane Negative sfrp1.L 0.29 3.65 5.24 6.38 55.77 26.01 21.16 37.29 60.53 24.73 21.9 sfrp1.S 0 0 0.11 1.65 3.95 1.92 1.4 0.75 1.37 2.64 5.44 sfrp1.L 3.13 8.11 7.48 0 3.43 3.36 4.73 105.99 80.83 18.8 29.73 49.44 21.85 0.21 sfrp1.S 0.02 0.19 0.05 0 0 0.1 2.83 7.33 8.94 1.19 1.32 0.98 1.78 0
Wnt signaling_Extracellular-Membrane Negative sfrp2.L 0 0.34 10.14 25.12 49.57 37.37 52.16 60.06 47.13 19.55 11.95 sfrp2.S 0 0.32 7.34 38.26 16.98 103.72 151.55 181.17 118.56 31.59 18.24 sfrp2.L 0.08 0.09 0.03 0.04 0.19 12.74 15.2 30.92 24.43 40.41 42.4 34.41 17.22 0 sfrp2.S 0.07 0.09 0.15 0.06 0.14 6.35 26.1 13.27 33.7 77.44 90.28 56.53 21 0.04
Wnt signaling_Extracellular-Membrane Negative sfrp4.L 0 0 0 0 0 0 0 0.1 0.07 0 0.06 sfrp4.L 0 0 0 0 0 0 0 0 0.14 0 0 0 0 0
Wnt signaling_Extracellular-Membrane Negative sfrp5.L 0 0 0.05 0.06 0 0.49 1.14 1 1.17 3.33 4.77 sfrp5.S 0 0.15 0.37 0.18 2.38 4.37 2.9 3.55 1.47 2.15 2.09 sfrp5.L 0.02 0 0.03 0 0 0 0 0 0.11 0.46 0.23 0.45 1.01 0 sfrp5.S 0 0.09 0.12 0 0.29 0 0 0.62 1.72 0.71 0.36 0.54 0.51 0
Wnt signaling_Extracellular-Membrane Negative sfrpx.L 0.05 0.32 0.23 0.54 0.15 0.13 0.62 1.27 5.9 11.89 15.98 sfrpx.S 2.09 12.15 12.27 9.05 2.13 1.56 3.59 3.61 9.69 16.94 24.23 sfrpx.L 0.32 0.5 0.37 0.19 0.72 0.44 0.51 0.04 0.3 2.01 4.04 15.51 17.44 0.23 sfrpx.S 26.76 16.57 22.79 0.74 16.58 17.54 11.63 3.49 1.42 8.65 11.19 24.79 27.3 0.43
Wnt signaling_Extracellular-Membrane Negative dkk1.L 0 0.78 13.03 21.48 24.55 20.58 20.14 10.59 9.49 8.1 7.99 dkk1.S 0 1.29 13.7 37 26.38 13.79 14.57 10.21 9.92 5.93 4.21 dkk1.L 0.03 0 0 0 0 9.64 26.56 47.07 32.81 27.11 18.9 14.36 9.83 0 dkk1.S 0 0 0 0 0 10.32 46.73 46.9 15.92 12.63 13.4 13.86 9.1 0
Wnt signaling_Extracellular-Membrane Negative dkk2.L 0 0 0 0.16 0.3 0.66 0.6 0.21 0.04 0.21 0.97 dkk2.S 0.85 1.09 0.34 0.16 0.54 4.5 2.97 1.71 0.46 0.3 1.21 dkk2.L 0.03 0 0 0 0 0 0.16 0.09 0.07 0.17 0.06 0 0.06 0 dkk2.S 1.5 1.25 1.45 0.17 0.18 0.27 0.08 0.09 0.7 0.41 0.39 0.14 0.09 0.16
Wnt signaling_Extracellular-Membrane Negative dkk3.L 0.71 7.89 7.36 5.52 3.08 3.03 3.31 3.86 4.03 3.95 4.31 dkk3.S 0 0.08 0.09 0.11 0.26 1.95 1.36 1.4 1.03 1.18 0.99 dkk3.L 20.14 12.67 9.05 1.36 4.44 6.12 5.37 2.35 2.59 3.92 4.65 3.76 3.85 3.05 dkk3.S 0.01 0.33 0.06 0.01 0.08 0.1 0.11 0.19 0.82 0.37 0.54 0.89 0.91 0.02
Wnt signaling_Extracellular-Membrane Negative dkkx.L 0 0.31 0.3 2.17 14.27 1.79 0.3 0 0.34 0 0 dkkxp.S 0 0 0 0 0 0 0 0 0 0 0 dkkx.L 1.88 1.41 1.81 0 0 0.29 6.11 27.76 6.03 1.79 0.57 0.15 0 0 dkkxp.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wnt signaling_Extracellular-Membrane Negative wif1.L 0 0.73 0.14 0.7 2.45 13.96 16.3 24.74 32.15 28.96 13.29 wif1.S 0 0.08 0.4 0.39 0.55 29.44 29.79 32.83 21.83 18.8 14.99 wif1.L 0.1 0.18 0.45 0 0.38 0.57 1.41 1.6 8.4 9.38 16.79 16.97 13.7 0 wif1.S 0.08 0.2 0.17 0.28 0.32 0.32 0.2 0.11 12.76 16.46 20.52 10.8 8.85 0
Wnt signaling_Extracellular-Membrane Negative cer1.L 0 0 0 63.15 92.11 0.32 0.24 0.12 0.04 0.1 0 cer1.S 0 0.31 2.12 266.48 655.6 7.33 3.81 1.68 0.28 0.13 0.1 cer1.L 0 0 0 0 0.1 0 53.1 64.81 0.45 0 0 0 0 0 cer1.S 0.02 0 0.11 0.17 0 0.79 199.08 563.66 17 0.7 0.49 0.21 0.07 0.24
Wnt signaling_Extracellular-Membrane Negative sostdc1.L 0 0.07 0 0.08 0.77 5.6 6.08 8.99 4.64 4.55 5.96 sostdc1.S 0 0 0.21 4.25 6.04 3.43 1.3 1.96 3.39 4.04 5.02 sostdc1.L 0 0.5 0.18 0 0.09 0 0.25 0.75 8.78 1.53 1.89 1.02 1.67 0 sostdc1.S 0.02 0.04 0 0 0 0.07 5.62 5.82 2.04 0.68 0.27 0.99 2.63 0
Wnt signaling_Extracellular-Membrane Negative igfbp4.L 0 0 0 0 0 0 0 0.1 0.3 5.15 3.49 igfbp4.S 0 0 0 0 0 0 0 0.07 0.28 5.31 7.05 igfbp4.L 1.46 9.77 3.49 0 0 0 0 0 0 0 0.13 1.02 7.98 0 igfbp4.S 0.29 5.59 1.05 0 0 0 0.1 0 0 0 0 0.65 2.33 0
Wnt signaling_Extracellular-Membrane Negative shisa1.L 132.22 467.97 452.55 347.99 213.23 30.72 17.44 5.88 2.68 1.22 0.52 shisa1.S 11.14 16.58 18.71 92.24 73.34 12.04 8.09 4.81 5.32 3.45 1.38 shisa1.L 129.58 97.49 131.1 178.79 631.48 561.62 279.53 219.1 48.29 13.55 6.48 2.83 0.88 142.06 shisa1.S 0.44 1.55 2.73 41.02 43.16 33.39 105.48 96.42 16.15 7.63 4.71 4.37 2.3 33.61
Wnt signaling_Extracellular-Membrane Negative shisa2.L 1.02 7.5 6.88 2.51 1.33 89.34 86.89 83.43 58.28 38.46 21.9 shisa2.S 0.04 0.12 0.23 0.17 0.4 24.34 28.23 33.36 21.07 13.42 7.77 shisa2.L 0.11 1.37 0.51 1.52 4.93 4.43 1.23 0.67 38.42 54.88 45.95 22.42 16.54 1.14 shisa2.S 0.04 0.06 0.07 0 0.06 0.16 0.17 0.23 12.23 25.67 23.04 13.11 10.52 0.05
Wnt signaling_Extracellular-Membrane Negative shisa4p.L 0 0 0 0 0 0 0 0 0 0 0 shisa4.S 0.09 1.94 1.35 2.09 1.66 3.53 6.08 7.05 6.92 7.69 7.53 shisa4p.L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 shisa4.S 0.12 1.47 0.37 0.65 1.84 1.6 1.64 2.35 2.61 2.84 3.83 3.23 3.53 0.62
Wnt signaling_Extracellular-Membrane Negative shisa6.L 0 0 0 0 0 0 0.38 0.53 0.17 0.1 0.11 shisa6.S 0.05 0.1 0.17 0.06 0.15 0.37 0.34 0.64 0.24 0.42 0.56 shisa6.L 0 0 0 0 0 0 0 0 0 0.06 0.14 0.08 0.08 0 shisa6.S 0.01 0.02 0.04 0.04 0.07 0.03 0.25 0.12 0.19 0.15 0.05 0.11 0.17 0.02
Wnt signaling_Extracellular-Membrane Negative shisa7.L 0 0.09 0 0 0 0 0 0.13 0.05 0.05 0.2 shisa7.S 0 0 0 0.09 0 0 0.15 0.18 0.3 0.14 0.18 shisa7.L 0 0 0 0 0.11 0 0 0 0 0 0 0.04 0.03 0 shisa7.S 0 0 0 0 0 0 0.09 0 0 0 0 0.16 0.09 0
Wnt signaling_Extracellular-Membrane Negative shisa9.L 0 0.36 0.18 0.21 0 0 0 0 0 0 0 shisa9.S 0 0 0 0 0 0 0 0 0 0 0.06 shisa9.L 0 0 0 0 0 0 0 0 0 0 0 0.09 0 0 shisa9.S 0 0 0 0 0 0 0 0 0 0 0 0 0.01 0
Wnt signaling_Extracellular-Membrane Negative kremen1.L 0 0.35 0.35 0.24 0.06 1.3 2.69 3.65 5.35 7.46 6.69 kremen1.S 0 0 0.02 0 0 0 0.9 2.42 3.96 4.99 5.31 kremen1.L 0.79 0.85 0.31 0 0.52 0.24 0.12 0.07 0.11 2.16 3.11 4.45 3.62 0 kremen1.S 0.02 0.6 0.22 0.02 0 0.02 0.03 0 0 0.28 1.82 3.98 3.08 0
Wnt signaling_Extracellular-Membrane Negative kremen2.L 0 0 0.06 1.13 12.25 4.16 4.75 6.8 10.66 10.89 7.57 kremen2.S 0 0 0.25 1.73 20.85 5.83 4.49 8.05 10.92 10.66 6.54 kremen2.L 0.01 0.04 0.06 0 0 0 2.15 20.38 8.38 3.99 6.02 7.53 7.36 0 kremen2.S 0.01 0 0 0 0 0 6.2 26.55 11.11 4.15 5.45 6.24 5.51 0
Wnt signaling_Extracellular-Membrane Negative apcdd1.L 14.43 57.52 77.38 59.45 8.94 8.84 9.48 8.84 5.14 6.23 6.06 apcdd1.S 0 0.06 0.37 2.73 1.82 5.35 7.18 10.73 4.44 3.08 2.08 apcdd1.L 19.48 35.32 57.77 4.72 39.49 54.99 25.8 4.71 5.82 5.76 3.47 2.78 3.02 3.05 apcdd1.S 0.01 0.04 0 0 0.08 0.24 2.18 2.14 5.03 7.5 9.7 4.28 2.86 0
Wnt signaling_Extracellular-Membrane Negative tpbg.L 63.04 38.94 38.33 36.92 52.89 17.57 11.41 14.74 5.45 2.57 1.64 tpbg.S 194.81 120.38 112.08 106.07 69.97 29.41 22.06 24.61 11.15 4.74 3.16 tpbg.L 4.41 14.58 9.71 29.87 20.95 20.6 19.91 40.73 14 2.59 2.85 1.02 0.84 26.32 tpbg.S 11.65 47.12 29.57 90.67 89.47 84.53 55.7 48.64 21.67 7.18 6.38 3.86 2.64 83.74
Wnt signaling_Extracellular-Membrane Negative tpbgl.L 0 0 0 0 0 0 0 1.29 0.94 2.47 1.32 tpbgl.S 0 0 0 0 0 0 0.16 0.49 1.39 3.06 1.34 tpbgl.L 0 0 0 0 0 0 0 0 0 0 0 0.55 0.34 0 tpbgl.S 0 0 0 0 0 0 0 0 0 0 0.3 1.43 1.09 0
Wnt signaling_Extracellular-Membrane Negative trabd2a.L (tiki1.L) 0 0 0 6.86 29.85 31.89 19.99 20.11 13.77 8.25 4.24 trabd2a.L (tiki1.L) 0 0 0.03 0.05 0 0 8.08 19.94 28.54 6.43 7.63 4.06 2.71 0
Wnt signaling_Extracellular-Membrane Negative trabd2b.L (tiki2.L) 0 0.03 0.12 0.15 0.84 5.63 6.52 8.19 3.15 1.47 1.28 trabd2b.S (tiki2.S) 0 0 0 0 0.3 2.46 2.12 2.4 2.15 1.73 1.71 trabd2b.L (tiki2.L)0.01 0.04 0.03 0 0.08 0 0.15 0.3 1.66 0.48 0.71 0.81 0.78 0.04 trabd2b.S (tiki2.S) 0 0.02 0 0.03 0 0.03 0.08 0.05 0.42 0.09 0.19 0.43 0.38 0
Wnt signaling_Extracellular-Membrane Negative znrf3.L 4.86 12.33 13.21 5.38 1.56 3.25 3.73 3.86 2.16 1.52 0.82 znrf3.S 2.57 1.38 2.14 2.37 2.08 2.77 2.44 2.17 1.52 1.04 0.78 znrf3.L 1.66 2.54 2.98 22.43 24.43 19.93 3.58 2.11 2.67 6.47 5.39 3.09 1.79 14.91 znrf3.S 1.58 4.16 2.75 10.17 2.4 1.75 1.55 3.11 2.4 3.01 3.09 2.29 1.32 4.24
Wnt signaling_Extracellular-Membrane Negative rnf43.L 0 0.13 0.32 0.53 0.58 5.37 4.4 4.56 1.71 0.77 0.46 rnf43.S 1.21 5.26 5.61 2.97 2.37 10.45 11.85 8.98 5.97 3.99 3.63 rnf43.L 0 0 0.1 0 0.5 0.12 0.46 0.62 2.18 2.7 1.83 1.38 0.52 0 rnf43.S 1.77 2.18 3.15 0.64 5.25 5.15 1.52 2.87 8.8 7.15 5.92 3.79 2.7 0.37
Wnt signaling_Extracellular-Membrane Negative notum1.L 9.16 27.67 25.74 23.31 16.64 5.31 4.92 7.97 6 4.72 3.23 notum1.S 14.45 58.83 56.7 45.12 44.68 65.05 46.03 35.58 9.69 3.84 2.38 notum1.L 3.75 4.87 8.12 4.15 21.91 20.12 18.34 12.17 3.2 0.92 1.02 2.16 1.85 2.74 notum1.S 6.1 8.36 10.88 9.74 33.83 39.15 26.3 23.23 36.89 16.13 11.86 3.36 1.75 8.4
Wnt signaling_Extracellular-Membrane Negative notum2.L 0 0.39 0.19 0.15 0 0.39 1.05 2.29 1.41 1.11 1.46 notum2.L 0 0 0.2 0 0.17 0.19 0.24 0 0.07 0.62 1.68 0.83 0.49 0
Wnt signaling_Cytoplasmic dvl1.L 0.17 2.27 2.27 1.8 0.12 4.28 7.98 8.85 4.81 5.41 3.97 dvl1.S 0.09 1.05 0.66 0.13 0 0 0.06 0.35 0.53 0.99 1.22 dvl1.L 0.01 0.29 0.04 0.09 1.84 2.86 0.88 0.35 2.03 6.7 8.44 3.65 4.39 0.47 dvl1.S 0.05 0.34 0.2 0.52 2.39 1.08 0.34 0 0.13 0.86 0.9 1.25 1.8 0
Wnt signaling_Cytoplasmic dvl2.L 191.87 118.47 123.06 95.82 51.68 51.63 69.65 74.64 84.36 72.42 64.56 dvl2.L 167.72 93 283.23 700.12 413.9 337.85 206.01 108.15 93.25 150.23 153.63 158.12 115.24 652.36
Wnt signaling_Cytoplasmic dvl3.L 15.28 73.21 75.4 57.36 18.55 14.46 17.9 17.16 14.65 12.65 9.44 dvl3.S 6.55 36.75 38.04 34.51 11.72 15.17 14.97 14.94 18.61 12.5 11.2 dvl3.L 40.72 58.72 75.44 25.22 97.1 96.65 54.1 11.93 12.83 15.69 16.75 11.48 8.63 13.94 dvl3.S 17.31 16.72 28.94 2.97 26.25 30.87 20.33 5.14 8.72 11.12 11.93 10.21 10.2 2.73
Wnt signaling_Cytoplasmic frat1.L 60.72 37.32 36.78 21.98 3.9 5.48 9.8 9.51 13.96 9.02 5.83 frat1.S 148.44 130.32 110.25 72.06 27.43 26.04 26.61 21.85 18.35 12.18 9.75 frat1.L 8.8 8.02 27.34 307.64 193.27 153.4 32.98 3.74 5.25 16.72 15.92 14.89 8.83 182.72 frat1.S 31.65 71.95 60.63 235.88 162.96 147.39 67.85 28.14 27.43 16.31 13.04 8.25 6.24 181.03
Wnt signaling_Cytoplasmic ctnnbl1.L 36.47 53.48 51.67 54.63 46 35.55 34.92 34.26 30.22 23.65 13.73 ctnnbl1.S 10.37 37.56 42.05 39.19 37.21 30.03 27.67 30.42 27.72 22.98 14.49 ctnnbl1.L 13.23 45.11 44.64 28.3 45.11 49.31 48.82 39.63 33.04 15.83 16.35 12.63 9.65 29.56 ctnnbl1.S 18.79 55.68 72.91 2.49 34.11 42.79 39.84 30.75 33.75 31.59 30.79 19.33 13.33 1.8
Wnt signaling_Cytoplasmic ctnnb1.L 268.1 335.13 350.98 534.99 758.27 384.74 265.31 251.56 227.51 179.34 124.02 ctnnb1.S 459.02 329.38 331.93 495.36 759.79 467.68 337.05 289.93 253.71 195.43 135.35 ctnnb1.L 69.85 23.23 33.08 492.53 518.76 449.64 648.71 678.29 363.45 176.5 177.57 104.85 58.94 266.89 ctnnb1.S 87.03 85.36 110.48 502.81 446.7 382.93 561.11 681.05 422.42 150.72 162.29 92.03 59.45 353.63
Wnt signaling_Cytoplasmic csnk1d.L 192.38 216.15 198.83 99.48 52.18 95 74.22 67.78 55.72 45.81 33.42 csnk1d.S 32.17 45.17 54.89 38.18 15.5 33.35 37.53 41.4 38.43 32.82 23.9 csnk1d.L 99.34 87.2 85.24 125.26 212.31 202.34 88.35 35.74 69.7 20.49 24.38 16.06 14.39 133.24 csnk1d.S 15.82 55.7 68.18 27.78 29.48 37.43 26.67 16.99 28.8 19.25 25.69 18.38 13.39 13.4
Wnt signaling_Cytoplasmic csnk1e.L 198.14 97.27 97.84 66.94 12.11 35.14 36.38 33.85 28.69 22.3 22.43 csnk1e.S 155.98 112.06 111.38 65.17 10.33 46.05 48.98 40.32 33.36 28.57 27.88 csnk1e.L 110.73 108.73 84.5 414.05 128.44 119.46 55.52 11.31 25.52 33.87 35.68 29.32 23.05 445.09 csnk1e.S 91.31 122.17 87.45 333.9 165.14 150.13 67.41 12.5 49.05 49.33 44.07 34.46 29.93 361.02
Wnt signaling_Cytoplasmic csnk1g1.L 100.13 72.81 70.15 75.23 36.6 22.58 23.86 22.12 17.17 14.53 11.79 csnk1g1.S 112.31 99.46 93.96 86.85 47.65 28.2 25.31 24.19 19.63 17.1 12.24 csnk1g1.L 8.49 25.63 24.18 75.32 63.11 62.98 63.91 31.61 18.53 6.54 8.23 7.45 6.49 66.66 csnk1g1.S 13.1 27.25 27.15 87.08 80.52 76.06 74.72 41.11 19.51 8.86 8.58 6.46 5.78 75.23
Wnt signaling_Cytoplasmic csnk1g2.L 645.37 374.77 320.46 273.23 68.63 26.67 21.99 28.97 23.75 15.47 8.09 csnk1g2.L 32.61 116.07 86.6 334.7 245.24 224.3 207 51.72 16.36 4.17 5.74 4.96 3.89 263.16
Wnt signaling_Cytoplasmic csnk1g3.L 60.44 59.04 50.92 37.62 7.41 10.7 11.88 12.75 5.98 3.13 3.03 csnk1g3.S 179.61 107.22 96.94 90.16 20.35 18.21 20.07 23.49 7.06 3.27 3.47 csnk1g3.L 5.22 15.59 9.67 25.25 30.32 30.62 18.95 4.22 4.41 2.04 2.19 1.55 1.44 17.07 csnk1g3.S 12.3 28.59 14.23 40.08 40.31 40.98 41.1 10.03 6.76 1.67 2.2 1.05 1.54 32.18
Wnt signaling_Cytoplasmic csnk2a1.L 53.27 48.6 52.67 50.83 45.55 54.97 42.34 45.68 38.31 32.7 23.71 csnk2a1.S 57.73 59.3 63.09 41.88 50.92 64.15 89.82 80.1 83.4 76.23 56.59 csnk2a1.L 6.15 4.06 19.34 135.06 112.08 86.59 58.44 46.57 50.02 92.4 85.36 64.07 37.26 102.64 csnk2a1.S 136.36 82.29 136.85 274.43 123.95 117.82 62.33 80.73 117.87 213.68 189.17 156.57 111.4 261.61
Wnt signaling_Cytoplasmic csnk2a2.L 17.16 48.35 45.95 58.09 115.11 152.25 125.41 110.55 127.62 112.92 102.95 csnk2a2.S 10.62 36.24 36.23 52.26 115.6 132.49 119.07 106.76 130.07 115.44 100.57 csnk2a2.L 23.53 23.51 40.7 5.89 42.54 43.69 56.01 88.77 107.89 87.75 82.87 67.64 63.81 5.37 csnk2a2.S 24.11 25.18 32.47 5.15 35.43 38.21 59.57 100.63 112.15 110.05 100.92 91.13 80.79 5.09
Wnt signaling_Cytoplasmic csnk2b.L 25.25 38.47 39.14 45.53 82.07 96.26 80.91 68.84 66.67 59.22 57.05 csnk2b.S 365.37 210.61 193.73 251.7 357.66 336.19 282.7 237.02 227.35 218.77 238.42 csnk2b.L 23.78 57.5 35.37 17.3 30.83 31.62 40.98 64.76 70.17 53.94 48.12 38.01 35.41 19.53 csnk2b.S 126.61 229.23 173.58 351.77 204.86 197.71 250.12 379.95 385.64 310.17 279.9 217.95 188.41 456.38
Wnt signaling_Cytoplasmic ccdc88c.L 1.99 13.52 19.7 13.25 20.35 48.73 39.14 30.89 10.76 5.75 4.46 ccdc88c.S 0 0 0.09 0.08 0.16 1.94 3.9 5.42 0.42 0.36 0.24 ccdc88c.L 2.2 4.24 2.83 0.18 3.59 5.81 4.22 10.33 20.34 3.92 3.5 1.63 1.22 0.06 ccdc88c.S 0.01 0.01 0 0 0 0.02 0 0 0.3 0.37 0.61 0.08 0.06 0.03
Wnt signaling_Cytoplasmic axin1.L 2.62 24.86 24.24 12.96 4.28 6.45 5.89 6.25 4.38 3.53 2.07 axin1.S 6.09 31.54 33.38 23.5 5.97 2.88 2.92 3.88 2.04 2.27 1.21 axin1.L 4.09 7.3 12.75 1.26 22.56 23.18 7.32 3.17 3.92 2.67 2.71 1.78 1.59 0.62 axin1.S 0.23 0.97 1.36 12.59 44.83 39.98 18.22 6.12 1.95 3.29 3.24 1.68 0.93 6.67
Wnt signaling_Cytoplasmic axin2.L 0.1 0.13 0.03 5.39 62.52 45.68 27.36 19.26 18.41 18.64 11.21 axin2.S 0.47 2.22 2.16 1.7 6.47 6.47 3.78 4.26 4.27 4.42 3.72 axin2.L 0.02 0.04 0.07 0 0.09 0.19 16.72 71.33 69.71 16.22 14.55 12.91 9.83 0.04 axin2.S 0.02 0.37 0.99 0.23 1.56 1.26 0.77 6.53 8.55 2.36 2.94 2.71 2.31 0.08
Wnt signaling_Cytoplasmic gsk3a.L 47.28 175.51 169.56 143.18 121.53 74.95 67.74 50.06 54.56 38.13 30.02 gsk3a.S 8.67 46.79 45.05 46.93 65.21 45.54 36.16 26.31 25.94 21.48 17.43 gsk3a.L 14.33 5.96 15.62 164.3 190.26 177.7 142.22 129.69 80.52 57.54 50.49 45.33 31.35 82.48 gsk3a.S 9.62 3.97 7.69 26.81 36.47 38.42 62.19 80.89 52.83 31.07 27.85 19.4 12.73 17.99
Wnt signaling_Cytoplasmic gsk3b.L 0.58 6.91 8.29 8.97 9.83 21.79 29.06 28.75 33.26 27.24 21.92 gsk3b.S 2.22 29.84 32.52 38.12 24.98 44.94 51.26 54.23 59.52 46.18 33.36 gsk3b.L 3.7 4.02 4.85 0.74 5.61 6.95 7.67 10.96 19.84 26.89 27.95 27.95 23.37 0.79 gsk3b.S 8.21 13.76 31.06 0.94 22.36 30.2 38.3 37.53 45.35 53.2 54.36 43.89 36.67 1.07
Wnt signaling_Cytoplasmic apc.L 49.3 21.59 25.32 10.32 4.54 8.87 8.16 10.09 4.37 2.97 3.22 apc.S 7.98 18.52 23.89 8.99 3.05 5.63 6.07 8.24 3.38 2.21 2.1 apc.L 1.49 6.03 3.42 10.86 9.89 8.93 3.35 1.9 3.6 0.88 0.86 0.51 0.71 8.56 apc.S 1.92 6.4 3.82 2.63 8.67 8.78 3.2 1.35 2.68 0.59 0.69 0.36 0.55 2.16
Wnt signaling_Cytoplasmic apc2.L 0.86 0.35 0.62 0.31 0.15 1.19 1.21 2.25 0.69 1.04 1.14 apc2.S 0.17 0.13 0.08 0.13 0 0.13 0.13 0.93 0.45 0.95 1.04 apc2.L 0 0.03 0.05 0.26 0.4 0.65 0.08 0.06 0.1 0.1 0.23 0.1 0.2 0.03 apc2.S 0 0.01 0.02 0.13 0.03 0.06 0 0 0 0.02 0.06 0.08 0.16 0.02
Wnt signaling_Cytoplasmic csnk1a1.L 278.56 322.29 318.39 410.58 574.69 400.17 322.5 282.98 190.32 131.58 113.31 csnk1a1.S 245.23 198.02 190.23 231.21 299.02 243.44 193.17 160.4 117.08 76.64 67.63 csnk1a1.L 59.85 121.87 82.13 223.52 269.38 251.41 377.23 488.18 347.15 79.7 83.44 46.89 40.84 231.88 csnk1a1.S 51.59 116.81 79.11 143.01 138.09 147.4 221.31 276.13 217.98 55.87 48.74 42.34 38.66 192.78
Wnt signaling_Cytoplasmic cxxc4.L 0 0.05 0 0.57 0.18 0.43 1.3 1.94 2.69 3.88 2.82 cxxc4.S 0 0.05 0.1 0.17 0 0.68 0.34 1.74 2.98 3.25 2.26 cxxc4.L 0.3 0.07 0.11 0.09 0 0.05 0.45 0.22 0.86 2.13 2.77 3.88 3.06 0 cxxc4.S 0.03 0.12 0.03 0.04 0.13 0.09 0 0 0.11 0.12 0.28 1.16 1.62 0
Wnt signaling_Cytoplasmic nkd1.L 2.63 32.83 31.67 18.78 13.73 11.72 11.4 11.28 3.43 1.58 1.05 nkd1.S 11.24 49.79 45.78 27.64 3.68 8.35 9.64 11.81 3.76 1.23 1.36 nkd1.L 1.1 1.31 1.69 0.64 13.51 16.08 4.84 4.24 4.56 2.35 2.33 0.6 0.52 0.27 nkd1.S 0.1 1.53 1.84 7.61 32.82 28.19 17.66 1.85 2.37 0.51 1.57 0.46 0.45 3.78
Wnt signaling_Cytoplasmic dact1.L 227.22 217.76 220.58 169.47 93.06 76.1 67.81 58.36 40.9 23.57 17.83 dact1.S 464.41 332.97 335.7 200.62 67.4 39.46 30.54 30.14 19.81 12.52 9.74 dact1.L 59.9 88.84 91.34 257.19 257.84 227.89 94.72 86.43 64.74 22.12 20.39 13.28 8.67 234.27 dact1.S 12.24 164.87 134.01 499 373.93 351.82 117.24 55.69 32.97 22.38 18.23 13.23 7.2 522.87
Wnt signaling_Cytoplasmic nxn.L 15.81 52.35 45.99 44.14 36.59 44.88 51.95 64.94 66.17 46.46 30.09 nxn.S 27.67 72.77 72.34 76.45 51.75 20.27 25.54 31.2 29.36 16.6 12.07 nxn.L 10.89 30.25 24.29 8.22 35.61 42.32 44.76 32.57 21.78 37.45 49.01 37.34 25.16 5.65 nxn.S 10.62 43.93 31.88 19.66 60.72 65.05 69.57 47.21 10.27 16.51 20.87 12.75 8.99 18.76
Wnt signaling_Cytoplasmic ppp2cb.L 54.07 60.84 56.41 52.34 34.52 16.64 11.1 14.39 15.43 19.66 19.08 ppp2cb.S 50.97 35.82 32.74 32.65 37.73 21.34 18.19 19.51 17.33 17.75 18.21 ppp2cb.L 16.56 36.06 47.2 79.75 79.05 70.99 55.01 30.86 10.45 16.28 18.89 16.81 14.89 79.53 ppp2cb.S 9.97 33.87 24.12 45.58 36.3 33.28 32.91 31.36 16.54 14.59 17.48 16.3 14.31 49.7
Wnt signaling_Cytoplasmic ppp2ca.S 204.46 352.05 337.03 358.97 294.21 283.24 237.3 224.55 258.52 230.7 211.7 ppp2ca.S 218.87 379.27 409.34 233.76 439.95 436.41 372.1 310.3 319.83 322.87 286.66 230.55 182.72 257.92
Wnt signaling_Nuclear lef1.L 0 0 0 1.57 7.72 10.54 5.17 7.34 4.83 4.28 1.96 lef1.S 0 0 0.15 0.17 2.96 4.1 4.88 7.69 3.85 2.79 1.4 lef1.L 0 0 0 0 0 0 4.77 5.64 3.15 4.91 7.26 3.07 2.1 0 lef1.S 0 0 0 0 0 0 0 1.81 1.49 3.15 4.19 1.95 1.61 0
Wnt signaling_Nuclear tcf7l1.L 7.66 33.41 41.91 92.22 93.64 42.52 41.07 38.38 35.42 29.65 23.75 tcf7l1.S 23.9 86.51 93.4 99.81 78.23 46.6 49.88 47.64 44.31 34.41 29.79 tcf7l1.L 31.43 30.42 57.38 5.87 46.53 54.22 109.11 114.44 56.58 46.27 43.31 33.87 28.25 5.26 tcf7l1.S 29.31 32.51 57.77 46.94 115.52 122.46 100.9 98.01 56.83 63.06 57.9 47.07 38.97 35.61
Wnt signaling_Nuclear tcf7l2.L 0.09 1.39 1.9 0.96 0.26 0.12 1.88 3.95 2.52 2.76 2.19 tcf7l2.S 0 0 0.04 0.15 0.2 2.51 2.15 4.61 2.22 2.22 2.09 tcf7l2.L 0.44 0.21 0.51 0 1.06 2.14 0.35 0.16 0.2 0.6 1.55 1.93 1.4 0.2 tcf7l2.S 0 0.03 0 0 0 0.13 0.1 0.06 0.44 1.34 0.83 1.36 1.36 0
Wnt signaling_Nuclear tcf7.S 25.67 61.93 56.29 35.09 28.65 13.03 11 8.57 4.53 2.18 1.27 tcf7.S 5.27 24.04 20.38 17.16 53.7 54.2 23.63 20.47 13.95 5.49 5.23 1.91 1.45 7.16
gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
Hh signaling_Ligands shh.L 0 0 0 0.45 5.69 23.96 28.19 29.99 27.1 17.15 15.29 shh.S 0 0 0.05 1.02 6.08 9.74 10.25 9.02 7.79 4.79 4.49 shh.L 0 0 0 0 0 0.1 0.13 2 20.99 15.05 21.33 24.14 14.26 0 shh.S 0.02 0.03 0 0 0 0 0.52 7.04 13.05 6.91 8.04 6.3 4.37 0
Hh signaling_Ligands dhh.L 1.26 1.13 1.09 1.03 37.84 43.46 35.99 22.41 7.87 4.08 3.38 dhh.S 0 0.11 0.21 2.74 25.99 41.36 35.89 24.23 10.92 1.81 1.05 dhh.L 0.08 0.57 0.13 3.22 2.02 1.48 0.7 18.69 22.31 11.18 7.59 3.39 1.78 0.75 dhh.S 0.02 0.21 0.09 0.02 0.08 0.15 1.95 11.78 18.92 13.03 9.37 4.08 1.06 0
Hh signaling_Ligands ihh.L 0.04 0 0.1 0.22 0 0 0.4 0.49 1.06 1.86 1.34 ihh.S 0 0 0.39 0 0 0 0.26 0.51 0.51 1.08 0.56 ihh.L 0.01 0.08 0.08 0 0.03 0.1 0.13 0.04 0.09 0.11 0.07 0.44 0.85 0.03 ihh.S 0 0 0.07 0 0 0 0 0 0 0 0.25 0.6 0.52 0
Hh signaling_Receptor-Membrane ptch1.L 4.91 8.52 9.07 3.73 6.97 16.83 18.23 17.39 8.27 4.7 2.93 ptch1.S 0.46 4.26 4.47 3.22 4.43 8.44 8.21 8.47 4.55 3.28 1.69 ptch1.L 0.12 0.26 0.68 1.4 5.39 4.97 1.28 4.18 5.85 2.62 3.11 1.58 1.39 1.03 ptch1.S 0.12 0.24 0.32 0.48 1.68 2.18 1.21 2.1 2.64 1.21 1.54 1.25 0.78 0.34
Hh signaling_Receptor-Membrane ptch2.L 0 0.51 2.41 3.12 6.88 32.34 27.21 28.23 19.03 8.68 5.13 ptch2.S 0 0 0.26 1.36 3.25 22.84 22.19 23.17 13.69 6.48 3.54 ptch2.L 0 0.02 0.17 0 0.11 1.06 2.67 6.09 16.24 11.27 11.5 6.63 3.89 0.03 ptch2.S 0 0 0 0 0.04 0.03 1.6 3.69 10.46 9.05 9.89 5.99 3.72 0
Hh signaling_Receptor-Membrane smo.L 4.31 23.24 20.74 36.03 63.86 65.04 45.86 39.29 12.87 5.92 4.36 smo.S 4.13 17.25 15.92 15.11 12.92 27.02 19 19.76 5.03 2.02 2.21 smo.L 2.5 5.86 5.89 1.43 11.41 12.69 24.83 38.05 38.37 6.45 5.8 3.19 2.58 1.41 smo.S 0.48 1.59 1.3 0.86 4.34 5.41 6.5 6.13 10.13 2.07 2.71 1.27 0.86 0.9
Hh signaling_Receptor-Membrane hhip.L 0.15 0.38 0.85 2.18 0.64 1.7 2.87 7.11 5.87 4.2 2.03 hhip.S 0.46 0.41 0.46 0.69 0.2 0 0.06 0.18 0.13 0.85 0.33 hhip.L 0.15 0.63 0.22 0.2 0.18 0.51 1.83 0.26 0.27 0.86 1.67 2.57 1.63 0.22 hhip.S 0 0.32 0 0.2 0.08 0.34 0.35 0.16 0.13 0.05 0.11 0.15 0.27 0.27
Hh signaling_Receptor-Membrane hhat.L 1.57 6.46 5.91 5.65 2.99 1.77 4.65 3.74 4.86 4.9 3.49 hhat.L 2.74 3.69 5.07 1.45 3.75 3.04 2.56 1.22 1.68 3.55 4.79 5.5 3.95 1.1
Hh signaling_Receptor-Membrane hhatl.L 0 0 0 0 0 0.18 0.55 2.93 4.49 5.92 2.4 hhatl.S 0 0 0 0 0.11 0.2 1.53 6.2 19.01 27.69 23.6 hhatl.L 0.02 0 0 0 0 0 0 0 0.1 1.26 6.46 15.54 13.04 0 hhatl.S 0.02 0.03 0.03 0.04 0.06 0 0.06 0 0.06 3.83 18.49 66.81 77.55 0
Hh signaling_Cytoplasmic-Cilia-Nuclear gli1.L 0.06 0.08 0.02 1.76 8.42 7.76 8.13 7.6 2.21 1 0.76 gli1.S 0.04 0.12 0.26 0.75 10.4 15.21 15.9 15.11 3.94 1.74 1.34 gli1.L 0 0 0 0.05 0.05 0.04 1.05 3.3 4.12 1.2 0.91 0.39 0.36 0.05 gli1.S 0.01 0.09 0.05 0.04 0.34 0.07 0.31 4.14 5.47 1.08 1.22 0.55 0.46 0.03
Hh signaling_Cytoplasmic-Cilia-Nuclear gli2.L 0.14 1.35 1.35 1.23 7.05 16.47 18.6 20.09 10.49 8.27 4.66 gli2.S 0.1 0.45 0.31 0.61 6.58 15.37 13.08 11.56 6.53 5.28 3.64 gli2.L 0.02 0.07 0.14 0.27 2.22 1.88 1.29 8.05 13.94 29.39 25.73 11.73 6.98 0.1 gli2.S 0.11 0.29 0.29 0.07 0.37 0.46 0.49 4.91 13.18 8.74 5.91 2.82 2.08 0.02
Hh signaling_Cytoplasmic-Cilia-Nuclear gli3.L 0.06 0.15 0.17 2.61 11.17 23.92 16.73 17.02 5.85 3.07 2.59 gli3.S 0.03 0.02 0 0.18 6.58 18.87 13.25 14.98 3.76 2.02 2.13 gli3.L 0.01 0.06 0.01 0 0.05 0.08 1.52 5.38 10.68 1.59 2.67 1.42 1.58 0 gli3.S 0 0.01 0 1.92 1.84 2.13 0.51 2.11 11.45 1.61 1.34 0.77 0.82 0
Hh signaling_Cytoplasmic-Cilia-Nuclear stk36.L 9.61 23.55 31.14 22.86 8.95 9.88 8.93 7.4 6.79 5.97 4.78 stk36.L 69.65 30.6 63.98 4.46 22.27 29.6 14.83 7 9.98 19.71 14.45 9.78 6.96 3.1
Hh signaling_Cytoplasmic-Cilia-Nuclear sufu.L 17.33 19.72 24.82 16.68 5.66 5.33 6.29 8.43 5.13 6.71 4.25 sufu.S 12.1 21.21 20.45 17.83 14.31 14.97 13.25 13.79 8.49 7.12 3.48 sufu.L 2.84 13.65 20.11 22.57 38.92 34.2 13.24 2.31 3.14 9.77 9.62 7.19 3.89 12.81 sufu.S 2.54 5.43 8.13 13.47 25.8 20.56 14.46 9.41 6.63 13.95 11.69 5.51 3.42 7.37
Hh signaling_Cytoplasmic-Cilia-Nuclear prkaca.L 53.06 29.29 26.13 25 12.38 3.96 3.14 4.44 5.46 7.11 5.14 prkaca.S 39.15 34 37.77 33.47 11.74 5.17 7.26 11.86 12.67 16.6 11.57 prkaca.L 4.61 3.92 12.45 111.28 63.7 48.21 30.58 7.98 1.76 10.83 12.55 11.44 11.79 83.21 prkaca.S 9.53 6.27 19.55 78.28 69.13 61.2 45.57 13.84 3.04 13.52 17.38 15.8 13.24 45.26
Hh signaling_Cytoplasmic-Cilia-Nuclear kif7.L 102.78 49.58 35.2 12.73 7.39 15.67 14.55 16.57 8.72 7.26 4.69 kif7.L 1.26 3.75 4.08 63.89 42.56 32.36 5.17 5.03 5.87 3.64 4.5 3.33 2.74 41.9
Hh signaling_Cytoplasmic-Cilia-Nuclear arl13b.L 12.66 22.51 28.15 61.58 27.83 14.08 12.95 14.61 8.62 7.62 5.73 arl13b.S 0.44 2.57 3.29 6.35 2.77 3.87 1.95 2.39 2.18 3.36 1.06 arl13b.L 2.03 7.24 5.22 8.1 20.51 25.3 51.73 23.48 12.37 11.99 11.17 6.48 4.17 7.89 arl13b.S 7.68 6.9 8.3 0.7 1.8 2.97 5 2.65 1.24 1.9 2.37 1.97 2.06 0.31
Hh signaling_Cytoplasmic-Cilia-Nuclear foxj1.L 0 0 0.61 4.25 19.89 11.88 11.4 11.73 7.4 4.52 3.18 foxj1.S 0 0.06 0.94 7.77 45.78 32.12 16.33 12.78 6.02 3.45 2.54 foxj1.L 0.04 0.17 0 0.1 0.22 0.27 4.81 10.97 9.95 11.78 10.56 6.56 3.86 0.07 foxj1.S 0.01 0.07 0 0 0 0.46 6.85 21.82 29.78 16.8 12.2 5.85 3.32 0
gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
HSPG_Core protein gpc1.L 0.06 0.08 0.2 0.43 0.91 0.32 1.39 4.08 9.47 13.84 11.36 gpc1.S 1.34 4.83 4.36 3.54 1.26 1 1.33 2.57 6.14 9.31 9.92 gpc1.L 0.15 0.35 0.59 0.07 0.32 0.35 0.64 0.39 0.14 1.99 3.52 7.72 8.65 0.05 gpc1.S 0.5 2.18 1.94 0.6 3.21 3.37 1.69 0.89 0.36 0.83 1.12 4.01 6.25 0.82
HSPG_Core protein gpc2.L 0.31 0.41 0.57 0.59 1.03 1.79 2.39 2.98 2.63 3.49 2.85 gpc2.S 1.63 0.52 0.78 0.83 0.2 0.17 0.18 0.88 0.34 1.1 0.58 gpc2.L 0.2 0.43 0.23 0.33 0.28 0.57 0.87 0.72 1 1.33 1.75 2.23 2.19 0.29 gpc2.S 0 0.05 0.18 0.37 1.02 1.1 0.42 0.24 0 0.45 1.08 0.49 0.76 0.5
HSPG_Core protein gpc3.L 0.22 0.14 0.42 0.59 0.16 0.14 0.14 0.55 0.91 0.45 0.3 gpc3.S 0.11 0.14 0 0.08 0.24 0 0.14 0.17 0.2 0.09 0.37 gpc3.L 0.07 0.13 0.07 0.6 0.83 0.41 0.51 0.19 0 0 0.07 0.29 0.21 0.16 gpc3.S 0.15 0.52 0.11 0.36 0 0.28 0.09 0.29 0.08 0.18 0 0.11 0.12 0.41
HSPG_Core protein gpc4.L 42.77 68.87 61.56 75.24 121.5 140.14 118.4 111.09 57.18 27.4 22.86 gpc4.S 26.24 52.48 43.73 53.26 69.75 48.92 46.98 47.27 38.2 22.9 16.67 gpc4.L 9.74 11.08 13.78 21.04 46.39 49.35 53.83 71.67 79.18 14.93 17.35 10.7 9.02 21.83 gpc4.S 6.6 6.8 7.98 12.31 30.75 31.59 45.25 46.77 29.54 8.26 9.35 7.91 7.27 13.12
HSPG_Core protein gpc5.L 2.3 11.98 13.29 9.95 2.17 1.01 1.91 3.24 4.53 6.58 5.04 gpc5.S 18.26 19.87 17.92 14.77 5.01 1.05 0.86 1.83 3.17 2.67 2.72 gpc5.L 0.54 6.16 6.75 1.48 7.41 9.73 3.78 0.57 0.84 1.46 0.75 1.51 1.96 0.96 gpc5.S 6.04 10.06 9.1 10.43 11.77 13.99 9.92 4.35 1.7 0.38 0.48 1.63 1.12 13.42
HSPG_Core protein gpc6.L 0.22 0.46 0.4 0.29 0.23 0.04 0.02 0.02 0 0.04 0.13 gpc6.S 0.22 0.73 0.61 0.34 0.02 0 0 0.01 0.02 0.01 0.02 gpc6.L 0.31 0.28 0.21 0.05 0.32 0.41 0.34 0.14 0 0.02 0 0 0 0 gpc6.S 0.1 0.23 0.2 0.12 0.61 1.01 0.39 0.07 0.02 0 0.02 0.02 0.02 0.04
HSPG_Core protein sdc1.L 139.82 117.15 85.85 32.5 35.42 15.96 12.86 12.11 14.16 9.99 12.7 sdc1.S 54.68 85.11 69.79 39.75 9.25 2.29 2.67 3.02 1.47 1.31 1.09 sdc1.L 62.53 59.93 34.17 125 92.31 72.12 35.08 50.46 35.62 2.49 3.34 4.94 4.73 108.56 sdc1.S 0.66 7.43 12.73 44.39 68.94 65.37 16.92 3.74 2.52 0.86 1.23 0.33 0.27 23.31
HSPG_Core protein sdc2.L 6.66 51.35 56.14 68.79 91.68 62.81 72.63 77.11 55.54 40.11 51.81 sdc2.S 6.42 21.83 21.28 30.38 50.97 36.73 42.22 46.76 32.95 24.15 26.22 sdc2.L 11.27 18.38 16.98 2.61 38.41 41.93 68.75 87 59.09 20.68 25.15 24.31 25.12 1.71 sdc2.S 4.01 14.78 9.16 2.5 18.66 21.81 39.05 44.21 20.13 3.72 7.3 10.56 11.31 3
HSPG_Core protein sdc3.L 0.15 0.36 0.66 0.35 0.11 2.11 3.55 7.16 5.35 4.81 6.11 sdc3.S 0 0 0 0 0.03 0.35 1.1 3.02 3.18 3.25 3.86 sdc3.L 0.01 0.1 0.1 0.08 0.09 0.22 0.12 0 0.45 0.51 1.45 2.19 3.26 0.12 sdc3.S 0.01 0 0.02 0 0 0.03 0 0 0.13 0.13 0.42 0.89 1.81 0
HSPG_Core protein sdc4.L 18.69 28.31 31.37 121.91 263.9 82.31 69.71 68.71 38.02 30.7 22.14 sdc4.S 194.34 116.28 126.03 97.54 56.05 23.1 36.64 51 31.36 24.04 14.33 sdc4.L 5.46 9.18 3.41 12.25 10.98 11.88 74.04 195.87 48.62 9.28 10.69 8.13 6.12 7.57 sdc4.S 9.61 7.78 10.11 212.51 154.4 135.02 97.26 52.69 16.41 12.93 19.1 14.34 7.85 114.91
HSPG_Enzyme ndst1.L 3.62 20.92 24.47 27.73 27.75 27.9 30.03 30.05 28.65 21.48 14.69 ndst1.S 6.2 15.42 15.28 14.82 6.64 9.41 14.84 19.4 22.3 21.73 18.91 ndst1.L 7.61 19.35 25.21 0.71 23.39 26.88 32.28 40.14 28.79 37.48 37.15 25.21 17.61 0.45 ndst1.S 2.18 5.8 8.18 4.76 14.14 14.41 11.3 5.25 5.06 12.86 17.62 14.1 13.22 5.56
HSPG_Enzyme ndst2.L 34.56 103.5 94.05 31.47 7.04 12.26 15.24 21.6 22.51 21.95 14.76 ndst2.S 1.53 7.94 7.45 3.91 0.59 0.45 1.29 2.11 0.96 1.9 0.64 ndst2.L 10.72 37.49 42.51 43.38 122.24 118.67 15.15 4.99 9.94 7.1 10.37 9.39 8.55 31.72 ndst2.S 0.23 0.46 1.86 5.03 17.16 16.47 1.54 0.52 0.68 0.9 1.79 0.61 0.63 2.17
HSPG_Enzyme ndst3.L 0 0.15 0.1 0.18 0 0 0.05 0.04 0.06 0.51 0.36 ndst3.S 0 0 0 0 0.05 0 0 0 0.02 0 0.35 ndst3.L 0.04 0.09 0.05 0.04 0.13 0.05 0.06 0 0 0 0.05 0.03 0.08 0.06 ndst3.S 0.01 0.03 0 0 0 0 0.05 0 0 0 0 0 0.03 0
HSPG_Enzyme ndst4.L 0 0 0 0 0 0 0.07 0.03 0.1 0.21 0.18 ndst4.S 0.38 0.65 0.48 0.25 0.04 0 0 0.03 0.06 0.09 0.1 ndst4.L 0 0 0 0 0 0 0 0 0 0 0.07 0 0.02 0 ndst4.S 0.14 0.27 0.13 0.09 0.23 0.13 0 0 0 0 0 0.02 0.01 0.08
HSPG_Enzyme sulf1.L 73.51 60.02 56.01 49.72 95.79 24.78 19.68 25.73 18.74 7.11 3.77 sulf1.S 0.95 1.16 1.33 0.97 0.44 4.23 5.21 10.49 4.3 1.92 0.84 sulf1.L 1.11 1.09 1.01 27.32 29.15 21.54 25.16 89.1 31.03 2.65 3.51 3.16 1.8 22.82 sulf1.S 0.01 0 0.02 0.4 0.39 0.46 0.21 0.06 0.44 0.56 1.61 1.15 0.63 0.1
HSPG_Enzyme sulf2.L 5.34 9.34 12.82 10.38 4.78 3.16 7.41 5.81 3.2 3.33 2.7 sulf2.S 3.75 13.53 13.6 15.25 7.75 4.48 5.89 8.07 12.99 16.52 11.9 sulf2.L 4.59 6.82 23.83 3.82 15.59 15.87 8.75 2.64 0.66 6.52 6.52 4.57 3.46 3.09 sulf2.S 6.35 14.27 18.22 0.87 10.53 11.92 13.63 5.96 3.67 4.94 5.11 12.23 10.41 1.24
gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
Notch signaling_Ligands-Receptors dlc.L 0 0.48 5.07 62.04 135.8 135.43 94.74 68.26 38.37 17.78 6.08 dlc.S 0 0 0.08 0.28 5.44 16.83 18.45 17.52 12.17 6.38 2.6 dlc.L 0.01 0.03 0 0 0.06 4.86 73.16 119.56 154.66 43.88 34.35 15.18 6.01 0 dlc.S 0 0 0 0 0 0 0.56 3.65 15.15 11.01 7.67 4.32 2.37 0
Notch signaling_Ligands-Receptors dll1.L 0.16 0.66 3.65 15.09 50.95 39.44 29.06 28.63 19.65 9.21 4.18 dll1.S 2.48 2.98 6.48 29.11 39.19 33.14 30.41 26.69 16.71 8.2 5.96 dll1.L 0.01 0.16 0.11 0.13 0 2.77 29.69 62.74 53.44 12.78 15.36 10.62 4.34 0.18 dll1.S 0.03 0.41 0.03 6.22 2.14 5.63 53.69 69.28 44.24 16.64 18.47 13.79 5.82 4.18
Notch signaling_Ligands-Receptors dll4.L 0.59 4.05 4.19 2.13 0.69 0.28 0.24 0.59 0.79 1.08 1.24 dll4.S dll4.L 0.22 1.07 1.28 0.36 2.58 2.07 0.8 0.13 0.38 0.2 0.27 0.19 0.35 0.22 dll4.S
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Notch signaling_Ligands-Receptors jag1.L 0.03 0.77 1.29 6.7 4.72 10 10.37 9.77 10.91 4.91 2.23 jag1.S 0.58 10.17 11.03 5.71 1.08 3.11 4.57 6.46 6.62 4.83 3.05 jag1.L 0.77 0.24 0.51 0.04 0.79 0.75 9.36 7.53 8.78 2.22 4.61 4.19 1.69 0.02 jag1.S 7.62 1.96 5.48 0.87 10.25 10.71 4.58 1.7 1.64 3.35 4.25 5.22 3.63 0.65
Notch signaling_Ligands-Receptors jag2.L 0.2 0.92 0.98 0.68 0.23 1.06 1.48 3.17 2.67 2.55 2.9 jag2.S 0.1 0.38 0.57 0.36 0.14 1.95 2.99 4.5 6.39 5.14 7.84 jag2.L 1.37 0.42 0.58 0.06 0.69 0.59 0.43 0.14 0.06 0.35 1.16 0.76 0.54 0.06 jag2.S 2.76 0.39 1.81 0.07 0.32 0.32 0.12 0.17 0.33 2.72 3.14 4.17 3.33 0.02
Notch signaling_Ligands-Receptors notch1.L 1.09 8.4 7.98 18.44 17.88 26.7 33.32 34.69 20.51 10.07 5.12 notch1.S 2.47 26.41 26.53 25.68 27.99 26.24 22.43 22.19 11.84 5.51 2.41 notch1.L 0.08 0.13 0.24 8.26 13.83 13.12 34.25 35.07 35.4 36.39 34.93 23.91 9.05 1.64 notch1.S 1.39 0.98 1.02 9.38 31.21 32.46 40.04 42.45 32.47 14.46 14.66 9.26 3.33 2.1
Notch signaling_Ligands-Receptors notch2.L 0.15 0.31 0.42 0.32 0.97 5.67 7.69 8.11 2.62 2.53 1.35 notch2.S 0.8 0.55 0.45 0.32 1.62 6.88 8.06 11.08 3.32 2.3 2.14 notch2.L 0.02 0.1 0.12 0.12 0.39 0.39 0.18 0.64 2.41 3.62 3.25 1.03 0.78 0.16 notch2.S 0.05 0.05 0.04 0.16 0.13 0.05 0.15 0.93 2.43 1.96 1.98 0.95 0.68 0.07
Notch signaling_Ligands-Receptors notch3.L 1.33 6.79 8.26 16 28.59 28.08 21.39 17.94 21.51 13.77 10.9 notch3.S 2.57 8.45 9.49 5.19 4.2 12.71 16.68 19.03 10.2 7.18 3.53 notch3.L 0.64 0.91 1.07 1.2 7.56 9.29 17.02 32.55 30.47 10.91 12.72 9.83 6.18 1.11 notch3.S 0.08 0.25 0.41 6.25 19.91 13.38 6.49 5.22 10.1 10.74 13.43 7.85 4.48 2.52
Notch signaling_Extracellular-Membrane psen1.L 5.1 33.95 34.12 36.52 29.21 24.32 21.27 22.07 19.82 16.29 11.88 psen1.S 6.19 52.45 53.65 43.53 15.04 21.71 16.8 15.6 15.63 13.99 9.78 psen1.L 9.21 25.53 21.17 0.4 25.72 30.68 29.49 23.71 21.14 9.34 8.84 7.99 6.31 0.55 psen1.S 16.26 20.31 25.96 3.4 51.12 56.38 36.78 12.07 14.48 7.69 9.1 6.63 4.98 2.45
Notch signaling_Extracellular-Membrane psen2.L 1.38 5.32 5.41 2.53 0.63 1.21 1.27 2.51 1.86 2.12 1.11 psen2.S 32.63 53.58 54.9 19.4 3.48 8.62 10.14 12.92 11.2 8.58 7.67 psen2.L 0.61 1.5 1.74 1.15 3.99 4.61 1.01 0.58 0.69 0.64 1.47 0.84 0.79 0.6 psen2.S 10.71 39.45 24.51 33.33 41.06 41.18 9.29 2.65 5.24 2.01 1.84 2.09 2.87 25.88
Notch signaling_Extracellular-Membrane psenen.L 8.68 23.6 25.81 29.07 56.71 102.42 141.02 118.2 141.85 134.54 126.09 psenen.S 5.73 26.92 26.69 40.33 37.38 68.98 68.99 59.55 76.44 47.56 50.84 psenen.L 150.14 71.36 77.56 11.54 25.63 38.42 46.4 110.58 171.38 201.61 215.69 207.49 195.68 6.58 psenen.S 193.12 106.21 102.94 3.59 26.02 31.02 55.45 65.47 90.73 124.7 110.29 104.74 91.86 2.4
Notch signaling_Extracellular-Membrane aph1a.L 3.93 10.61 10.58 9.52 5.22 4.02 4.76 6.86 7.81 7.42 5.54 aph1a.S 8.5 25.37 23.36 22.85 15.45 16.85 25.89 39.12 38.21 41.31 26.49 aph1a.L 18.52 6.39 22.3 8.87 22.95 21.72 14.4 7.73 5.2 18.63 15.83 12.72 9.75 6.88 aph1a.S 114.23 19.76 58.85 6.42 39.94 46.55 25.02 15.12 15.11 62.68 60.86 42.46 30.69 5.44
Notch signaling_Extracellular-Membrane ncstn.L 2.97 15.14 14.33 14.21 13.77 37.64 40.57 48.86 51.3 48.07 38.84 ncstn.S 76.78 47.27 48.31 41.26 56.9 56.44 54.13 51.4 50.42 40.9 32.84 ncstn.L 21.21 17.85 41.47 0.99 31.1 31.25 27.5 23.89 37.67 78.4 80.02 70.42 56.21 0.93 ncstn.S 50.44 56.86 90 207.98 58.27 51.74 51.75 82.18 79.08 71.97 61.3 55.29 38.62 176.62
Notch signaling_Extracellular-Membrane adam10.L 199.44 112.84 97.36 68.63 20.43 14.57 18.54 26.3 16.25 10.97 8.39 adam10.S 231.61 156.85 139.79 147.63 56.17 35.94 38.45 57.4 22.96 10.16 7.3 adam10.L 7.52 21.73 12.13 61.82 72.39 70.91 35.42 12.01 6.27 2.76 5.06 4.15 4.3 43.3 adam10.S 0.75 13.41 18.95 87.53 159.9 155.77 135.48 51.16 19.99 11.48 14.47 6.47 4.32 37.52
Notch signaling_Extracellular-Membrane adam17.L 18.77 24.5 22.59 17.29 4.64 12.07 14.21 15.4 15.84 12.85 8.92 adam17.S 3.58 16.67 15.68 14.11 4.44 4.08 4.47 5.96 4.97 5.97 4.19 adam17.L 5.48 10.86 15.74 24.06 32.67 30.4 14.46 3.3 6.84 12.18 13.9 12.04 9.27 21.89 adam17.S 1.73 3.73 6.25 2.49 16.11 16.72 12.68 4.41 1.58 2.78 2.88 2.28 1.98 1.1
Notch signaling_Extracellular-Membrane lfng.L 1.19 17.51 34.95 59.27 105.93 74.64 70.65 68.76 63.55 34.82 19.95 lfng.S 4 104.29 99.1 45.82 72.71 77.33 64.45 66.4 71.09 45.29 28.39 lfng.L 0.26 0.5 2.47 2.55 25.35 45.32 43.98 76.93 41.42 47.44 55.06 35.27 16.27 1.23 lfng.S 9.87 18.01 32.06 1.67 81.32 101.13 25.28 63.63 49.54 59.31 63.4 57.66 29.89 2.37
Notch signaling_Extracellular-Membrane rfng.L 9.4 10.77 15.2 33.23 72.79 51.97 38.97 31.07 27.64 26.09 18.24 rfng.L 8.65 18.89 13.99 2.64 7.68 12.05 35.75 64.76 52.34 10.54 12.51 10.36 8.27 2.58
Notch signaling_Extracellular-Membrane furin.L 108.63 89.47 87.74 59.75 21.35 58.97 47.01 37.75 27.07 27.04 17.26 furin.S 42.07 58.41 55.4 38.46 7.58 4.9 6.88 9.05 9.42 11.06 7.61 furin.L 7.01 27.57 18.81 78.34 90.21 81.7 40.33 15.66 53.54 19.01 13.28 8.4 7.89 60.81 furin.S 5.72 5.53 12.66 42.14 54.55 48.53 22.39 6.09 1.48 4.22 4.97 4.8 5 31.66
Notch signaling_Extracellular-Membrane pofut1.L 33.44 22.05 23.01 19.93 21.34 15.73 16.78 15.22 19.85 24.14 21.52 pofut1.L 70.81 47.27 57.42 72.46 39.31 32.86 34.12 31.67 22.46 23.65 21.57 24.16 25.65 74.88
Notch signaling_Extracellular-Membrane pofut2.L 57.41 37.08 35.56 38.73 29.41 19.43 15.1 17.31 17.55 16.1 10.4 pofut2.S 2.41 11.76 13.08 13.62 11.04 19.74 16.3 18.49 11.48 10.93 8.83 pofut2.L 5.42 17.29 11.89 42.81 33.22 33.83 34.19 24.97 15.61 8.34 9.5 9.13 7.23 44.99 pofut2.S 4.74 7.79 7.04 0.54 10.2 12.8 10.92 8.68 14.42 7.42 7.43 4.56 4.33 0.16
Notch signaling_Cytoplasmic cul1.L 131.3 86.91 79.44 70.16 54.82 11.62 12.01 13.48 8.93 6.52 5.16 cul1.S 114.14 76.07 77.32 73.06 53.43 24.25 17.99 17.98 11.47 7.53 5.14 cul1.L 25.08 56.57 32.65 61.2 56.01 56.49 71.55 73.77 13.64 2.02 2.84 3.16 3.52 82.47 cul1.S 13.83 63.81 36.63 68.35 58.6 57.38 71.01 51.23 20.41 3.96 5.75 5.42 5.89 99.26
Notch signaling_Cytoplasmic dtx1.L 0 0 0.05 0.16 0.64 0.7 0.57 1.33 1.71 3.31 5.02 dtx1.S 0 0.03 0.12 0.7 0.25 0.5 1.29 1.93 1.56 3.22 4.81 dtx1.L 0 0 0 0 0.07 0 0.2 0.56 0.25 0.77 0.82 0.97 1.79 0 dtx1.S 0 0 0 0 0.24 0.09 0.6 0.34 0.18 0.81 0.98 0.75 1.27 0
Notch signaling_Cytoplasmic dtx2.L 30.29 69.22 63.93 41.58 12.15 13.66 11.15 12.98 8.33 5.72 5.04 dtx2.S 6.94 5.43 5.74 2.52 0.77 4.95 6.92 6.37 4.56 2.33 1.63 dtx2.L 9.49 19.74 16.78 16.03 59.02 56.99 15.2 4.73 6.61 4.9 4.33 2.72 2.01 14.73 dtx2.S 0.81 2.05 2.09 6.92 6.29 6.05 1.41 0.43 1.62 1.47 1.5 1.21 0.83 5.87
Notch signaling_Cytoplasmic dtx3.L 0.06 0.04 0.04 0.2 0.05 0.08 0.21 0.13 0.48 1.73 2.53 dtx3.S 0 0 0 0 0 0 0 0.09 0.16 0.81 0.86 dtx3.L 0.12 0.1 0.09 0 0.11 0.08 0.1 0.06 0 0.04 0.04 0.43 0.72 0 dtx3.S 0 0.04 0 0 0 0 0 0 0.07 0 0 0.21 0.25 0
Notch signaling_Cytoplasmic dtx3-like.1.L 24.3 30.01 24.88 21.05 4.76 0.57 0.29 0 0.32 2.19 2.33 dtx3-like.1.L 6.24 49.05 36.79 21.78 31.21 26.45 16.85 6.25 0.32 0.49 0.27 0.15 0.72 29.84
Notch signaling_Cytoplasmic dtx3l-like.L 10.36 38.08 39.68 33.14 16.73 2.36 1.34 1.99 1.89 8.17 9.94 dtx3l-like.L 2.62 10.99 9.21 1.03 22.64 25.94 21.58 10.56 2.14 0.48 0.56 1.19 2.91 1.03
Notch signaling_Cytoplasmic dtx4.L 0.04 0.12 0.34 12.08 22.28 40.78 36.23 51.94 21.81 8.18 4.97 dtx4.L 0.01 0.06 0.01 0 0.03 0.07 6.57 11.97 15.46 5.15 7.52 5.08 3.46 0
Notch signaling_Cytoplasmic dtx5.L 0 0 0 0 0 0 0.1 0.05 0.03 0.48 0.88 dtx5.S 0.09 0.14 0.42 0.1 0.03 0 0 0.07 0.02 0.14 0.28 dtx5.L 0 0.04 0 0 0.12 0.06 0.08 0 0 0 0 0.02 0.1 0 dtx5.S 0.12 0.1 0.06 0 0.15 0.25 0.07 0 0 0 0 0.04 0.06 0
Notch signaling_Cytoplasmic fbxw7.L 5.01 14.41 11.7 6.1 7.88 12.26 10.45 11.07 6.37 4.13 2.88 fbxw7.S 11.68 40.49 37.36 16.59 12.11 13.08 13.61 14.41 7.83 5.02 3.25 fbxw7.L 1.17 1.6 1.11 7.81 9.53 7.92 4.41 6.12 11.76 2.55 2.47 1.28 0.74 3.41 fbxw7.S 0.82 1.35 1.17 14.81 19.14 20.07 7.59 7.44 11.48 1.83 3.89 1.93 0.8 6.54
Notch signaling_Cytoplasmic itch.L 12.55 27.55 34.35 25.73 12.99 24.39 22.6 24.23 16.01 11.51 6.74 itch.S 7.25 25.19 25.06 22.02 9.35 4.4 4.27 6.83 5.63 6.21 3.31 itch.L 9.55 31.16 26.35 7.94 17.84 23.87 15.18 9.76 12.39 12.33 12.61 8.29 5.52 2.34 itch.S 0.85 1.23 5.13 11.27 31.19 32.06 19.19 6.39 2.08 3.79 4.93 3.08 2.72 3.93
Notch signaling_Cytoplasmic skp1.L 85.49 106.65 104.32 82.06 63.16 54.56 45.99 42.42 45.73 56.91 66.71 skp1.S 62.08 80.37 78.72 87.55 121.14 120.36 86.68 70.18 77.74 85.22 74 skp1.L 84.53 118.21 79.68 52.83 74.8 77.65 74.95 62.35 50.06 26.15 25.07 21.9 29.39 65.83 skp1.S 50.71 93.83 57.42 23.95 59.29 64.61 90.73 101.44 88.74 65.99 58.95 41.89 37.36 30.73
Notch signaling_Cytoplasmic nedd4.L 0.5 4.01 4.28 2.17 2.68 3.3 3.39 3.41 0.71 0.2 0.13 nedd4.S 0 0 0 0 0 0.18 0.14 0.36 0 0.06 0.04 nedd4.L 0 0.03 0.07 0.04 2.38 2.14 2.49 1.14 0.42 0.59 0.92 0.24 0.05 0 nedd4.S 0 0 0 0.04 0 0 0 0.06 0.05 0.12 0.04 0 0.02 0
Notch signaling_Cytoplasmic nedd4l.L 1.95 3.29 3.47 2.58 0.74 1.12 4.58 8.21 9.49 6.66 4.89 nedd4l.S 16.8 17.15 18.33 13.51 3.5 9.16 16.11 19.05 17.08 11.61 9.6 nedd4l.L 4.98 5.79 7.27 2.68 3.73 4.39 2.07 1.16 0.32 3.23 4.72 5.48 4.67 2.47 nedd4l.S 6.79 15.02 15.29 17.56 18.64 18.74 15.95 3.02 5.45 11.75 11.62 7.54 6.72 20.14
Notch signaling_Cytoplasmic mib1.L 12.17 64.84 64.61 61.57 47.55 30.74 26.44 22.75 13.61 8.81 6.59 mib1.S 8.62 22.36 22.94 18.99 13.75 8.1 8.12 11.09 4.76 3 1.25 mib1.L 6.26 21.96 12.73 4.01 44.06 50.76 39.58 29.6 21.54 7.12 5.97 3.54 2.91 3.14 mib1.S 1.39 6.12 6.42 6.01 19.8 21.26 16.21 8.84 4.42 4.91 3.88 1.88 1.25 1.39
Notch signaling_Cytoplasmic mib2.L 20.65 32.56 31.29 25.49 7.15 1.86 2.51 4.22 6.82 8.67 7.85 mib2.S 11.25 24.71 24.82 18.01 5.7 0.65 0.53 0.84 1.34 2.86 2.88 mib2.L 4.14 16.2 15.1 9.08 22.05 22.7 13.54 5.04 0.88 0.91 1.6 3.11 4.12 7.9 mib2.S 8.33 16.89 21.25 6.37 21.12 23.94 13.17 3.17 0.41 0.2 0.19 0.63 1.54 6.08
Notch signaling_Cytoplasmic neurl1.L 0 0 0.02 0.18 0.02 3.23 3.47 3.95 3.48 3.08 3.17 neurl1.S 1.47 1.3 1.17 0.52 0.07 1.88 3.12 5.43 3.23 3.1 2.79 neurl1.L 0.01 0 0.01 0 0.03 0 0.05 0 2.16 1.32 1.42 1.05 1.01 0 neurl1.S 0.29 1 0.92 0.61 0.91 1.23 0.42 0.09 1.22 1.13 1.05 0.63 0.83 0.41
Notch signaling_Cytoplasmic neurl1b.L 0 0.08 1.1 13.98 2.45 4.82 6.53 8.6 3.27 3.6 2.85 neurl1b.S 0.34 1.78 1.75 2.15 0.74 1.32 2.19 4 3.96 6.09 4.03 neurl1b.L 0.1 0.04 0.05 0 0.05 0.2 9.32 2.22 1.28 2.16 2.08 1.1 1.99 0 neurl1b.S 0.55 0.71 1.3 0.27 1.74 1.95 1.76 0.63 0.23 1.36 2.44 1.9 3.05 0.37
Notch signaling_Cytoplasmic neurl2.L 0.17 0.05 0 0 0.06 3.31 5.41 8.55 9.27 8.82 5.72 neurl2.L 0.02 0.03 0.08 0.05 0.07 0.05 0.06 0 1.89 6.13 8.03 7.22 7.25 0.12
Notch signaling_Cytoplasmic neurl3.L 5.78 2.38 2.31 0.85 0.2 2.26 1.87 2.1 1.43 0.94 0.65 neurl3.S 0.21 0.07 0.07 0.08 0 0 0.41 0.16 0.99 0.78 0.26 neurl3.L 5.87 10.04 16.59 1.42 1.47 1.1 0.22 0 0.41 0.92 0.74 0.89 0.5 1.25 neurl3.S 0.02 0.21 0.28 0 0 0 0 0.09 0 0 0.07 0 0.07 0.08
Notch signaling_Cytoplasmic neurl4.S 37.63 100.98 106.76 71.55 17.17 22.8 34.69 30.37 27.32 24.17 20.26 neurl4.S 204.51 55.39 158.77 45.12 229.45 207.68 110.4 22.85 31.68 59.67 61.4 52.21 40.83 32.02
Notch signaling_Cytoplasmic numb.L 138.48 56.69 56.96 39.88 34.45 49.81 45.74 37.98 18.94 13.23 9.53 numb.S 31.48 40.01 34 30.62 8.71 8.78 9.46 9.15 7.56 6.04 5.27 numb.L 1.57 5.32 10.03 130.51 59.52 49.39 22.67 26.89 37.03 11.42 12.5 7.26 4.8 132.69 numb.S 0.98 1.54 2.68 70.95 60.32 47.51 23.06 5.91 5.05 12.18 10.51 7.07 3.85 50.77
Notch signaling_Cytoplasmic numbl.L 0.67 1.75 1.71 4.59 12.06 13.08 8.67 6.43 4.22 3.02 2.17 numbl.S 0.14 0.04 0.22 0.11 0.18 0.81 1.14 1.73 1.86 2.31 1.84 numbl.L 0.12 0.53 0.68 0.56 1.56 1.18 3 7.4 8.92 1.74 1.56 1.16 1.15 0.32 numbl.S 0.11 0.23 0.14 0.06 0.18 0.24 0.27 0.03 0.46 0.43 0.67 0.96 0.94 0.11
Notch signaling_Nuclear hey1.L 3.76 20.73 28.14 28.87 13.41 17.75 25.08 36.23 47.43 23.11 15.62 hey1.S 8.75 14.05 14.79 7.8 4.51 15.26 28.28 36.82 78.28 43.93 31.6 hey1.L 27.8 14.62 15.99 3.81 19.77 26.92 15.95 8.26 12.18 13.57 20.26 22.56 15.6 3.53 hey1.S 9.58 7.12 4.62 19.2 17.89 17.93 6.39 2.91 11.85 14.9 24.41 41.65 25.92 16.58
Notch signaling_Nuclear hey2.L 0 0 0 0.19 0 0 0.16 0.68 1.15 0.35 0.19 hey2.L 0 0.43 0.08 0 0 0.08 0 0 0 0 0.15 0.32 0.24 0
Notch signaling_Nuclear maml1.L 5.3 23.64 21.84 15.17 9.2 11.9 8.94 8.9 3.67 2.55 2 maml1.S 3.93 41.56 39.07 45.4 24.74 12.62 11.32 12.16 7.72 5.12 3.88 maml1.L 3.21 4.49 8.4 5.05 23.92 22.98 9.37 7.27 6.9 2.4 2.27 1.44 1.22 4.7 maml1.S 1.07 1.74 2.54 3.34 42.73 41.47 34.8 20.08 8.91 4.85 4.15 2.84 2.34 2.58
Notch signaling_Nuclear maml2.L 0.99 1.1 1.2 1.27 0.08 0 0 0.24 0.65 1.19 1.13 maml2.S 1.43 9.81 7.96 6.57 2.1 1.1 0.89 1.03 0.63 0.97 0.52 maml2.L 0.15 0.33 0.28 0.63 1.7 1.4 0.49 0.09 0.04 0.12 0.13 0.28 0.48 0.16 maml2.S 0.41 1.43 1.5 0.81 5.18 7.49 2.08 0.96 0.87 0.35 0.24 0.34 0.38 0.38
Notch signaling_Nuclear maml3.L 0 0 0 0 0 0.3 0.23 0.41 0.17 0.1 0.22 maml3.S 0.46 0.6 0.72 0.64 1.25 1.87 1.91 2.59 1.16 0.89 0.63 maml3.L 0 0 0 0 0 0 0 0 0 0.07 0.22 0.12 0.07 0 maml3.S 0.05 0.54 0.15 0.2 0.38 0.43 0.4 0.62 0.84 0.37 0.39 0.26 0.3 0.34
Notch signaling_Nuclear rbpj.L 3.16 10.61 10.4 7.55 3.97 5.01 5.72 5.05 3.72 2.11 1.59 rbpj.S 2.15 10.73 11.08 5.86 2.82 4.49 4.4 4.99 2.56 1.79 1.55 rbpj.L 1.55 1.67 2.68 1.5 4.71 5.93 5.26 2.74 4.24 0.83 1.31 1.02 0.94 2.38 rbpj.S 3.57 4.11 6.62 2.68 7.81 9.01 4.64 2.6 2.1 1.03 1.59 1.08 0.72 2.36
gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
Hippo signaling_Membrane dchs1.L 1.26 1 0.61 0.38 0.17 1.91 4.15 8.65 11.72 11.63 8.84 dchs1.S 0.65 0.36 0.39 0.19 0.1 2.31 3.49 7.13 6.35 7.39 3.35 dchs1.L 0.33 0.44 0.5 1.83 1 1.03 0.26 0.08 0.85 4.65 7.09 8.52 7.54 1.52 dchs1.S 0.02 0.02 0.15 0.88 0.62 0.28 0.17 0.02 0.74 7.47 11.78 7.69 5.39 0.62
Hippo signaling_Membrane dchs2.L 0.05 0.07 0.1 0.02 0.08 0 0.02 0.01 0 0 0.02 dchs2.S 0 0 0.22 0.15 0 0.09 0 0 0 0.03 0 dchs2.L 0 0 0 0 0.14 0.03 0.08 0 0 0.02 0 0 0.01 0 dchs2.S 0 0 0 0 0 0.04 0.11 0 0.05 0 0 0 0 0
Hippo signaling_Membrane crb1.L 0.07 0.02 0.16 0.08 0.08 0.09 0.09 0.16 0.95 1.52 1.25 crb1.L 0.02 0.07 0.07 0.04 0.2 0.11 0.16 0.06 0 0.02 0.15 0.54 0.79 0
Hippo signaling_Membrane crb2.L 0 0 0 0.1 0.25 10.44 12.16 14.39 7.97 6.26 3.05 crb2.S 0 0.02 0.02 0.41 7.42 23.44 20.83 14.16 6.79 5.62 2.39 crb2.L 0 0 0 0 0 0 0 0.12 2.53 7.16 6.49 2.81 1.57 0 crb2.S 0.01 0 0.01 0 0 0.04 0.61 4.63 10.91 6.34 4.33 2.08 1.77 0
Hippo signaling_Membrane crb3.L 38.65 20.68 18.74 11.57 6.5 15.93 18.88 17.04 14.49 12.3 12.37 crb3.S 16.68 11.6 14.45 11.78 5.04 8.22 5.93 7.52 6.49 5.57 7.92 crb3.L 30.42 36.94 39.12 91.03 32.14 24.9 12.06 10.99 20.26 32.01 27.85 18.24 15.03 80.5 crb3.S 39.67 7.7 40.18 76.2 31.57 33.98 11 6.23 9.66 26.51 12.94 10.64 8.84 39.85
Hippo signaling_Membrane fat1.L 2.31 10.74 10.15 4.66 6.38 6.82 8.41 11.53 2.75 2.03 0.98 fat1.S 2.57 10.49 10.17 7.73 12.82 23.52 27.05 33.06 18.71 9.79 6.12 fat1.L 0.01 0.05 0.12 1 6.42 6.63 3.08 1.79 2.44 3.14 2.8 0.78 0.38 0.5 fat1.S 0.08 0.73 0.89 1.05 6.32 7.87 7.03 8.17 12.51 6.25 7.03 4.46 2.78 1.52
Hippo signaling_Membrane fat2.L 0.02 0.02 0.08 0.61 0.28 2.22 2.75 3.46 1 0.75 0.33 fat2.S 0.01 0.07 0.19 0.4 0.82 14.2 16.47 17.8 10.9 6.56 3.59 fat2.L 0.01 0.03 0.06 0.17 0.08 0.1 0.44 0.18 0.59 0.48 0.54 0.17 0.13 0.1 fat2.S 0.02 0.12 0.02 0.02 0.06 0.09 0.17 0.39 4.75 5.01 5.76 4.11 2.8 0.03
Hippo signaling_Cytoplasmic amot.L 2.6 20.75 18.07 5.16 2.26 4.6 5.63 7.77 7.28 8.58 5.68 amot.S 1.32 8.78 8.02 5.01 1.87 5.5 5.61 7.25 5.05 4.06 2.7 amot.L 2.06 7.29 7.97 0.96 16.89 14.14 1.73 1.56 2.34 1.8 2.54 2.32 2.77 1.11 amot.S 0.37 1.38 1.27 0.28 6.46 6.2 2.49 1.05 2.09 1.41 1.29 0.93 0.79 0.17
Hippo signaling_Cytoplasmic amotl1.L 0 0.24 0.38 3.66 8.75 7.99 10.22 14.13 10.97 9.57 8.74 amotl1.S 8.01 18.77 20.06 13.65 4.54 3.78 6.39 9.23 9.96 6.3 6.17 amotl1.L 1.5 0.61 1.14 0.28 0.74 0.74 12.08 21.46 11.55 18.54 19.76 16.17 14.16 0.06 amotl1.S 25.35 30.14 38.29 10.94 31.08 30.05 13.45 5.89 3.79 8.39 12.69 13.54 9.57 8.27
Hippo signaling_Cytoplasmic amotl2.L 18.31 4.66 7.35 16.69 30.62 27.26 30.43 39.25 25.05 22.32 8.29 amotl2.S 3.8 1.5 2.58 19.57 42.57 47.87 40.15 40.02 24.05 20.04 11.48 amotl2.L 0.38 2.4 7.77 26.41 2.24 3.63 29.05 36.58 24.65 16.5 21.95 14.43 8.43 13.42 amotl2.S 0.44 1.48 1.46 9.11 0.71 1.14 28.29 34.46 41.01 15.08 13.7 11.33 7.33 4.58
Hippo signaling_Cytoplasmic ctnna1.L 165.89 105.61 83.12 37.41 27.32 22.35 17.16 18.8 12.44 11.81 11.97 ctnna1.S 331.28 163.64 151.1 180.24 280.47 233.38 176.83 145.48 64.89 26.96 21.96 ctnna1.L 15.23 31.68 16.48 81.32 70.36 60.55 21.22 22.3 17.78 3.56 4.55 4.02 5.09 64.76 ctnna1.S 22.93 30.05 25.24 118.55 97.94 103.82 153.07 212.42 180.26 33.66 32.31 15.82 12.77 89.04
Hippo signaling_Cytoplasmic ctnna2.L 0 0 0.16 0 0 0 0 0 0 0.31 0 ctnna2.S 0 0 0 0 0.18 0 0 0.12 0.09 1.09 0.52 ctnna2.L 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 ctnna2.S 0 0 0 0 0 0 0 0 0 0.13 0 0.32 0.25 0
Hippo signaling_Cytoplasmic dlg1.L 20.54 56.43 59.92 23.61 4.85 15.94 14.8 20.32 4.38 1.85 1.29 dlg1.S 222.68 110.82 105.8 54.05 16.35 39.02 37.15 41.28 14.63 7.13 6.26 dlg1.L 0.07 0.55 0.77 21.19 32.14 31.11 9.31 2.27 4.6 3.3 3.81 1.5 0.82 6.12 dlg1.S 10.26 9.96 7.9 88.54 64.73 62.77 24.24 7.45 16.09 5.6 6.73 3.91 3.34 66.96
Hippo signaling_Cytoplasmic dlg4.L 0 0 0 0 0.06 0 0.05 0.27 0.58 3.2 3.66 dlg4.S 0 0 0 0 0 0 0.22 0.17 0.16 0.7 1.09 dlg4.L 0.03 0.09 0 0 0 0 0 0.14 0.11 0.17 0.38 1.12 2.66 0 dlg4.S 0 0.04 0 0 0.1 0 0 0 0 0 0.7 0.53 0.81 0
Hippo signaling_Cytoplasmic scrib.L 43.03 26.67 25.61 15.43 12.08 16.07 19.68 20.53 16.28 13.32 8.04 scrib.S 9.39 13.98 13.88 10.14 4.21 5.55 10.97 12.79 12.13 8.64 5.01 scrib.L 6.47 1.66 11.43 131.61 92.07 68.58 28.13 23.54 22.71 50.08 56.38 36.49 22.24 112.4 scrib.S 1.01 1.53 5.95 18.27 29.28 28.03 15.64 6.5 4.96 17.32 26.37 20.97 14.47 15.63
Hippo signaling_Cytoplasmic llgl1.L 16.85 96.54 112.87 89.25 40.06 41.39 49.27 44.98 35.4 25.1 17.08 llgl1.S 71.62 65.22 59.69 49.99 24.06 32.27 38.82 32.26 23.35 16.58 15.18 llgl1.L 25.05 30.05 52.6 39.05 157.53 167.23 118.15 61.76 51.17 62.43 54.13 38.61 23.85 19.39 llgl1.S 52.29 44.03 80.65 141.58 116.38 103.57 78.29 39.73 28.5 55.24 47.15 27.1 18.25 110.7
Hippo signaling_Cytoplasmic llgl2.L 30.12 49.02 44.66 33.84 12.29 4.44 5.87 6.56 8.69 10.96 9.28 llgl2.S 10.91 64.32 59.96 40.8 19.48 11.8 19.59 22.82 19.98 18.53 17.41 llgl2.L 39.2 15.54 48.09 103.12 106.89 77.36 54.9 22.27 6.56 10.57 11.47 13.29 8.81 92.05 llgl2.S 56.92 30.61 81.51 4.14 143.72 121.73 80.37 30.86 16.75 47.94 50.75 30.89 17.64 2.62
Hippo signaling_Cytoplasmic ptpn14.L 16.89 17.14 16.33 10.5 4.17 12 12.73 14 7.77 6.78 3.94 ptpn14.S 1.76 2.55 2.95 2.84 2.73 9.13 11.42 13.64 7.65 4.61 2.68 ptpn14.L 1.8 3.46 3.69 22.51 22.37 18.85 10.08 6.18 6.58 7.07 8.18 5.61 3.03 15.36 ptpn14.S 5.82 2.86 5.59 1.69 2.78 2.4 4.37 2.09 6.12 7.8 9.17 6.37 3.79 1.31
Hippo signaling_Cytoplasmic stk3.L 26.07 32.01 23.82 20.76 6.46 1 1.85 3.85 0.93 0.79 0.48 stk3.S 27.15 89.86 85.44 71.71 23.6 3.02 2.89 3.84 2.9 3.35 2.34 stk3.L 0.06 0.86 0.52 20.66 32.92 25.59 14.78 3.55 1.32 1.58 1.51 0.43 0.37 7.53 stk3.S 2.3 4.71 3.49 13.05 61.3 62.86 43.85 13.53 2.01 1.81 2.65 1.53 1.35 8.89
Hippo signaling_Cytoplasmic stk4.L 0 0 0.08 0 0.43 1.98 6.56 11.05 15.9 21.83 15.22 stk4.S 0 0 0.04 0 0.05 0.24 0.89 3.85 4.65 2.92 1.98 stk4.L 0.05 0.32 0.04 0.06 0 0.07 0.28 0.11 1.21 2.76 4.96 8.64 11.88 0 stk4.S 0.04 0.02 0.04 0.03 0 0.04 0 0.06 0.05 0.14 1.07 1.68 0.94 0
Hippo signaling_Cytoplasmic sav1.L 38.45 41.39 43.4 45.32 17.52 11 9.25 13.02 7.5 3.22 1.56 sav1.S 1.35 4.82 5.13 6.8 8.95 12.39 12.74 11.64 11.14 6.98 5.55 sav1.L 1.1 9.87 13.06 22.13 36.07 37.87 28.74 12.01 6.69 5.89 5.78 2.58 1.93 20.95 sav1.S 2.39 2.52 4.27 3.74 5.45 6.16 5.78 7.26 7.38 6.45 6.93 6.22 4.8 3.51
Hippo signaling_Cytoplasmic lats1.S 16.41 74.79 68.98 35.99 18.49 25.72 18.48 17.53 5.47 2.99 2.24 lats1.S 3.97 11.98 11.42 7.81 48.86 49.08 12.09 7.48 12.26 2.9 2.61 1.18 0.96 4.87
Hippo signaling_Cytoplasmic lats2.L 1.84 16.48 14.46 9.54 1.96 1.48 1.99 3.58 0.8 1.44 0.31 lats2.S 12.17 19.74 15.65 5.58 1.58 1.7 2.18 3.22 2.48 1.85 1.34 lats2.L 0.07 0.21 0.36 3.63 19.03 19.09 5.74 1.86 0.64 1.43 1.33 0.63 0.38 1.32 lats2.S 1.33 3.26 2.58 10.78 16.77 13.94 2.49 1.63 1.42 1.19 1.3 1.03 0.95 8.09
Hippo signaling_Cytoplasmic mob1a.L 169.33 126.91 119.49 128.82 104.43 125.25 118 120.59 89.04 71.98 46.1 mob1a.S 56.23 89.23 86.81 101.82 84.82 80.65 59.91 50.19 34.52 25.12 17.44 mob1a.L 15.01 34.8 25.74 75.72 79.09 75.86 80.27 70.93 71.51 27.85 33.25 21.1 19.07 51.39 mob1a.S 17.53 28.33 28.97 80.62 95.76 96.03 98.6 68.29 54.95 36.01 28.38 17.14 12.34 56.49
Hippo signaling_Cytoplasmic mob1b.L 1.85 2.9 3.37 2.09 0.24 1.2 1.06 2.47 0.83 0.82 1.17 mob1b.S 0 0.85 0.98 0.75 0.66 0.54 0.68 3.03 1.48 1.71 1.52 mob1b.L 0.09 0.37 0.29 0.21 1.29 1.22 0.54 0.22 0.1 0.23 0.22 0.23 0.25 0.23 mob1b.S 0 0.05 0.07 0.08 0.47 0.35 0.49 0.19 0.15 0.43 0.86 0.81 0.94 0
Hippo signaling_Cytoplasmic limd1.L 2.76 12.99 11.05 6.42 2.72 7.58 9.2 12.49 5.3 4.26 2.55 limd1.L 0.68 2.71 1.66 0.55 8.35 8.41 3.54 1.01 1.96 1.52 2.18 1.39 1.17 0.2
Hippo signaling_Cytoplasmic nf2.L 20.28 34.48 39.01 36.37 8.46 4.48 6.07 9.93 9.48 7.82 4.33 nf2.S 118.15 116.38 115.63 95.82 44.27 41.17 35.23 34.36 16.9 9.52 4.97 nf2.L 6.61 0.89 4.38 14.8 23.52 27.35 28.7 7.26 1.89 1.43 2.61 2.18 2.31 14.07 nf2.S 15.74 33.27 31.42 49.43 68.92 73.73 56.77 22.91 28.51 6.75 6.4 4.09 3.36 57.82
Hippo signaling_Cytoplasmic frmd6.L 1.62 22.34 24.42 15.17 9.27 14.69 9.57 8.8 6.23 6 4.41 frmd6.S 0.88 2.56 3.01 1.34 1.23 4.2 2.58 2.99 3 4.03 3.45 frmd6.L 0.92 2.78 2.63 0.27 11.69 13.39 5.59 2.63 13.38 1.21 1.61 1.14 1.21 0.22 frmd6.S 0.32 0.65 0.47 0.43 2.52 1.8 0.93 0.56 2.92 2.45 2.32 1.98 2.84 0.45
Hippo signaling_Cytoplasmic wwc1.L 1.98 1.71 1.15 1.02 0.46 2.31 3.97 6.05 3.05 1.77 1.33 wwc1.S 15.74 20.25 18.34 10.07 1.78 3.75 3.68 4.69 2.97 2.32 1.44 wwc1.L 0.01 0.14 0.02 1.33 1.84 1.52 0.41 0.31 0.51 0.84 1.18 0.63 0.65 0.65 wwc1.S 0.88 5.9 4.39 10.62 16.51 14.86 3.21 0.7 1.05 0.85 0.8 0.8 0.56 10.08
Hippo signaling_Cytoplasmic wwc2.L 0.26 2.93 3.75 2.15 1.2 1.79 2.48 3.37 1.25 0.88 0.47 wwc2.S 1.8 13.1 13.83 9.03 7.96 13.62 13.61 14.72 6.74 4.15 2.45 wwc2.L 0.01 0.1 0.22 0.14 2.02 2.93 1.04 0.59 1.09 1.31 1.3 0.66 0.36 0 wwc2.S 1.42 3.77 3.33 1.47 8.91 9.43 5.07 6.71 9.69 3.04 3.96 2.69 2.43 0.88
Hippo signaling_Cytoplasmic wwc3.L 0 0.13 0.21 0.1 1.38 4.55 6.06 9.94 5.17 4.06 2.15 wwc3.S 0 0 0.07 0 0.57 7.94 8.26 8.2 2.9 0.6 0.79 wwc3.L 0 0.1 0.09 0 0.05 0.16 0.05 0.93 2.88 1.56 2.99 1.58 1.31 0 wwc3.S 0 0.13 0.11 0 0 0 0 0.6 5.5 0.56 1.17 0.56 0.22 0
Hippo signaling_Cytoplasmic pard6b.L 17.67 97.21 100.38 83.6 11.15 3.41 3.37 5.09 2.13 2.99 1.94 pard6b.S 10.24 45.64 45.27 30.14 8.51 9.14 9.27 11.17 8.98 7.34 6.39 pard6b.L 0.86 4.34 3.03 35.06 114.5 120.92 72.8 16.66 2.03 3.85 3.8 1.42 1.22 26.19 pard6b.S 2.2 5.59 5.14 11.29 44.52 43.04 19.05 5.92 4.42 5.86 5.49 4.19 3.52 10.96
Hippo signaling_Cytoplasmic pard6g.L 185.48 107.06 100.8 57.01 15.12 26.49 26.28 20.23 16.14 10.94 5.26 pard6g.S 90.58 109.03 109.41 99.62 55.3 36.57 34.29 32.33 24.79 13.4 8.78 pard6g.L 15.28 53.19 31.48 124.42 89.08 89.37 36.01 9.13 15.41 7.83 6.68 3.24 2.68 104.66 pard6g.S 12.69 38.3 32.76 93.8 106.72 103.6 71.6 45.68 27.26 15.72 18.04 10.15 5.65 87.41
Hippo signaling_Cytoplasmic prkci.L 23.35 47.31 39.65 32.61 17.11 16.77 15.24 15.51 9.8 6.71 3.46 prkci.S 8.52 12.99 11.53 8.91 4 4.73 6.41 6.86 3.99 3.87 2.68 prkci.L 0.36 0.91 1.44 20.42 35.14 32.14 24.36 12.87 9.04 6.51 6.37 3.11 2 9.59 prkci.S 0.6 0.58 1.57 7.19 10.93 10.41 3.79 1.3 1.89 14.38 11.6 4.34 2.05 5.02
Hippo signaling_Cytoplasmic rassf1.L 1.86 5.98 8.22 3.71 5.14 9.16 12.68 19.58 19.68 17.02 17.04 rassf1.S 0 0.6 0 3.57 7.7 14.92 15.51 18.83 14.2 15.38 13.06 rassf1.L 27.69 8.02 20.38 0.13 8.27 10.07 4.82 10.97 16.07 21.6 22.83 26.84 18.79 0.17 rassf1.S 20.03 4.32 11.28 0 0.39 0.87 5.95 8.41 16.39 27.07 23.62 20.54 15.33 0
Hippo signaling_Cytoplasmic rassf2.L 28.92 41.51 31.93 22.54 7.35 4.03 3.58 5.07 8.8 9.31 6.84 rassf2.S 0.12 0.76 2.34 3.24 4.61 14.86 12.28 10.82 5.2 5.39 3.66 rassf2.L 7.2 16.88 18.77 25.45 31.71 32.65 17.58 5.22 2.63 1.56 1.85 2.74 3.16 31.43 rassf2.S 0.02 0.69 0.27 0.06 0.1 1.48 3.3 3.24 6.38 2.87 2.54 1.59 1.9 0.09
Hippo signaling_Cytoplasmic rassf3.L 36.78 88.41 80 52.01 66.77 45.57 28.9 26.85 15.29 9.68 6.37 rassf3.S 122.55 319.28 292.43 124.82 19.73 47.96 36.8 30.91 11.28 8.49 4.92 rassf3.L 9.2 7.45 10.13 11.73 35.41 40.51 31.29 40.46 37.23 5.58 5.65 3.72 2.98 15.74 rassf3.S 17.54 25.76 25.12 51.88 171.92 176.6 46.12 9.46 16.14 6.3 5.86 2.81 2.74 53
Hippo signaling_Cytoplasmic rassf4.L 0.23 1.15 0.14 0.26 0.41 1.88 8.48 18.56 6.16 2.15 2.21 rassf4.L 0.02 0.22 0.11 0.12 0 0 0 0.2 0.16 0.56 1.31 1.74 1.37 0
Hippo signaling_Cytoplasmic rassf5.L 7.3 1.29 0.64 1.14 0 0 0.08 0.31 1.08 0.66 0.46 rassf5.S 0 0 0.02 0.03 0 0.8 1.65 2.23 0.7 0.33 0.49 rassf5.L 0.35 0.34 0.79 0.55 0.73 0.55 0 0.33 0 0 0 0.04 0.09 0.37 rassf5.S 0 0 0.01 0 0 0.05 0.06 0.03 0 0.04 0.22 0.06 0.2 0
Hippo signaling_Cytoplasmic rassf6.L 0.33 0.97 0.76 1.85 3.9 2.36 3.29 4.53 1.32 0.64 1.25 rassf6.S 0 0.27 0.2 1.37 1.53 16.55 31.72 43.38 7.15 2.88 2.62 rassf6.L 0.15 0.41 0.24 0.22 0.44 0.37 2.5 5.12 2.74 0.33 0.65 0.35 0.66 0.1 rassf6.S 0 0.04 0 0 0 0.07 0.16 1.03 1.39 2.51 6.23 2.26 1.58 0
Hippo signaling_Cytoplasmic tjp1.L 20.27 19.94 18.56 15.72 5.59 14.34 12.4 13.86 6.28 3.97 3.31 tjp1.S 11.57 25.48 27.71 19.33 6.25 10 10.43 12.03 5.93 3.96 2.94 tjp1.L 1.29 1.7 0.91 13.92 7.84 9.41 8.59 3.55 6.18 2.64 2.06 0.98 0.97 5.96 tjp1.S 2.61 2.98 1.84 6.14 11.92 14.59 12.01 4.26 3.76 1.75 1.87 0.97 0.77 3.27
Hippo signaling_Cytoplasmic tjp2.L 3.19 20.2 22.15 37.19 87.36 69.81 53.09 33.21 13.38 5.86 3.96 tjp2.S 0.37 16.52 15.89 12.96 5.15 4.77 9.89 16.2 10.52 8.05 6.01 tjp2.L 3.31 8.93 11.25 0.47 9.63 14.16 34.67 65.22 54.59 16.62 11.59 3.88 2.11 0.29 tjp2.S 0.01 0.16 0.11 0.29 12.18 12.57 10.66 3.8 2.12 2.6 4.47 3.15 2.85 0.15
Hippo signaling_Cytoplasmic tjp3.L 38.69 19.11 18.68 19.35 15.03 20.42 14.51 15.31 5.59 3.37 2.18 tjp3.S 36.61 16.31 14.08 14.4 8.7 5.48 4.5 5.49 1.87 1.04 0.53 tjp3.L 3.94 12.48 8.6 17.56 16.91 15.27 16.84 12.02 14.25 5.23 5.06 2.33 1.45 17.15 tjp3.S 1.44 9.81 6.63 17.32 14.42 13.82 9.48 3.63 4.36 1.41 1.67 0.76 0.38 12.91
Hippo signaling_Nuclear taz.L 181.93 108.75 119.75 121.49 87.24 74.49 82.7 84.97 82.81 80.54 67.53 taz.L 199.85 157.22 161.14 451.25 241.94 228.24 213.09 122.24 114.9 161.02 135.79 115.33 82.24 485.15
Hippo signaling_Nuclear tead1.L 2.2 5.6 5.47 2.43 0.73 0.65 0.77 0.93 0.36 0.31 0.23 tead1.S 4.13 14.98 18.13 8.27 1.59 0.82 1.6 3.03 0.1 0.19 0.36 tead1.L 0.83 1.64 1.79 1.7 3.72 5.35 1.04 0.6 0.8 0.23 0.36 0.3 0.14 0.63 tead1.S 0.08 0.75 0.18 2.24 13.42 17.11 6.24 1.54 0.73 0.61 0.45 0.15 0.07 0.61
Hippo signaling_Nuclear tead4.L 1.81 7.39 7.16 32.19 126.51 124.02 83.5 55.83 26.98 13.57 8.96 tead4.S 1.75 3.01 4.41 36.39 75.86 72.73 49.46 41.44 21.54 13.96 9.55 tead4.L 1.44 2.61 2.49 3.08 2.95 4.13 34.84 95.87 96.95 22.75 15.56 7.93 5.59 2.03 tead4.S 2.27 6.5 7.11 0.5 1.96 2.46 37.73 51.9 59.39 31.56 26.09 11.22 7.73 0.06
Hippo signaling_Nuclear yap1.L 155.87 164.25 144.79 113.25 99 160.12 124.26 84.8 47.35 29.92 21.8 yap1.S 16.81 44.4 41.37 42.3 46.47 40.56 34 29.28 21.13 15.53 11.68 yap1.L 12.75 28.68 18.21 134.16 88.48 92.06 74.22 72.96 109.2 46.5 30.75 14.89 10.79 74.71 yap1.S 4.54 7.51 7.12 16.1 44.63 44.61 42.23 43.73 33.9 21.15 17.23 10.4 7.84 14.9
Hippo signaling_Nuclear vgll4.L 5.69 64.37 59.67 54.28 31.83 29.04 33.74 44.08 44.06 29.44 16.94 vgll4.S 9.38 27.19 32.06 29.29 29.35 40.35 36.56 31.49 33.46 24.31 18.83 vgll4.L 4.8 3.18 25.18 18.31 71.08 70.57 65.61 38.39 26.2 50.25 49.95 37.41 20.39 12.34 vgll4.S 8.74 14.86 12.72 16.74 23.44 27.5 27.27 37.41 42.95 24.14 22.65 20.69 14.2 15.54
gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name egg.T st08.T st09.T st10.T st12.T st15.T st20.T st25.T st30.T st35.T st40.T gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U gene name oo12.U oo34.U oo56.U egg.U st08.U st09.U st10.U st12.U st15.U st20.U st25.U st30.U st35.U2 st40.U
TLE_Nuclear tle1.L 44.22 86.43 80.75 45.8 32.88 64.57 44.39 34.25 27.63 16.91 11.8 tle1.S 13.19 37.19 37.66 26.75 18.65 27.05 22.18 19.78 15.68 10.13 7.57 tle1.L 17.29 21.6 16.75 58.92 80.47 74.44 40.74 29.69 45.82 15.04 15.49 9.92 6.17 49.39 tle1.S 1.86 4.47 6.48 12.57 30.05 29.04 19.94 16.21 23.4 10.94 10.25 6.86 3.84 10.9
TLE_Nuclear tle2.L 121.51 63.92 70.37 67.58 49.53 38.05 46.36 39.7 25.61 18.66 15.1 tle2.S 19.68 10.39 11.06 10.36 11.1 10.18 10.18 9.66 6.94 6.05 4.47 tle2.L 71.88 83.85 111.26 248.13 136.64 116.36 83.26 50.24 36.66 61.73 59.47 33.09 21.06 255.5 tle2.S 11.65 15.83 19 44.04 21.62 20.46 16.57 11.87 8.7 12.18 9.43 6.6 4.95 54.29
TLE_Nuclear tle4.L 5.36 30.07 28.55 13.39 7.15 11.22 11.55 9.13 8.04 5.6 4.78 tle4.S 36.07 51.4 50.86 18.26 8.83 10.81 9.4 8.23 6.56 5.14 3.83 tle4.L 3.36 8.94 6.66 10.49 31.93 27.58 5.13 5.14 9.91 4.99 5.7 3.39 2.88 9.23 tle4.S 7.58 19.63 15.52 43.43 56.59 45.42 10.32 7.94 8.08 4.96 4.69 3.42 2.51 42.9
TLE_Nuclear aes.L 18.55 55.3 53.18 40.19 27.8 55.53 66.15 70.18 81.17 76.21 77.71 aes.S 39.66 145.68 150.04 140.74 170.98 206.85 186.56 181.36 168.76 154.74 145.23 aes.L 16.34 53.7 59.57 11.33 54.46 56.95 40.93 22.42 46.03 57.27 69.12 60.19 55.43 10.67 aes.S 33.43 149.51 129.65 12.41 172.27 194.72 161.44 163.41 187.25 136.74 138.64 103.06 84.01 10.76
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gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
Wnt signaling_Wnt ligands wnt1.L 0.58 0 0 0 0 0.03 0.02 0 0 0 0 0 0 0.18 wnt1.S 12.08 6.62 7.93 4.82 11.93 3.38 5.74 1.56 1.62 0.71 3.87 10.47 3.2 7.42 wnt1.L 0.13 0 0 0 0.02 0.02 0 0 0 0 0 0 0 0.14 wnt1.S 7.52 3.57 2.83 2.5 7.31 1.28 3.59 1.57 0.15 1.1 4.72 4.19 1.52 1.38
Wnt signaling_Wnt ligands wnt2.L 3.09 0 0 0 0 0 0 0 0.06 0 0 0 0 4.07 wnt2.S 4.75 0 0 0.11 0.09 0 0.06 0.13 0.08 0 0.11 0 0.08 0.33 wnt2.L 2.56 0 0 0.05 0 0 0 0 0 0 0.06 0 0 0.17 wnt2.S 4.04 0.09 0 0 0.07 0 0 0 0.08 0 0 0.08 0.06 0.07
Wnt signaling_Wnt ligands wnt2b.L 1.73 2.9 1.74 7.76 0.72 0.59 13.19 0 0 0.07 0 0.52 2.94 1.21 wnt2b.L 1.17 2.15 0.59 2.73 0.3 0.18 20.1 0 0 0.38 0.16 1.23 1.99 0.08
Wnt signaling_Wnt ligands wnt3.L 3.07 0.07 0 0 0 0 0 0 0.05 0 0 0.15 0 0 wnt3.S 0.26 0 0 0 0.14 0 0 0 0 0 0 0 0 0 wnt3.L 6.42 0 0 0 0 0 0 0 0.05 0 0 0 0 0.09 wnt3.S 0.35 0 0 0 0.2 0 0 0 0 0 0 0 0 0
Wnt signaling_Wnt ligands wnt3a.L 2.08 1.86 0.02 0 0.03 0.05 1.31 0.04 0 0 3.71 0 0.01 0.11 wnt3a.S 0 0.17 0 0 0 0 0.1 0 0 0 1.83 0 0 0.18 wnt3a.L 0.49 0.2 0.01 0 0.01 0 0.6 0.01 0 0.01 2.63 0 0 0 wnt3a.S 0.19 0 0 0 0 0 0.09 0 0 0 1.2 0 0 0
Wnt signaling_Wnt ligands wnt4.L 3.76 6.07 0.81 0.89 9.27 0 2.1 0.49 0.12 0 6.33 0 5.51 7.51 wnt4.S 3.49 4.05 1.35 0 2.18 0 0.13 1.03 0.09 0.07 4.11 0.13 1.19 0.85 wnt4.L 4.27 4 0.46 0.85 7.17 0 1.23 0.06 0.11 0.11 12.38 0 5.6 3.58 wnt4.S 1.57 3.24 1.18 0 1.98 0 0.11 0.28 0 0.27 7.33 0.09 0.88 0.24
Wnt signaling_Wnt ligands wnt5a.L 2.38 4.49 4.8 7.85 10.78 0.79 4.62 1.12 0.83 0.18 0.57 2.45 1.1 0.45 wnt5a.S 3.15 4.93 1.11 1.22 3.51 0.32 9.76 0.72 2.8 0.18 0.61 0.64 1.3 1.61 wnt5a.L 1.2 1.78 1.93 0.94 5.18 0.25 2.89 0.43 0.08 0.36 0.2 0.52 0.54 0.22 wnt5a.S 1.16 1.29 0.57 0.45 1.96 0.03 2.74 0.09 0.08 0.18 0.37 0.08 1.09 0.42
Wnt signaling_Wnt ligands wnt5b.L 14.64 6.09 8.58 1.65 10.2 0.07 98.61 0.47 4.16 0.02 0.37 0.57 15.18 1.54 wnt5b.S 2.04 0.92 0 11.89 0.71 0.43 52.03 1.55 1.12 0.49 0.27 0.42 46.34 1.18 wnt5b.L 15.87 9.97 15.01 1.23 9.89 0.03 78.19 0.3 3.23 0.02 0.09 1.35 3.49 3.98 wnt5b.S 2.57 0.63 0.14 6.02 0.77 0.12 45.73 1.37 1.33 0.25 0.18 0.61 3.15 0.51
Wnt signaling_Wnt ligands wnt6.L 2.93 9.54 0 0.56 0.2 0 0.03 0 0.14 0 3.88 0 0.07 0.14 wnt6.S 1.64 0.36 0 0 0 0 0 0 0.46 0 0.12 0 0 0.13 wnt6.L 4.6 12.86 0.08 0.47 0.21 0 0 0.04 0 0 1.84 0.1 0.17 0.03 wnt6.S 0.55 0.1 0 0.14 0.24 0 0 0 0 0 0 0 0 0
Wnt signaling_Wnt ligands wnt7a.L 14.67 6.4 0.16 0 3.44 1.12 3.28 0 0 0 5.02 7.46 0 0.14 wnt7a.S 13.88 8.64 0.29 0.38 0.45 0.21 0.29 0.09 0.57 0.04 4.55 0.85 0.14 0.99 wnt7a.L 37.14 12.8 0.58 0.08 4.95 0.74 1.76 0 0 0.13 1.91 23.22 0 0.47 wnt7a.S 16.15 9.31 0.27 0.15 0.38 0.21 0.16 0.22 0.51 0.09 3.48 0.54 0.06 0.81
Wnt signaling_Wnt ligands wnt7b.L 16.87 7.08 0.82 0.07 0.19 0 49.7 0.27 0 0.04 4.01 0 0.03 1.42 wnt7b.S 3.67 4.4 0 0.15 0.37 0 37.69 0 0 0 2.79 0 0 0 wnt7b.L 7.76 1.14 0.06 0 0.14 0 18.13 0 0 0.13 3.31 0.05 0.04 0 wnt7b.S 2.79 1.16 0 0 0 0 19.35 0 0 0.32 4.96 0 0 0
Wnt signaling_Wnt ligands wnt7c.L 2.76 4.16 0.22 0.07 0.28 0 0.16 0 0 0 10.22 0.04 0.08 0.23 wnt7c.S 3.66 1.86 0.16 0 0.24 0 0.16 0 0 0 3.19 0 0 1.29 wnt7c.L 3.85 2.93 0.22 0.02 0.44 0 0.16 0.03 0 0.04 8.72 0.1 0.05 0.35 wnt7c.S 7.56 1.39 0.23 0.08 0.36 0 0.4 0.11 0 0 2.47 0 0.22 0.57
Wnt signaling_Wnt ligands wnt8a.L 0.18 0 0 0 0 0 0 0.41 0 0 0 0 0 1.24 wnt8a.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0.34 wnt8a.L 0 0.18 0 0 0 0 0 0.35 0 0 0 0 0 0.22 wnt8a.S 0 0 0 0 0 0 0 0.06 0 0 0 0 0 0.06
Wnt signaling_Wnt ligands wnt8b.L 13.41 0.09 0.11 0.61 0.19 5.27 0.02 0.08 0 0 0.09 0.1 0.05 0.03 wnt8b.S 20.45 2.06 0 0.44 0 0.05 0 0 0 0 0.05 0 0 0.4 wnt8b.L 3.76 0.03 0 0.75 0.04 0.1 0 0 0 0.01 0.06 0.12 0.02 0 wnt8b.S 12.16 1.53 0 0.19 0 0 0 0 0 0 0 0 0 0
Wnt signaling_Wnt ligands wnt9a.L 2.27 3.13 10.05 1.3 15.77 0.99 2.26 0.86 0.08 0.54 0.31 0.65 1.47 1.1 wnt9a.S 1.06 4.05 6.05 0.82 12.43 1.2 6.02 0.98 0 0.4 0.44 0.47 1.8 1.63 wnt9a.L 0.68 1.03 2.28 0.36 7.59 0.22 2.57 1.28 0 0.33 0.13 0.52 0.29 0.05 wnt9a.S 0.47 1.16 0.89 0.21 4.16 0.2 0.67 0.58 0 0.13 0.1 0.27 0.17 0.1
Wnt signaling_Wnt ligands wnt9b.L 0 1.18 0.14 0.26 0.44 0 0.07 0.16 0 0 0 0.14 0 0 wnt9b.S 0.28 0.2 0.68 0.26 18.77 0 0.26 0.16 0.03 0.1 0.08 0.24 0.16 0.53 wnt9b.L 0 2.38 0.1 0 1.68 0 0 0.1 0.09 0 0 0 0.13 0.51 wnt9b.S 0.09 0.71 0.67 0.27 52.1 0.06 0.04 0.07 0.03 0.04 0.09 0.06 0.02 0.17
Wnt signaling_Wnt ligands wnt10a.L 0.1 2.25 0 0.03 0.42 0 5.84 0.51 0 0 0 0 0.01 0.26 wnt10a.S 0.03 2.49 0.05 0 0.26 0 0.01 0.12 0 0 0.33 0 0 0.27 wnt10a.L 0.03 1.32 0.16 0 0.43 0 2.9 0.81 0 0.01 0 0 0.08 0.02 wnt10a.S 0 0.76 0 0 0.22 0 0 0.25 0 0 0.95 0 0 0.03
Wnt signaling_Wnt ligands wnt10b.L 0.86 2.55 0 0 0.04 0 0 0.25 0 0 26.64 0 0 0 wnt10b.S 2.96 3.55 0.62 0.28 0.45 0.44 0.17 0.24 1.21 0.02 20.48 0.45 0.08 0.23 wnt10b.L 0.66 0.13 0 0 0 0 0 0.16 0 0.02 38.5 0 0 0 wnt10b.S 1.09 0.45 0.3 0.11 0.41 0.1 0.24 0.13 0.06 0.06 31.57 0.08 0.09 0.02
Wnt signaling_Wnt ligands wnt11a.L 9.75 8.18 1.95 2.74 22.41 0.11 1.01 4.47 0 0.06 16.18 4.81 1.45 1.12 wnt11a.S 1.82 1.99 0.96 0.58 0.98 0 0.78 0.35 0 0 1.8 2.93 0.21 0 wnt11a.L 8.39 5.27 1.33 4.18 16.07 0.3 2.83 2.76 0 0.08 6.69 3.04 1.66 0.43 wnt11a.S 1.08 2.43 0.35 2.21 2.33 0 0.81 1.32 0 0.06 0.76 5.61 0.51 0.09
Wnt signaling_Wnt ligands wnt11b.L 0.31 0 0.07 0.32 6.3 0 0.1 0 134.58 0.03 0.12 0.69 0 0.38 wnt11b.L 0.34 0.21 0.1 0.11 5.71 0.14 0.12 0.05 168.46 0 0.08 0.37 0.03 0.71
Wnt signaling_Wnt ligands wnt16.L 2.94 3.17 0 0.13 0.45 0 0.14 0 0 0 0 0.14 0 0.13 wnt16.S 0.84 6.47 0 0 0 0 0.07 0 0.1 0 0.13 0 0 1.32 wnt16.L 0.14 1.49 0 0.07 0 0 0 0 0 0 0 0 0 0 wnt16.S 0.14 0.75 0 0 0 0 0 0 0 0 0 0 0 0.09
Wnt signaling_Fzd receptors fzd1.L 13.59 12.9 11.4 4.42 5.95 0.63 15.83 4.5 3.74 0.53 6.9 12.04 3.04 2.78 fzd1.S 7.52 10.11 31.27 4.04 10.33 0.49 12.29 4.69 9.7 0.28 5.03 4.36 3.79 1.35 fzd1.L 16.1 19.28 8.73 3.37 7.14 1.01 7.02 2.56 5.27 0.6 3.73 19.95 2.2 2 fzd1.S 13.75 20.15 38.59 2.69 18.19 1.12 10.88 2.6 7.12 0.79 2.51 10.98 3.51 1.28
Wnt signaling_Fzd receptors fzd2.L 3.11 3.68 1.13 0.25 0.94 0.82 5.66 6.26 0 0.05 0.24 0.37 0.77 0.94 fzd2.S 2.73 4.19 3.87 1.52 3.68 0.3 8.64 6.19 0.65 0.15 0.95 2.03 0.55 2.35 fzd2.L 3.46 5.27 0.76 0.56 1.17 0.87 3.28 3.2 0.12 0.11 0.51 0.37 0.39 1.62 fzd2.S 2.51 5.85 4.16 0.82 4.25 0.33 5.61 6.76 0.95 0.3 0.54 2.85 0.86 5.98
Wnt signaling_Fzd receptors fzd3.L 37.24 5.48 2.22 0.72 3.9 0.34 0.9 3.84 2.45 0.48 1.93 0.53 0.87 4.43 fzd3.S 19.51 3.46 0.42 0.64 1.81 1.25 4.69 0.17 2.37 0.59 1.81 0.95 0.92 6.24 fzd3.L 34.26 5.28 0.92 0.13 2.61 0.17 0.25 0.86 1.25 0.33 0.72 0.34 0.24 1.61 fzd3.S 19.69 3.46 0.35 0.26 1.74 0.23 3.47 0.17 1.33 0.17 1.14 0.72 0.14 4.23
Wnt signaling_Fzd receptors fzd4.L 1.01 1.56 3.98 0.85 2.34 0.1 1.2 0.13 1.37 0.06 0.31 0.34 0.34 0.74 fzd4.S 5.33 3.3 7.23 1.33 2.82 0.5 5.41 2.65 9.33 0.27 0.62 1.47 4.91 3 fzd4.L 1.47 2.64 6.24 0.17 2.57 0.31 0.1 0.32 0.3 0.14 0 0.69 0.27 0.76 fzd4.S 4.85 5.12 5.98 1.15 3.14 0.83 2.27 2.13 3.55 0.61 0.56 2.22 4.57 5.34
Wnt signaling_Fzd receptors fzd5.L 3.59 5.15 1.81 38.95 12.5 12.67 1.36 0.06 1.75 0.33 9.36 0.11 22.69 5.15 fzd5.S 1.74 2.46 0.13 20.91 2.8 9.18 9.32 0 0.8 0.76 0.29 0 8.05 0.64 fzd5.L 2.08 3.75 0.49 30.26 4.82 1.86 1.38 0 0.28 0.48 10.35 0.04 8.57 0.68 fzd5.S 1.05 1.6 0.06 8.13 2.87 1.48 5.34 0.05 0.29 0.38 0.62 0.01 3.3 0.57
Wnt signaling_Fzd receptors fzd6.L 3.88 11.93 3.73 3.85 8.92 2.06 10.57 0.7 5.47 0.89 20.04 1.7 9.85 7.99 fzd6.S 3.27 10.52 11.05 5.67 9.6 0.62 6.81 1.24 8.52 0.67 15.99 1.93 2.71 20.73 fzd6.L 4.55 8.96 2.74 1.79 8.98 2.21 5.1 0.84 4.42 1.36 16.26 2.25 9.82 6.7 fzd6.S 4.26 9.83 8.37 2.97 9.34 0.8 3.32 1.09 8.03 1.23 13.5 2.01 5.63 15.73
Wnt signaling_Fzd receptors fzd7.L 5.35 2.63 3.62 0.36 9.72 0.32 13.44 0.16 41.39 0.15 0.92 4.14 0.49 3.27 fzd7.S 3.27 1.32 4.4 0.16 0.55 0 6.8 0.07 1.55 0.19 0.34 0.12 0.13 4.72 fzd7.L 5.8 5.47 1.51 0.27 8.33 0.66 5.11 0.44 28.35 0.07 0.26 6.72 0.6 1.49 fzd7.S 4.2 2.68 1.82 0.15 0.81 0.08 2.37 0.04 0.97 0.08 0.25 0.53 0.1 2.45
Wnt signaling_Fzd receptors fzd8.L 2.77 1.87 0.27 0.59 4.55 5.23 1.06 2.45 0.11 0.19 0.14 0.32 0.32 0.15 fzd8.S 8.65 4.17 6.74 3.99 13.92 3.04 3.14 1.79 0.73 0.34 1.8 3.84 2.96 2.33 fzd8.L 6.96 4.16 0.44 1.72 10.98 10.33 0.28 4.2 0.07 0.6 0.26 0.76 0.36 0.46 fzd8.S 9.75 4.94 6.03 8.01 22.16 2.85 1.47 1.68 0.12 0.49 2.23 3.03 3.21 1.39
Wnt signaling_Fzd receptors fzd9.L 3.07 4.02 15.65 1.99 2.35 0.88 1.51 0.72 0.48 0.11 1.57 6.47 1.53 3.17 fzd9.S 0.98 0.47 0.62 1.52 0.17 0.1 0.87 0.06 0.04 0.08 0 0.27 1.72 1.49 fzd9.L 7.43 8.07 11.04 0.94 3.54 0.52 2.4 0.78 0.06 0.27 0.77 13.58 1.47 1.1 fzd9.S 3.07 1.61 0.7 0.93 0.83 0.49 1.59 0.2 0.04 0.11 0.03 0.3 1.5 0.57
Wnt signaling_Fzd receptors fzd10.L 6.32 3.07 0.3 0.19 4.57 20.33 0.82 0.85 0.28 9.25 21.62 0.8 16.74 3.55 fzd10.S 6.01 1.43 0 0.4 0.64 15.35 0.73 0.05 0.73 9.34 1.19 3.24 1.1 0.8 fzd10.L 8.87 3.29 0.16 0.32 5.79 25.34 0.74 0.3 0.36 3.87 17.83 0.86 14.99 4.49 fzd10.S 5.47 1.25 0.07 0.1 0.44 16.2 0.38 0.07 0.25 3.98 0.7 3.13 0.77 0.44
Wnt signaling_Extracellular-Membrane Positive lrp5.L 11.74 15.82 13.82 10.48 18.86 9.93 28.46 6.14 49.7 1.74 15.7 11.14 5.64 5.33 lrp5.L 5.55 10.22 8.44 4.46 13.66 3.06 9.66 3.67 1.89 2.05 12.07 10.83 3.93 3.3
Wnt signaling_Extracellular-Membrane Positive lrp6.L 3.86 3.17 2.96 3.65 3.21 0.63 4.14 0.46 4.13 0.21 1.66 2.13 1.48 6.77 lrp6.S 9.31 7.79 5.35 6.94 7.18 2.83 8.72 0.59 5.47 0.4 3.61 7.8 2.75 11.73 lrp6.L 6.14 5.64 2.75 2.6 4.1 1.56 1.23 0.67 4.34 0.36 1.17 3.5 1.52 5.15 lrp6.S 14.64 12.47 5.62 9.51 12.3 5.89 2.59 0.98 4.2 0.93 2.59 11.82 4.46 11.66
Wnt signaling_Extracellular-Membrane Positive ror1.L 6.84 3.77 22.09 1.92 8.08 0.27 6.04 0.37 0.68 0.23 0.81 12.13 1.43 9.19 ror1.S 3.56 1.43 0.21 0.34 1.16 0 1.15 0.09 0.98 0.04 0.54 3.13 0.45 1.82 ror1.L 1.75 1.72 7.63 0.47 2.55 0.23 3.56 0.2 0.07 0.37 0.52 5.78 0.54 2.76 ror1.S 0.93 0.58 0.31 0.29 0.4 0 1.36 0 0 0.07 0.28 1.79 0.43 0.37
Wnt signaling_Extracellular-Membrane Positive ror2.L 3.97 2.45 15.13 2.11 2.34 0.57 1.79 0.28 0.06 0.3 0.98 4.03 1.03 4.14 ror2.S 5.52 0.9 2.24 4.1 2.02 0.57 0.94 0.31 3.16 0.21 0.54 3.16 3.17 1.92 ror2.L 2.1 1.46 4.17 0.68 1.28 0.09 1.6 0.32 0.04 0.72 0.23 4.64 0.68 1.71 ror2.S 3.98 0.31 0.8 0.9 1.02 0.08 0.85 0.16 0.33 0.28 0.36 2.5 1.05 0.63
Wnt signaling_Extracellular-Membrane Positive ryk.L 7.15 7.37 7.59 8.3 10.02 4.55 12.04 3.13 38.42 1.03 4.44 9.89 3.58 4.93 ryk.S 18.21 13.96 12.9 10.81 15.96 3.4 19.95 3.78 109 1.64 5.87 16.47 5.83 12.46 ryk.L 10.6 9.06 6.53 7.65 13.55 5 9.12 4.26 17.66 1.25 3.53 10.3 3.42 3.78 ryk.S 32.22 22.14 12.67 8.3 20.09 6.17 12.37 2.96 98.82 1.39 4.15 20.65 5.65 18.04
Wnt signaling_Extracellular-Membrane Positive porcn.L 55.09 29.61 8.71 9.03 18.7 6.17 13.8 5.4 45.61 1.91 6.85 15.33 5.51 19.37 porcn.L 118.8 50.3 18.9 11 32.71 26.26 11.68 7.91 257.23 2.31 8.36 24.06 9.16 89.29
Wnt signaling_Extracellular-Membrane Positive wls.L 29.71 19.7 14.56 5.21 11.64 1.49 16.7 2.2 38.82 0.86 9.59 3.31 4.65 15.94 wls.S 19.02 15.76 24.36 3.23 9.68 1.1 22.44 0.93 17.8 0.3 8.1 6.18 2.7 4.53 wls.L 25.31 20.99 10.43 2.82 13.36 0.66 7.85 1.41 14.12 0.78 6.14 2.06 2.54 14.11 wls.S 15.04 12.45 11.82 1.23 8.31 0.63 9.39 0.75 6.89 0.58 3.12 5.85 1.38 5.71
Wnt signaling_Extracellular-Membrane Positive rspo1.L 7.75 4.06 5.05 5.96 2.24 0.22 2.33 0.07 0 0.19 1.26 5.54 1.98 0.75 rspo1.S 1.09 0 1.18 0.72 1.18 0 0.77 0 0 0 0 0 1.02 1.38 rspo1.L 1.78 0.51 1.21 1.45 0.82 0.08 1.51 0 0 1.02 1.32 1.29 1.64 0.08 rspo1.S 0.37 0.28 0.83 0.57 0.65 0 0.64 0.26 0 0.61 0.23 0.25 0.89 0
Wnt signaling_Extracellular-Membrane Positive rspo2.L 12.01 4.47 0.69 0.11 0.53 0.06 6.79 0 0.29 0.03 0.44 0.61 0.29 0.23 rspo2.S 4.04 1.51 0.33 0.07 0.13 0 2.32 0 2.95 0.04 0.5 0 0 0.07 rspo2.L 14.93 7.97 0.42 0.22 0.61 0 4.9 0.09 0.64 0.08 0.23 0.75 0.47 0.04 rspo2.S 6.72 1.87 0.36 0 0.7 0 2.39 0 5.09 0.4 0.4 0 0.04 0.15
Wnt signaling_Extracellular-Membrane Positive rspo3.L 18.9 2.33 1.77 3.56 7.3 1.14 1.09 0.22 0 0.44 2.67 1.13 4.93 1.18 rspo3.L 4.97 0.55 0.65 1.02 3.4 0.5 0.64 0.29 0 0.47 0.9 0.04 1.78 0.08
Wnt signaling_Extracellular-Membrane Positive lgr4.L 3.46 4.28 4.19 8.86 3.55 3.28 0.17 0.08 21.77 0.85 3.51 0.72 15.59 4.92 lgr4.S 4.12 6.7 14.24 13.05 6.04 1.9 2.85 0.63 5.49 0.58 6.99 1.4 10.58 7.36 lgr4.L 5.57 6.13 2.9 4.59 5.36 3.76 0.07 0.12 4.53 1.36 3.44 0.79 9.42 1.97 lgr4.S 5.85 8.72 9.87 16.46 8.28 2.93 1.75 1.13 3.42 1.75 5.21 2 9.49 5.83
Wnt signaling_Extracellular-Membrane Positive lgr5.L 2.95 5.52 0.75 3.43 2.65 0.13 0.17 0.12 0.46 0.12 0.74 0.84 1.7 10.85 lgr5.S 1.78 7.16 0.55 2.41 0.72 0 0.98 0.26 0.04 0.01 1.22 0.1 3.26 1.59 lgr5.L 1.32 2.02 0.5 0.66 1.79 0.02 0.28 0.08 0.05 0.17 0.17 0.87 0.43 3.71 lgr5.S 0.43 1.94 0.17 0.37 0.45 0 0.53 0.01 0 0.03 0.64 0.03 1.07 0.22
Wnt signaling_Extracellular-Membrane Positive ndp.L 4.32 5.72 0.2 13.6 1.23 0 15.42 1.54 0 0 1.58 0.2 1.39 1.63 ndp.S 0.45 0.26 0.42 0.28 0.08 0 1.69 0.23 2.26 0 0.82 0 0.17 6.57 ndp.L 1.17 2.05 0.15 0.8 0.57 0 10.02 0.69 0 0.4 1.2 0.13 1.49 1.07 ndp.S 0.51 0.31 0.31 0.05 0.06 0.21 1.07 0 1.47 0 1.45 0 0.24 1.25
Wnt signaling_Extracellular-Membrane Negative frzb.L 51.69 25.41 96.97 2.31 0.79 3.14 1.25 5.38 1 0 30.95 17.08 8.64 1.21 frzb.S 13.19 23.44 2.92 3.06 0.75 0.43 0.55 0.44 0.11 0.36 37.92 137.76 3.71 0.74 frzb.L 52.62 22.38 41.59 1.48 0.81 1.23 2.62 5.13 0.26 0.62 21.78 9.17 4.52 1.71 frzb.S 9.67 12.54 0.65 0.97 0.64 1.13 0.35 1.64 0.15 0.36 31.13 83.93 1.62 0.39
Wnt signaling_Extracellular-Membrane Negative frzb2.L 0 0.26 0 0 0 0 0.03 0.06 0.24 0.08 0 0.05 0.19 0.19 frzb2.S 0.53 0 0 0 0 0 0 0 0 0 0 0 0 0.17 frzb2.L 0.05 0.27 0.04 0.03 0.03 0 0 0.04 0 0.04 0 0 0.07 0.03 frzb2.S 0.18 0.13 0 0 0.1 0 0 0.13 0 0 0 0.12 0 0.11
Wnt signaling_Extracellular-Membrane Negative sfrp1.L 31.36 72.79 33.28 6.63 4.03 0.32 38.5 1 4.48 0.68 7.27 7.16 8.9 2.33 sfrp1.S 16.1 36.7 11.64 1.85 7.86 0 3.72 5.76 0 0.21 2.53 0.84 2.68 1.17 sfrp1.L 40.1 80.19 30.41 9.47 7.89 1.1 80.65 1.02 9.88 1.96 4.73 14.25 7.34 57.99 sfrp1.S 33.27 54.53 9.13 1.02 8.81 0.71 3.48 8.15 0.14 0.26 1.54 1.55 1.25 1.41
Wnt signaling_Extracellular-Membrane Negative sfrp2.L 3.82 47.15 0.68 6.15 3.73 0 0.19 4.49 0.06 0.22 6.24 0.86 0.72 0.58 sfrp2.S 12.62 27.75 5.21 1.12 19.49 0.03 4.57 12.89 0.05 0.78 8.96 1.81 4.89 2.21 sfrp2.L 2.61 66.46 1.47 7.35 1.41 0 0.46 4.17 0 0.91 4.61 0.84 0.59 0.38 sfrp2.S 10.98 30.14 5.65 0.7 11.22 0.22 5.45 6.45 0.02 1.6 6.16 1.42 3.1 0.83
Wnt signaling_Extracellular-Membrane Negative sfrp4.L 13.2 2.28 52 5.95 1.14 1.63 3.45 1.36 0 0.12 1.51 4.23 3.58 0 sfrp4.L 6.37 0.45 13.24 7.04 0.35 0.25 2.42 1.38 0 0.4 0.74 3.5 1.44 0
Wnt signaling_Extracellular-Membrane Negative sfrp5.L 8.99 7.08 28.21 1.2 3.35 0.17 7.61 1.19 0 1.35 0.21 0.58 1.68 0.36 sfrp5.S 16.79 2.67 24.12 4.38 1.64 0 1.29 1.25 0.1 0.9 0 0.22 1.57 0.69 sfrp5.L 4.94 3.97 10.59 0.71 2.07 0.1 4.05 0.55 0 2.01 0.09 0.39 0.51 0.03 sfrp5.S 7.31 0.72 7.53 1.33 0.69 0 1.23 0.21 0 1.13 0 0.1 1.06 0.14
Wnt signaling_Extracellular-Membrane Negative sfrpx.L 0.28 3.16 0.62 0.35 4.15 0.34 0.92 0.18 0.21 0.08 4.44 0.7 0.33 1.1 sfrpx.S 2.68 4.25 2.5 1.04 4.86 0.41 4.31 0.76 9.19 0.23 7.2 2.53 1.09 4.01 sfrpx.L 0.7 3.82 0.6 0.42 6.32 0.55 0.64 0.21 0.94 0.22 2.65 1.19 0.7 0.88 sfrpx.S 4.73 8.04 2.93 2.43 6.76 1.42 5.39 0.78 34.87 0.47 4.14 3.89 1.42 8.96
Wnt signaling_Extracellular-Membrane Negative dkk1.L 0.75 12.81 0.91 0.59 1.3 0 4.95 0 0 0.58 2.04 0 0.43 0.35 dkk1.S 2.6 4.42 3.76 0 2.48 0 0.06 0 0 0.06 1.69 0.5 0 0 dkk1.L 1.51 17.44 2.28 1.04 2.06 0.09 2.98 0.09 0.08 0.73 1.87 0.09 0.96 0.54 dkk1.S 2.63 5.55 1.89 0.32 2.7 0 0 0 0.08 0 1.47 0.17 0.3 0.31
Wnt signaling_Extracellular-Membrane Negative dkk2.L 11.37 18.66 8.54 2.68 10.91 0.06 1.48 3.69 0.04 0.69 2.99 10.58 1.43 1.08 dkk2.S 6.16 17.63 10.05 1.36 5.78 0 5.08 1.81 2.55 0.27 4.18 0.47 1.98 3.5 dkk2.L 5.66 9.29 4.13 0.79 8.77 0.4 0.57 3.88 0 0.93 0.32 5.02 0.46 0.24 dkk2.S 2.07 8.55 2.27 0.24 3.08 0 0.59 1.01 0.13 0.47 0.25 0.23 0.96 0.08
Wnt signaling_Extracellular-Membrane Negative dkk3.L 16.79 51.51 26.36 12.16 12.37 1.14 25.75 1.29 2.93 1.08 4.84 6.19 5.98 4.45 dkk3.S 4.53 4.97 44.13 1.84 1.47 0.4 3.76 0.8 0.09 0.12 1.16 2.41 1.03 0.69 dkk3.L 24.77 71.77 36.29 13.7 16.23 1.25 33.98 2.7 3.29 3.73 3.16 8.6 8.2 6.11 dkk3.S 6.65 7.6 62.28 2.07 1.58 0.44 4.14 1.89 0.04 0.32 1.21 2.43 1.33 0.28
Wnt signaling_Extracellular-Membrane Negative dkkx.L 0.86 0 0 0 0 0 0 0 0.2 0 0 0 0 0 dkkxp.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 dkkx.L 6.73 0 0 0 0.17 0 0 0 0.77 0 0 0.2 0.14 0 dkkxp.S 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wnt signaling_Extracellular-Membrane Negative wif1.L 6.13 5.9 3.1 3.34 8.14 0.9 10.14 2.58 13.88 0.36 2.95 2.72 2.12 36.32 wif1.S 5.56 2.67 0 0.15 0.51 0 8.57 0 0.32 0.04 2.42 0 0.03 41.66 wif1.L 3.85 9.44 1.72 2.2 8.63 1.27 3.87 1.84 0.47 0.41 1.93 2.51 2.25 13.87 wif1.S 5.5 1.62 0 0.04 0.7 0 6.86 0 0.21 0 1.38 0.05 0 20.94
Wnt signaling_Extracellular-Membrane Negative cer1.L 0.12 0.07 0 0 0 0 0 0 0 0 0.14 0 0 0.15 cer1.S 2.07 1.03 32.97 0 0 0 0.1 0 0.54 0.1 0 0 0.07 0.47 cer1.L 0.08 0 0 0 0.05 0 0 0 0 0 0 0.05 0 0 cer1.S 1.1 0.3 5.12 0.2 0.23 0 0 0.07 0 0.12 0 0 0.05 0
Wnt signaling_Extracellular-Membrane Negative sostdc1.L 11.52 17.17 9.91 2.54 3.55 0.48 13.53 0.83 0.04 0.34 56.61 1.61 5.59 3.19 sostdc1.S 15.52 7.71 9.96 2.27 2.11 0.19 12.2 1.66 0 0.29 27.27 0.07 3.43 0.52 sostdc1.L 6.42 8.05 3.18 0.69 1.36 0.14 4.7 0.34 0 0.42 13.24 0.63 6.24 0.53 sostdc1.S 6.8 3.64 3.12 3.49 1.43 0.05 1.6 1.41 0 1.16 5.71 0.33 4.56 0.04
Wnt signaling_Extracellular-Membrane Negative igfbp4.L 7.91 21.62 21.81 27.84 56.1 43.34 30.46 14.09 2.09 5.62 8.53 26.12 19.93 12.75 igfbp4.S 9.09 47.04 54.13 23.49 517.66 698.53 63.01 5.96 1.11 2.99 11.18 18.34 20.25 13.38 igfbp4.L 13.13 33.15 29.31 21.63 90.09 174.96 36.78 9.68 5.37 11.66 5.13 28.5 23.83 18.31 igfbp4.S 12.73 56.54 81.15 35.19 169.18 1457.75 63.01 5.57 0.92 5.03 5.05 14.74 20.22 11.75
Wnt signaling_Extracellular-Membrane Negative shisa1.L 0.52 0.4 0 0.05 3.63 1.01 0.12 0 99.82 0.33 0 0.41 0 7.32 shisa1.S 0.25 0.05 0 0 0 0 0 0 0.23 0.12 0 0 0 1.65 shisa1.L 0.41 0.8 0.18 0 3.15 2.3 0.41 0.08 140.82 0.1 0.15 0.12 0.03 4.54 shisa1.S 0.96 0.26 0.09 0 0.03 0 0 0 0.97 0.05 0.03 0 0 1.04
Wnt signaling_Extracellular-Membrane Negative shisa2.L 26.69 8.72 56.85 4.19 4.87 0.4 4.33 66.52 1.2 0.14 2.17 2.08 2.71 4.78 shisa2.S 8.07 2.53 12.15 1.03 1.2 0.23 2.43 12.2 0.03 0.02 0.1 1.33 0.5 0.54 shisa2.L 24.44 7.26 26.29 0.82 4.86 0.08 2.7 117.54 0.18 0.15 0.3 2.46 1.07 1.69 shisa2.S 8.92 1.67 4.98 0.31 1.35 0.2 1.17 6.28 0.05 0.06 0.06 1.46 0.53 0.22
Wnt signaling_Extracellular-Membrane Negative shisa4p.L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 shisa4.S 31 8.76 14.64 9.49 13.53 4.99 15.88 5.9 0.31 1.23 5.87 18.91 5.57 10.68 shisa4p.L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 shisa4.S 40.27 12.62 22.47 11.75 16.3 13.05 13.68 9.89 0.72 1.31 5.9 20.99 5.63 11.94
Wnt signaling_Extracellular-Membrane Negative shisa6.L 9.95 0.89 0 0 0 0 0 0 0 0 0 0 0.02 0 shisa6.S 35.46 4.86 0.27 0.12 0.69 0.55 1.37 0.06 0.03 0.02 0.07 0.1 0.42 0.31 shisa6.L 11.55 0.17 0 0 0 0 0 0 0 0 0 0 0 0.05 shisa6.S 26.26 1.84 0.23 0.04 0.39 0.01 0.94 0.05 0 0.03 0.26 0.08 0.11 0.05
Wnt signaling_Extracellular-Membrane Negative shisa7.L 4.11 0.72 0 0 0 0 0 0 0 0 0 0 0 0.24 shisa7.S 3.65 0.38 0 0 0 0 0 0 0 0.04 0.07 0 0 0.21 shisa7.L 2.85 0.06 0 0 0 0 0 0 0 0 0 0 0 0.15 shisa7.S 4.39 0.22 0 0 0.04 0 0 0 0 0.03 0 0 0 0
Wnt signaling_Extracellular-Membrane Negative shisa9.L 15.79 1.96 0 0 0.14 0 0 0 0 0 0 0.35 0 0.49 shisa9.S 4 0.34 0 0 0.82 0 0 0 0 0.03 0.05 0 0 0.11 shisa9.L 5.25 0.39 0 0 0.2 0 0 0 0.11 0.07 0 0 0 0 shisa9.S 4.35 0.04 0 0 0.37 0 0 0 0 0 0 0 0.03 0
Wnt signaling_Extracellular-Membrane Negative kremen1.L 7.8 5.59 9.52 0.59 3.85 0.13 9.68 1.49 0.43 0.05 1.93 0.54 1.98 10.79 kremen1.S 2.27 1.43 4.84 0 1.46 0.2 6.16 0.44 0.05 0 1.08 0.05 0.05 2.27 kremen1.L 9.7 6.75 5.78 0.18 4.2 0.57 8.37 7.36 1.16 0.08 0.57 0.4 2.25 12.74 kremen1.S 2.52 1.46 1.23 0 1.6 0.25 4.8 0.42 0.29 0 0.39 0.1 0.06 1.4
Wnt signaling_Extracellular-Membrane Negative kremen2.L 0 2 0.12 0.16 0.18 0.1 0.06 0 0.04 0 8.21 0 0.02 0.44 kremen2.S 0.18 8.58 0.13 0 0.1 0 0 0 0 0 20.19 0.06 0 3.02 kremen2.L 0.06 1.58 0.04 0.06 0.1 0.16 0 0 0.04 0.02 11.38 0.08 0.06 0.18 kremen2.S 0.25 4.86 0 0 0.07 0 0 0 0 0 15.59 0 0.18 0.27
Wnt signaling_Extracellular-Membrane Negative apcdd1.L 8.73 5.81 0.75 0.32 3.39 0.16 3.95 0.03 72.54 0.24 4.61 0.79 1.22 2.42 apcdd1.S 2.72 5.55 1.19 0.39 1.26 0 2.25 0.21 0.04 0.09 2.72 0.06 0.33 1.14 apcdd1.L 9.18 5.08 0.64 0.04 3.32 0 7.14 0.08 25.37 0.31 1.94 0.14 2.41 1.44 apcdd1.S 4.39 5.73 0.83 0.19 1.35 0.04 1.23 0.04 0.12 0.23 0.83 0.12 0.35 0.52
Wnt signaling_Extracellular-Membrane Negative tpbg.L 15.23 5 1.14 2.89 3.11 0.16 2.49 0.08 32.93 0.08 1.34 1.51 2.24 8.98 tpbg.S 10.77 6.89 2.37 1.47 5.74 0.29 1.47 0.22 79.91 0.14 2.8 1.4 1.12 58.63 tpbg.L 5.43 1.99 0.36 0.19 1.38 0.05 1.31 0.13 4.85 0.08 0.45 0.8 0.96 3.18 tpbg.S 5.09 2.55 0.57 0.25 2.65 0.14 1.12 0.17 8.43 0.02 2.06 0.35 0.29 3.64
Wnt signaling_Extracellular-Membrane Negative tpbgl.L 5.53 3.32 0 0.54 5.14 0 0.86 0 0 0 0 0 1.13 1.49 tpbgl.S 19.39 5.77 0 2.57 3.26 0 0.85 0.34 0.1 0 0 7.49 0.72 0.71 tpbgl.L 8.11 4.45 0 1.94 3.74 0 1.85 0 0 0.22 0 0 1.8 0 tpbgl.S 18.87 2.75 0.23 0.78 2.13 0 1.33 0.33 0 0.13 0 3.91 0.8 0
Wnt signaling_Extracellular-Membrane Negative trabd2a.L (tiki1.L)3.65 3.03 2.85 0.64 0.95 0.97 4.5 1.63 0 0.9 1.24 1.26 1.06 8.84 trabd2a.L (tiki1.L)2.71 2.04 1.52 0.16 0.59 0.48 2.99 0.23 0.04 0.37 0.27 0.81 0.57 2.43
Wnt signaling_Extracellular-Membrane Negative trabd2b.L (tiki2.L)4.82 6.62 5.75 0.84 4.66 7.86 7.94 1.8 0 0.57 1.16 1.06 0.64 1.33 trabd2b.S (tiki2.S)1.94 5.39 1.17 3.51 1.34 0.03 3.81 2.05 0.02 0.51 0.93 0.23 5.09 2.17 trabd2b.L (tiki2.L)1.15 1.48 1.99 0.19 3.55 0.71 1.68 0.54 0 0.83 1.14 0.78 0.26 0.15 trabd2b.S (tiki2.S)0.36 1.1 0.57 2.02 0.82 0.02 1.38 0.96 0.02 0.97 0.52 0.07 0.81 0.06
Wnt signaling_Extracellular-Membrane Negative znrf3.L 2.09 0.84 0.63 1.08 1.56 0.25 1.03 0 3.38 0.07 1.5 0.66 0.96 1.71 znrf3.S 1.12 0.82 0.62 0.23 1.47 0.09 1.28 0.17 3.97 0.08 1.3 0.3 0.22 2.17 znrf3.L 3.7 1.44 0.46 2.04 3.22 1.41 0.41 0 4.39 0.41 1.39 0.79 1.59 1.69 znrf3.S 1.51 0.79 1.06 0.59 1.76 0.55 0.31 0.07 1.98 0.08 2.36 0.41 0.41 0.83
Wnt signaling_Extracellular-Membrane Negative rnf43.L 2.51 2.1 7.35 7.65 5.96 0.96 3.13 0.07 0.34 0.61 1.9 1.63 2.09 1.35 rnf43.S 3.72 1.93 0.71 9.42 6.34 1.79 7.26 0.43 4.24 0.35 7.19 1.21 1.3 1.99 rnf43.L 3.32 1.41 4.35 6.66 5.95 0.3 3.69 0.04 0.04 1.17 2.32 1.44 2.55 0.35 rnf43.S 6.59 2.46 0.54 10.51 6.55 3.44 3.39 0.61 2.16 0.48 3.67 1.11 1.43 1.48
Wnt signaling_Extracellular-Membrane Negative notum1.L 5.34 5.2 1.44 0.25 3.18 0.05 9.96 1.24 16.73 0.06 0.83 2.73 0.19 4.76 notum1.S 0.47 0.37 0.42 0.25 2.93 0.53 17.18 0.05 23.01 0.08 0.3 0.55 0.05 0.19 notum1.L 2.18 1.64 0.9 0.14 2.21 0.23 7.32 1.18 1.22 0.06 0.18 1.87 0.11 0.35 notum1.S 0.07 0.1 0.29 0.07 1.42 0.38 3.07 0.03 2.83 0.09 1.03 0.31 0.04 0.07
Wnt signaling_Extracellular-Membrane Negative notum2.L 2.84 0.71 0.52 0.77 0.61 0.29 0.57 0.14 0.47 0 0.11 6.7 0.02 1.96 notum2.L 3.18 0.81 1.49 0.46 0.67 0.31 0 1.28 0.13 0.11 0.35 3.49 0.18 0.47
Wnt signaling_Cytoplasmic dvl1.L 41.45 10.55 5.36 13.63 4.73 0.93 25.71 1.36 0.05 1.51 7.54 0.75 6.4 8.33 dvl1.S 36.97 6.77 3.69 18.06 3.62 0.79 17.35 1.35 0.33 0.47 4.96 1.04 2.11 2.65 dvl1.L 49.53 12.39 4.25 18.84 5.37 0.61 15.87 1.48 0.09 2.79 5.16 2.2 9.67 7.35 dvl1.S 55.82 11.88 2.76 16.07 6.09 1.42 8.09 1.29 0.18 0.95 2.72 2.58 3.96 3.04
Wnt signaling_Cytoplasmic dvl2.L 39.3 38.25 59.38 24.52 59.35 12.95 49.83 22.56 159.98 4.31 20.93 41.33 20.17 38.46 dvl2.L 90.93 69.59 97.49 39.78 110.6 34.68 55.26 50.57 578.65 10.81 29.45 87.91 41.07 97.28
Wnt signaling_Cytoplasmic dvl3.L 12.31 9.4 7.4 6.26 11.54 3 13.02 4.69 77.73 0.78 8.07 10.18 4.33 16.91 dvl3.S 10.42 7.36 11.13 4.19 7.19 2.07 9.82 6.93 37.51 0.84 5.27 7.68 2.63 16.28 dvl3.L 14.28 10.63 10.03 5.2 11.41 3.53 9.08 5.76 43.99 0.97 8.52 11.31 4.78 14.97 dvl3.S 10.75 6.63 11.01 3.61 7.25 2.53 7.51 7.59 12.86 1.03 5 7.32 3.28 11.82
Wnt signaling_Cytoplasmic frat1.L 6.22 11.39 2.44 5.23 7.93 0.7 5.2 1.32 37.59 1.16 2.47 3.49 4.63 44.07 frat1.S 9.82 8.48 1.81 4.84 8.74 0.69 4.39 3.88 99.02 0.21 11.03 4.02 4.53 47.5 frat1.L 18.85 17.89 10.92 10.07 14.69 3.1 4.97 17.69 57.53 2.2 15.35 10.82 11.19 98.35 frat1.S 10.71 9.96 2.33 6.07 12.04 2.35 3.77 5.64 61.33 0.98 9.85 7.46 9.55 69.86
Wnt signaling_Cytoplasmic ctnnbl1.L 17.65 10.94 10.29 9.2 12.7 4.87 13.41 4.15 50.14 1.36 6.49 14.82 5.88 33.45 ctnnbl1.S 25.8 14.16 14.35 13.65 17.24 5.75 15.65 3.22 63.72 2.34 9.42 16.11 7.68 31.9 ctnnbl1.L 13.53 8.53 5.35 6.91 9.91 2.83 11.35 3.93 24.83 1.15 9.34 8.85 4.8 10.11 ctnnbl1.S 24.97 14.77 8.21 9.44 14.73 4.57 13.7 4.97 38.1 1.44 10.84 15.48 5.46 19.43
Wnt signaling_Cytoplasmic ctnnb1.L 171.99 76.93 252.69 104.61 73.88 25.33 102.24 10.08 69.24 8.65 70.29 68.66 70.35 54.82 ctnnb1.S 321.88 147.68 160.2 174.65 171.46 43.21 243.44 33.27 226.47 19.05 112.91 115.54 82.6 92.1 ctnnb1.L 201.24 94.26 218.68 61.18 72.56 17.48 40.93 10.65 26.78 6.92 49.25 73.83 67.09 33.62 ctnnb1.S 330.23 154.12 100.53 89.99 156.14 28.87 71.27 23.59 75.97 23.99 97.4 129.9 74.92 59.39
Wnt signaling_Cytoplasmic csnk1d.L 93.15 52.41 35.8 37.63 48.2 14.89 48.79 15.77 169.45 4.75 42.55 61.76 25.92 111.19 csnk1d.S 51.6 22.25 21.15 22.93 33.1 7.25 21.31 11.71 159.17 5.82 11.93 25.31 12.82 257.83 csnk1d.L 71.74 35.84 22.33 22.44 32.29 8.16 28.97 13.23 11.15 3.74 57.18 48.77 14.01 20.22 csnk1d.S 51.56 23.66 18.75 16.73 20.2 5.43 9.36 13 26.82 4.69 9.73 19.71 11.12 32.75
Wnt signaling_Cytoplasmic csnk1e.L 39.87 44.75 11.25 10.95 18.8 4.87 11.51 3.98 83.04 1.76 12.12 13.19 7.05 17.1 csnk1e.S 41.59 21.41 7.69 12.54 16.09 5.02 16.65 9.66 77.33 1.49 17.82 19.69 7.04 15.1 csnk1e.L 55.24 54.68 13.08 6.82 17.15 8.04 9.25 3.67 29.45 1.61 10.38 17.39 6.55 13.07 csnk1e.S 58.19 26.87 6.71 9.76 16.85 7.35 18.54 21.47 44.71 1.57 30.26 29.83 6.66 13.83
Wnt signaling_Cytoplasmic csnk1g1.L 25.59 16.45 6.46 14.65 15.96 3.17 11.37 3.5 30.8 1.42 5.94 14.98 7.28 40.95 csnk1g1.S 31.17 20.71 8.73 14.81 17.53 6.26 14.04 3.9 36.36 1.66 8.01 21.48 8.81 22.95 csnk1g1.L 18.55 14.46 3.18 9.66 11.81 1.99 5.93 3.71 11.58 1.06 6.87 11.38 3.45 10.69 csnk1g1.S 22.82 14.96 4.04 9.07 12.71 2.48 5.07 2.84 11.68 1.32 10.45 14.73 4.45 7.45
Wnt signaling_Cytoplasmic csnk1g2.L 31.61 17.56 13.91 15.98 26.41 4.7 17.3 6.75 255.95 1.34 12.48 24.05 7.89 34.32 csnk1g2.L 18.58 9.5 6.49 6.82 13.32 1.81 6.17 5.98 39.43 1.56 11.3 13.45 3.17 6.1
Wnt signaling_Cytoplasmic csnk1g3.L 19.45 12.11 5.71 8.82 10.2 3 13.18 4.1 30.44 1.31 7.8 15.47 4.13 9.75 csnk1g3.S 19.64 15.24 5.82 11.25 11.46 3.55 10.38 3.15 66.27 1.18 8.11 14.32 5.08 25.23 csnk1g3.L 6.14 1.9 1.86 2.02 2.74 0.37 4.01 2.83 1.04 0.76 8.47 4.02 1.09 0.51 csnk1g3.S 4.04 1.8 1.39 1.92 2.72 0.21 2.98 1.52 2.04 0.55 9.2 3.05 0.98 0.85
Wnt signaling_Cytoplasmic csnk2a1.L 15.27 11.34 9.41 11.85 13.2 5.3 8.43 6.08 23.69 2.07 10.21 12.02 5.91 10.62 csnk2a1.S 16.67 18.78 18.42 20.34 26.9 10.05 21.6 20.22 73.74 6.05 18.12 23.65 13.73 136.88 csnk2a1.L 31.49 17.2 10.74 13.34 16.66 7.29 5.66 10.55 37.6 1.88 4.65 15.15 6.87 9.38 csnk2a1.S 33.7 31.45 31.62 45.71 37.63 29.27 23.3 26 186.72 6.26 12.12 38.33 18.71 134.97
Wnt signaling_Cytoplasmic csnk2a2.L 42.81 31.08 42.77 19.66 29.24 15.74 36.4 40.62 54.02 6.24 26.16 41.45 18.01 128.8 csnk2a2.S 35.81 29.2 33.03 18.62 24.39 14.76 29.68 34.42 55.66 5.48 23.52 42 15.4 86.12 csnk2a2.L 44.65 40.14 27.49 15.86 30.51 14.65 31.79 31.58 43.26 5.18 24.96 37.59 17.63 126.58 csnk2a2.S 41.32 35.38 24.2 14.74 27.36 18.95 25.83 29.32 55.3 4.13 25.16 39.84 12.61 100.83
Wnt signaling_Cytoplasmic csnk2b.L 43.81 24.85 19.15 16.61 22.05 10.31 15.24 14.58 26.91 2.84 15.4 19.01 10.46 72.71 csnk2b.S 133.49 77.21 73.62 58.91 81.26 27.81 69.81 64.41 122.46 17.39 64.7 79.47 43.73 335.78 csnk2b.L 38.11 22.76 11.67 16.49 19.61 13.33 15.14 23.26 36.5 2.53 20 14.06 8.5 42.46 csnk2b.S 163.65 89.05 57.02 64.34 81.37 87.07 73.05 93.41 249.64 15.44 99.83 91.75 41.35 356.55
Wnt signaling_Cytoplasmic ccdc88c.L 3.35 5 1.51 9.84 5.45 17.65 1.35 0.64 8.51 0.4 0.98 32.97 3.13 5.07 ccdc88c.S 0.24 0.18 0.47 0.85 1.3 0.77 0.14 0.47 0.08 0.01 0.27 23.43 0.14 0.43 ccdc88c.L 0.81 0.66 0.11 1.69 0.98 1.25 0.26 0.1 0.29 0.45 0.97 4.23 0.71 0.17 ccdc88c.S 0.05 0.03 0.02 0.43 0.22 0 0 0.17 0 0.03 0.24 2.42 0.08 0.07
Wnt signaling_Cytoplasmic axin1.L 8.62 3.36 2.61 3.48 3.65 1.27 4.84 0.94 18.42 0.33 3.2 4.21 1.97 6.42 axin1.S 6.24 2 1.72 4.54 1.9 0.89 2.45 0.04 4.89 0.35 2.28 3.29 1.26 3.79 axin1.L 5.47 2.42 1.65 3.61 2.58 0.68 1.66 0.79 3.08 0.28 2.67 3.39 1.08 2.56 axin1.S 4.38 1.66 1.15 2.7 1.89 0.5 0.5 0.41 1.08 0.14 1.18 2.38 0.77 1.05
Wnt signaling_Cytoplasmic axin2.L 34.37 12.6 5.4 13.16 2.14 0.2 36.77 1.37 0.45 4.54 6.64 1.06 1.82 6.98 axin2.S 27.19 4.28 2.35 3.13 0.75 0.03 12.88 0.62 2.07 0.02 3.17 2.55 0.57 0.73 axin2.L 44.36 14.85 4.05 8.73 2.88 0.33 21.93 1.04 0.21 4.16 2.4 4.05 2.34 4.09 axin2.S 27.41 4.67 3.78 3.35 1.24 0.02 6.99 0.21 0.47 0.31 1.39 5.16 0.86 0.54
Wnt signaling_Cytoplasmic gsk3a.L 28.73 17.61 11.34 29.68 18.48 5.78 15.55 5.89 32.34 2.15 10.36 18.85 8.96 35.45 gsk3a.S 10.88 7.53 4.6 8.06 10.76 1.71 6.47 3.17 6.69 0.78 4.82 6.75 4.13 21.52 gsk3a.L 41.81 23.6 11.65 17.23 21.26 13.38 10.56 8.65 32.26 2.77 6.91 21.47 7.4 43.04 gsk3a.S 15.15 11.22 5.18 6.35 10.82 3.3 2.98 4.03 5.93 1.03 3.98 9.44 4.17 17.37
Wnt signaling_Cytoplasmic gsk3b.L 32.71 19.2 10.48 8.57 11.53 5.06 11.97 5.1 1.73 1.44 8.87 14.93 4.59 24.16 gsk3b.S 54.45 28.66 22.68 19.83 26.65 10.39 23.66 8.96 22.66 3.11 14.47 22.33 11.57 34.33 gsk3b.L 50.77 25.24 10.16 5.51 10.91 4.82 7.12 11.07 3.36 1.14 9.22 13.68 3.71 26.93 gsk3b.S 91.22 40.29 18.01 10.72 20.82 8.14 12.27 19.48 26.33 1.9 9.07 22.97 6.53 38.58
Wnt signaling_Cytoplasmic apc.L 46.57 12.04 15.71 2.87 6.04 1.89 2.87 1.1 25.55 0.35 3.31 11.27 2.7 16.93 apc.S 36.14 12.46 5.11 3.21 5.38 1.65 3.2 1.74 21.2 0.39 4.33 9.95 2.42 7.38 apc.L 7.1 1.1 2.19 0.5 1.16 0.13 0.63 0.63 0.48 0.28 3.01 1.09 0.33 0.69 apc.S 6.05 0.98 0.61 0.74 1.34 0.2 1.53 0.64 0.52 0.63 5.45 1.01 0.32 0.54
Wnt signaling_Cytoplasmic apc2.L 63.48 13.39 1.22 0.8 2.11 0.64 0.84 0.24 1.64 0.08 0.21 2.65 0.72 2.19 apc2.S 41.73 11.44 0.06 0.21 0.61 0 0.06 0 0.46 0.03 0.06 0.04 0.51 2.04 apc2.L 10.46 0.73 0.13 0.29 0.42 0.07 0.38 0.08 0.06 0.21 0.11 0.38 0.15 0.61 apc2.S 8.02 0.86 0.08 0.05 0.27 0.01 0 0 0 0.13 0.1 0.04 0.14 0.2
Wnt signaling_Cytoplasmic csnk1a1.L 140.01 155.78 65.69 125.52 88.77 27.48 90.3 33.55 180.78 9.58 250.37 98.1 51.35 56.94 csnk1a1.S 92.52 97.18 49.21 72.77 64.88 20.73 51.53 19.26 114.05 7.78 116.07 57.84 27.6 107.53 csnk1a1.L 113.78 112.35 47.77 70.7 77.81 20.51 59.79 33.9 34.77 9.32 356.66 82.13 52.87 21.93 csnk1a1.S 60.14 56.03 27.14 29.35 45.41 15.9 28.74 20.37 14.88 6.7 150.2 40.28 23.18 33.5
Wnt signaling_Cytoplasmic cxxc4.L 7.42 2.26 0.16 0.19 0.88 0.05 0.21 0.12 0.35 0.03 0.14 0.84 0.04 2.41 cxxc4.S 0.84 0.53 0.19 0.09 0.67 0 0.02 0.21 0.09 0 0.25 0.09 0.06 0.27 cxxc4.L 3.99 1.5 0.12 0 0.92 0 0.09 0 0.17 0.07 0.1 0.25 0.08 2.45 cxxc4.S 0.57 0.18 0 0.02 0.14 0 0 0 0.03 0.04 0.03 0.1 0 0.09
Wnt signaling_Cytoplasmic nkd1.L 0.68 0.29 3.04 0.58 2.3 0.31 1.05 0.96 6.73 0.32 2.03 4.11 0.96 1.76 nkd1.S 5.2 2.4 2.12 0.96 3.6 0 2.14 0.33 19.25 1.63 1.32 1.47 0.79 2.46 nkd1.L 2.44 0.04 1.2 0.26 1.06 0.08 0.95 0.24 0.48 0.28 0.63 1.81 0.46 0.28 nkd1.S 1.32 0.77 0.44 0.08 1.19 0.1 0.38 0 0.77 2.05 1.53 0.2 0.14 0
Wnt signaling_Cytoplasmic dact1.L 68.58 14.5 16.24 7.2 17.85 0.61 37.55 1.9 194.52 0.49 7.03 9.6 6.54 6.83 dact1.S 18.41 5.23 3.89 3.88 18.47 0.21 17.06 1.49 271.49 0.51 2.66 3.79 3.83 5.62 dact1.L 53.26 9.8 8.29 4.55 10.55 0.46 18.85 1.03 14.8 0.82 1.53 9.19 9.16 1.16 dact1.S 14.88 5.01 1.5 2.86 12.02 0.36 11.23 0.41 106.2 0.45 0.44 2.44 5.05 5.1
Wnt signaling_Cytoplasmic nxn.L 62.35 31.51 46.31 10.4 32.98 5.95 92.93 26.11 29.99 2.09 30.83 20.22 10.08 30.98 nxn.S 29.88 19.34 23.24 15.13 18.05 31.46 30.12 11.44 38.57 4.17 20.67 12.03 9.12 24.15 nxn.L 73.5 35.52 35.67 5.42 39.28 4.06 65.88 32 20.75 3.37 18.88 21.33 6.9 18.49 nxn.S 30.21 20.05 16.7 18.9 14.19 12.13 26.3 28.17 18.71 7.53 23.83 9.45 18.26 7.61
Wnt signaling_Cytoplasmic ppp2cb.L 95.37 23.83 21.78 25.7 29.76 8.58 33.46 16.02 49.79 4.75 23.71 27.33 16.79 83.02 ppp2cb.S 93.65 25.53 32.39 32.51 39.15 20.7 52.4 20.81 25.92 8.18 29.9 46.71 29.4 95.09 ppp2cb.L 120.24 35.3 21.65 30.1 35.72 9.68 24.28 15.97 40.58 4.26 34.77 29.45 25.34 57.7 ppp2cb.S 97.22 32.23 27.55 44.76 41.93 21.89 46.42 15.61 18.4 7.2 29.57 47.47 38.57 63.52
Wnt signaling_Cytoplasmic ppp2ca.S 127.51 91.4 46.1 80.02 85.92 29.05 68.2 39.65 282.39 8.83 77.29 60.13 36.75 87.06 ppp2ca.S 160.65 98.53 42.31 60.46 78.23 27.97 51.5 44.75 342.04 6.25 72.99 60.6 23.46 97.33
Wnt signaling_Nuclear lef1.L 5.95 0.87 0.59 0.4 0.46 0 2.53 0 0 0.15 1.68 3.46 0.39 6.16 lef1.S 4.04 1.24 0.15 0.81 0.34 0.26 5.43 0 0 0.07 0.52 3.75 0.1 3.48 lef1.L 5.17 1.83 0.54 0.52 0.75 0.98 0.25 0.21 0 0.24 0.53 3.78 0.14 2.28 lef1.S 2.58 0.97 0.54 0.37 0.25 0.78 1.38 0 0 0.24 2.12 4.07 0.48 0.79
Wnt signaling_Nuclear tcf7l1.L 5 7.19 4.26 4.95 5.89 1.21 8.55 1.84 48.34 0.46 3.28 3.52 2.63 8.39 tcf7l1.S 7.62 5.63 6.3 3.66 9.48 1.15 12.99 4.46 51.42 0.28 4.22 4.22 2.31 11.48 tcf7l1.L 6.84 9.9 3.52 7.66 7.83 3.02 4.82 2.35 38.42 0.95 1.89 5.4 4.62 12.34 tcf7l1.S 13.06 10.16 6.18 5.45 13.33 3.25 8.01 6.8 51.8 1.29 3.75 8.25 5.28 15.42
Wnt signaling_Nuclear tcf7l2.L 19.5 2.05 5.61 9.45 1.89 4.61 6.07 1.6 1.56 0.12 3.86 18.74 3.06 6.91 tcf7l2.S 28.29 2.54 3.83 9.46 1.88 4.01 4.52 0.91 0.03 0.32 4.27 13.35 3.04 3.85 tcf7l2.L 14.93 1.03 2.1 6.82 2.28 1.21 1.85 2.61 0.37 0.4 1.61 11.98 1.41 1.67 tcf7l2.S 17.79 0.83 1.38 6.09 1.61 1.11 2.54 1.49 0.03 0.44 3.09 7.8 1.2 0.75
Wnt signaling_Nuclear tcf7.S 2.14 0.29 2.26 6.3 11.7 3.96 8.44 0.54 44.29 0.31 2.27 244.78 0.95 13.23 tcf7.S 1.44 1.19 0.93 2.12 6.08 4.9 3.02 0.1 14.01 0.4 1.36 176.21 0.79 11.28
gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
Hh signaling_Ligands shh.L 9.15 0.45 0.11 4.47 5.47 0 24.18 0 0 0 0.66 0.21 7.48 0 shh.S 1.6 0.4 0 0.6 0 0 0 0.05 0 0 0.04 0 1.75 0.04 shh.L 10.21 1.19 0.08 11.27 7.58 0.04 21.16 0 0 0.02 0.23 0 27.85 0.03 shh.S 2.06 0.42 0.04 1.08 0 0 0.04 0 0 0 0 0 3.63 0
Hh signaling_Ligands dhh.L 2.12 35.24 0.1 22.06 11.48 0.06 14.51 0 0.38 0.02 1.67 0.1 11.23 7.75 dhh.S 0.41 18.88 0.02 1.91 2.18 0.06 0.08 0.07 0.03 0.1 0.21 0.02 0.95 17.23 dhh.L 1.61 25.43 0.07 2.78 10.83 0.04 5.22 0.18 0.08 0.11 0.66 0.11 3.22 2.19 dhh.S 0.23 12.92 0.02 0.02 2.71 0 0.02 0.03 0.03 0.05 0.09 0 1.11 3.99
Hh signaling_Ligands ihh.L 1.89 35.33 0.99 24.53 13.89 1.15 17.47 0.09 0.05 0.16 0.66 1.43 8.68 7.95 ihh.S 0.19 16.81 0 8.04 3.16 0 5.43 0 0.09 0 0 0.26 0.09 7.43 ihh.L 1.37 31.54 0.52 12.47 10 0.44 11.8 0.13 0.02 0.21 0.71 2.82 8.95 5.76 ihh.S 0.51 24.34 0 3.69 2.84 0.18 1.35 0.09 0.08 0.11 0 0.52 0.37 4.8
Hh signaling_Receptor-Membrane ptch1.L 7.4 6.58 2.39 4.44 5.38 0.32 4.21 0.41 4.1 0.17 3.35 1.96 2.87 3.79 ptch1.S 4.07 3.08 1.07 3.31 1.81 0.18 4.48 0.1 1.11 0.07 2.53 1.29 1.66 2.23 ptch1.L 5.13 4.42 1.22 1.9 2.63 0.05 2.12 0.08 0.09 0.34 1.23 1.34 1.78 0.66 ptch1.S 2.09 2.74 0.39 1.31 1.17 0.08 2.74 0 0.1 0.25 1.03 1.01 1.13 0.44
Hh signaling_Receptor-Membrane ptch2.L 6.66 6.56 0.14 3.12 2.83 0.12 2.69 0.12 0.8 0.05 0.48 3.32 1.66 1 ptch2.S 4.86 4.3 0.09 2.49 3.19 0.05 2.47 0.16 0.04 0.04 0.45 0.23 1.2 2.46 ptch2.L 5.3 5.62 0.2 1.86 2.27 0.05 1.67 0.08 0.09 0.17 0.21 2.39 1.93 0.64 ptch2.S 3.07 4.09 0.15 2.1 2.05 0 1.71 0.06 0 0.09 0.52 0.52 2.01 0.55
Hh signaling_Receptor-Membrane smo.L 5.71 5.47 11.67 1.97 5.61 0.26 4.72 0.93 13.31 0.33 1.59 3.51 0.99 9.5 smo.S 5.66 3.18 5.52 2.42 2.65 0.23 2.78 0.69 2.81 0.13 1.53 3.02 1.26 7.09 smo.L 1.76 1.28 4.09 0.62 1.94 0.15 3.07 0.51 0.63 0.61 0.63 1.86 0.5 0.92 smo.S 0.99 0.51 1.53 0.43 0.96 0.08 1.16 0.3 0.06 0.24 0.42 1.04 0.47 0.65
Hh signaling_Receptor-Membrane hhip.L 0.76 2.82 0.71 2.82 1.36 2.67 16.71 0 1.27 0.07 3.72 0.09 1.64 3.69 hhip.S 0.17 1.47 0.29 0.53 1.49 0.05 0.6 0 0.34 0.06 0.41 1.03 0.71 8.7 hhip.L 0.97 1.99 0.35 1.5 0.78 2 11.33 0 0.39 0.12 0.26 0.03 1.4 0.54 hhip.S 0.34 1.5 0.04 0.44 4.59 0.12 0.3 0 0.26 0.07 0.11 1.74 0.57 3.39
Hh signaling_Receptor-Membrane hhat.L 12.17 5.05 0.71 2.45 2.38 1.4 2.19 0 6.67 0.18 0.67 0.64 1.81 9.77 hhat.L 12.22 6.12 0.35 2.01 2.59 1.23 0.86 0 8.02 0.07 1.03 0.67 0.77 7.78
Hh signaling_Receptor-Membrane hhatl.L 2.66 0.54 0 0 0.07 0 0 8.57 0 0 0.72 0 0 0.25 hhatl.S 0.92 5.17 5.94 0 0 0 0.02 62.78 0 0 0.04 0.05 0.05 0.04 hhatl.L 4.92 1.41 0.2 0 2.09 0 0 18.22 0 0 1.32 0 0 0.05 hhatl.S 0.67 7.84 2.38 0.07 0.03 0 0.04 74.6 0.03 0 0.12 0.06 0.07 0.03
Hh signaling_Cytoplasmic-Cilia-Nuclear gli1.L 0.82 1.1 0.16 1.3 0.99 0.1 1.84 0.23 0.04 0.02 1.16 0.13 0.7 1.08 gli1.S 3.85 4.3 2.18 2.72 6.27 0.67 5.86 0.39 0.12 0.38 4.04 2.48 2.01 8.02 gli1.L 0.21 0.28 0.04 0.6 0.62 0.04 1.37 0.05 0.01 0.09 0.54 0.09 0.53 0.35 gli1.S 1.32 0.85 0.68 1.02 2.47 0.08 2.79 0.13 0.03 0.44 3.06 1.02 0.84 1.18
Hh signaling_Cytoplasmic-Cilia-Nuclear gli2.L 4.25 4.51 3.31 1.62 2.83 0.46 9.45 1.4 0.59 0.14 2.57 2.87 1.27 10.19 gli2.S 1.78 2.72 0.97 1.1 0.84 0.18 0.83 0.45 0.48 0.11 1.82 1.86 0.64 3.55 gli2.L 6.11 5.2 2.2 1.03 2.91 0.62 2.09 0.79 0.13 0.65 1.29 4.48 1.42 6.84 gli2.S 1.15 1.82 0.38 0.27 0.6 0.02 0.53 0.1 0.15 0.17 0.44 0.78 0.2 1.8
Hh signaling_Cytoplasmic-Cilia-Nuclear gli3.L 5.9 4.02 1.07 2.83 1.38 0.39 2.47 0.68 0.04 0.18 1.71 4.68 1.94 1.62 gli3.S 6.75 1.17 1.29 1.64 1.5 0.23 1.02 0.54 0 0.07 1.24 5.2 1.03 2.62 gli3.L 1.12 0.6 0.26 0.42 0.43 0.05 0.74 0.41 0.01 0.2 1.32 1.26 0.48 0.05 gli3.S 0.91 0.05 0.2 0.17 0.52 0.03 0.42 0.12 0.03 0.21 0.58 0.74 0.27 0.13
Hh signaling_Cytoplasmic-Cilia-Nuclear stk36.L 5.2 5.53 2.48 1.34 9.18 1.79 3.59 0.63 52.06 0.19 0.86 2.48 0.79 66.55 stk36.L 10.55 8.9 3.17 0.94 12.95 1.61 2.13 1.02 144.07 0.66 1.39 3.58 1.53 130.82
Hh signaling_Cytoplasmic-Cilia-Nuclear sufu.L 3.59 6.24 6.59 3.33 8.9 3.93 2.81 0.87 23.53 0.39 2.51 6.21 1.8 29.21 sufu.S 4.84 5.07 5.05 1.91 7.5 1.8 2.27 0.61 15.04 0.29 3.24 8.15 1.77 9.13 sufu.L 8.03 10.19 8.69 4.77 11.61 7.68 3.99 1.25 34.64 1.24 3.64 8.39 4.07 26.49 sufu.S 7.9 7.31 3.91 2.64 8.22 1.88 1.95 0.63 9.48 0.47 3.33 6.47 1.7 5.52
Hh signaling_Cytoplasmic-Cilia-Nuclear prkaca.L 16.24 17.8 28.3 21.29 24.63 6.14 16.57 5.01 18.15 1.55 8.73 16.85 6.53 9.83 prkaca.S 47.9 27.82 20.23 21.02 33.1 7.53 25.45 11.84 33.56 2.87 13.28 25.23 9.28 15.78 prkaca.L 27.32 45.57 62.39 13.53 39.87 14.2 10.8 6.84 35.26 1.55 8.55 25.88 8.22 19.6 prkaca.S 80 50.59 23.93 19.94 40.06 8.86 6.5 13.51 34.32 2.33 10.18 36.79 10.46 14.71
Hh signaling_Cytoplasmic-Cilia-Nuclear kif7.L 9.85 7.31 7.24 5.37 8.17 3.19 8.46 1.94 22.01 0.78 6.97 12.84 3.79 39.2 kif7.L 6.67 2.73 3.15 2.5 3.81 1.25 3.61 0.69 1.06 1.13 5.66 7.42 2.02 7.08
Hh signaling_Cytoplasmic-Cilia-Nuclear arl13b.L 18.28 21.15 9.21 5.31 9.95 4.46 10.75 3.09 6.19 1.28 4.21 8.1 2.83 83.23 arl13b.S 9.22 2.83 3.99 1.82 4.95 0.74 0.28 0 8.81 0.27 3.21 0.55 0.46 59.01 arl13b.L 16.61 14.92 7.04 5.35 11.06 5.64 10.6 5.68 2.83 1.75 5.17 11.05 5.33 17.53 arl13b.S 9.78 6.12 2.45 0.56 5.04 1.29 0.71 2.13 6.75 0.22 1.5 0.55 0.39 71.12
Hh signaling_Cytoplasmic-Cilia-Nuclear foxj1.L 12.81 0.09 0.28 0.15 13.19 0.35 0.19 0 0 0.06 0 0 0.65 0.51 foxj1.S 5.16 0.25 0.77 0 10.6 0.63 0 0 0 0.06 0 0 0.78 2.33 foxj1.L 17.23 0.25 0.17 0 11.2 0.53 0.24 0 0 0.23 0 0.11 0.84 0.2 foxj1.S 6.01 0.04 0.13 0.06 11.3 0.08 0.05 0.08 0 0.14 0.07 0.04 2.58 0.39
gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
HSPG_Core protein gpc1.L 48.6 20.36 1.14 9.56 5.02 36.78 10.39 0.8 0.79 4.46 9.67 6.99 7.24 68.83 gpc1.S 30.64 13.96 0.85 0.95 1.12 1.63 1.44 0.35 1.77 0.21 13.08 4.87 0.46 25.79 gpc1.L 59.48 20.9 2.15 5.38 4.13 39.72 6.37 0.77 0.52 1.74 3.1 5.75 6.76 69.57 gpc1.S 29.13 10.97 0.65 0.76 0.87 0.69 1.89 0.2 1.11 0.19 4.95 3.19 0.29 14.89
HSPG_Core protein gpc2.L 12.98 2.99 0.79 0.82 1.14 0.5 1.06 1 0.19 0.13 0.56 1.11 0.39 2.35 gpc2.S 1.14 0.07 0 0.08 0 0 0 0 0.06 0 0 0 0 0.56 gpc2.L 11.44 2.25 0.98 0.81 1.32 0.3 0.73 0.92 0.13 0.19 0.84 1.03 0.39 2.23 gpc2.S 3.23 0.13 0.19 0 0 0 0 0 0.11 0 0 0 0.04 0.42
HSPG_Core protein gpc3.L 28.15 10.57 7.33 0.26 0.82 0 20.5 0 0.37 0 0.12 6.31 1.03 4.01 gpc3.S 22.62 4.12 0.21 0.19 2.37 0 7.99 1.49 0.19 0.04 0.06 0.35 0.14 0.33 gpc3.L 16.17 5.36 1.41 0.18 1.05 0 15.31 0 0.05 0.14 0.09 3.52 0.23 0.47 gpc3.S 22.31 3.92 0.16 0.29 0.85 0 3.67 1.2 0 0 0.13 0.19 0 0.17
HSPG_Core protein gpc4.L 23.98 41.35 27.31 27.51 22.91 5.31 22.94 3.72 19.28 1.5 15.62 14.37 15.95 18.76 gpc4.S 13.98 19.58 10.54 17.82 13.13 4.56 14.16 2.73 7.41 1.47 5.19 7.07 7.74 26.5 gpc4.L 7.64 14.76 6.75 11.27 9.08 0.56 13.09 1.88 1.91 1.72 8.04 7.47 4.31 1.6 gpc4.S 5.26 12.12 3.49 9.94 9 1.95 8 1.83 0.84 1.48 2.33 5.22 4.39 2.36
HSPG_Core protein gpc5.L 17.59 17.32 11.37 3.4 7.6 0.12 19.43 35.29 7.91 0.3 3.17 34.24 2.63 8.76 gpc5.S 30.58 26.3 31.42 6.19 13.31 3.22 28.57 14.9 14.46 0.67 6.8 1.98 11 37.43 gpc5.L 12.95 15.16 5.68 1.29 5.93 0.06 8.39 15.02 3.78 0.54 0.42 30.62 1.27 3.86 gpc5.S 27.69 25.71 22.44 3.8 13.85 1.02 24.5 10.15 1.28 1.14 3.58 2.27 6.07 23.51
HSPG_Core protein gpc6.L 3.36 1.26 0 0 0.03 0 0.17 0 0.42 0 0.14 0 0.14 0.54 gpc6.S 3.08 0.65 0.11 0.05 0.1 0 0.14 0 0.39 0 0.09 0 0.05 0.53 gpc6.L 1.47 0.21 0 0 0.06 0 0.14 0 0.1 0 0.09 0 0.02 0 gpc6.S 0.75 0.12 0.03 0.02 0.05 0 0.03 0 0.12 0.01 0.01 0 0.01 0.03
HSPG_Core protein sdc1.L 9.63 9.38 2.75 56.48 43.54 4.78 28.16 0.85 14.63 5.57 40.37 2.57 21.38 7.71 sdc1.S 9.98 15.08 0.58 73.25 8.49 2.15 9.02 0.24 67.19 1.57 114.06 7.72 24.12 73.06 sdc1.L 4.55 4.63 1.59 30.01 21.46 4.21 17.29 0.73 3.2 4.56 55.13 2.54 19.69 8.6 sdc1.S 6.99 10.21 0.21 37.43 4.53 0.91 0.98 0.05 10.42 1.86 101.64 3.94 14.54 16.72
HSPG_Core protein sdc2.L 183.07 190.53 257.13 35.1 87.74 169.84 109.32 31.15 25.24 7.75 68.99 25.46 29.95 79.63 sdc2.S 140.52 189.13 176.27 35.51 62.27 98.77 97.03 63.67 21.69 13.22 97.13 30.23 38.38 55.2 sdc2.L 109.45 101.54 130.8 21.23 81.97 87.38 116.72 32.47 2.44 10.19 30.77 26.3 25.59 11.16 sdc2.S 65.59 71.18 100.7 15.78 42.43 29.74 84.03 73.29 1.17 16.63 71.59 30.32 25.59 9.11
HSPG_Core protein sdc3.L 223.39 48.02 28.23 20.75 10.69 11.48 50.66 4.1 0.37 1.07 9.59 48.75 14.58 5.78 sdc3.S 122.23 19.92 56.09 6.58 3.29 2.31 15.69 1.2 0.1 1.1 3.59 14.18 8.17 3.24 sdc3.L 68.29 9.78 7.11 4.02 6.58 2.89 36.34 1.56 0 1.52 2.39 26.86 4.41 1.23 sdc3.S 30.08 2.64 8.28 0.7 1.38 0.16 7.38 0.25 0 0.59 0.92 1.96 1.75 0.49
HSPG_Core protein sdc4.L 30.55 75.54 64.68 86.44 121.91 54.37 183.5 17.32 8.09 7.19 89.28 123.8 86.98 20.69 sdc4.S 11.29 62.11 10.31 67.57 75.07 20.09 70.19 3.36 11.64 4.99 64.65 46.11 32.61 14.89 sdc4.L 14.71 23.56 26.7 58.21 91.16 26.41 67.85 10.8 2.34 10.72 263.18 66.9 65.3 3.09 sdc4.S 10.36 40.56 10.74 97.57 93.03 21.07 32.37 5.09 5 8.21 148.67 84.66 54.65 1.96
HSPG_Enzyme ndst1.L 10.77 9.28 4.2 5.11 6.68 5.39 3.25 3.02 21.24 0.57 4.64 4.47 2.45 4.79 ndst1.S 20.78 11.5 6.45 4.59 8.22 4.94 9.48 1.8 7.75 1.22 6.41 8.64 4.08 6.37 ndst1.L 17.38 17.48 2.85 7.86 6.94 7.06 2.39 2.25 29.04 0.62 3.08 4.77 2.52 5.55 ndst1.S 25.05 15.74 4.9 6.85 8.63 6.54 9.25 1.67 8.27 1.17 4.28 9.4 5.44 5.58
HSPG_Enzyme ndst2.L 105.25 45.23 9.17 8.47 19.35 16.73 21.8 5.23 76.73 1.55 13.48 27.47 6.11 19.95 ndst2.S 13.08 8.39 1.44 2.93 3.55 1.79 3.49 0.25 13.27 0.22 2.1 2.95 0.92 3.02 ndst2.L 127.42 64.61 7.86 10.43 19.67 20.05 15.65 5.09 33.37 2.28 13.51 34.15 7.41 15.26 ndst2.S 18.49 11.6 1.16 2.49 3.04 2.26 0.84 0.37 3.61 0.3 1.72 2.89 1.37 1.93
HSPG_Enzyme ndst3.L 24.49 3.98 0 0.05 0.04 0 0.07 0 0.16 0 0.09 0.15 0.03 1.52 ndst3.S 27.38 6.27 0 0 0.17 0 0 0 0 0.02 0 0 0.01 0.96 ndst3.L 9.96 1.15 0 0.03 0.03 0 0.09 0 0 0 0 0.03 0 0.03 ndst3.S 10.84 1.41 0.03 0 0.05 0 0 0.03 0 0 0.03 0 0.02 0.23
HSPG_Enzyme ndst4.L 3.85 0.52 0 0 0 0 0 0 0 0 0 0 0 0.17 ndst4.S 6.05 1.54 0.03 0 0 0 0 0 0.91 0.09 0 0 0.01 0.1 ndst4.L 1.04 0.11 0 0 0 0 0 0.03 0 0 0 0 0 0.02 ndst4.S 2 0.38 0.03 0 0 0 0 0 0.07 0.04 0 0 0 0.02
HSPG_Enzyme sulf1.L 5.14 19.62 14.86 1.73 9.71 0.37 5.03 0.75 4.8 0.66 2.14 1.75 2.56 3.24 sulf1.S 4.97 9.61 5.17 0.74 2.35 0.34 16.6 1.14 1.02 0 2.87 0.59 0.51 3.41 sulf1.L 1.35 4.99 3.07 0.87 4.74 0.04 2.17 0.6 0.24 0.68 1.07 0.99 1.55 0.37 sulf1.S 1.65 1.24 1.34 0.22 0.76 0.12 8.56 0.33 0 0.14 0.86 0.11 0.04 0.1
HSPG_Enzyme sulf2.L 110.68 44 6.39 13.02 35.04 33.99 71.85 2.02 21.08 1 1.97 15.55 3.47 40.11 sulf2.S 106.59 46.95 12.92 12.56 31.78 7.46 75.6 3.16 19.85 2.16 27.25 33.77 2.74 16.07 sulf2.L 173.23 96.31 4.12 9.38 32.6 25.71 6.95 1.29 23.26 2.7 0.65 19.95 2.61 29.23 sulf2.S 162.97 80.72 11.78 10.05 29.18 6.13 27.94 2.49 16.91 3.97 29.06 37.56 3.33 18.21
gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
Notch signaling_Ligands-Receptors dlc.L 1.75 0.28 0.19 0.83 0.37 0.04 3.71 0.11 0 0.05 1.01 0.05 0.16 1.23 dlc.S 1.25 0.13 0 0.21 0.3 0 0.08 0 0 0.08 0 0.84 0.03 0.07 dlc.L 1.41 0.67 0.57 0.48 0.16 0.19 0.54 0.2 0 0 0.17 0 0.16 0.26 dlc.S 1.07 0.23 0 0 0.27 0.05 0 0 0 0.03 0 0.47 0.04 0
Notch signaling_Ligands-Receptors dll1.L 5.42 2.61 1.23 3.69 6.01 2.57 12.22 0.67 0.03 0.66 1.47 16.67 2.1 0.98 dll1.S 7.27 2.51 0.74 5.19 7.1 5.06 7.9 1.28 0.28 0.43 0.64 40.66 2.03 1.06 dll1.L 3.79 2.59 0.79 2 4.16 1.78 1.36 1.11 0 0.66 0.89 26.25 2.01 0.24 dll1.S 7.99 3.5 0.63 3.28 5.39 2.29 1.26 1.37 0.08 1.14 0.77 79.02 2.46 0.4
Notch signaling_Ligands-Receptors dll4.L 11.71 7.31 9.57 22.29 17.45 4.43 122.56 6.36 2.29 0.95 12.45 22.82 4.38 5.73 dll4.S dll4.L 3.89 1.92 3.61 15.27 11.59 1.97 10.36 1.76 0.3 1.48 4.35 12.64 2.29 0.54 dll4.S
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Notch signaling_Ligands-Receptors jag1.L 3.9 14.04 6.09 3.07 9.81 0.9 13.09 1.49 0.6 0.6 8.9 7.74 1.02 2.78 jag1.S 1.79 7.27 1.59 7.18 7.14 0.37 7.16 0.54 2.58 0.37 5.01 5.29 0.34 3.73 jag1.L 4.4 16.74 3.44 3.01 9.27 1.27 3.68 1.41 0.22 1.42 12.06 10.63 1.32 0.84 jag1.S 2.84 11.83 1.12 3.59 8.18 0.52 2.17 0.52 2.03 0.72 10.7 12.13 0.25 2.62
Notch signaling_Ligands-Receptors jag2.L 12.6 8.94 17.98 2.17 7.9 0.38 18.1 3.54 1.25 0.8 13.05 2.27 1.95 5.28 jag2.S 6.5 6.3 7.18 2.26 8.13 0.23 12.05 1.59 1.98 0.68 8.91 4.3 2.1 8.94 jag2.L 7.55 5.95 7.91 1.09 7.02 0.42 5.66 2.03 0.36 2.54 11.09 2.99 1.82 0.56 jag2.S 9.49 9.43 5.25 2.01 11.35 0.59 3.44 1.89 1.37 1.71 12.6 8.81 3.49 6.5
Notch signaling_Ligands-Receptors notch1.L 7.61 7.3 67.3 4.16 15.63 2.09 11.89 0.64 1.8 0.71 6.57 22.83 1.75 14.84 notch1.S 4.85 7.09 19.01 3.03 6.88 1.33 12.81 0.93 2.85 0.72 6.09 13.43 1.11 3.16 notch1.L 11.47 11.17 53.66 3.83 22.49 2.16 1.62 0.9 0.31 1.18 5.82 33.05 2.96 11.07 notch1.S 4.18 7.14 10.47 2.31 5.87 0.69 1.63 0.82 0.26 0.82 3.68 11.17 1.25 1.4
Notch signaling_Ligands-Receptors notch2.L 2.2 4.54 10.81 3.07 5.98 4.05 2.71 0.17 0.59 0.16 4.85 18.48 0.96 1.8 notch2.S 6.24 11.33 11.7 11.14 12.52 5.32 8.84 1.9 0.26 0.32 7.9 30.52 2.56 0.64 notch2.L 2.25 4.02 3.56 1.05 3.84 1.35 2.18 0.11 0.06 0.32 4.03 8.46 0.49 1.15 notch2.S 2.32 3.52 5.01 4.25 5.92 1.19 4.97 1.06 0.02 0.6 4.51 11.22 1.23 0.28
Notch signaling_Ligands-Receptors notch3.L 5.1 4.35 2.18 2.31 5.65 0.49 12.43 1.46 0.33 0.82 9.55 5.17 1.84 4.52 notch3.S 9.46 8.37 0.87 1.12 9.62 0.23 1.37 0.13 2.86 0.13 3.7 2.22 0.81 4.31 notch3.L 5.04 2.94 1.35 2.74 4.01 0.54 11.45 1.79 0.24 1.16 4.29 5.85 1.43 1.98 notch3.S 19.55 11.27 1.2 0.61 10.44 0.31 1.79 0.36 0.75 0.3 2.55 3.35 1.06 3.31
Notch signaling_Extracellular-Membrane psen1.L 18.01 14.32 7.65 32.61 43.26 6.48 16.64 1.57 36.99 3.33 13.23 11.38 26.84 49.78 psen1.S 24.14 11.31 5.97 7.87 11.73 5.76 14.12 0.97 33.58 2.27 5.33 14.84 5.16 24.2 psen1.L 13.6 13.24 3.92 32.52 29.85 5.56 8.35 1.82 17.79 2.32 21.58 10.3 11.02 32.85 psen1.S 21.13 9.92 3.68 7.72 8.63 5.49 6.6 1.18 19.23 4.53 7.12 12.65 2.6 15.49
Notch signaling_Extracellular-Membrane psen2.L 6.97 5 2.95 2.65 4.26 0.9 4.29 1.23 8.76 0.42 1.79 3.74 1.53 3.5 psen2.S 19.25 15.13 6.87 7.7 17.41 5.81 15.8 6.29 56.78 1.43 9.43 19.35 6.19 8.38 psen2.L 4.14 3.6 0.93 1.85 2.68 0.34 1 1.31 0.99 0.3 3.31 2.19 0.76 0.53 psen2.S 12.89 11.38 3.28 5.71 9.75 2.31 9.23 6.76 2.62 1.21 10.66 10.6 3.5 0.98
Notch signaling_Extracellular-Membrane psenen.L 76.7 57.16 20.27 32.09 54.3 16.99 34.58 8.72 30.72 3.59 19.14 34.58 19.03 125.23 psenen.S 63.53 25.01 14.98 20.52 38.88 11.85 27.97 8.11 24.92 5.55 13.81 29.3 14.23 66.97 psenen.L 165.99 125.46 38.35 56.15 99.22 66.73 74.44 23.83 129.36 10.84 36 53.49 22.25 355.06 psenen.S 99.89 54.44 22.05 42.25 57.56 48.63 54.35 8.02 103.01 13.16 15.53 47.73 23.84 192.33
Notch signaling_Extracellular-Membrane aph1a.L 4.1 4.42 3.71 5.45 6.02 2.81 7.18 1.59 24.12 0.97 3.63 5.21 3.09 37.09 aph1a.S 19.12 29.68 10.39 53.37 38.15 13.42 41.09 6.24 112.21 4.51 20.14 30.89 18.39 167.04 aph1a.L 10.87 10.21 4.79 7.03 9.68 8.06 6.51 1.25 60 1.06 3.32 6.4 3.98 72.02 aph1a.S 35.61 43.8 18.64 52.23 50.25 36.31 33.79 8.46 126.7 4.62 26.49 40.73 22.59 203.72
Notch signaling_Extracellular-Membrane ncstn.L 36.43 26.76 15.06 16.45 21.68 7.09 22.43 4.35 36.93 1.58 13.97 20.2 7.4 32.66 ncstn.S 33.55 25.96 23.18 40.48 44.39 17.56 36.58 4.82 88.73 3.61 15.08 25.31 13.99 29.83 ncstn.L 71.1 45.16 16.5 21.28 27.14 11.1 13.48 8.11 35.38 1.87 13.12 27.15 7.14 59.75 ncstn.S 63.54 48.65 25.93 83.36 85.16 46.07 29.42 9.96 114.24 5.68 9.2 39.79 24.04 37.6
Notch signaling_Extracellular-Membrane adam10.L 81.64 39.01 27.95 47.24 29.34 16.94 49.14 6.38 63.66 6.32 16.91 61.97 55.71 38.98 adam10.S 42.79 46.71 30.4 48.57 50.22 25.57 71.23 5.39 124.31 5.71 32.07 90.84 39.2 22.4 adam10.L 31.72 8.33 6.49 16.9 10.81 1.99 16.14 3.64 2.39 3.87 12.92 19.74 14.52 4.3 adam10.S 15.67 13.95 9.27 19.51 19.4 2.38 21.57 3.66 5.17 3.2 45.4 32.62 9.72 2.08
Notch signaling_Extracellular-Membrane adam17.L 23.71 14.57 11.04 10.85 13.53 5.57 16.84 2.28 19.18 1.86 8.62 19.9 4.61 15.8 adam17.S 7.47 4.01 6.11 6.64 8.05 2.98 5.12 0.47 12.85 0.96 4.39 12.49 4.35 5.41 adam17.L 24.96 13.8 6.58 4.26 9.46 4.2 6.69 3.14 8.52 1.57 8.61 17.03 3.04 10.93 adam17.S 16.42 4.9 3.55 3.4 6.29 1.7 4.71 0.75 3.99 0.96 6.66 11.19 2.28 2.27
Notch signaling_Extracellular-Membrane lfng.L 23.32 13.67 30.27 10.31 26.21 7.72 28.58 8.99 2.73 1.55 10.78 66.67 4.9 3.44 lfng.S 21.68 13.26 23.87 7.36 26.13 8.53 21.63 5.78 16.46 2.26 8.93 56.22 2.7 3.15 lfng.L 21.43 16.09 30.84 2.63 28.66 5.96 5.81 4.17 5.92 2.1 5.11 55.41 3.41 2.4 lfng.S 18.96 15.05 10.04 2.78 20.89 7.43 6.1 3.77 41.28 1.54 6.67 46.91 1.79 6.29
Notch signaling_Extracellular-Membrane rfng.L 33.77 22.07 19.16 13.84 18.14 12.25 29.13 6.91 24.65 3.37 15.31 27.25 12.79 81.32 rfng.L 30.81 15.85 12.84 11.56 16.68 9.18 16.44 7.27 4.17 3.3 25.84 29.89 10.68 28.17
Notch signaling_Extracellular-Membrane furin.L 25.36 21.96 22.21 60.34 41.74 59.89 34.15 4.4 62.98 1.77 16.89 26.11 8.32 17.83 furin.S 8.65 11.47 34.29 16.85 10.95 23.03 15.23 2 21.13 4.51 11.25 24.97 5.21 8.58 furin.L 18.97 20.15 14.22 27.08 36.71 58.05 13.47 5.9 6.42 1.99 33.66 26.29 2.89 4.57 furin.S 7.01 8.92 26.52 8.71 8.27 17.56 5.28 2.01 7.25 4.07 15.48 20.33 2.45 3.12
Notch signaling_Extracellular-Membrane pofut1.L 9.58 7.27 7.73 4.71 8 2.37 9.5 3.15 34.45 0.77 4.47 8.71 3.17 6.96 pofut1.L 14.46 10.33 7.39 4.95 10.65 4.96 9.07 4.35 58.15 1.03 4.97 11.91 3.22 14.67
Notch signaling_Extracellular-Membrane pofut2.L 6.59 3.14 1.96 1.39 3.22 0.26 2.19 0.37 16.04 0.12 0.94 3.96 0.71 18.74 pofut2.S 16.91 11.31 4.66 6.8 11.26 3.77 11.04 1.62 11.48 0.38 4.29 12.04 3.14 23.87 pofut2.L 8.21 3.49 1.41 1.27 2.09 0.25 0.93 0.23 5.42 0.19 0.75 3.75 0.29 10.32 pofut2.S 11.59 8.41 2.9 3.98 6.52 1.32 5.36 0.49 1.03 0.71 3.51 9.35 1.81 4.62
Notch signaling_Cytoplasmic cul1.L 28.69 15.16 13.08 13.45 16.07 4.65 12.48 6.82 73.69 1.92 13.54 16.22 6.43 37.84 cul1.S 26.33 9.71 10.63 9.79 11.44 3.32 9.78 6.5 56.31 1.2 7.13 13.2 5.48 34.46 cul1.L 9.27 2.47 4.25 2.84 4.42 0.54 4.91 5.09 2.47 0.91 12.81 5.24 1.39 1.85 cul1.S 11.61 2.39 3.71 3 4.15 0.6 5.49 6.87 3.96 0.89 8.21 5.45 1.96 2.7
Notch signaling_Cytoplasmic dtx1.L 29.18 33.69 0.03 0.17 1.59 0 0.16 0.06 0 0 0 0.03 0.12 1.38 dtx1.S 37.26 154.02 0.03 0.2 0.05 0 0.21 0 0 0 0 0 0.07 9.31 dtx1.L 25.93 50.16 0 0.09 1.29 0 0.19 0.02 0 0 0.02 0 0.1 0.71 dtx1.S 29.79 129 0.02 0.16 0.05 0 0.11 0 0 0 0 0.12 0.09 2.54
Notch signaling_Cytoplasmic dtx2.L 12.28 12.94 8.02 16.46 11.67 3.45 14.61 3.03 46.96 0.75 21.94 32.97 3.86 20.2 dtx2.S 6.05 5.78 2.51 3.46 4.39 2.03 5.24 2.06 5.23 0.51 6.63 10.34 2.07 12.45 dtx2.L 6.92 6.8 4.01 16.6 11.43 1.39 5.46 1.87 6.82 1.11 24.62 19.44 3.9 5.58 dtx2.S 2.84 1.47 0.82 4.66 2.03 0.46 1.52 0.74 0.62 0.38 4.92 3.18 1.49 4.3
Notch signaling_Cytoplasmic dtx3.L 18.94 5.15 1.67 0.15 0.68 0 0.38 0.14 0.16 0.02 0.14 3.74 0.11 0.87 dtx3.S 17.16 4.37 2.1 0.31 1.97 0.05 1.61 0 0 0.06 0.4 3.12 0.3 4.19 dtx3.L 17.19 5.95 0.37 0.15 0.69 0.06 0.36 0.03 0.03 0.1 0.15 2.48 0.19 0.72 dtx3.S 13.35 3.41 1.8 0.2 2.11 0.39 1.09 0.08 0 0.09 0.66 2.65 0.54 1.32
Notch signaling_Cytoplasmic dtx3-like.1.L 4.13 12.38 28.49 27.59 27.98 14.46 25.73 5.09 41.43 1.84 6.12 92.11 11.1 14.55 dtx3-like.1.L 4.76 5.47 8.4 11.36 12.51 2.65 13.36 5.57 15.39 1.84 16.54 44.07 5.22 2.91
Notch signaling_Cytoplasmic dtx3l-like.L 16.89 19.01 37.01 76.65 33.95 23.07 66.14 15.96 29.7 3.05 26.78 115.34 13.54 34.07 dtx3l-like.L 7.85 6.21 10.17 24.23 12.39 3.84 34.94 10.13 1.61 1.94 16.59 41.95 5.37 13.15
Notch signaling_Cytoplasmic dtx4.L 8.45 1.87 0.85 0.67 0.77 0.17 1.56 0.19 0.05 0.06 0.59 2.33 0.54 25.84 dtx4.L 1.94 0.41 0.05 0.13 0.22 0 0.69 0.17 0 0.11 0.93 1 0.1 1.86
Notch signaling_Cytoplasmic dtx5.L 9.79 5.3 14.45 16.74 12.43 6.87 22.61 1.97 1.44 1.16 5.34 46.85 6.14 7.92 dtx5.S 0.87 0.76 2.08 4.34 2.55 0.95 2.98 0.37 0.37 0.16 0.52 9.07 1.77 1.17 dtx5.L 1.23 0.3 1.05 4.42 1.44 0.32 3.82 0.64 0 0.84 3.95 4.26 1.24 0.36 dtx5.S 0.33 0.08 0.25 2.98 0.5 0.27 1.03 0.06 0.02 0.16 0.29 1.36 0.81 0.07
Notch signaling_Cytoplasmic fbxw7.L 14.93 4.51 3.16 1.11 3.69 0.61 2.04 0.59 2.08 0.25 1.92 2.75 1.4 3.64 fbxw7.S 19.69 5.01 5.34 1.28 2.13 0.43 1.75 1.22 3.04 0.38 2.39 2.56 0.84 4.58 fbxw7.L 8.19 2.71 0.95 0.7 2.86 0.21 0.52 0.42 0.28 0.37 1.92 1.32 0.66 0.3 fbxw7.S 8.91 1.66 1.77 0.27 0.91 0.18 0.76 0.68 0.09 0.36 1.95 1.03 0.25 0.19
Notch signaling_Cytoplasmic itch.L 16.86 17.45 13.16 27.19 22.41 7.17 15.92 7.49 72.93 1.61 17.87 21.4 10.03 11.26 itch.S 10.71 10.98 7.21 17.78 18.95 8.81 13.58 1.65 18.71 2.67 17.52 21.99 14.88 14.73 itch.L 13.19 11.38 6.69 23.56 16.2 2.92 9.6 10.08 6.08 1.19 20.46 14.2 5.15 2.78 itch.S 9.67 12.25 7.77 23.74 16.61 7.75 10.78 1.91 4.39 1.98 21.43 15.63 24.64 6.61
Notch signaling_Cytoplasmic skp1.L 141.63 81.98 96.3 43.73 75.52 23.16 67.46 123.22 90.29 9.34 43.87 72.32 27.75 93.74 skp1.S 175.59 95.94 91.03 62.78 79.25 19.84 72.24 103.9 67.4 7.5 58.4 53.41 33.22 130.15 skp1.L 123.64 77.29 73.26 25.65 72.05 17.58 50.87 115.84 36.43 6.33 51.39 55.92 21.63 30.02 skp1.S 195.03 112.66 82.05 43 91.74 20.36 39.52 108.26 31.68 6.63 62.79 49.21 24.86 42.92
Notch signaling_Cytoplasmic nedd4.L 1.8 3.58 3.82 2.36 3.13 1.29 1.63 1.76 1.59 0.05 1.64 7.11 0.69 4.03 nedd4.S 1.72 0.65 0.78 0.33 0.92 0.64 0.6 1.45 0 0.07 0.48 1.38 0.28 7.37 nedd4.L 0.45 0.54 1.29 0.55 0.76 0 0.79 0.61 0.03 0.17 1.58 1.58 0.26 0.22 nedd4.S 0.31 0.23 0.24 0.02 0.16 0.09 0.12 0.77 0 0.07 0.3 0.42 0.11 0.25
Notch signaling_Cytoplasmic nedd4l.L 32.66 7.72 24.41 8.13 17.12 1.38 19.12 3.74 9.38 1.04 2.67 1.9 12.94 5.72 nedd4l.S 45.36 13.06 19.97 17.59 14.17 3.11 10.87 5.91 18.77 0.65 7.32 7.07 9.68 27.82 nedd4l.L 44.04 8.78 22.12 7.92 29.41 1.26 14.71 10.64 2.65 1.55 3.34 2.34 11.36 3.39 nedd4l.S 41.11 11.9 16.68 14.15 14.09 2.76 4.93 4.34 4.95 0.83 4.57 5.45 4.37 6.35
Notch signaling_Cytoplasmic mib1.L 17.61 10.19 16.04 14.09 17.38 7.03 19.31 9.62 37.76 1.79 12.24 25.97 8.22 15.6 mib1.S 2.91 2.2 7.81 5.75 8.95 3.02 2.66 9.7 25.49 0.64 4.73 11.15 4.24 7.19 mib1.L 12.41 6.68 6.44 7.47 11.56 2.28 16.72 9.09 2.88 2.01 10.2 17.59 5.02 4.91 mib1.S 6.44 2.68 3.22 3.51 5.5 0.8 2.62 5.05 1.95 0.8 4.86 5.57 1.54 1.57
Notch signaling_Cytoplasmic mib2.L 44.29 43.34 6.4 7.78 7.8 13.24 8.94 12.15 28.83 0.96 20.63 7.23 10.8 100.48 mib2.S 21.29 27.43 11.82 5.35 9.84 4.75 10.55 16.33 43.13 0.73 4.75 5.32 4.1 5.59 mib2.L 29.27 19.06 4.58 5.35 5.5 6.64 4.91 10.54 5.78 1.91 29.76 5.2 6.28 29.46 mib2.S 16.78 15.79 7.9 4.58 7.31 1.75 6.29 14.85 7.77 1.69 6.39 5.52 3.71 2.3
Notch signaling_Cytoplasmic neurl1.L 28.59 17.38 1.23 2.87 5.5 1.17 3.66 0.36 0.04 0.37 1.5 8.41 2.2 2.54 neurl1.S 30.13 10.5 0.07 1.61 4.71 0.06 0.4 0.82 1.83 0.17 0.74 0.54 0.83 4.27 neurl1.L 24.43 13.95 0.27 2.29 2.8 0.47 1.11 0.23 0 0.18 0.49 6.18 2.19 0.31 neurl1.S 18.38 7.69 0 1.39 3.41 0 0.09 0.37 0.39 0.32 0.28 0.25 0.44 0.71
Notch signaling_Cytoplasmic neurl1b.L 31.89 6.63 14.36 3.99 15.51 1.58 17.44 3.95 0.17 0.27 13.86 9.04 10.51 7.13 neurl1b.S 24.99 6.11 4.7 6.46 9.39 1.33 26.4 1.86 0.86 0.55 6.26 18.78 2.62 7.68 neurl1b.L 13.31 1.38 4.04 0.85 11.34 0.34 6.96 2.22 0.04 0.44 10.15 6.51 1.92 2.54 neurl1b.S 26.93 5.17 2.64 2.45 11.53 0.69 14.33 1.8 1.73 1.03 2.86 20.24 1.43 2.71
Notch signaling_Cytoplasmic neurl2.L 2.41 1.44 18.95 0.05 0.12 0.05 0.13 38.22 0.21 0 0.33 0.32 0.04 0.78 neurl2.L 2.09 1.81 27.35 0.05 0.43 0.04 0 31.47 0 0.02 0.13 0.32 0.03 0.22
Notch signaling_Cytoplasmic neurl3.L 0.09 2.95 0.6 19.74 3.14 0.32 5.88 0.07 35.03 0.09 4.06 12.41 0.71 0.11 neurl3.S 0 0 0.14 3.71 1.06 0.24 1.93 0 0.18 0.07 5.79 5.49 0.16 0.25 neurl3.L 0.23 2.81 0.22 40.16 3.03 0.24 1.69 0.17 4.13 0.29 1.91 5.74 2.43 0 neurl3.S 0.07 0.1 0.15 13.91 1.28 0.09 1.06 0.05 0.09 0.03 7.2 1.58 1.05 0
Notch signaling_Cytoplasmic neurl4.S 19.8 11.97 7.33 11.07 15.87 4.39 14.62 3.72 98.33 1.12 7.79 16.08 4.25 43.59 neurl4.S 47.54 24.57 12.84 11.18 21.91 9.86 7.69 8.11 335.6 1.47 7.41 23.39 6.01 75.65
Notch signaling_Cytoplasmic numb.L 28.05 21.79 145.1 42.59 49.37 9.76 63.87 9.04 32.19 4.26 18.71 27.08 14.96 54.47 numb.S 16.63 9.16 9.64 14.6 15.26 4.78 15.94 2.18 3.43 1.35 7.22 11.18 3.76 29.59 numb.L 26.17 18.26 68.34 30.19 40.16 5.96 27.42 12.37 4.2 5.31 39.21 25.83 20.54 14.43 numb.S 22.82 12.9 9.6 25.01 18.17 8.2 10.07 2.29 3.11 1.99 7.63 14.02 6.13 17.43
Notch signaling_Cytoplasmic numbl.L 28.02 13.72 2.86 10.82 5.56 0.39 13.15 1.36 0.94 0.26 3.49 3.65 1.49 17.44 numbl.S 24.62 6.43 2.26 1.44 4.29 0.54 12.96 0.59 0.24 0.28 2.59 2.1 1.1 54.13 numbl.L 13.92 5.96 0.65 0.57 2.43 0.07 2.92 0.76 0.22 0.19 1.12 2.24 0.34 2.91 numbl.S 21.08 4.22 0.7 0.4 4.3 0.3 4.37 0.38 0.07 0.35 1.66 2.82 0.48 17.22
Notch signaling_Nuclear hey1.L 32.7 25.92 15.66 1.82 6.27 3.39 21.68 7.23 17.31 0.72 26.71 17.69 0.87 13.26 hey1.S 46.72 25.55 5.34 3.98 7.92 2.94 31.54 16.74 7.73 2.34 6.88 13.14 2.07 4.43 hey1.L 38.3 28 13.78 0.89 6.03 3.38 10.87 6.86 3.85 0.68 9.28 36.38 0.38 5.04 hey1.S 69.24 29.45 7.71 1.9 9.14 3.55 19.5 9.34 5.92 2.15 3.65 20.32 1.06 5.08
Notch signaling_Nuclear hey2.L 7.12 5.58 27.1 0.72 3.07 0.56 18.58 0.78 0.83 0.28 1.32 3.73 0.29 8.47 hey2.L 3.71 2.91 10.05 0.32 2.66 0.32 5.91 0.33 0.05 0.61 0.62 2.88 0.11 2.04
Notch signaling_Nuclear maml1.L 9.45 5.27 5.65 2.64 5.87 2.12 6.66 1.37 14.64 0.47 3.61 12.18 1.63 8.33 maml1.S 5.81 4.52 4.71 2.81 4.43 2.02 5.01 1.06 4.36 0.26 5.2 11.95 2.62 5.34 maml1.L 5.5 3.18 3.12 2.97 4.42 0.65 3.64 1.37 1.14 0.92 5.87 7.84 1.39 1.14 maml1.S 5.16 3.46 2.93 4.12 3.97 1.1 3.35 0.89 0.68 0.55 5.38 7.67 1.8 1.56
Notch signaling_Nuclear maml2.L 5.36 3.51 5.96 3.87 4.99 2.36 12.12 0.55 1.23 0.57 1.32 5.16 2.58 7.56 maml2.S 5.53 1.93 3.93 1.29 2.64 1.03 8.8 0.36 5.36 0.24 0.7 4.63 0.71 5.23 maml2.L 3.34 1.65 1.96 1.38 4.59 0.77 5.54 0.19 0.15 0.87 0.28 4.72 1.76 1.69 maml2.S 3.61 1.02 1.65 0.92 2.86 0.74 9.39 0.15 0.66 0.37 0.57 4.03 0.48 1.4
Notch signaling_Nuclear maml3.L 4.51 1.08 0.61 1.99 1.41 0.27 0.82 0.08 0 0.08 0.4 2.75 0.35 2.22 maml3.S 7.59 2.63 2.48 2.66 4.26 1.96 3.15 0.98 0.31 0.24 1.19 10.25 0.95 2.41 maml3.L 1.7 0.39 0.5 0.8 0.86 0.05 0.26 0.16 0 0.06 0.18 1.46 0.32 0.41 maml3.S 2.78 0.9 0.92 2.3 1.73 0.58 0.99 1.22 0.05 0.28 0.86 3.39 0.6 0.47
Notch signaling_Nuclear rbpj.L 3.83 2.99 2.79 2.17 2.91 0.93 4.65 1.01 2.32 0.7 2.65 5.61 1.18 3.07 rbpj.S 1.79 1.31 2.55 2.94 3.46 1.28 2.52 0.56 10.89 0.72 3.67 8.21 1.18 5.35 rbpj.L 2.14 1.36 1.37 1.46 1.97 0.58 2.57 0.91 0.17 0.9 2.01 3.78 1.04 0.6 rbpj.S 2.2 1.68 1.55 1.55 3.02 0.46 1.93 0.76 2.16 0.9 3.8 5.65 1.09 0.91
gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
Hippo signaling_Membrane dchs1.L 12.73 6.98 3.47 1.43 2.43 0.25 5.71 0.87 1.37 0.16 1.15 2.66 1.02 8.43 dchs1.S 8.44 4.8 1.64 0.91 1.54 0.06 3.42 0.37 1.1 0.05 0.52 1.49 0.42 5.44 dchs1.L 17.14 8.05 2.54 0.71 2 0.46 2.74 0.94 0.77 0.23 0.33 2.81 0.85 9.32 dchs1.S 14.57 6.77 1.17 0.44 1.6 0.13 0.69 0.31 0.54 0.14 0.08 1.72 0.54 5.75
Hippo signaling_Membrane dchs2.L 1.8 2 0.12 0.03 0.11 0.02 0.01 0 0.11 0.01 0.3 0.03 0.12 3.13 dchs2.S 4.51 0.92 0.09 0.12 0.2 0 0.02 0 0.03 0.02 0.46 0.09 0 0.4 dchs2.L 0.26 0.27 0 0.03 0.04 0 0 0 0.02 0.04 0 0.01 0 0.26 dchs2.S 0.77 0.03 0 0 0.1 0 0.04 0 0 0.04 0.08 0 0.04 0.05
Hippo signaling_Membrane crb1.L 7.46 16.9 0.04 0.02 0.1 0 0.04 0 0.04 0 0.04 0.09 0.01 1.54 crb1.L 8.58 36.26 0.02 0.01 0 0 0.04 0.02 0.04 0 0.01 0.06 0.01 1.19
Hippo signaling_Membrane crb2.L 9.63 21.67 21.23 0.31 4.9 0.54 2.14 0 0.31 0.17 0 0.38 1.23 15.28 crb2.S 7.17 11.19 0.49 0.02 0.26 0.01 0.08 0.01 0.08 0.02 0 0.01 0.08 5.52 crb2.L 10.73 22.57 14.04 0.02 3.83 0.06 0.45 0.03 0.03 0.62 0.05 0.09 0.43 4.26 crb2.S 8.14 8.81 0.61 0.02 0.16 0 0.04 0 0.01 0.07 0 0.02 0.03 1.6
Hippo signaling_Membrane crb3.L 1.46 12.42 0.4 10.56 27.59 1.86 10.57 0 23.2 2.48 21.03 0.05 6.41 4 crb3.S 1.98 8.64 0 5.73 11.05 0.82 5.89 0 25.39 0.9 12.85 0 4.97 12.84 crb3.L 2.6 11.3 0.41 16.2 37.13 4.62 9.59 0.04 51.01 2.44 38.22 0.1 9.16 5.36 crb3.S 2.7 7.75 0 20.98 23.37 4.52 5.4 0 95.32 2.19 20.96 0.3 6.21 22.41
Hippo signaling_Membrane fat1.L 3.23 1.97 34.53 4.29 10.45 1.95 1.71 0.06 4.86 0.29 3.86 1.57 4.13 2.48 fat1.S 16.33 16.9 54.48 55.93 28.69 2.24 16.75 0.94 3.24 1.2 11.08 10.27 13.23 9.3 fat1.L 2.74 1.97 5.56 1.07 3.61 0.21 2.24 0 0.05 0.38 1.32 0.22 0.88 1.09 fat1.S 9.15 9.33 13.8 23.02 12.43 0.54 8.97 0.55 0.17 1.35 5.02 3.29 4.34 2.87
Hippo signaling_Membrane fat2.L 0 1.45 0.04 0.12 0.82 0 0.13 0 0.08 0 3.02 0 0.22 0.02 fat2.S 2.43 5.69 0.19 1.67 1.59 0.12 0.41 0.1 0.03 0.03 18.77 0.37 0.64 0.23 fat2.L 0.01 0.35 0 0.01 0.32 0 0.06 0 0.08 0 1.34 0 0.09 0.01 fat2.S 2.4 3.69 0.13 1.16 0.76 0.04 0.21 0.22 0.01 0.03 21.67 0.21 0.28 0.07
Hippo signaling_Cytoplasmic amot.L 15.91 7.96 11.61 6.27 7.44 1.72 15.18 1.58 11.96 0.69 11.35 9.82 4.58 3.83 amot.S 11.44 5.61 11.67 8.32 10.04 2.89 19.36 1.07 3.2 0.73 8.61 9.55 4.9 4.18 amot.L 11.16 4.79 5.47 5.46 5.75 1.03 4.93 1.29 1.16 0.98 18.83 7.32 4.16 1.08 amot.S 6.07 2.72 3.36 5.27 6.85 1.18 6.57 0.67 0.33 0.88 4.51 7.27 2.82 0.79
Hippo signaling_Cytoplasmic amotl1.L 15.24 8.76 8.96 1.98 9.98 0.63 11.11 2.36 1.12 0.26 2.29 4.86 2.23 4.06 amotl1.S 17.22 7.35 5.05 0.18 3.67 2.59 6.45 1.75 20.5 0.27 5.95 3.12 0.82 28.3 amotl1.L 20.92 12.1 8.21 2.23 13.67 1.02 11.48 1.81 1.53 0.73 2.88 8.1 2.95 5.52 amotl1.S 24.17 9.78 4.45 0.8 5.22 1.44 5.78 1.22 31.06 0.59 3.96 2.97 1.1 16.08
Hippo signaling_Cytoplasmic amotl2.L 15.56 17.14 41.04 11.85 32.99 7.93 114.42 12.18 47.8 1.4 13.89 6.77 8.7 10.72 amotl2.S 11.09 26.05 50.98 10.51 30.35 5.17 97.9 20.78 1.48 1.38 9 7.69 8.23 10.6 amotl2.L 17.36 20.68 34.67 11.01 40.28 7.47 23.53 14.52 4.93 2.65 5.25 12.25 6.33 8.4 amotl2.S 10.2 34.46 35.02 7.18 37.06 8.95 27.67 7.83 0.91 2.47 4.38 14.52 7.12 5.93
Hippo signaling_Cytoplasmic ctnna1.L 14.8 21.47 55.39 31.22 20.36 5.5 42.38 3.2 31.66 2.77 18.97 24.24 24.81 34.95 ctnna1.S 23.72 55.43 90.99 94.72 57.24 15.13 86.03 10.41 96.13 5.9 90.27 59.82 40.8 34.96 ctnna1.L 5.97 6.21 17.03 7.63 6.69 1.07 10.74 2.42 1.66 1.45 14.83 9.84 5.61 2.72 ctnna1.S 5.66 7.78 23.88 26.24 17.76 1.69 37.3 7.73 2.21 4.4 95.08 17.74 13.49 2.62
Hippo signaling_Cytoplasmic ctnna2.L 29.02 4.77 0 0 0.38 0 0.08 0 0 0 0 0 0 0 ctnna2.S 29.28 15.06 0 0 0.61 0 0.15 0 0 0 0 0 0.05 0 ctnna2.L 27.02 7.13 0 0 0.18 0 0 0 0 0 0 0 0 0 ctnna2.S 22.98 13.59 0 0 0.62 0 0.13 0 0 0 0 0 0.07 0
Hippo signaling_Cytoplasmic dlg1.L 43.02 16.48 8.24 14.52 17.62 3.29 16.85 2.52 10.51 1.57 11.15 9.56 6.4 13.79 dlg1.S 54.08 22.54 15.25 21.26 19.61 5.51 28.72 6.18 23.43 3.03 17.31 18.8 9.41 35.47 dlg1.L 11.76 3.25 1.69 6.12 5.07 1.04 4.76 1.38 0.24 1.12 7.64 3 2.04 1.05 dlg1.S 19.41 4.65 5.27 10.27 8.53 1.56 13.92 3.12 0.76 2.41 16.79 7.18 4.86 3.71
Hippo signaling_Cytoplasmic dlg4.L 59.43 11.46 0.35 0.45 0.42 0.09 0.75 0.98 0 0.02 0.13 0.58 0.11 0.09 dlg4.S 32.28 8.81 0.07 0.2 0.34 0 0.61 0.16 0.05 0 0.13 0.36 0.22 0.47 dlg4.L 98.02 16.13 1.13 0.65 0.93 0.23 0.55 0.56 0 0.12 0.51 3.61 0.53 0.15 dlg4.S 59.18 16.08 0.87 0.11 1.01 0.1 0.38 0.31 0.05 0.09 0.13 1.37 0.41 0.4
Hippo signaling_Cytoplasmic scrib.L 9.76 10.41 8.91 6.7 10.06 2.12 14.98 11.51 19.17 0.61 8.47 7.92 3.5 5.24 scrib.S 8.05 7.75 18.45 2.95 4.68 1.14 5.97 6.06 12.2 0.34 4.54 3.9 1.73 3.87 scrib.L 16.8 18.81 10.29 7.67 15.33 5.09 6.77 12.99 30.81 0.97 7.26 15.96 5.88 7.47 scrib.S 14.02 9.19 14.47 3.59 7.29 2.08 2.67 7.56 11.4 0.82 4.12 6.41 2.87 4.64
Hippo signaling_Cytoplasmic llgl1.L 24.84 13.9 15.32 5.83 9.83 10.74 12.91 13.49 52.39 0.91 7.36 18.99 4.21 5.31 llgl1.S 23.99 20.51 10.42 6.23 19.57 3.89 18.76 12.27 66.98 0.92 14.03 25.56 4.91 23.47 llgl1.L 48.47 23.45 12.18 5.13 11.37 15.11 7.16 9.57 121.06 1.47 3.79 34.11 5.4 6.85 llgl1.S 49.41 31.92 8.47 5.1 22.5 7.21 7.83 9 170.96 1.56 10.75 37.22 4.92 44.74
Hippo signaling_Cytoplasmic llgl2.L 12.69 9.25 1.02 21.89 13.41 5.56 5.1 0.04 37.77 2.39 12.98 3.06 9.47 2.64 llgl2.S 11.93 32.34 6.69 47.16 28.79 4.67 14.83 1.91 54.99 3.7 50.21 6.07 19.27 4.98 llgl2.L 18.4 12.07 1.33 22.29 12.38 9.24 2.01 0.19 60.06 3.23 8.56 3.39 9.58 2.2 llgl2.S 23.28 44 9.19 68.39 37.15 13.95 8.92 2.01 144.99 3.1 58.37 6.66 30.08 7.82
Hippo signaling_Cytoplasmic ptpn14.L 5.95 5.81 13.12 2.99 6.34 1.02 17.59 1.17 8.26 0.96 7.19 0.88 2.09 9.15 ptpn14.S 4.51 6.17 7.9 1.17 3.37 0.27 10.05 0.19 6.83 0.27 5.13 0.72 0.6 8.44 ptpn14.L 6.62 5.14 12.52 1.18 10.14 1.2 8.55 1.66 1.22 1.88 8.06 2.15 2.24 4.28 ptpn14.S 6.39 7.95 7.16 0.91 4.84 0.36 4.42 0.23 5.13 1.68 6.37 1.27 1.09 5.4
Hippo signaling_Cytoplasmic stk3.L 1.7 0.7 2.35 3.86 5.75 1.99 0.98 0.09 6.06 0.33 4.16 9.25 2.78 8.31 stk3.S 3.54 1.2 1.81 3.52 6.28 3.37 0.82 0.18 15.97 0.21 4.43 11.45 2.5 10.81 stk3.L 3.26 1.17 1.05 0.96 2.42 0.22 1.43 0.06 0.53 0.34 3.32 2.65 0.39 1.1 stk3.S 5.91 2.56 1.24 2.26 3.09 0.87 1.81 0.21 0.51 0.34 4.43 5.3 0.81 2.24
Hippo signaling_Cytoplasmic stk4.L 9.76 5.84 10.46 23.27 22.74 18.4 32.99 3.19 0.3 3.16 8.75 116.25 7.3 3.7 stk4.S 1.46 1.95 4.66 6.1 10.37 3.53 14.59 2.24 0.08 0.9 3.39 29.58 4.98 2.86 stk4.L 9.78 4.38 6.82 22.36 14.89 8.24 24.87 3.11 0.1 4.02 17.92 92.26 12.48 1.69 stk4.S 1.8 1.12 1.69 5.59 6.05 0.65 7.17 2.79 0.05 1.23 5.65 23.71 11.53 0.26
Hippo signaling_Cytoplasmic sav1.L 4.59 9.25 16.19 7.3 13.53 4.91 14.25 4.24 36.39 0.64 11.54 18.22 3.96 14.65 sav1.S 16.14 8.17 9.81 3.87 6.34 2.41 9.25 2.1 5.62 0.47 4.72 9.18 2.38 22.94 sav1.L 5.54 4.41 9.73 2.53 10.47 2.19 8.24 4.36 4.94 1.56 7.23 24.5 2.96 2.31 sav1.S 11.83 8.45 6.85 3.9 9.4 2.89 5.28 1.97 5.1 0.66 6.91 10.41 2.89 11.69
Hippo signaling_Cytoplasmic lats1.S 8.01 8.8 7.71 8.29 10.55 3.28 7.68 1.27 36.27 0.79 9.09 13.86 5.16 10.64 lats1.S 2.65 1.86 1.72 2.26 3.29 0.48 2.79 0.62 1.14 0.43 7.43 3.62 0.78 1.83
Hippo signaling_Cytoplasmic lats2.L 0.7 0.48 4.47 1.42 3.38 1.15 1.19 0.05 3.39 0.04 1.18 4.15 0.8 4.79 lats2.S 4.24 4.64 7.13 3.45 4.5 2 25.92 2.69 5.16 0.41 2.42 6.02 1.93 7.64 lats2.L 2.13 1.48 2 1.73 3.83 0.26 2.25 0.15 0.2 0.37 0.82 4.2 0.57 1.8 lats2.S 3.86 3.66 4.73 3.01 6.42 0.81 10.57 3 0.26 0.61 1.83 6.4 1.05 2.07
Hippo signaling_Cytoplasmic mob1a.L 32.55 41.26 44.68 57.02 60 26.17 77.75 12.57 61.96 8.97 49.94 87.97 35.35 40.78 mob1a.S 16.86 27.97 26.54 22.56 26.68 12.34 36.24 9.27 22.19 3.81 33.36 40.13 15.18 15.9 mob1a.L 18.61 19.32 24.4 22.96 34.21 7.91 52.52 11.97 9.32 5.17 58.72 55.05 14.01 12.19 mob1a.S 13.51 24.82 24.15 13.4 28.69 15.52 26.31 9.8 9 2.75 41.63 33.73 8.98 6.93
Hippo signaling_Cytoplasmic mob1b.L 39.75 13.72 18.4 12.63 19.62 10.22 14.12 8.1 1.92 1.48 16.45 67.41 5.31 17.56 mob1b.S 13.88 3.25 15.88 12.03 7.02 6.04 5.71 0.94 0.32 0.49 12.18 65.74 3.85 13.16 mob1b.L 8.1 1.42 2.43 2.09 6.82 0.56 4.83 1.33 0.08 0.95 8.23 6.61 0.66 0.63 mob1b.S 10.48 1.13 4.59 3.01 2.65 0.67 3.22 0.38 0.17 0.4 12.39 16.02 1.33 2.62
Hippo signaling_Cytoplasmic limd1.L 7.46 9.04 17.76 8.4 13.54 6.62 8.26 4.08 14.8 1.31 10.54 28.3 7.49 12.68 limd1.L 2.91 2.95 5.96 7.47 6.99 0.81 3.27 1.58 0.61 1.54 7.86 10.56 3.01 0.52
Hippo signaling_Cytoplasmic nf2.L 14.48 7.13 11.09 4.01 5.9 2.02 10.26 10.47 8.87 0.44 4.13 7.57 2.3 41.13 nf2.S 18.34 13.06 16.25 10.67 19.81 8.29 21.13 16.97 89.1 2.56 9.53 21.6 7.4 38.68 nf2.L 9.35 4.71 8.05 2.82 4.32 1.8 6.38 6.34 1.28 0.87 4.42 6.71 2.17 12.97 nf2.S 8.43 5.68 6.74 6 8.79 2.35 11.67 11.14 4.14 1.67 11.72 11.83 3.48 5.17
Hippo signaling_Cytoplasmic frmd6.L 4.88 11.14 29.39 2.34 14.79 0.23 8.18 1.7 13.06 0.33 9.56 4.38 1.89 4 frmd6.S 2.59 6.49 6.56 2.33 6.94 0.64 5.3 0.49 1.36 0.11 10.1 5.83 1.84 5.69 frmd6.L 2.57 5.24 8.12 0.69 8.2 0.1 4.53 0.9 0.42 0.42 8.26 4.01 0.92 1.42 frmd6.S 3.57 6.51 4.01 1.25 9.46 0.61 3.36 0.47 0.1 0.34 12.37 10.06 1.05 2.11
Hippo signaling_Cytoplasmic wwc1.L 45.04 14.66 1.28 22.63 24.5 8.5 28.7 0 0.81 1.47 13.42 0.22 10.38 8.28 wwc1.S 10.24 6.88 5.21 13.35 22.13 1.79 15.89 0.56 18.92 2.98 7.25 5.21 5.06 4.65 wwc1.L 15.7 4.48 0.39 11.61 12.94 0.45 4.98 0.05 0.12 0.77 6.51 0.1 4.23 1.72 wwc1.S 5.6 2.22 1.54 7.35 14.26 0.56 4.8 0.73 1.21 1.5 4.66 3.33 1.97 0.7
Hippo signaling_Cytoplasmic wwc2.L 0.53 0.61 2.9 0.81 2.42 0.35 0.27 0.04 1.06 0.08 0.75 1.11 0.23 1.76 wwc2.S 3.94 4.19 6.85 1.72 7.65 0.87 9.13 0.41 6.93 0.3 2.41 3.76 1.44 3.27 wwc2.L 0.68 1.12 1.2 1.1 1.57 0.04 1 0.05 0.19 0.17 0.38 0.53 0.3 0.5 wwc2.S 2.61 2.61 2.93 3.66 6.39 0.43 4.65 0.17 0.35 0.54 1.04 3.33 0.8 0.59
Hippo signaling_Cytoplasmic wwc3.L 7.67 12.93 27.99 5.33 14.31 2.68 37.68 7.61 0.17 0.95 8.84 14.21 4.03 33.22 wwc3.S 3.36 7.47 7.21 1.97 10.82 1.47 11.95 2.55 0.05 1.66 2.4 8.94 2.57 5.76 wwc3.L 3.38 5 8.49 2.29 7.78 0.54 9.85 4.33 0 1.13 5.3 9.44 3.16 2.61 wwc3.S 1.27 1.17 2.46 0.62 3.46 0.34 0.81 1.37 0 2.43 2.97 5.47 1.46 0.26
Hippo signaling_Cytoplasmic pard6b.L 2.48 6.36 4.02 7.75 14.25 1.87 2.51 0.09 6.28 0.28 5.91 1.6 5.71 6.4 pard6b.S 14.23 10.78 4.98 8.64 13.25 2.1 14.65 2.05 5.63 0.9 6.81 10.15 7.53 7.68 pard6b.L 5.88 14.6 2.04 5.55 13.26 1.69 7.75 0.06 2.92 0.86 5 1.46 5.14 1.85 pard6b.S 10.35 8.46 3.02 8.23 11.77 1.62 8.33 1.79 1.71 1.05 4.59 6.99 5.44 2.29
Hippo signaling_Cytoplasmic pard6g.L 7.97 11.72 4.43 1.79 9.79 0.32 2.19 1.92 59.95 0.54 18.32 2.84 1.36 1.93 pard6g.S 15.18 15.67 2.28 1.81 4.87 0.73 4.74 0.62 51.48 0.59 20.66 4.8 1.66 4.15 pard6g.L 7.57 10.26 1.53 0.86 6.03 0.19 1.09 0.53 8.87 0.39 21.62 3.43 0.41 0.36 pard6g.S 14.84 11.7 0.87 1.11 3.9 0.55 3.14 0.47 12.28 0.63 27.13 4.64 1.32 0.65
Hippo signaling_Cytoplasmic prkci.L 7.44 5.5 3.46 5.49 5.41 1.94 3.65 0.45 4.98 0.63 5.93 4.21 3.31 6.33 prkci.S 1.72 1.49 1.61 1.29 3.17 0.21 1.13 0.13 2.98 0.12 2.85 2.97 0.9 2.22 prkci.L 6.3 3.16 1.64 3.44 3.87 0.45 1.66 0.27 0.5 0.37 5.43 2.87 1.36 1.84 prkci.S 6.37 6.02 2.45 2.32 4.29 0.6 1.83 0.17 1.9 0.24 2.75 4.01 1.47 1.56
Hippo signaling_Cytoplasmic rassf1.L 4.94 6.62 8.56 9.37 12.52 3.8 17.98 4.42 14.11 1.55 5.48 24.74 3.04 7.43 rassf1.S 13.22 10.21 10.61 10.69 16.24 4.23 23.18 5.12 12.67 1.04 5.92 26.89 3.96 7.37 rassf1.L 7.97 9.8 10.7 7.36 11.3 7.42 12.42 4.56 32 2.03 11.34 37.02 6.31 5.85 rassf1.S 19.16 14.19 10.25 6.01 19.32 5.29 9.98 5.75 25.02 2.36 11.27 43.91 4.41 10.29
Hippo signaling_Cytoplasmic rassf2.L 50.07 16.49 26.68 15.3 30.61 23.04 43.29 5.55 34.09 2.02 11.16 173.38 3.1 12.65 rassf2.S 14.67 8.49 4.9 3.58 7.95 6.9 8.4 1.17 0.8 0.68 5.38 21.02 2.25 7.09 rassf2.L 52.83 15.61 11.42 7.04 19.86 12.02 27.35 5.53 17.96 3.06 9.3 129.32 3.09 5.58 rassf2.S 11.14 7.32 2.47 2.71 4.07 4.23 4.96 0.69 0 0.77 6.14 19.99 1.39 1.91
Hippo signaling_Cytoplasmic rassf3.L 40.65 78.88 20.38 54.06 28.81 30.71 30.8 22.08 24.13 2.66 22.61 39.29 16.65 40.76 rassf3.S 27.3 23.01 16.98 19.72 26.15 12.18 13.93 50.92 63.16 1.83 8.83 18.62 11.1 35.33 rassf3.L 19.76 42.7 9.91 29.32 20.32 10.29 6.94 12.42 0.92 2.73 17.04 29.54 19.08 3.89 rassf3.S 13.03 9.78 5.56 20.92 28.17 3 2.2 40.17 2.53 1.88 7.43 11.63 6.45 3.7
Hippo signaling_Cytoplasmic rassf4.L 37.61 6.68 6.7 8.39 6.73 3.13 7.36 1.99 0.14 0.47 1.77 24.06 1.81 25.41 rassf4.L 5.94 0.43 1.01 3.7 1.4 0.05 1.93 1.98 0 0.59 2.14 4.7 0.58 0.39
Hippo signaling_Cytoplasmic rassf5.L 19.29 2.03 3.41 5.18 5.74 4.05 8.63 0.71 0.69 0.24 1.62 55.45 0.58 9.5 rassf5.S 41.58 2.1 4.42 4.82 3.85 4.08 4.49 0.25 0.1 0.29 1.55 45.2 0.61 0.18 rassf5.L 6.53 0.89 1.78 1.54 1.61 0.86 2.42 0 0.05 0.26 1.7 28.38 0.26 0.34 rassf5.S 11.24 0.13 1.19 1.08 0.57 0.34 1.81 0.21 0 0.27 0.97 10.43 0.16 0.02
Hippo signaling_Cytoplasmic rassf6.L 0.25 2.73 0.17 11.14 14.42 1.98 6.57 0 0.55 0.44 2.18 0.25 10.72 0.12 rassf6.S 0.2 6.79 0 12.31 0.63 0.06 8.53 0 0.13 0.14 8.26 0 3.92 1.18 rassf6.L 0.08 0.28 0.06 3.29 3.54 0.17 2.26 0 0 0.39 2.14 0.17 1.92 0.08 rassf6.S 0 0.1 0 1.33 0.15 0 4.67 0 0 0.39 7.54 0 1.21 0
Hippo signaling_Cytoplasmic tjp1.L 22.61 15.66 20.55 16.69 14.6 3.07 41.79 3.41 4.22 1.25 19.68 10.35 10.31 17.98 tjp1.S 21.15 14.84 8.77 8.18 8.9 2.1 19.03 1.98 7.4 1.12 9.17 8.41 7.43 23.83 tjp1.L 5.41 3.14 5.31 6.03 5.82 0.53 12.32 2.45 0.11 1.25 13.74 3.56 4.02 2.98 tjp1.S 4.81 2.38 1.95 2.17 3.47 0.46 2.79 1.2 0.21 1.19 5 2.97 1.95 3.15
Hippo signaling_Cytoplasmic tjp2.L 14.87 15.62 2.72 4.93 9.81 2.26 7.22 0.59 35.68 0.94 5.92 3.12 4.92 8.66 tjp2.S 13.99 24.37 6.03 30.28 13.77 3.5 15.57 1.41 24.67 1.57 26.36 2.6 15.28 8.62 tjp2.L 7.68 6.04 1.07 4.08 10.15 0.67 2.34 0.68 3.8 1.41 7.13 1.32 3.55 2.05 tjp2.S 3.88 8.12 0.23 15.46 7.34 0.6 5.54 0.07 0.02 1.14 22.03 0.19 7.4 2.17
Hippo signaling_Cytoplasmic tjp3.L 1.51 11.15 2.3 15.5 12.23 2.14 11.4 1.38 32.29 1.75 16.53 3.23 19.46 9.5 tjp3.S 0.68 6.26 0.31 8.73 7.61 0.68 3.91 0.02 23.51 0.38 7.68 2.17 3.24 9.99 tjp3.L 0.77 1.61 0.53 5.62 5.14 0.24 3.48 0.43 1.68 1.34 14.05 1.4 9.19 0.84 tjp3.S 0.28 1.55 0.2 3.09 2.91 0.1 1.51 0.02 0.95 0.48 8.38 1.13 2.14 0.45
Hippo signaling_Nuclear taz.L 17.9 12.18 5.28 8.35 10.65 4.98 10.77 1.5 70.92 1.34 7.58 11.07 5.4 6.76 taz.L 23.12 15.39 11.25 9.49 18.29 8.53 6.9 5.49 259.9 1.18 12.74 19.44 4.31 6.05
Hippo signaling_Nuclear tead1.L 0.39 0.59 3.21 1.03 1.47 0.33 0.55 0.12 1.45 0.08 0.94 1.33 0.69 5.1 tead1.S 0 0.15 3.66 0.37 0.82 0.41 0.11 0.06 0.73 0 0.97 1.56 0.56 2.47 tead1.L 0.63 0.52 0.84 0.35 0.89 0.22 0.56 0.57 0.87 0.11 1.53 0.68 0.4 1.13 tead1.S 0.29 0.04 1.22 0.32 0.6 0.08 0.4 0 0.08 0.07 1.06 0.43 0.08 0.28
Hippo signaling_Nuclear tead4.L 6.65 15.52 14.36 7.81 10.52 0.68 17.82 19.6 4.06 0.65 6.02 7.3 3.04 6.94 tead4.S 3.19 13.99 12.55 9.34 8.85 0.9 14.53 11.1 13.14 0.36 7.75 3.59 2.47 3.93 tead4.L 3.52 8.04 6.69 4.58 8.39 0.42 3.81 10.78 0.85 1.1 6.76 6.65 2.38 0.48 tead4.S 2.29 6.39 5.15 5.9 7.65 1.18 3.36 9.25 5.38 0.71 10.42 3.5 2.65 2.57
Hippo signaling_Nuclear yap1.L 5.77 27.76 26.89 19.51 15.45 1.66 23.44 4.19 21.25 0.7 21.82 5.94 5.88 9.96 yap1.S 3.03 7.04 11.11 8.57 7.82 1.02 9.81 1.42 8.95 0.27 3.48 3.2 4.75 4.61 yap1.L 4.02 17.32 11.31 10.46 14.33 1.48 14.56 3.96 7.19 1.4 31.7 6.46 5.46 5.99 yap1.S 2.78 7.86 8.49 10.24 9.83 0.93 8.48 2.49 3.7 0.61 3.84 3.92 6.18 3.47
Hippo signaling_Nuclear vgll4.L 20.76 16.14 19.02 8.29 21.45 4.93 30.41 8.48 56.95 1.39 12.37 14.86 5.78 26.93 vgll4.S 23.12 20.17 10.12 14.08 21.99 5.98 29.98 3.73 11.34 1.82 17.24 20.55 6.84 14.45 vgll4.L 35.4 31.56 16.3 12.91 39.54 11.62 13.08 5.75 73.09 2.19 9.59 21.36 8.28 20.43 vgll4.S 31.1 26.3 10.62 17.03 28.79 8.84 21.33 4.79 7.62 3.52 16.09 30.41 13.3 6.24
gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.T eye.T heart.T intestine.Tkidney.T liver.T lung.T muscle.T ovary.T pancreas.Tskin.T spleen.T stomach.Ttestis.T gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.Utestis.U gene name brain.U eye.U heart.U intestine.Ukidney.U liver.U lung.U muscle.U ovary.U pancreas.Uskin.U spleen.U stomach.U testis.U
TLE_Nuclear tle1.L 9.36 8.8 2.65 2.67 5.75 1.69 3.54 0.87 15.55 0.99 10.16 5.29 3.15 7.09 tle1.S 3.56 3.02 0.84 0.94 2.87 0.83 3 1.38 10.26 0.42 2.96 2.35 1.27 4.34 tle1.L 6.89 7 1.26 0.91 5.55 0.51 1.99 0.36 7.22 0.37 10.65 3.75 2.34 2.95 tle1.S 3.21 2.42 0.42 0.29 2.97 0.84 0.58 0.91 4.28 0.53 3.11 1.63 1.22 1.25
TLE_Nuclear tle2.L 18.85 10.6 10.39 6.28 10.68 4.3 18.1 1.33 68.4 3.32 9.18 6.25 5.69 11.14 tle2.S 8.93 2.39 3.31 2.41 7.29 3.6 5.32 0.57 9.19 0.3 2.15 3.22 2.85 1.85 tle2.L 30.07 15.97 6.11 3.89 13.35 8.17 10.56 2.1 132.83 5.33 7.97 9.44 15.45 23.29 tle2.S 11.1 2.57 2.43 4.38 6.89 2.45 2.7 0.62 24.77 0.39 1.24 3.57 2.14 3.72
TLE_Nuclear tle4.L 23.84 6.66 3.23 6.23 8.22 2.53 7.9 1.84 12.76 0.54 5.17 16.58 3.11 6.33 tle4.S 14.77 7.43 3.03 7.39 8.18 3.28 6.17 1.16 26.84 0.39 3.76 15.73 4.61 4.63 tle4.L 20.68 7.36 2 6.36 7.61 1.84 3.62 2.11 3.5 0.8 4.43 10.85 3.3 3.14 tle4.S 12.38 6.67 1.97 6.97 5.53 1.16 3.58 1.82 3.32 0.78 4.5 11.33 3.54 1.91
TLE_Nuclear aes.L 103.48 46.25 48.52 29.59 39.87 12.89 63.38 17.86 49.97 6.02 27.76 39.91 37.39 56.43 aes.S 142.29 67.06 76.85 52.64 140.01 26.39 85.33 37.98 165.32 6.81 56.39 73.32 38.32 120.53 aes.L 140.56 59.12 43.22 32.62 52.58 20.59 60.24 24.5 57.95 7.86 28.31 51.42 39.29 72.45 aes.S 173.6 73.4 72.64 56.95 171.74 37.64 85.27 50.49 92.91 8.61 77.61 87.39 39.29 92.2
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gene group gene name gnee ID cell2 cell4 cell8 cell16 st06 st08 st09 st10 st11 st13 st15 st16 st19 st20 st22 st24 st28 st31 st33 st38 st40 st41 st44
Wnt signaling_ligandswnt1 Xetrov90006199m 1.47 1.92 1.1 1.94 2.18 1.01 0.35 0 1.227 2.785 10.46 13.47 10.07 8.24 10.91 6.02 6.69 3.505 2.43 1.81 0.605 1.42 1.36
wnt2 Xetrov90008153m 0 0 0 0 0 0 0 0 0 0 0 0 0.157 1.125 1.605 1.453 1.73 0.42 0.31 0.55 0.185 0.575 0.41
wnt2b Xetrov90005248m 0 0 0 0 0 0 0.185 0.205 0.527 1.405 16.21 15.265 17.767 10.89 10.715 7.883 6.32 5.25 5.93 8.31 11.22 8.825 8.31
wnt3 Xetrov90024857m 0 0 0 0 0 0 0 0 0 0 0.19 0.195 0.217 0.205 0.1 0.327 0 0.08 0.21 0.31 0.145 0.06 0.31
wnt3a Xetrov90015461m 0 0 0 0.25 0 0 0.135 0 4.073 8.695 10.96 12.39 10.92 10.62 8.245 6.883 5.795 5.255 5.24 3.72 3.35 4.615 3.36
wnt4 Xetrov90018493m 0 0 0 0.3 0.34 0 0 1.055 3.777 7.865 21.85 24.92 22.177 19.545 14.875 10.703 8.48 5.655 5.715 3.34 3.515 4.805 5.85
wnt5a Xetrov90030795m 18.55 12.76 18.5 17.61 25.54 32.49 41.065 10.935 9.547 11.835 33.43 49.545 43.09 53.565 37.2 36.993 37.815 44.395 42.44 49.1 46.605 47.36 37.47
wnt5b Xetrov90030950m 0.45 0.59 0.45 0.2 0.3 0.48 10.265 42.865 76.577 122.165 64.37 80.43 59.683 48.1 37.82 23.137 18.765 16.39 13.69 17.15 14.685 13.445 10.26
wnt6 Xetrov90024498m 0 0 0 0 0 0 0 0 0 0 1.16 0.88 0.79 1.5 1.315 1.8 1.53 1.975 1.285 1 1.78 0.93 1
wnt7b Xetrov90028160m 0.63 0 0 0.55 0 0 0.285 1.29 3.463 2.845 0 0.455 1.76 5.91 6.21 11.66 14.48 21.215 21.49 28.34 23.71 30.645 21.33
wnt8a Xetrov90007482m 0.25 0 0 0 0 2.55 115.01 276.94 242.3 141.15 70.42 61.105 47.87 32.155 26.85 11.753 4.955 0.86 0.135 0.16 0 0.135 0
wnt8b Xetrov90017928m 0 0 0 0 0 0 0.14 0.16 3.9 4.745 8.45 9.415 5.607 6.56 5.93 4.493 2.625 2.15 1.715 1.5 1.27 0.45 1.12
wnt9a Xetrov90015459m 0 0 0 0 0 0 0 0 0 0.575 0.8 0.85 0.76 3.385 3.455 3.543 5.07 3.065 3.36 2.81 4.585 3.55 3.5
wnt9b Xetrov90024859m 0 0 0 0 0 0 0 0 0.1 0 0.28 0.72 0.247 0.895 0.695 2.013 1.37 1.32 1.455 1.43 1.28 0.68 0.48
wnt10a Xetrov90024501m 0 0 0 0 0 0 0.17 0 0.58 0.555 28.86 28.895 31.433 27.965 28.97 31.95 26.675 24.15 22.045 21.64 14.495 14.055 11.94
wnt10b Xetrov90006200m 0 0 0 0 0.13 0.12 0.07 0 0.07 0.135 1.71 2.12 2.167 5.88 5.8 4.09 5.15 6.8 6.95 5.35 7.83 6.92 6.53
wnt11a Xetrov90007000m 3.84 3.97 2.99 4.49 5.19 9.25 5.56 1.475 3.89 5.555 21.08 23.975 27.693 49.92 52.495 48.397 40.215 40.275 31.045 37.89 32.55 37.185 33.37
wnt11b.1 (wnt11b.e1)Xetrov90020286m 23.91 24.3 18.75 20.24 18.81 13.67 20.035 16.935 17.627 14.275 8.06 6.335 5.943 3.675 3.16 3.02 3.075 2.155 1.56 1.93 1.565 0.91 0.71
wnt11b.2 (wnt11b.e2)Xetrov90020285m 3.05 5.03 5.31 3.87 3.56 3.1 17.75 13.39 16.863 13.83 8.43 6.425 5.95 3.51 3.255 2.143 1.63 1.19 0.86 0.55 0.475 0.385 0.14
wnt16 Xetrov90008168m 0 0 0 0 0 0.33 0 0 0 0 0 0 0.08 0.55 0.91 0.82 0.34 1.34 1.005 0.67 2.03 2.19 1.56
HSPG_Core protein sdc4 Xetrov90024779m 5.53 5.73 3.95 4.62 5.71 6.99 11.175 20.89 26.007 24.235 10.22 16.03 15.023 22.39 17.035 12.27 11.935 12.355 12.165 13.09 7.86 9.04 10.99
Hippo signaling_Nucleart z Xetrov90027507m 177.2 187.28 180.72 191.67 178.44 146.87 146.35 135.27 43.853 18.2 10.16 12.675 9.45 10.08 11.055 6.903 6.695 11.48 7.33 6.74 6.185 10.04 7.24
yap1 Xetrov90006851m 378.32 410.91 422.25 404.69 393.27 384.87 304.995 214.11 213.9 315.805 154.73 240.425 156.263 136.775 94.685 79.287 83.39 86.36 71.67 78.99 64.695 70.56 62.17
TLE/Groucho tle1 Xetrov90002301m 161.34 176.79 174.14 192.63 205.14 257.17 252.765 150.795 105.283 106.91 107.98 112.91 96.407 83.11 80.155 67.603 61.14 58.305 44.84 40.34 28.72 26.855 21.2
tle2 Xetrov90002028m 637.22 645.39 639.88 589.49 556.19 510.9 524.8 514.95 392.903 294.665 248.23 272.28 198.85 208.82 187.335 156.207 127.81 100.03 74.58 63.82 69.77 54.185 57.62
tle4 Xetrov90002299m 145.64 153.57 159.89 157.78 172.96 205.33 140.145 42.215 27.993 28.205 42.67 41.845 39.51 31.425 30.85 26.21 23.39 24.555 24.225 26.54 21.47 24.21 22.29
aes Xetrov90002031m 176.83 177.9 182.49 178.49 192.84 182.13 176.6 131.21 87.293 84.665 113.04 96.81 107.77 143.015 146.035 132.65 134.795 106.8 90.045 88.24 95.395 79.64 83.34
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Transcriptome correlation analysis
developmental stages adult tissues
gene category L gene ID annotation S gene ID annotation pair/singleton Clutch T Clutch U consensus Clutch T Clutch U consensus
Wnt signaling_Wnt ligands wnt1.L Xelaev18013314m1.8.3 wnt1.S Xelaev18015825m1.8.3 pair HCDE NCDE inc. NCDE n/a inc.
Wnt signaling_Wnt ligands wnt2.L Xelaev18017647m1.8.3 wnt2.S Xelaev18021067m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt2b.L Xelaev18012349m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Wnt ligands wnt3.L Xelaev18043371m1.8.3 wnt3.S Xelaev18046111m.8.3 pair n/a n/a n/a n/a n/a n/a
Wnt signaling_Wnt ligands wnt3a.L Xelaev18030578m1.8.3 wnt3a.S Xelaev18032766m1.8.3 pair HCDE n/a inc. HCDE HCSE inc.
Wnt signaling_Wnt ligands wnt4.L Xelaev18035683m1.8.3 wnt4.S Xelaev18037535m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Wnt ligands wnt5a.L Xelaev18001788m1.8.3 wnt5a.S Xelaev18003033m1.8.3 pair HCDE NCDE inc. HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt5b.L Xelaev18003003m1.8.3 wnt5b.S Xelaev18019874m1.8.3 pair HCSE HCDE inc. HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt6.L Xelaev18044506m1.8.3 wnt6.S Xelaev18047041m.8.3 pair NCSE NCSE NCSE NCSE NCSE NCSE
Wnt signaling_Wnt ligands wnt7a.L Xelaev18001817m1.8.3 wnt7a.S Xelaev18002574m1.8.3 pair NCDE NCDE NCDE HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt7b.L Xelaev18016659m1.8.3 wnt7b.S Xelaev18019743m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
Wnt signaling_Wnt ligands wnt7c.L Xelaev18000031m1.8.3 wnt7c.S Xelaev18041727m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt8a.L Xelaev18017109m1.8.3 wnt8a.S Xelaev18021528m1.8.3 pair HCDE HCDE HCDE n/a n/a n/a
Wnt signaling_Wnt ligands wnt8b.L Xelaev18034863m1.8.3 wnt8b.S Xelaev18037115m1.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt9a.L Xelaev18030576m1.8.3 wnt9a.S Xelaev18032762m1.8.3 pair HCSE HCSE HCSE HCSE HCDE inc.
Wnt signaling_Wnt ligands wnt9b.L Xelaev18043372m1.8.3 wnt9b.S Xelaev18046112m1.8.3 pair HCDE HCDE HCDE NCSE HCSE inc.
Wnt signaling_Wnt ligands wnt10a.L Xelaev18044503m1.8.3 wnt10a.S Xelaev18047040m1.8.3 pair HCDE HCSE inc. NCSE NCSE NCSE
Wnt signaling_Wnt ligands wnt10b.L Xelaev18013315m1.8.3 wnt10b.S Xelaev18015826m1.8.3 pair NCSE n/a inc. HCSE HCSE HCSE
Wnt signaling_Wnt ligands wnt11a.L Xelaev18014070m1.8.3*(wnt11.L) wnt11a.S Xelaev18016398m1.8.3*(wnt11.S) pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Wnt ligands wnt11b.L Xelaev18038627m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Wnt ligands wnt16.L Xelaev18017661m1.8.3 wnt16.S Xelaev18021055m1.8.3 pair NCSE n/a inc. HCSE n/a inc.
Wnt signaling_Fzd receptors fzd1.L Xelaev18030849m1.8.3 fzd1.S Xelaev18032956m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Fzd receptors fzd2.L Xelaev18043274m1.8.3 fzd2.S Xelaev18046040m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Fzd receptors fzd3.L Xelaev18028255m1.8.3 fzd3.S Xelaev18030211m.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Wnt signaling_Fzd receptors fzd4.L Xelaev18013898m1.8.3 fzd4.S Xelaev18016347m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Fzd receptors fzd5.L Xelaev18044974m1.8.3 fzd5.S Xelaev18047383m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Wnt signaling_Fzd receptors fzd6.L Xelaev18032266m1.8.3 fzd6.S Xelaev18033927m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Fzd receptors fzd7.L Xelaev18044942mthis study fzd7.S Xelaev18047362mthis study pair NCDE NCDE NCDE HCDE HCDE HCDE
Wnt signaling_Fzd receptors fzd8.L Xelaev18030715m1.8.3 fzd8.S Xelaev18032854m1.8.3 pair HCDE HCDE HCDE NCDE HCDE inc.
Wnt signaling_Fzd receptors fzd9.L Xelaev18011798m1.8.3 fzd9.S Xelaev18014524m1.8.3 pair HCDE HCSE inc. NCDE NCDE NCDE
Wnt signaling_Fzd receptors fzd10.L Xelaev18007747m1.8.3 fzd10.S Xelaev18010581m.8.3 pair HCDE HCSE inc. HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Positivelrp5.L Xelaev18022268m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Positivelrp6.L Xelaev18002521m1.8.3 lrp6.S Xelaev18019843m1.8.3 pair NCSE NCSE NCSE HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Positiveror1.L Xelaev18022993m1.8.3 ror1.S Xelaev18025126m1.8.3 pair HCDE NCDE inc. HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Positiveror2.L Xelaev18007002m1.8.3 ror2.S Xelaev18010203m1.8.3 pair HCSE HCSE HCSE NCSE HCSE inc.
Wnt signaling_Extracellular-Membrane Positiveryk.L Xelaev18027943m1.8.3 ryk.S Xelaev18029985m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Positiveporcn.L Xelaev18038108m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Positivewls.L Xelaev18022960m1.8.3 wls.S Xelaev18025100m1.8.3 pair HCSE HCSE HCSE HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Positiverspo1.L Xelaev18012511m1.8.3 rspo1.S Xelaev18015192m1.8.3 pair n/a n/a n/a NCDE HCDE inc.
Wnt signaling_Extracellular-Membrane Positiverspo2.L Xelaev18032283m1.8.3 rspo2.S Xelaev18033943m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Positiverspo3.L Xelaev18026994m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Positivelgr4.L Xelaev18021987m1.8.3 lgr4.S Xelaev18024382m1.8.3 pair HCDE HCDE HCDE HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Positivelgr5.L Xelaev18017557m1.8.3 lgr5.S Xelaev18021159m1.8.3 pair NCDE NCSE inc. HCSE NCSE inc.
Wnt signaling_Extracellular-Membrane Positivendp.L Xelaev18012416m1.8.3 ndp.S Xelaev18014729m1.8.3 pair HCSE NCSE inc. NCSE NCSE NCSE
Wnt signaling_Extracellular-Membrane Negativefrzb.L Xelaev18044787m1.8.3 frzb.S Xelaev18047243m1.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativefrzb2.L Xelaev18024021m1.8.3 frzb2.S Xelaev18025927m1.8.3 pair HCDE HCDE HCDE n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativesfrp1.L Xelaev18018658m1.8.3 sfrp1.S Xelaev18020242m1.8.3 pair HCDE HCDE HCDE HCDE NCDE inc.
Wnt signaling_Extracellular-Membrane Negativesfrp2.L Xelaev18005470m1.8.3 sfrp2.S Xelaev18009214m1.8.3 pair HCSE HCSE HCSE HCDE HCSE inc.
Wnt signaling_Extracellular-Membrane Negativesfrp4.L Xelaev18031275m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativesfrp5.L Xelaev18034703m1.8.3 sfrp5.S Xelaev18037070m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativesfrpx.L Xelaev18013916m1.8.3 sfrpx.S Xelaev18016536m1.8.3 pair HCDE HCDE HCDE HCDE NCDE inc.
Wnt signaling_Extracellular-Membrane Negativedkk1.L Xelaev18034450m1.8.3 dkk1.S Xelaev18036781m.8.3 pair HCSE HCSE HCSE HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Negativedkk2.L Xelaev18005695m1.8.3 dkk2.S Xelaev18009390m1.8.3 pair HCDE n/a inc. HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Negativedkk3.L Xelaev18021777m1.8.3 dkk3.S Xelaev18024570m1.8.3 pair NCDE NCDE NCDE HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Negativedkkx.L Xelaev18043185m1.8.3 dkkxp.S Xelaev18900484this study singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativewif1.L Xelaev18017519m1.8.3 wif1.S Xelaev18021197m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
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Wnt signaling_Extracellular-Membrane Negativecer1.L Xelaev18006799m1.8.3 cer1.S Xelaev18010056m1.8.3 pair HCDE HCSE inc. n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativesostdc1.L Xelaev18030924m1.8.3 sostdc1.S Xelaev18033014m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
Wnt signaling_Extracellular-Membrane Negativeigfbp4.L Xelaev18043135m1.8.3 igfbp4.S Xelaev18045901m.8.3 pair HCSE HCSE HCSE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativeshisa1.L Xelaev18038736mthis study shisa1.S Xelaev18042071mthis study pair HCDE HCDE HCDE NCSE HCSE inc.
Wnt signaling_Extracellular-Membrane Negativeshisa2.L Xelaev18013772m1.8.3 shisa2.S Xelaev18016220m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Negativeshisa4p.L Xelaev18900850 this study shisa4.S Xelaev18015002m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativeshisa6.L Xelaev18044162m1.8.3 shisa6.S Xelaev18046777m1.8.3 pair HCSE n/a inc. HCDE HCSE inc.
Wnt signaling_Extracellular-Membrane Negativeshisa7.L Xelaev18035942m1.8.3 shisa7.S Xelaev18037713m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativeshisa9.L Xelaev18045165m1.8.3 shisa9.S Xelaev18047497m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativekremen1.L Xelaev18007911m1.8.3 kremen1.S Xelaev18010707m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
Wnt signaling_Extracellular-Membrane Negativekremen2.L Xelaev18045673m1.8.3 kremen2.S Xelaev18047883m1.8.3 pair HCSE HCSE HCSE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativepcdd1.L Xelaev18031847m1.8.3 apcdd1.S Xelaev18033587m1.8.3 pair HCDE NCDE inc. NCSE NCDE inc.
Wnt signaling_Extracellular-Membrane Negativetpbg.L Xelaev18027329m1.8.3 tpbg.S Xelaev18029423m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativetpbgl.L Xelaev18004367mthis study tpbgl.S Xelaev18016469mthis study pair HCSE HCSE HCSE HCSE HCSE HCSE
Wnt signaling_Extracellular-Membrane Negativetrabd2a.L (tiki1.L)Xelaev18006601m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Extracellular-Membrane Negativetrabd2b.L (tiki2.L)Xelaev18023146m1.8.3 trabd2b.S (tiki2.S)Xelaev18025255m1.8.3 pair HCDE n/a inc. NCSE NCSE NCSE
Wnt signaling_Extracellular-Membrane Negativeznrf3.L Xelaev18007912m1.8.3 znrf3.S Xelaev18010708m1.8.3 pair NCDE NCDE NCDE HCSE HCDE inc.
Wnt signaling_Extracellular-Membrane Negativernf43.L Xelaev18011819m1.8.3 rnf43.S Xelaev18014536m1.8.3 pair HCDE HCDE HCDE NCSE NCSE NCSE
Wnt signaling_Extracellular-Membrane Negativenotum1.L Suzuki00074 this study notum1.S Xelaev18046470m1.8.3*(notum.S) pair HCDE HCDE HCDE HCDE NCSE inc.
Wnt signaling_Extracellular-Membrane Negativenotum2.L Xelaev18045202m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Cytoplasmic dvl1.L Xelaev18035651m1.8.3 dvl1.S Xelaev18037506m1.8.3 pair NCDE NCDE NCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic dvl2.L Xelaev18019661m1.8.3 dvl2.S no model pair n/a n/a n/a n/a n/a n/a
Wnt signaling_Cytoplasmic dvl3.L Xelaev18027442m1.8.3 dvl3.S Xelaev18029558m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic frat1.L Xelaev18032205m1.8.3 frat1.S Xelaev18033878m1.8.3 pair HCDE HCSE inc. HCSE HCDE inc.
Wnt signaling_Cytoplasmic ctnnbl1.L Xelaev18003084m1.8.3 ctnnbl1.S Xelaev18046580m1.8.3 pair HCDE NCSE inc. HCDE HCDE HCDE
Wnt signaling_Cytoplasmic ctnnb1.L Xelaev18031149m1.8.3 ctnnb1.S Xelaev18033202m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic csnk1d.L Xelaev18043776m1.8.3 csnk1d.S Xelaev18002058m1.8.3 pair NCDE NCDE NCDE HCDE HCSE inc.
Wnt signaling_Cytoplasmic csnk1e.L Xelaev18023699m1.8.3 csnk1e.S Xelaev18025701m.8.3 pair HCSE HCDE inc. HCSE HCSE HCSE
Wnt signaling_Cytoplasmic csnk1g1.L Xelaev18018082m1.8.3 csnk1g1.S Xelaev18020746m1.8.3 pair HCDE HCDE HCDE HCDE HCSE inc.
Wnt signaling_Cytoplasmic csnk1g2.L Xelaev18006348m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Cytoplasmic csnk1g3.L Xelaev18007961m1.8.3 csnk1g3.S Xelaev18010742m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Cytoplasmic csnk2a1.L Xelaev18043651mthis study csnk2a1.S Xelaev18046367mthis study pair NCDE HCDE inc. HCDE HCDE HCDE
Wnt signaling_Cytoplasmic csnk2a2.L Xelaev18022836m1.8.3 csnk2a2.S Xelaev18024992m1.8.3 pair HCDE HCSE inc. HCDE HCSE inc.
Wnt signaling_Cytoplasmic csnk2b.L Xelaev18039202m1.8.3 csnk2b.S Xelaev18042465m1.8.3 pair NCDE NCDE NCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic ccdc88c.L Xelaev18039541m1.8.3 ccdc88c.S Xelaev18041322m1.8.3 pair HCDE NCDE inc. HCDE HCDE HCDE
Wnt signaling_Cytoplasmic axin1.L Xelaev18045581m1.8.3 axin1.S Xelaev18047809m1.8.3 pair HCSE HCDE inc. HCDE HCDE HCDE
Wnt signaling_Cytoplasmic axin2.L Xelaev18044248m1.8.3 axin2.S Xelaev18046851m.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic gsk3a.L Xelaev18035964m1.8.3 gsk3a.S Xelaev18037733m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic gsk3b.L Xelaev18011240m1.8.3 gsk3b.S Xelaev18014462m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic apc.L Xelaev18008006m1.8.3 apc.S Xelaev18010775m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Cytoplasmic apc2.L Xelaev18006224m1.8.3 apc2.S Xelaev18009755m1.8.3 pair NCDE n/a inc. HCDE HCSE inc.
Wnt signaling_Cytoplasmic csnk1a1.L Xelaev18017218m1.8.3 csnk1a1.S Xelaev18021437m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Cytoplasmic cxxc4.L Xelaev18005708m1.8.3 cxxc4.S Xelaev18009406m1.8.3 pair HCSE HCDE inc. HCDE HCDE HCDE
Wnt signaling_Cytoplasmic nkd1.L Xelaev18022467m1.8.3 nkd1.S Xelaev18024736m1.8.3 pair HCSE HCSE HCSE HCSE NCSE inc.
Wnt signaling_Cytoplasmic dact1.L Xelaev18039817m1.8.3 dact1.S Xelaev18041122m1.8.3 pair HCSE HCSE HCSE HCDE HCSE inc.
Wnt signaling_Cytoplasmic nxn.L Xelaev18012739m1.8.3 nxn.S Xelaev18015350m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Wnt signaling_Cytoplasmic ppp2cb.L Xelaev18006173m1.8.3 ppp2cb.S Xelaev18009707m1.8.3 pair HCSE HCDE inc. HCDE HCSE inc.
Wnt signaling_Cytoplasmic ppp2ca.S Xelaev18019995mthis study singleton n/a n/a n/a n/a n/a n/a
Wnt signaling_Nuclear lef1.L Suzuki00098 this study lef1.S Suzuki00099 this study pair HCDE HCDE HCDE HCSE HCSE HCSE
Wnt signaling_Nuclear tcf7l1.L Xelaev18018649m1.8.3 tcf7l1.S Xelaev18020249m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Wnt signaling_Nuclear tcf7l2.L Suzuki00095 this study tcf7l2.S Suzuki00096 this study pair NCSE NCSE NCSE HCSE HCSE HCSE
Wnt signaling_Nuclear tcf7.S Suzuki00097 this study singleton n/a n/a n/a n/a n/a n/a
Hh signaling_Ligands shh.L Xelaev18030676m1.8.3 shh.S Xelaev18032832m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
Hh signaling_Ligands dhh.L Xelaev18013326m1.8.3 dhh.S Xelaev18015834m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hh signaling_Ligands ihh.L Xelaev18044498m1.8.3 ihh.S Xelaev18047031m.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hh signaling_Receptor-Membrane ptch1.L Xelaev18006956m1.8.3 ptch1.S Xelaev18010170m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hh signaling_Receptor-Membrane ptch2.L Xelaev18023085m1.8.3 ptch2.S Xelaev18025200m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Hh signaling_Receptor-Membrane smo.L Xelaev18017905m1.8.3 smo.S Xelaev18020875m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hh signaling_Receptor-Membrane hhip.L Xelaev18005527m1.8.3 hhip.S Xelaev18009257m1.8.3 pair NCDE n/a inc. NCDE NCSE inc.
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Hh signaling_Receptor-Membrane hhat.L Xelaev18026180m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hh signaling_Receptor-Membrane hhatl.L Xelaev18030596m1.8.3 hhatl.S Xelaev18032774m1.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Hh signaling_Cytoplasmic-Cilia-Nuclear gli1.L Xelaev18013435m1.8.3 gli1.S Xelaev18015926m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
Hh signaling_Cytoplasmic-Cilia-Nuclear gli2.L Xelaev18044365m1.8.3 gli2.S Xelaev18046929m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hh signaling_Cytoplasmic-Cilia-Nuclear gli3.L Xelaev18031191m1.8.3 gli3.S Xelaev18033248m1.8.3 pair HCDE NCSE inc. HCSE HCSE HCSE
Hh signaling_Cytoplasmic-Cilia-Nuclear stk36.L Xelaev18045625m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hh signaling_Cytoplasmic-Cilia-Nuclear sufu.L Xelaev18034640m1.8.3 sufu.S Xelaev18036928m1.8.3 pair HCSE HCSE HCSE HCSE HCDE inc.
Hh signaling_Cytoplasmic-Cilia-Nuclear prkaca.L Xelaev18018940m1.8.3 prkaca.S Xelaev18020107m1.8.3 pair HCDE HCSE inc. HCDE HCSE inc.
Hh signaling_Cytoplasmic-Cilia-Nuclear kif7.L Xelaev18018352m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hh signaling_Cytoplasmic-Cilia-Nuclear arl13b.L Xelaev18011556m1.8.3 arl13b.S Xelaev18014252m1.8.3 pair NCDE HCDE inc. HCDE HCDE HCDE
Hh signaling_Cytoplasmic-Cilia-Nuclear foxj1.L Xelaev18044086m1.8.3 foxj1.S Xelaev18046720m1.8.3 pair HCSE HCSE HCSE HCSE HCSE HCSE
HSPG_Core protein gpc1.L Xelaev18027873m1.8.3 gpc1.S Xelaev18029917m1.8.3 pair HCSE NCSE inc. HCDE HCDE HCDE
HSPG_Core protein gpc2.L Xelaev18019198m1.8.3 gpc2.S Xelaev18000875m1.8.3 pair NCSE NCSE NCSE HCDE HCDE HCDE
HSPG_Core protein gpc3.L Xelaev18039001m1.8.3 gpc3.S Xelaev18042314m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
HSPG_Core protein gpc4.L Xelaev18038999m1.8.3 gpc4.S Xelaev18042313m1.8.3 pair HCDE HCDE HCDE HCDE HCSE inc.
HSPG_Core protein gpc5.L Xelaev18027874m1.8.3 gpc5.S Xelaev18029918m1.8.3 pair HCSE NCSE inc. HCSE HCSE HCSE
HSPG_Core protein gpc6.L Xelaev18013153m1.8.3 gpc6.S Xelaev18015674m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
HSPG_Core protein sdc1.L Xelaev18028097m1.8.3 sdc1.S Xelaev18030115m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
HSPG_Core protein sdc2.L Xelaev18032236m1.8.3 sdc2.S Xelaev18033900m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
HSPG_Core protein sdc3.L Xelaev18012477m1.8.3 sdc3.S Xelaev18015163m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
HSPG_Core protein sdc4.L Xelaev18043244m1.8.3 sdc4.S Xelaev18046006m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
HSPG_Enzyme ndst1.L Xelaev18016917m1.8.3 ndst1.S Xelaev18020040m1.8.3 pair NCDE NCSE inc. HCSE HCSE HCSE
HSPG_Enzyme ndst2.L Xelaev18034893m1.8.3 ndst2.S Xelaev18037149m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
HSPG_Enzyme ndst3.L Xelaev18005673m1.8.3 ndst3.S Xelaev18009369m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
HSPG_Enzyme ndst4.L Xelaev18005671m1.8.3 ndst4.S Xelaev18009366m1.8.3 pair n/a n/a n/a HCSE HCSE HCSE
HSPG_Enzyme sulf1.L Xelaev18032097m1.8.3 sulf1.S Xelaev18033783m1.8.3 pair NCDE HCDE inc. HCSE HCDE inc.
HSPG_Enzyme sulf2.L Xelaev18043428m1.8.3 sulf2.S Xelaev18046154m1.8.3 pair NCDE NCSE inc. HCSE HCSE HCSE
Notch signaling_Ligands-Receptors dlc.L Xelaev18039430m1.8.3 dlc.S Xelaev18041388m1.8.3 pair HCDE HCDE HCDE NCSE HCSE inc.
Notch signaling_Ligands-Receptors dll1.L Xelaev18026769m1.8.3 dll1.S Xelaev18029016m1.8.3 pair HCSE HCDE inc. HCSE HCDE inc.
Notch signaling_Ligands-Receptors dll4.L Xelaev18040076m1.8.3 dll4.S no model pair n/a n/a n/a n/a n/a n/a
Notch signaling_Ligands-Receptors jag1.L Xelaev18026450m1.8.3 jag1.S Xelaev18028524m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
Notch signaling_Ligands-Receptors jag2.L Xelaev18039762m1.8.3 jag2.S Xelaev18041150m1.8.3 pair HCSE NCSE inc. HCSE HCDE inc.
Notch signaling_Ligands-Receptors notch1.L Xelaev18038316m1.8.3 notch1.S Xelaev18041536m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Notch signaling_Ligands-Receptors notch2.L Xelaev18023583m1.8.3 notch2.S Xelaev18025592mthis study pair HCDE HCSE inc. HCDE HCDE HCDE
Notch signaling_Ligands-Receptors notch3.L Xelaev18018885m1.8.3 notch3.S Xelaev18020118m1.8.3 pair NCDE NCSE inc. HCSE HCSE HCSE
Notch signaling_Extracellular-Membrane psen1.L Xelaev18039884m1.8.3 psen1.S Xelaev18041078m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane psen2.L Xelaev18026786m1.8.3 psen2.S Xelaev18029032m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane psenen.L Xelaev18036462m1.8.3 psenen.S Xelaev18038022m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane aph1a.L Xelaev18040555m1.8.3 aph1a.S Xelaev18042790m1.8.3 pair NCDE HCDE inc. HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane ncstn.L Xelaev18040642m1.8.3 ncstn.S Xelaev18042802m1.8.3 pair NCDE HCSE inc. HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane adam10.L Xelaev18018164m1.8.3 adam10.S Xelaev18020677m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Notch signaling_Extracellular-Membrane adam17.L Xelaev18028032m1.8.3 adam17.S Xelaev18030073m1.8.3 pair NCDE NCDE NCDE HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane lfng.L Xelaev18045227m1.8.3 lfng.S Xelaev18047541m.8.3 pair HCSE HCSE HCSE HCSE HCSE HCSE
Notch signaling_Extracellular-Membrane rfng.L Xelaev18043769m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Extracellular-Membrane furin.L Xelaev18018314m1.8.3 furin.S Xelaev18020545m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Notch signaling_Extracellular-Membrane pofut1.L Xelaev18043053m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Extracellular-Membrane pofut2.L Xelaev18044882m1.8.3 pofut2.S Xelaev18047320m1.8.3 pair NCDE NCDE NCDE HCDE HCDE HCDE
Notch signaling_Cytoplasmic cul1.L Xelaev18031169mthis study cul1.S Xelaev18033225mthis study pair HCSE HCDE inc. HCDE HCSE inc.
Notch signaling_Cytoplasmic dtx1.L Xelaev18007429m1.8.3 dtx1.S Xelaev18010370m1.8.3 pair HCSE HCSE HCSE HCSE HCSE HCSE
Notch signaling_Cytoplasmic dtx2.L Xelaev18012698m1.8.3 dtx2.S Xelaev18015323m1.8.3 pair NCDE HCDE inc. HCDE HCDE HCDE
Notch signaling_Cytoplasmic dtx3.L Xelaev18013445m1.8.3 dtx3.S Xelaev18015941m.8.3 pair HCSE n/a inc. HCSE HCSE HCSE
Notch signaling_Cytoplasmic dtx3-like.1.L Xelaev18040251m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Cytoplasmic dtx3l-like.L Xelaev18044336m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Cytoplasmic dtx4.L Xelaev18035125m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Cytoplasmic dtx5.L Xelaev18043843mthis study dtx5.S Xelaev18046510mthis study pair n/a n/a n/a HCDE HCDE HCDE
Notch signaling_Cytoplasmic fbxw7.L Xelaev18005488m1.8.3 (fbxw7-like.L) fbxw7.S Xelaev18009227m1.8.3 (fbxw7-like.S) pair HCDE HCDE HCDE HCSE HCSE HCSE
Notch signaling_Cytoplasmic itch.L Xelaev18043930m1.8.3 itch.S Xelaev18046611m.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Notch signaling_Cytoplasmic skp1.L Xelaev18016889m1.8.3 skp1.S Xelaev18019996m1.8.3 pair NCSE NCSE NCSE HCSE HCDE inc.
Notch signaling_Cytoplasmic nedd4.L Xelaev18018180m1.8.3 nedd4.S Xelaev18020659m1.8.3 pair n/a n/a n/a HCDE NCDE inc.
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Notch signaling_Cytoplasmic nedd4l.L Xelaev18008410m1.8.3 nedd4l.S Xelaev18011058m1.8.3 pair HCDE NCDE inc. HCDE HCSE inc.
Notch signaling_Cytoplasmic mib1.L Xelaev18031901m1.8.3 mib1.S Xelaev18033643m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Notch signaling_Cytoplasmic mib2.L Xelaev18035630m1.8.3 mib2.S Xelaev18037521m.8.3 pair HCDE HCDE HCDE HCSE NCSE inc.
Notch signaling_Cytoplasmic neurl1.L Xelaev18034635m1.8.3 neurl1.S Xelaev18036913m1.8.3 pair HCSE NCSE inc. HCSE HCSE HCSE
Notch signaling_Cytoplasmic neurl1b.L Xelaev18017235m1.8.3 neurl1b.S Xelaev18021427m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Notch signaling_Cytoplasmic neurl2.L Xelaev18043870m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Cytoplasmic neurl3.L Xelaev18018582m1.8.3 neurl3.S Xelaev18020308m1.8.3 pair NCDE n/a inc. HCDE HCSE inc.
Notch signaling_Cytoplasmic neurl4.S Xelaev18001087m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Cytoplasmic numb.L Xelaev18039881m1.8.3 numb.S Xelaev18041082m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Notch signaling_Cytoplasmic numbl.L Xelaev18039315m1.8.3 numbl.S Xelaev18042529m1.8.3 pair NCDE NCDE NCDE HCSE HCSE HCSE
Notch signaling_Nuclear hey1.L Xelaev18032125m1.8.3 hey1.S Xelaev18033820m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Notch signaling_Nuclear hey2.L Xelaev18027001m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Notch signaling_Nuclear maml1.L Xelaev18016823m1.8.3 maml1.S Xelaev18019988m1.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Notch signaling_Nuclear maml2.L Xelaev18013849m1.8.3 maml2.S Xelaev18016312m1.8.3 pair NCDE HCDE inc. HCDE HCSE inc.
Notch signaling_Nuclear maml3.L Xelaev18005555m1.8.3 (maml3-like.1.L)maml3.S Xelaev18009281m1.8.3 (maml3-like.1.S)pair n/a n/a n/a HCDE HCDE HCDE
Notch signaling_Nuclear rbpj.L Xelaev18005188m1.8.3 rbpj.S Xelaev18008976m1.8.3 pair HCDE HCSE inc. HCSE HCSE HCSE
Hippo signaling_Membrane dchs1.L Xelaev18013988m1.8.3 dchs1.S Xelaev18016563m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
Hippo signaling_Membrane dchs2.L Xelaev18005469m1.8.3 dchs2.S Xelaev18009213m1.8.3 pair n/a n/a n/a HCSE n/a inc.
Hippo signaling_Membrane crb1.L Xelaev18023448m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hippo signaling_Membrane crb2.L Xelaev18038421m1.8.3 crb2.S Xelaev18041846m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hippo signaling_Membrane crb3.L Xelaev18019125m1.8.3 crb3.S Xelaev18000831m.8.3 pair HCDE HCDE HCDE HCSE HCSE HCSE
Hippo signaling_Membrane fat1.L Xelaev18005336m1.8.3 fat1.S Xelaev18009106m1.8.3 pair NCDE HCDE inc. HCDE HCDE HCDE
Hippo signaling_Membrane fat2.L Xelaev18016840mthis study fat2.S Xelaev18019906mthis study pair HCDE NCDE inc. HCDE HCDE HCDE
Hippo signaling_Cytoplasmic amot.L Xelaev18038818m1.8.3 amot.S Xelaev18042142m1.8.3 pair HCDE HCDE HCDE HCSE HCDE inc.
Hippo signaling_Cytoplasmic amotl1.L Xelaev18013858m1.8.3 amotl1.S Xelaev18016322m1.8.3 pair HCSE NCSE inc. NCSE NCSE NCSE
Hippo signaling_Cytoplasmic amotl2.L Xelaev18027945m1.8.3 amotl2.S Xelaev18029987m1.8.3 pair HCSE HCDE inc. HCSE HCSE HCSE
Hippo signaling_Cytoplasmic ctnna1.L Xelaev18016936m1.8.3 ctnna1.S Xelaev18020018m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic ctnna2.L Xelaev18004810m1.8.3 ctnna2.S Xelaev18008821m.8.3 pair n/a n/a n/a HCSE HCSE HCSE
Hippo signaling_Cytoplasmic dlg1.L Xelaev18027514mthis study dlg1.S Xelaev18029654mthis study pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic dlg4.L Xelaev18019541m1.8.3 dlg4.S Xelaev18001034m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic scrib.L Xelaev18032547m1.8.3 scrib.S Xelaev18034135m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic llgl1.L Xelaev18045557m1.8.3 llgl1.S Xelaev18047789m1.8.3 pair NCSE NCSE NCSE HCSE HCSE HCSE
Hippo signaling_Cytoplasmic llgl2.L Xelaev18044062m1.8.3 llgl2.S Xelaev18046704m1.8.3 pair HCDE NCSE inc. HCDE HCDE HCDE
Hippo signaling_Cytoplasmic ptpn14.L Xelaev18026221m1.8.3 ptpn14.S Xelaev18028680m1.8.3 pair NCDE NCDE NCDE HCDE HCSE inc.
Hippo signaling_Cytoplasmic stk3.L Xelaev18032220m1.8.3 stk3.S Xelaev18033889m1.8.3 pair HCDE HCDE HCDE HCSE HCDE inc.
Hippo signaling_Cytoplasmic stk4.L Xelaev18043241m1.8.3 stk4.S Xelaev18046001m.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic sav1.L Xelaev18039624m1.8.3 sav1.S Xelaev18041240m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
Hippo signaling_Cytoplasmic lats1.S Xelaev18029123m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hippo signaling_Cytoplasmic lats2.L Xelaev18013789m1.8.3 lats2.S Xelaev18016235m1.8.3 pair HCSE HCSE HCSE NCDE HCDE inc.
Hippo signaling_Cytoplasmic mob1a.L Xelaev18018517m1.8.3 mob1a.S Xelaev18020374m1.8.3 pair HCDE HCSE inc. HCDE HCDE HCDE
Hippo signaling_Cytoplasmic mob1b.L Xelaev18005794m1.8.3 mob1b.S Xelaev18009476m1.8.3 pair NCSE NCSE NCSE HCDE HCSE inc.
Hippo signaling_Cytoplasmic limd1.L Xelaev18031309m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hippo signaling_Cytoplasmic nf2.L Xelaev18007416m1.8.3 nf2.S Xelaev18010360m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic frmd6.L Xelaev18039672m1.8.3 frmd6.S Xelaev18041211m.8.3 pair NCDE NCSE inc. HCSE HCSE HCSE
Hippo signaling_Cytoplasmic wwc1.L Xelaev18017133m1.8.3 wwc1.S Xelaev18021501m.8.3 pair NCDE NCDE NCDE NCSE HCSE inc.
Hippo signaling_Cytoplasmic wwc2.L Xelaev18005388m1.8.3 wwc2.S Xelaev18009141m.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic wwc3.L Xelaev18012373m1.8.3 wwc3.S Xelaev18014777m1.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic pard6b.L Xelaev18043447m1.8.3 pard6b.S Xelaev18046178m1.8.3 pair HCSE HCSE HCSE HCDE HCSE inc.
Hippo signaling_Cytoplasmic pard6g.L Xelaev18031741m1.8.3 pard6g.S Xelaev18033515m1.8.3 pair HCSE HCDE inc. HCSE HCDE inc.
Hippo signaling_Cytoplasmic prkci.L Xelaev18027593m1.8.3 prkci.S Xelaev18004739m1.8.3 pair HCDE NCDE inc. HCDE HCSE inc.
Hippo signaling_Cytoplasmic rassf1.L Xelaev18023842m1.8.3 rassf1.S Xelaev18025785m1.8.3 pair HCSE HCSE HCSE HCDE HCSE inc.
Hippo signaling_Cytoplasmic rassf2.L Xelaev18018561m1.8.3 rassf2.S Xelaev18020333m1.8.3 pair HCSE HCDE inc. HCDE HCDE HCDE
Hippo signaling_Cytoplasmic rassf3.L Xelaev18017523m1.8.3 rassf3.S Xelaev18021192m1.8.3 pair HCSE HCSE HCSE HCDE HCSE inc.
Hippo signaling_Cytoplasmic rassf4.L Xelaev18035163m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hippo signaling_Cytoplasmic rassf5.L Xelaev18012202m1.8.3 rassf5.S Xelaev18014974m1.8.3 pair NCSE n/a inc. HCSE HCDE inc.
Hippo signaling_Cytoplasmic rassf6.L Xelaev18005832m1.8.3 rassf6.S Xelaev18009505m1.8.3 pair HCSE NCSE inc. HCSE HCSE HCSE
Hippo signaling_Cytoplasmic tjp1.L Xelaev18018146m1.8.3 tjp1.S Xelaev18020691m.8.3 pair HCSE HCSE HCSE HCDE HCDE HCDE
Hippo signaling_Cytoplasmic tjp2.L Xelaev18006873m1.8.3 tjp2.S Xelaev18010094m1.8.3 pair NCDE HCDE inc. HCDE HCSE inc.
Hippo signaling_Cytoplasmic tjp3.L Xelaev18006094m1.8.3 tjp3.S Xelaev18009647m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
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Hippo signaling_Nuclear taz.L Xelaev18038086m1.8.3 singleton n/a n/a n/a n/a n/a n/a
Hippo signaling_Nuclear tead1.L Xelaev18021781mthis study tead1.S Xelaev18024564mthis study pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Nuclear tead4.L Xelaev18036091mthis study tead4.S Xelaev18037815mthis study pair HCDE HCSE inc. HCSE HCSE HCSE
Hippo signaling_Nuclear yap1.L Xelaev18013813m1.8.3 yap1.S Xelaev18016252m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
Hippo signaling_Nuclear vgll4.L Xelaev18001858m1.8.3 vgll4.S Xelaev18002595m1.8.3 pair HCSE NCDE inc. HCSE NCSE inc.
TLE_Nuclear tle1.L Xelaev18006924m1.8.3 tle1.S Xelaev18010143m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
TLE_Nuclear tle2.L Xelaev18006642m1.8.3 tle2.S Xelaev18001139m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
TLE_Nuclear tle4.L Suzuki00121 this study tle4.S Xelaev18010139m1.8.3 pair HCSE HCDE inc. HCSE HCDE inc.
TLE_Nuclear aes.L Xelaev18006647m1.8.3 aes.S Xelaev18001138m1.8.3 pair HCDE HCDE HCDE HCDE HCDE HCDE
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